13.07.2015 Views

Good Practice in Postoperative and Procedural Pain Management ...

Good Practice in Postoperative and Procedural Pain Management ...

Good Practice in Postoperative and Procedural Pain Management ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

PediatricAnesthesiaVolume 22 Supplement 1 July 2012<strong>Good</strong> <strong>Practice</strong> <strong>in</strong> <strong>Postoperative</strong><strong>and</strong> <strong>Procedural</strong> Pa<strong>in</strong> <strong>Management</strong>2nd Edition, 2012A Guidel<strong>in</strong>e from the Association of PaediatricAnaesthetists of Great Brita<strong>in</strong> <strong>and</strong> Irel<strong>and</strong>Endorsed by the British Pa<strong>in</strong> Society, the RoyalCollege of Nurs<strong>in</strong>g <strong>and</strong> the Royal College ofPaediatrics <strong>and</strong> Child Health


PediatricAnesthesiaCONTENTSVolume 22 Supplement 1 July 2012Section 1 Background 11.1 Introduction 11.2 Guidel<strong>in</strong>e development committee 11.3 Use, scope, <strong>and</strong> <strong>in</strong>tention 11.4 Methodology <strong>and</strong> evidence grad<strong>in</strong>g, good practice po<strong>in</strong>ts 21.5 Supplementary material 21.6 Contact <strong>in</strong>formation 31.7 Conflicts of <strong>in</strong>terest 3Section 2 Executive Summary <strong>and</strong> Quick Reference Guide 42.1 Introduction 42.2 Pa<strong>in</strong> assessment 42.3 Medical procedures 52.4 <strong>Procedural</strong> pa<strong>in</strong> <strong>in</strong> the neonate: general recommendations 52.5 <strong>Procedural</strong> pa<strong>in</strong> <strong>in</strong> the neonate: specific recommendations 52.6 <strong>Procedural</strong> pa<strong>in</strong> <strong>in</strong> older children 62.7 <strong>Postoperative</strong> pa<strong>in</strong> 7Section 3 Pa<strong>in</strong> Assessment 103.1 General pr<strong>in</strong>ciples of pa<strong>in</strong> assessment 103.2 Pa<strong>in</strong> measurement tools 12Section 4 Medical Procedures 174.1 General Considerations 174.2 <strong>Procedural</strong> pa<strong>in</strong> <strong>in</strong> the neonate 174.3 <strong>Procedural</strong> pa<strong>in</strong> management <strong>in</strong> <strong>in</strong>fants <strong>and</strong> older children 21Section 5 <strong>Postoperative</strong> Pa<strong>in</strong> 335.1 General pr<strong>in</strong>ciples of postoperative pa<strong>in</strong> management 335.2 ENT surgery 345.3 Opthalmology 375.4 Dental procedures 385.5 General surgery <strong>and</strong> urology (m<strong>in</strong>or <strong>and</strong> <strong>in</strong>termediate) 395.6 General surgery <strong>and</strong> urology (major) 445.7 Laparoscopic surgery 485.8 Orthopaedics, sp<strong>in</strong>al <strong>and</strong> plastic surgery 485.9 Cardiothoracic surgery 535.10 Neurosurgery 54Section 6 Analgesia 666.1 Analgesia 666.2 Local anesthetics 666.3 Neuraxial analgesic drugs 706.4 Opioids 726.5 Nonsteroidal anti-<strong>in</strong>flammatory drugs (NSAIDs) 756.6 Paracetamol 766.7 Nitrous oxide (N 2O) 776.8 Sucrose 786.9 Nonpharmacological strategies 78Pediatric Anesthesia is <strong>in</strong>dexed <strong>in</strong> Index Medicus, MEDLINE, Current Contents/Cl<strong>in</strong>ical Medic<strong>in</strong>e, EMBASE/Excerpta Medica, Sci Search, Research Alert, Ad Referendum Anaesthesiology,SUBIS <strong>and</strong> Current Op<strong>in</strong>ion <strong>in</strong> Anaesthesiology


doi: 10.1111/j.1460-9592.2012.3838.xSection 1.0Background1.1 IntroductionThis guidance was orig<strong>in</strong>ally commissioned by theAssociation of Paediatric Anaesthetists of Great Brita<strong>in</strong><strong>and</strong> Irel<strong>and</strong> (APA). It is <strong>in</strong>tended to be used byprofessionals <strong>in</strong>volved <strong>in</strong> the acute care of childrenundergo<strong>in</strong>g pa<strong>in</strong> management after surgery or forpa<strong>in</strong>ful medical procedures. It is designed to provideevidence-based <strong>in</strong>formation on the efficacy of analgesicstrategies such that an <strong>in</strong>formed choice of analgesicsthat are appropriate for the patient <strong>and</strong> cl<strong>in</strong>ical sett<strong>in</strong>gcan be made. The document <strong>in</strong>cludes advice on theassessment of pa<strong>in</strong>, a summary of current evidence forthe efficacy of analgesic strategies, <strong>in</strong>clud<strong>in</strong>g evidencebasedrecommendations grouped accord<strong>in</strong>g to namedprocedures, <strong>and</strong> a resume of analgesic pharmacology.This is the second edition of the guidel<strong>in</strong>es – it was lastpublished <strong>in</strong> 2008.1.2 Guidel<strong>in</strong>e development committee1.3 Use, scope, <strong>and</strong> <strong>in</strong>tentionThis guidance was developed by a committee of healthprofessionals with the assistance of a patient representative.It was published follow<strong>in</strong>g a period of open publicconsultation, <strong>in</strong>clud<strong>in</strong>g advice from representativesfrom patient groups <strong>and</strong> professional organisations. Itis <strong>in</strong>tended for use by qualified heath professionals whoare <strong>in</strong>volved <strong>in</strong> the management of acute pa<strong>in</strong> <strong>in</strong> children.In its present form, it is not suitable for use byother groups. At the present time, <strong>and</strong> largely becauseof resource limitations, no consumer guide is planned toenable the recommendations to be easily <strong>in</strong>terpreted bythose who do not already possess knowledge <strong>and</strong> tra<strong>in</strong><strong>in</strong>g<strong>in</strong> the field of children’s acute pa<strong>in</strong> management.The guidance is relevant to the management of children0–18 years undergo<strong>in</strong>g surgery or pa<strong>in</strong>ful procedures<strong>in</strong> hospital sett<strong>in</strong>gs. It <strong>in</strong>cludes recommendationsfor pa<strong>in</strong> assessment, general pr<strong>in</strong>ciples of pa<strong>in</strong> management,<strong>and</strong> advice on the use of pharmacological <strong>and</strong>nonpharmacological pa<strong>in</strong> management strategies forspecific medical <strong>and</strong> surgical procedures.Richard Howard Pediatric AnesthetistPa<strong>in</strong> medic<strong>in</strong>e specialistChairBernadette Carter Professor of Children’s Nurs<strong>in</strong>gRepresent<strong>in</strong>g RCNJoe Curry Pediatric SurgeonRepresent<strong>in</strong>g BAPSAnoo Ja<strong>in</strong> NeonatologistRepresent<strong>in</strong>g RCPCHChrist<strong>in</strong>a Liossi Pediatric PsychologistSenior Lecturer <strong>in</strong> Health PsychologyNeil Morton Pediatric AnesthetistPa<strong>in</strong> medic<strong>in</strong>e specialistKate Rivett Lay RepresentativeMary Rose Pediatric AnesthetistPa<strong>in</strong> medic<strong>in</strong>e specialist, Represent<strong>in</strong>g BPSJennifer Tyrrell PediatricianRepresent<strong>in</strong>g RCPCHSuellen Walker Pediatric AnesthetistSenior Lecturer <strong>in</strong> Pa<strong>in</strong> Medic<strong>in</strong>eGlyn Williams Pediatric AnesthetistPa<strong>in</strong> medic<strong>in</strong>e specialistProceduresThe procedures are divided <strong>in</strong>to two categories, pa<strong>in</strong>fuldiagnostic <strong>and</strong> therapeutic (Medical procedures; Section4) <strong>and</strong> surgical procedures (<strong>Postoperative</strong> pa<strong>in</strong>;Section 5). Guidance covers the management of acutepa<strong>in</strong> dur<strong>in</strong>g medical procedures <strong>and</strong> after surgery. Itdoes not <strong>in</strong>clude advice on the <strong>in</strong>traoperative managementof pa<strong>in</strong> unless it is relevant to postoperative managementor is otherwise stated, for example, the use ofperioperative nerve blocks.The procedures that have been <strong>in</strong>cluded are notexhaustive <strong>and</strong> were selected by the committee becausethey are relatively commonplace <strong>and</strong>, or, because it wasexpected that there would be sufficient publications toallow recommendations to be made on the basis of anadequate level of evidence. For each procedure, there isa brief description, list of recommendations, <strong>and</strong> ‘goodpractice po<strong>in</strong>ts’ followed by a discussion of the relevantpublished evidence <strong>in</strong>clud<strong>in</strong>g Evidence tables (see below)summariz<strong>in</strong>g the level of evidence available for the efficacy<strong>in</strong>dividual analgesic strategies.ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 1


Evidence tablesEvidence tables are <strong>in</strong>tended to allow the reader a rapidassessment of the strength of support<strong>in</strong>g evidence for <strong>in</strong>dividualanalgesics or analgesic strategies relevant to theprocedure <strong>in</strong> question. Evidence tabled as ‘Direct’ is thatderived from studies that have specifically <strong>in</strong>vestigated theprocedure <strong>in</strong> question. ‘Indirect’ evidence is derived fromstudies of procedures that the committee considered to besufficiently similar, <strong>in</strong> terms of expected pa<strong>in</strong> <strong>in</strong>tensity, toallow extrapolation of evidence. Recommendations havenot been formulated on the basis of <strong>in</strong>direct evidence.1.4 Methodology <strong>and</strong> evidence grad<strong>in</strong>g,good practice po<strong>in</strong>tsSystematic methods were used to search for evidence.Electronic searches were performed on the publishedliterature between January 2006 <strong>and</strong> December 2011.Search strategies <strong>in</strong>clud<strong>in</strong>g databases <strong>and</strong> keywords aredescribed <strong>in</strong> detail <strong>in</strong> Appendix 1, the technical report.The bibliographies of meta-analyses, systematicreviews, <strong>and</strong> review articles published dur<strong>in</strong>g this periodwere also scrut<strong>in</strong>ized for relevant articles. Studies<strong>in</strong> English were <strong>in</strong>cluded if they were directly relevantto the patient population <strong>and</strong> procedures. Abstractswere obta<strong>in</strong>ed to confirm <strong>in</strong>clusion or exclusion wherenecessary. Full text versions of <strong>in</strong>cluded articles wereobta<strong>in</strong>ed, a tabulated data extraction method was usedto summarize the articles, <strong>and</strong> they were graded from1 to 4 accord<strong>in</strong>g to the criteria <strong>in</strong> Table 1.Table 1 Criteria for assign<strong>in</strong>g levels of evidenceEvidence levels1 1++ High quality meta-analyses, systematic reviews of RCTs,or RCTs with a very low risk of bias1+ Well-conducted meta-analyses, systematic reviews of RCTs,or RCTs with a low risk of bias1) Meta-analyses, systematic reviews of RCTs, or RCTs with ahigh risk of bias2 2++ High quality systematic reviews of case–control or cohortstudies. High quality case–control or cohort studies with a verylow risk of confound<strong>in</strong>g, bias, or chance <strong>and</strong> a high probabilitythat the relationship is causal2+ Well-conducted case–control or cohort studies with a lowrisk of confound<strong>in</strong>g, bias, or chance <strong>and</strong> a moderate probabilitythat the relationship is causal2) Case–control or cohort studies with a high risk ofconfound<strong>in</strong>g, bias, or chance <strong>and</strong> a significant risk that therelationship is not causal3 Non-analytic studies, e.g. case reports, case series4 Expert op<strong>in</strong>ionRecommendations were formulated, where appropriate,<strong>and</strong> graded from A to D accord<strong>in</strong>g to the criteriadescribed <strong>in</strong> Table 2 us<strong>in</strong>g guidance published bythe Scottish Intercollegiate Guidel<strong>in</strong>es Network(SIGN), which are available at: http://www.sign.ac.uk/methodology/<strong>in</strong>dex.html <strong>and</strong> the National Instituteof Cl<strong>in</strong>ical Evidence (NICE) http://guidance.nice.org.uk.Table 2 Grad<strong>in</strong>g of recommendationsABCDAt least one meta analysis, systematic review, or RCT ratedas 1++, <strong>and</strong> directly applicable to the target population; or Asystematic review of RCTs or a body of evidence consist<strong>in</strong>gpr<strong>in</strong>cipally of studies rated as 1+, directly applicable to the targetpopulation, <strong>and</strong> demonstrat<strong>in</strong>g overall consistency of resultsA body of evidence <strong>in</strong>clud<strong>in</strong>g studies rated as 2++, directlyapplicable to the target population, <strong>and</strong> demonstrat<strong>in</strong>g overallconsistency of results; or Extrapolated evidence fromstudies rated as 1++ or 1+A body of evidence <strong>in</strong>clud<strong>in</strong>g studies rated as 2+, directly applicableto the target population <strong>and</strong> demonstrat<strong>in</strong>g overall consistency ofresults; or Extrapolated evidence from studies rated as 2++Evidence level 3 or 4; or Extrapolated evidence from studies ratedas 2+<strong>Good</strong> practice po<strong>in</strong>ts <strong>in</strong>dicate best practice based onthe cl<strong>in</strong>ical experience <strong>and</strong> op<strong>in</strong>ion of the guidel<strong>in</strong>edevelopment committee but not necessarily supportedby research evidence; they are provided <strong>in</strong> situationswhere published evidence is <strong>in</strong>sufficient to make aformal recommendation but the committee wish toemphasize an important aspect of good practice.1.5 Supplementary materialThe follow<strong>in</strong>g supplementary material is available forthis guidel<strong>in</strong>e:Appendix 1. Technical ReportAppendix 2. Implementation, cost effectiveness <strong>and</strong>auditAppendix 3. Research implicationsPlease note: Wiley-Blackwell are not responsible forthe content or functionality of any supplementarymaterials supplied by the authors. Any queries (otherthan miss<strong>in</strong>g material) should be directed to the correspond<strong>in</strong>gauthor for the article.2 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


1.6 Contact <strong>in</strong>formationCorrespondence <strong>in</strong> relation to this guidel<strong>in</strong>e should beaddressed to:Dr RF Howard FRCA FFPMRCAAssociation of Paediatric Anaesthetists of GreatBrita<strong>in</strong> <strong>and</strong> Irel<strong>and</strong>21 Portl<strong>and</strong> PlaceLondon W1B 1PY, UKapagbiadm<strong>in</strong>istration@aagbi.orgfund<strong>in</strong>g support from the follow<strong>in</strong>g: Johnson <strong>and</strong>Johnson Pharmaceutical Research LLD, GrunenthalLtd, Napp Pharmaceuticals Ltd <strong>and</strong> Wochardt UKLtd. Dr Neil S. Morton is Editor-<strong>in</strong>-Chief, PediatricAnesthesia <strong>and</strong> has received consultancy fees fromAstraZeneca, Smith & Nephew <strong>and</strong> Scher<strong>in</strong>g-Plough.His department has received research fund<strong>in</strong>g fromAbbott, AstraZeneca, Smith & Nephew <strong>and</strong> Carefusion(Alaris). The rema<strong>in</strong><strong>in</strong>g members of the guidel<strong>in</strong>edevelopment committee confirm that they have no conflictsof <strong>in</strong>terest to declare.1.7 Conflicts of <strong>in</strong>terestDr Richard Howard has acted as a Consultant <strong>and</strong>/orhis department has received research or educationalª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 3


Section 2.0Executive Summary <strong>and</strong> Quick Reference GuideContents2.1 Introduction2.2 Pa<strong>in</strong> assessment2.3 Medical procedures2.4 <strong>Procedural</strong> pa<strong>in</strong> <strong>in</strong> the neonate: general recommendations2.5 <strong>Procedural</strong> pa<strong>in</strong> <strong>in</strong> the neonate: specific recommendations2.6 <strong>Procedural</strong> pa<strong>in</strong> <strong>in</strong> older children2.7 <strong>Postoperative</strong> pa<strong>in</strong>2.1 IntroductionThis evidence-based guidel<strong>in</strong>e for the management ofpostoperative <strong>and</strong> procedural pa<strong>in</strong> <strong>in</strong> children was developedby a multidiscipl<strong>in</strong>ary guidel<strong>in</strong>e development groupof the Association of Paediatric Anaesthetists of GreatBrita<strong>in</strong> <strong>and</strong> Irel<strong>and</strong> with representation from consumers,the Royal College of Paediatrics <strong>and</strong> Child Health(RCPCH), the British Pa<strong>in</strong> Society (BPS), the RoyalCollege of Nurs<strong>in</strong>g (RCN) <strong>and</strong> the Faculty of Pa<strong>in</strong> Medic<strong>in</strong>eof the Royal College of Anaesthetists (FPMRCA).The guidel<strong>in</strong>e was complied us<strong>in</strong>g methodology developedby the Scottish Intercollegiate Guidel<strong>in</strong>e Network(SIGN). Descriptions of levels of evidence, grad<strong>in</strong>g ofrecommendations <strong>and</strong> their associated symbols can befound <strong>in</strong> Section 1.0 <strong>and</strong> <strong>in</strong> the technical report, Appendix1, of the supplementary materials. The guidel<strong>in</strong>e wasdeveloped for the use of health professionals. It is<strong>in</strong>tended to <strong>in</strong>form decision mak<strong>in</strong>g <strong>in</strong> the managementof acute postoperative <strong>and</strong> procedural pa<strong>in</strong>. This is thesecond edition of the guidel<strong>in</strong>e, it supersedes previousversions. The guidel<strong>in</strong>e will be updated every 5 years.The guidel<strong>in</strong>e comprises evidence-based ‘Recommendations’<strong>and</strong> ‘<strong>Good</strong> practice po<strong>in</strong>ts’. Recommendations aregraded A–D accord<strong>in</strong>g to the strength of evidence underp<strong>in</strong>n<strong>in</strong>gthem, the grad<strong>in</strong>g does not reflect the importanceof the recommendation. <strong>Good</strong> practice po<strong>in</strong>ts<strong>in</strong>dicate best practice accord<strong>in</strong>g to the cl<strong>in</strong>ical experience<strong>and</strong> op<strong>in</strong>ion of the guidel<strong>in</strong>e development committee.Not all recommendations are <strong>in</strong>cluded <strong>in</strong> this quickreference guide, common abbreviations <strong>and</strong> completedetails are available <strong>in</strong> the relevant sections of theguidel<strong>in</strong>e.2.2 Pa<strong>in</strong> assessmentPa<strong>in</strong> assessment <strong>and</strong> measurement of pa<strong>in</strong> <strong>in</strong>tensity arevital components of good pa<strong>in</strong> management practice.Self-report of pa<strong>in</strong> by children who are able to do so,observation of behaviors or physiological parameters thatare known to reflect pa<strong>in</strong> <strong>in</strong>tensity us<strong>in</strong>g a st<strong>and</strong>ardizedpa<strong>in</strong> ‘measure’, ‘<strong>in</strong>strument’, or ‘tool’ are options. Toselect an appropriate method, the pr<strong>in</strong>ciples <strong>and</strong> limitationsof st<strong>and</strong>ardized pa<strong>in</strong> measures must be understood.A simple guide to valid measures for postoperative<strong>and</strong> procedural pa<strong>in</strong> is given <strong>in</strong> Table 1. But pleasenote that reliance on chronological age as the sole<strong>in</strong>dicator of a child’s capacity to self-report will <strong>in</strong>evitablygenerate both false positives (<strong>in</strong>valid scores fromTable 1 Recommended measures for procedural <strong>and</strong> postoperativepa<strong>in</strong> assessment as a function of the child’s chronological ageChild’s age*MeasureNewborn–3 years oldCOMFORT or FLACC4 years old FPS-R + COMFORT or FLACC5–7 years old FPS-R7 years old + VAS or NRS or FPS-R*With normal or assumed normal cognitive developmentchildren who do not underst<strong>and</strong> the scale) <strong>and</strong> falsenegatives (not obta<strong>in</strong><strong>in</strong>g valid scores from childrenwho do underst<strong>and</strong> the scale but were not asked).<strong>Good</strong> practice po<strong>in</strong>tsTo assess pa<strong>in</strong>, effective communication should occurbetween the child whenever feasible, their family or carers,<strong>and</strong> the professionals <strong>in</strong> the multi-discipl<strong>in</strong>ary team.St<strong>and</strong>ardized <strong>in</strong>struments should be used <strong>in</strong> their f<strong>in</strong>alvalidated form. Even m<strong>in</strong>or modifications that alterthe psychometric properties of the tool may bias cl<strong>in</strong>icalassessments <strong>and</strong> render comparison between studies<strong>in</strong>valid.4 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


RecommendationsChildren’s self-report of their pa<strong>in</strong> is the preferredapproach: Grade BNo <strong>in</strong>dividual measure can be broadly recommended forpa<strong>in</strong> assessment across all children or all contexts:Grade BAn observational measure should be used <strong>in</strong> conjunctionwith self-report with 3–5-year-olds as there is limited evidencefor the reliability <strong>and</strong> validity of self-report measuresof pa<strong>in</strong> <strong>in</strong>tensity <strong>in</strong> this age group: Grade B2.3 Medical proceduresRout<strong>in</strong>e medical care <strong>in</strong>volv<strong>in</strong>g blood sampl<strong>in</strong>g <strong>and</strong>other pa<strong>in</strong>ful diagnostic <strong>and</strong> therapeutic procedurescan cause great distress for children <strong>and</strong> their families.When such procedures are essential, it is importantthat they should be achieved with as little pa<strong>in</strong> as possible.There are 10 general considerations to rememberprior to plann<strong>in</strong>g the management of a pa<strong>in</strong>ful procedure:see Box 1.Box 1: Plann<strong>in</strong>g a pa<strong>in</strong>ful procedure1. Infants <strong>and</strong> children of all ages, <strong>in</strong>clud<strong>in</strong>g prematureneonates, are capable of feel<strong>in</strong>g pa<strong>in</strong> <strong>and</strong>require analgesia for pa<strong>in</strong>ful procedures.2. Developmental differences <strong>in</strong> the response topa<strong>in</strong> <strong>and</strong> analgesic efficacy should be consideredwhen plann<strong>in</strong>g analgesia.3. Consider whether the planned procedure is necessary,<strong>and</strong> how the <strong>in</strong>formation it will providemight <strong>in</strong>fluence care? Avoid multiple procedures ifpossible.4. Plan the tim<strong>in</strong>g of procedures to m<strong>in</strong>imize thefrequency of a pa<strong>in</strong>ful procedure.5. Is sedation or even general anesthesia likely tobe required for a safe <strong>and</strong> satisfactory outcome?6. Would modification of the procedure reducepa<strong>in</strong>? For example, venepuncture is less pa<strong>in</strong>ful thanheel lance for blood sampl<strong>in</strong>g <strong>in</strong> <strong>in</strong>fants.7. Is the planned environment suitable? Ideally,this should be a quiet, calm place with suitable toys<strong>and</strong> distractions.8. Ensure that appropriate personnel who possessthe necessary skills are available, enlist experiencedhelp when necessary.9. Allow sufficient time for analgesic drugs <strong>and</strong>other analgesic measures to be effective.10. Formulate a clear plan of action should theprocedure fail or pa<strong>in</strong> become unmanageable us<strong>in</strong>gthe techniques selected.<strong>Good</strong> practice po<strong>in</strong>tsPa<strong>in</strong> management for procedures should <strong>in</strong>clude bothpharmacological <strong>and</strong> nonpharmacological strategieswhenever possible.Children <strong>and</strong> their parents/carers benefit from psychologicalpreparation prior to pa<strong>in</strong>ful procedures.2.4 <strong>Procedural</strong> pa<strong>in</strong> <strong>in</strong> the neonate:general recommendationsBreast-feed<strong>in</strong>g should be encouraged dur<strong>in</strong>g the procedure,if feasible: Grade ANonpharmacological measures <strong>in</strong>clud<strong>in</strong>g nonnutritivesuck<strong>in</strong>g, ‘kangaroo care’, swaddl<strong>in</strong>g/facilitated tuck<strong>in</strong>g,tactile stimulation, <strong>and</strong> heel massage can be used forbrief procedures: Grade A2.5 <strong>Procedural</strong> pa<strong>in</strong> <strong>in</strong> the neonate:specific recommendations2.5.1 Blood Sampl<strong>in</strong>g <strong>in</strong>clud<strong>in</strong>g percutaneous centralvenous catheter <strong>in</strong>sertionSucrose or other sweet solutions can be used: Grade AVenepuncture (by a tra<strong>in</strong>ed practitioner) is preferred to heellance for larger samples as it is less pa<strong>in</strong>ful: Grade ATopical local anesthetics can be used for venepuncturepa<strong>in</strong>: Grade BNonpharmacological measures <strong>in</strong>clud<strong>in</strong>g tactile stimulation,breast-feed<strong>in</strong>g, nonnutritive suck<strong>in</strong>g, ‘kangaroocare’, <strong>and</strong> massage of the heel can be used for heelprickblood sampl<strong>in</strong>g: Grade ATopical local anesthetics alone are <strong>in</strong>sufficient for heellance pa<strong>in</strong>: Grade AUs<strong>in</strong>g the whole plantar surface of the heel reduces thepa<strong>in</strong> of heelprick blood sampl<strong>in</strong>g: Grade BTopical tetraca<strong>in</strong>e plus morph<strong>in</strong>e is superior to topicalanalgesia alone for CVC <strong>in</strong>sertion pa<strong>in</strong> <strong>in</strong> ventilated<strong>in</strong>fants: Grade B2.5.2 Ocular exam<strong>in</strong>ation for ret<strong>in</strong>opathy ofprematurity (ROP)Sucrose may contribute to pa<strong>in</strong> response reduction <strong>in</strong>exam<strong>in</strong>ation for ret<strong>in</strong>opathy: Grade AInfants undergo<strong>in</strong>g exam<strong>in</strong>ation for ret<strong>in</strong>opathy shouldreceive local anesthetic drops <strong>in</strong> comb<strong>in</strong>ation with othermeasures if an eyelid speculum is used: Grade BSwaddl<strong>in</strong>g, developmental care, nonnutritive suck<strong>in</strong>g,pacifier should be considered for neonates undergo<strong>in</strong>gexam<strong>in</strong>ation for ret<strong>in</strong>opathy: Grade Bª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 5


2.5.3 Lumbar punctureTopical local anesthesia is effective <strong>in</strong> reduc<strong>in</strong>g LP pa<strong>in</strong>:Grade A2.5.4 Ur<strong>in</strong>e sampl<strong>in</strong>gTransurethral catheterization with local anesthetic gel ispreferred as it is less pa<strong>in</strong>ful than suprapubic catheterizationwith topical local anesthesia: Grade BSucrose reduces the pa<strong>in</strong> response to urethral catheterization:Grade C2.5.5 Chest dra<strong>in</strong> (tube) <strong>in</strong>sertion <strong>and</strong> removalSee older children below2.5.6 Nasogastric tube placement (See also; olderchildren, below)Sucrose can reduce the pa<strong>in</strong> response from NGT <strong>in</strong>sertion:Grade B2.5.7 Immunization <strong>and</strong> <strong>in</strong>tramuscular <strong>in</strong>jectionSwaddl<strong>in</strong>g, breast-feed<strong>in</strong>g or pacifier, <strong>and</strong> sucroseshould be considered <strong>in</strong> neonates undergo<strong>in</strong>g vacc<strong>in</strong>ation:Grade A2.6 <strong>Procedural</strong> pa<strong>in</strong> <strong>in</strong> older childrenThis section <strong>in</strong>cludes all <strong>in</strong>fants <strong>and</strong> children outsidethe neonatal period. Pa<strong>in</strong>ful procedures are often identifiedas the most feared <strong>and</strong> distress<strong>in</strong>g component ofmedical care for children <strong>and</strong> their families. Whenmanag<strong>in</strong>g procedural pa<strong>in</strong> <strong>in</strong> <strong>in</strong>fants, older children<strong>and</strong> adolescents special emphasis should given not onlyto proven analgesic strategies but also to reduction <strong>in</strong>anticipatory <strong>and</strong> procedural anxiety by suitable preparatorymeasures. Families, play therapists, nurs<strong>in</strong>g staff<strong>and</strong> other team members play key roles <strong>in</strong> reduc<strong>in</strong>ganxiety by suitable preparation.Specific Recommendations2.6.1 Blood sampl<strong>in</strong>g <strong>and</strong> <strong>in</strong>travenous cannulationTopical local anesthesia should be used for <strong>in</strong>travenouscannulation: Grade APsychological strategies, for example, distraction or hypnosis,to reduce pa<strong>in</strong> <strong>and</strong> anxiety should be used: Grade A2.6.2 Lumbar punctureBehavioral techniques of pa<strong>in</strong> management should beused to reduce LP pa<strong>in</strong>: Grade ATopical LA <strong>and</strong> LA <strong>in</strong>filtration are effective for LP pa<strong>in</strong><strong>and</strong> do not decrease success rates: Grade B50% nitrous oxide <strong>in</strong> oxygen should be offered to childrenwill<strong>in</strong>g <strong>and</strong> able to cooperate: Grade C2.6.3 Chest dra<strong>in</strong> (tube) <strong>in</strong>sertion <strong>and</strong> removalThere is little published evidence look<strong>in</strong>g at analgesicoptions for chest dra<strong>in</strong> <strong>in</strong>sertion or removal.<strong>Good</strong> practice po<strong>in</strong>tsFor chest dra<strong>in</strong> <strong>in</strong>sertion, consider general anesthesia orsedation comb<strong>in</strong>ed with subcutaneous <strong>in</strong>filtration of bufferedlidoca<strong>in</strong>e. Selection of appropriate dra<strong>in</strong> type mayreduce pa<strong>in</strong> by facilitat<strong>in</strong>g easy <strong>in</strong>sertion.For chest dra<strong>in</strong> removal, consider a comb<strong>in</strong>ation of twoor more strategies known to be effective for pa<strong>in</strong>ful proceduressuch as psychological <strong>in</strong>terventions, sucroseor pacifier (<strong>in</strong> neonates), opioids, nitrous oxide, <strong>and</strong>NSAIDs2.6.4 Bladder catheterization <strong>and</strong> related ur<strong>in</strong>e sampl<strong>in</strong>gproceduresPsychological preparation <strong>and</strong> psychological <strong>and</strong> behavioral<strong>in</strong>terventions should be used dur<strong>in</strong>g bladder catheterization<strong>and</strong> <strong>in</strong>vasive <strong>in</strong>vestigations of the renal tract:Grade BInfants: consider procedure modification as urethralcatheterization is less pa<strong>in</strong>ful than SPA for ur<strong>in</strong>esampl<strong>in</strong>g: Grade B2.6.5 Insertion of nasogastric tubes<strong>Good</strong> practice po<strong>in</strong>tTopical local anesthetics such as lidoca<strong>in</strong>e conta<strong>in</strong><strong>in</strong>glubricant gel applied prior to placement are likely toreduce the pa<strong>in</strong> <strong>and</strong> discomfort of NGT <strong>in</strong>sertion.2.6.6 Immunization <strong>and</strong> <strong>in</strong>tramuscular <strong>in</strong>jectionPsychological strategies such as distraction should beused for <strong>in</strong>fants <strong>and</strong> children undergo<strong>in</strong>g vacc<strong>in</strong>ation:Grade AConsider additional procedure modifications such as vacc<strong>in</strong>eformulation, order of vacc<strong>in</strong>es (least pa<strong>in</strong>ful first)needle size, depth of <strong>in</strong>jection (25–mm, 25-gauge needle)or the use of vapocoolant spay: Grade ASwaddl<strong>in</strong>g, breast-feed<strong>in</strong>g or pacifier, <strong>and</strong> sucrose shouldbe considered <strong>in</strong> <strong>in</strong>fants undergo<strong>in</strong>g vacc<strong>in</strong>ation: Grade A2.6.7 Repair of lacerationsFor repair of simple low-tension lacerations, tissue adhesivesshould be considered as they are less pa<strong>in</strong>ful, quickto use, <strong>and</strong> have a similar cosmetic outcome to suturesor adhesive sk<strong>in</strong> closures (steri-strips): Grade A6 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


Topical anesthetic preparations, for example, LAT (lidoca<strong>in</strong>e–adrenal<strong>in</strong>e–tetraca<strong>in</strong>e)if available, can be used <strong>in</strong>preference to <strong>in</strong>jected LA, as they are less pa<strong>in</strong>ful toapply; it is not necessary to use a preparation conta<strong>in</strong><strong>in</strong>gcoca<strong>in</strong>e: Grade ABuffer<strong>in</strong>g <strong>in</strong>jected lidoca<strong>in</strong>e with sodium bicarbonateshould be considered: Grade A‘HAT’ should be considered for scalp lacerations. It isless pa<strong>in</strong>ful than sutur<strong>in</strong>g, does not require shav<strong>in</strong>g, <strong>and</strong>produces a similar outcome: Grade BIf <strong>in</strong>jected lidoca<strong>in</strong>e is used, pretreatment of the woundwith a topical anesthetic preparation, for example, lidoca<strong>in</strong>e–adrenal<strong>in</strong>e–tetraca<strong>in</strong>e(LAT) gel reduces the pa<strong>in</strong>of subsequent <strong>in</strong>jection: Grade B50% nitrous oxide reduces pa<strong>in</strong> <strong>and</strong> anxiety dur<strong>in</strong>g lacerationrepair: Grade B2.6.8 Change of dress<strong>in</strong>gs <strong>in</strong> children with burnsPotent opioid analgesia given by oral, transmucosal,or nasal routes accord<strong>in</strong>g to patient preference <strong>and</strong>availability of suitable preparations should be consideredfor dress<strong>in</strong>g changes <strong>in</strong> burned children: Grade ANonpharmacological therapies such as distraction <strong>and</strong>relaxation should be considered as part of pa<strong>in</strong> managementfor dress<strong>in</strong>g changes <strong>in</strong> burned children:Grade B2.6.9 Botul<strong>in</strong>um <strong>in</strong>jections for children with musclespasm<strong>Good</strong> practice po<strong>in</strong>t50% Nitrous oxide/oxygen should be considered <strong>in</strong> childrenwho are able to cooperate with self-adm<strong>in</strong>istration.2.7 <strong>Postoperative</strong> pa<strong>in</strong><strong>Postoperative</strong> care is frequently shared between heathprofessionals from different discipl<strong>in</strong>es: they shouldunderst<strong>and</strong> the general pr<strong>in</strong>ciples of pa<strong>in</strong> assessment<strong>and</strong> pa<strong>in</strong> management <strong>in</strong> children. <strong>Postoperative</strong> analgesiashould be planned <strong>and</strong> organized prior to surgery<strong>in</strong> consultation with patients <strong>and</strong> their families orcarers, <strong>and</strong> other members of the perioperative team.<strong>Good</strong> practice po<strong>in</strong>tsProviders of postoperative care should underst<strong>and</strong> thegeneral pr<strong>in</strong>ciples of good pa<strong>in</strong> management <strong>in</strong> children;this <strong>in</strong>cludes knowledge of assessment techniques <strong>and</strong> theuse of analgesics at different developmental ages.Pediatric anesthetists are responsible for <strong>in</strong>itiat<strong>in</strong>g postoperativeanalgesia. They should liaise with patients <strong>and</strong>their families/carers, surgeons, <strong>and</strong> other members of theteam provid<strong>in</strong>g postoperative care to ensure that pa<strong>in</strong> isassessed, <strong>and</strong> suitable ongo<strong>in</strong>g analgesia is adm<strong>in</strong>istered.<strong>Postoperative</strong> analgesia should be appropriate to developmentalage, surgical procedure, <strong>and</strong> cl<strong>in</strong>ical sett<strong>in</strong>g toprovide safe, sufficiently potent, <strong>and</strong> flexible pa<strong>in</strong> reliefwith a low <strong>in</strong>cidence of side effects.Comb<strong>in</strong>ations of analgesics should be used unless thereare specific contra<strong>in</strong>dications, for example; local anesthetics,opioids, NSAIDs, <strong>and</strong> paracetamol can be given<strong>in</strong> conjunction, not exceed<strong>in</strong>g maximum recommendeddose.Recommendations2.7.1 ENT surgeryMyr<strong>in</strong>gotomyOral paracetamol or NSAIDS (ibuprofen, diclofenac, orketorolac) <strong>in</strong> suitable doses can achieve adequate earlypostoperative analgesia: Grade BOpioids are effective but not recommended for rout<strong>in</strong>euse because of side effects: Grade BTonsillectomyA comb<strong>in</strong>ation of <strong>in</strong>dividually titrated <strong>in</strong>traoperative opioids,dexamethasone, <strong>and</strong> regularly adm<strong>in</strong>istered perioperativemild analgesics (NSAIDS <strong>and</strong> /or paracetamol)is recommended for management of tonsillectomy pa<strong>in</strong>:Grade ATopical application or <strong>in</strong>jection of local anesthetic <strong>in</strong> thetonsillar fossa improves early pa<strong>in</strong> scores follow<strong>in</strong>g tonsillectomy:Grade AImplementation of st<strong>and</strong>ardized protocols <strong>in</strong>clud<strong>in</strong>g <strong>in</strong>traoperativeopioid ± anti-emetic, perioperative NSAID(diclofenac or ibuprofen) <strong>and</strong> paracetamol are associatedwith acceptable pa<strong>in</strong> relief <strong>and</strong> low rates of PONV:Grade CMastoid <strong>and</strong> middle ear surgeryGreat auricular nerve block can provide similar analgesia<strong>and</strong> reduced PONV compared with morph<strong>in</strong>e. Pre<strong>in</strong>cisiontim<strong>in</strong>g of the block confers no additional benefit:Grade Bª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 7


2.7.2 OpthalmologyStrabismus surgeryIntraoperative LA blocks (subtenon’s or peribulbar)reduce PONV <strong>and</strong> may improve perioperative analgesia<strong>in</strong> comparison with IV opioid but provide no benefit overtopical LA: Grade BTopical NSAIDS do not improve pa<strong>in</strong> scores or postoperativeanalgesic requirements when compared with topicalLA or placebo: Grade BIntraoperative opioid <strong>and</strong> NSAID provide similar postoperativeanalgesia but opioid use is associated with<strong>in</strong>creased PONV: Grade BVitreoret<strong>in</strong>al surgeryIn vitreoret<strong>in</strong>al surgery NSAID can provide similar analgesiabut lower rates of PONV compared with opioid:Grade CPeribulbar block improves early analgesia <strong>and</strong> mayreduce PONV compared with opioid: Grade C2.7.3 Dental proceduresNSAIDS with or without paracetamol reduce pa<strong>in</strong> follow<strong>in</strong>gdental extractions: Grade BSwabs soaked with bupivaca<strong>in</strong>e on exposed tooth socketsfollow<strong>in</strong>g extraction produce no or m<strong>in</strong>or improvements<strong>in</strong> pa<strong>in</strong> <strong>in</strong> the immediate postoperative period: Grade BIntraoperative LA <strong>in</strong>filtration reduces postoperative pa<strong>in</strong>follow<strong>in</strong>g dental extractions, but provides little additionalbenefit over NSAIDS <strong>and</strong> paracetamol alone:Grade B2.7.4 General surgery <strong>and</strong> urology (m<strong>in</strong>or <strong>and</strong><strong>in</strong>termediate)Sub-umbilical surgeryLA should be used when feasible: wound <strong>in</strong>filtration,transversus abdom<strong>in</strong>is plane (TAP) block, ilio-<strong>in</strong>gu<strong>in</strong>alnerve block <strong>and</strong> caudal analgesia are effective <strong>in</strong> theearly postoperative period follow<strong>in</strong>g sub-umbilical surgery:Grade ACircumcisionCaudal epidural <strong>and</strong> dorsal nerve block are effective <strong>in</strong>the early postoperative period, with low rates of complications<strong>and</strong> side effects: Grade ANeonatal circumcisionLA should be used as it is superior to other techniquesfor circumcision pa<strong>in</strong>: Grade ADorsal nerve block is more effective than subcutaneousr<strong>in</strong>g block or topical LA: Grade AWhen us<strong>in</strong>g topical local anesthetic it must be appliedcorrectly <strong>and</strong> sufficient time allowed for it to becomeeffective: Grade AHypospadias repairLA central neuraxial or dorsal nerve block is effectivereduc<strong>in</strong>g the need for postoperative supplementary opioidadm<strong>in</strong>istration follow<strong>in</strong>g hypospadias surgery: Grade AOrchidopexyCaudal block is effective <strong>in</strong> the early postoperative periodfor orchidopexy with low rates of complications <strong>and</strong>side effects: Grade AOpen <strong>in</strong>gu<strong>in</strong>al hernia repairLA wound <strong>in</strong>filtration, ilio-<strong>in</strong>gu<strong>in</strong>al nerve block, paravertebralblock or caudal analgesia are effective <strong>in</strong> the earlypostoperative period: Grade A2.7.5 General surgery <strong>and</strong> urology (Major)Major <strong>in</strong>tra-abdom<strong>in</strong>al surgeryIntravenous opioids either as cont<strong>in</strong>uous <strong>in</strong>fusion, NCA,or PCA are effective follow<strong>in</strong>g major abdom<strong>in</strong>al surgery:Grade AEpidural analgesia with LA should be considered formajor abdom<strong>in</strong>al surgery. The addition of neuraxialclonid<strong>in</strong>e or opioid may further improve analgesia butside effects may also be <strong>in</strong>creased: Grade BAppendicectomy (open)PCA comb<strong>in</strong>ed with NSAID is effective for postappendicectomypa<strong>in</strong>: Grade BFundoplication (open)Epidural LA + opioid is effective <strong>and</strong> may be associatedwith improved cl<strong>in</strong>ical outcome <strong>in</strong> selected patientsfollow<strong>in</strong>g fundoplication: grade D8 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


2.7.6 Laparoscopic surgery<strong>Good</strong> practice po<strong>in</strong>tsInfiltration of port sites with LA as part of a multimodalanalgesic strategy may reduce postoperative pa<strong>in</strong> follow<strong>in</strong>glaparoscopy.Although overall postoperative analgesic requirementsappear to be reduced follow<strong>in</strong>g laparoscopy, pa<strong>in</strong> maybe equivalent to the equivalent open procedure <strong>in</strong> somecircumstances, particularly dur<strong>in</strong>g the first 24 h.2.7.7 Orthopaedics, sp<strong>in</strong>al <strong>and</strong> plastic surgery<strong>Good</strong> practice po<strong>in</strong>tThere is no evidence from studies <strong>in</strong> children thatNSAIDs have a deleterious effect on bone fusion. Theanalgesic benefit of short-term NSAID use has beendemonstrated <strong>and</strong> may frequently outweigh any hypotheticalrisk.Lower limb surgeryPeripheral nerve blocks provide superior analgesia <strong>and</strong>are associated with fewer adverse effects compared with<strong>in</strong>travenous opioids: Grade BCont<strong>in</strong>uous peripheral nerve blocks are feasible, effective<strong>and</strong> safe, <strong>and</strong> are associated with lower pa<strong>in</strong> scores:Grade BEpidural opioids are effective, reduce the dose requirementsof local anesthetic, <strong>and</strong> rescue IV opioids but<strong>in</strong>crease the <strong>in</strong>cidence of side effects: Grade BEpidural techniques are associated with lower pa<strong>in</strong>scores than <strong>in</strong>travenous opioid analgesia: Grade CSystemic paracetamol <strong>and</strong> NSAID reduce <strong>in</strong>travenousopioid requirements: Grade CUpper Limb SurgeryBrachial plexus blocks provide satisfactory analgesia forh<strong>and</strong> <strong>and</strong> forearm surgery extend<strong>in</strong>g <strong>in</strong>to the postoperativeperiod: Grade BThe axillary, <strong>in</strong>fraclavicular, supraclavicular, <strong>and</strong> <strong>in</strong>terscaleneapproach are feasible <strong>and</strong> effective: Grade BSp<strong>in</strong>al surgeryEpidural techniques produce a modest improvement <strong>in</strong>pa<strong>in</strong> control, compared with <strong>in</strong>travenous opioids <strong>in</strong>patients undergo<strong>in</strong>g corrective surgery for adolescent idiopathicscoliosis: Grade BIntrathecal opioids decrease <strong>in</strong>tra-operative blood loss<strong>and</strong> IV opioid consumption postoperatively. The durationof action is 18–24 h: Grade CDual catheter epidural techniques should be considered, asthis permits coverage of multiple sp<strong>in</strong>al levels: Grade CThe use of LA + lipophilic opioid <strong>in</strong> the epidural spacewith a s<strong>in</strong>gle epidural catheter does not show an analgesicbenefit over <strong>in</strong>travenous opioid techniques: Grade CThe use of LA + hydrophilic opioids <strong>in</strong> the epiduralspace has a favorable analgesic profile compared withIV opioid, but at the expense of <strong>in</strong>creased adverseeffects: Grade DCleft lip <strong>and</strong> palate <strong>and</strong> related procedures of head<strong>and</strong> neckInfraorbital nerve block provides effective analgesia forcleft lip repair <strong>in</strong> the early postoperative period: GradeA2.7.8 Cardiothoracic surgeryCardiac surgery (sternotomy)Epidural <strong>and</strong> <strong>in</strong>trathecal techniques with opioid <strong>and</strong>/orLA are effective for sternotomy pa<strong>in</strong> but only marg<strong>in</strong>albenefits have been demonstrated, <strong>and</strong> there is <strong>in</strong>sufficientdata concern<strong>in</strong>g the <strong>in</strong>cidence of serious complications:Grade BThoracotomyEpidural analgesia is effective for post-thoracotomypa<strong>in</strong>: Grade D2.7.9 NeurosurgeryCraniotomy <strong>and</strong> major neurosurgery<strong>Good</strong> practice po<strong>in</strong>tAnalgesia follow<strong>in</strong>g neurosurgery requires good communication<strong>and</strong> close cooperation between members of theperioperative team. Frequent pa<strong>in</strong> assessments should bea rout<strong>in</strong>e part of postoperative care. A multimodal analgesicapproach is suitable, which may <strong>in</strong>clude the use ofLA <strong>in</strong>filtration, paracetamol, NSAID (when not contra<strong>in</strong>dicated),<strong>and</strong> parenteral or oral opioid as determ<strong>in</strong>edby assessed analgesic requirements.ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 9


Section 3.0Pa<strong>in</strong> AssessmentContents3.1 General pr<strong>in</strong>ciples of pa<strong>in</strong> assessment3.2 Pa<strong>in</strong> measurement toolsChildren’s pa<strong>in</strong> should be assessed. Effective pa<strong>in</strong>assessment is essential both <strong>in</strong> terms of its contribution tothe prevention <strong>and</strong> relief of a child’s pa<strong>in</strong> (1–4) <strong>and</strong> also<strong>in</strong> its role as a diagnostic aid. The centrality of pa<strong>in</strong>assessment to high-quality pa<strong>in</strong> management is enshr<strong>in</strong>ed<strong>in</strong> many current pa<strong>in</strong> management recommendations,position statements, reports, <strong>and</strong> guidel<strong>in</strong>es (5–9).Assessment refers to a broad endeavor aim<strong>in</strong>g toidentify the factors that shape the pa<strong>in</strong> experience<strong>in</strong>clud<strong>in</strong>g physiological, cognitive, affective, behavioral<strong>and</strong> contextual, <strong>and</strong> their dynamic <strong>in</strong>teractions.Measurement refers to the application of a metricon one aspect of pa<strong>in</strong>, usually <strong>in</strong>tensity. This guidel<strong>in</strong>efocuses primarily on pa<strong>in</strong> measurement assum<strong>in</strong>g thatthe appropriate pa<strong>in</strong> assessment as per cl<strong>in</strong>ical practicetakes place.Table 1 Evaluation criteria for IMMPACT reviews (12)I. A wellestablishedassessmentCriteria for categoriesThe measure must have been presented <strong>in</strong> atleast 2 peer-reviewed articles by different<strong>in</strong>vestigators or <strong>in</strong>vestigatory teams.Sufficient detail about the measure to allowcritical evaluation <strong>and</strong> replication.Detailed <strong>in</strong>formation <strong>in</strong>dicat<strong>in</strong>g good validity<strong>and</strong> reliability <strong>in</strong> at least 1 peer-reviewedarticle.II. Approach<strong>in</strong>g The measure must have been presentedwell-established <strong>in</strong> at least 2 peer-reviewed articles, whichassessment might be by the same <strong>in</strong>vestigator or<strong>in</strong>vestigatory team.Sufficient detail about the measure to allowcritical evaluation <strong>and</strong> replication.Validity <strong>and</strong> reliability <strong>in</strong>formation eitherpresented <strong>in</strong> vague terms (e.g., no statisticspresented) or only moderate valuespresented.III. Promis<strong>in</strong>gassessmentThe measure must have been presented <strong>in</strong> atleast 1 peer-reviewed article.Sufficient detail about the measure to allowcritical evaluation <strong>and</strong> replication.Validity <strong>and</strong> reliability <strong>in</strong>formation eitherpresented <strong>in</strong> vague terms or only moderatevalues presented.Exist<strong>in</strong>g guidel<strong>in</strong>es: An evidence-based guidel<strong>in</strong>e ‘TheRecognition <strong>and</strong> Assessment of Pa<strong>in</strong> <strong>in</strong> Children wasfirst produced by the Royal College of Nurs<strong>in</strong>g (RCN),UK, <strong>in</strong> 1999 <strong>and</strong> was revised <strong>in</strong> 2009 (10). The RCNguidel<strong>in</strong>e was endorsed <strong>in</strong> 2001 by the Royal College ofPaediatrics <strong>and</strong> Child Health that produced ‘Guidel<strong>in</strong>esfor <strong>Good</strong> <strong>Practice</strong>’ (11), which were the recommendationsbased on the orig<strong>in</strong>al RCN guidel<strong>in</strong>e. We suggestthat both these documents be consulted for further <strong>and</strong>more detailed <strong>in</strong>formation; the evidence <strong>and</strong> recommendationspresented here are <strong>in</strong>tended to support <strong>and</strong> supplementthis exist<strong>in</strong>g guidance.Technical note for this section of the guidel<strong>in</strong>e: <strong>in</strong>addition to the SIGN criteria, <strong>and</strong> <strong>in</strong> l<strong>in</strong>e with currentpractice, <strong>in</strong>struments were also evaluated based on a setof evaluation criteria for the assessment of quality ofevidence for IMMPACT reviews (12) (see Table 1, <strong>and</strong>Appendix 1, Technical Report for further <strong>in</strong>formation).3.1 General pr<strong>in</strong>ciples of pa<strong>in</strong> assessment<strong>Good</strong> pa<strong>in</strong> assessment contributes to the prevention<strong>and</strong>/or early recognition of pa<strong>in</strong> as well as the effectivemanagement of pa<strong>in</strong> (1,4). There are three fundamentalapproaches to pa<strong>in</strong> assessment <strong>in</strong> children:Self-report: measur<strong>in</strong>g expressed experience of pa<strong>in</strong>.Observational/Behavioral: measur<strong>in</strong>g behavioral distressassociated with pa<strong>in</strong> or measur<strong>in</strong>g the perceivedexperience of pa<strong>in</strong> by parent or carer report.Physiological: primarily measur<strong>in</strong>g physiologicalarousal consequent to pa<strong>in</strong>As self-report is the only truly direct measure ofpa<strong>in</strong>, it is often considered the ‘gold st<strong>and</strong>ard’ of measurement.However, for developmental reasons, selfreportmay be difficult or impossible <strong>in</strong> some children<strong>and</strong> therefore a proxy measure must be used. For pa<strong>in</strong>to be measured as accurately as possible, the pr<strong>in</strong>ciplesunderp<strong>in</strong>n<strong>in</strong>g assessment at different developmentalages <strong>and</strong> <strong>in</strong> different sett<strong>in</strong>gs must be appreciated.<strong>Good</strong> practice po<strong>in</strong>tsChildren’s pa<strong>in</strong> should be assessed, documented, <strong>and</strong>appropriate action taken. This requires both tra<strong>in</strong><strong>in</strong>g ofhealthcare professionals <strong>in</strong> pa<strong>in</strong> assessment <strong>and</strong> measurementwith st<strong>and</strong>ardized <strong>in</strong>struments.10 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


In order to assess pa<strong>in</strong>, effective communication shouldoccur between the child whenever feasible, their family orcarers, <strong>and</strong> the professionals <strong>in</strong> the multidiscipl<strong>in</strong>ary team.St<strong>and</strong>ardized <strong>in</strong>struments should be used <strong>in</strong> their f<strong>in</strong>alvalidated form. Even m<strong>in</strong>or modifications alter the psychometricproperties of the tool <strong>and</strong> render comparisonsbetween studies <strong>in</strong>valid <strong>and</strong> cl<strong>in</strong>ical assessment biased.RecommendationsNo <strong>in</strong>dividual measure can be broadly recommended forpa<strong>in</strong> assessment across all children or all contexts:Grade B (12–14).Children’s self-report of their pa<strong>in</strong>, is the preferredapproach, where feasible: Grade B (13).An observational measure should be used <strong>in</strong> conjunctionwith self-report with 3–5 year olds as there is limited evidencefor the reliability <strong>and</strong> validity of self-report measuresof pa<strong>in</strong> <strong>in</strong>tensity <strong>in</strong> this age group: Grade B (15).Sole use of physiological measures <strong>in</strong> cl<strong>in</strong>ical practice isunproven <strong>and</strong> therefore not recommended: Grade D (16,17).EvidenceThe results of pa<strong>in</strong> assessment must be documented,acted upon, reassessed, <strong>and</strong> re-evaluated to determ<strong>in</strong>ethe effectiveness of <strong>in</strong>terventions (1,18–21). Improveddocumentation can result <strong>in</strong> improved pa<strong>in</strong> management(22–25). Studies demonstrate that there is low utilizationof pa<strong>in</strong> tools <strong>and</strong> policies (26) <strong>and</strong> that pa<strong>in</strong> isunder-assessed (3,27) <strong>and</strong> poorly documented (28,29),result<strong>in</strong>g <strong>in</strong> children be<strong>in</strong>g under-medicated <strong>and</strong>/ortheir pa<strong>in</strong> be<strong>in</strong>g poorly managed (3,27,30–32). Regularpa<strong>in</strong> evaluation can contribute to the safety <strong>and</strong> efficacyof the management of acute pa<strong>in</strong> (33).Self-report: Pa<strong>in</strong> is a highly complex <strong>and</strong> multidimensionalexperience, <strong>and</strong> pa<strong>in</strong> <strong>in</strong>tensity scores are a necessaryoversimplification. Children’s self-report of pa<strong>in</strong> isregarded as the gold st<strong>and</strong>ard, <strong>and</strong> <strong>in</strong> most circumstances,it is the preferred approach. Children’s selfreportof pa<strong>in</strong> may differ to that of their parents or thenurse car<strong>in</strong>g for them (34). However, it must also berecognized that self-report <strong>in</strong> both children <strong>and</strong> adultsis complex (13,35), dependent upon age <strong>and</strong>/or level ofcognition (36), affected by a range of social <strong>and</strong> other<strong>in</strong>fluences (37–39), <strong>and</strong> is subject to biases (15,37,40).Nevertheless, although children’s subjective reports ofpa<strong>in</strong> are probably the best way of document<strong>in</strong>g the presence<strong>and</strong> <strong>in</strong>tensity of pa<strong>in</strong>, it requires quite advancedcognitive skills (<strong>in</strong>clud<strong>in</strong>g classification, seriation, <strong>and</strong>match<strong>in</strong>g) for children to be able to provide reliable <strong>and</strong>valid self-reports of pa<strong>in</strong> <strong>in</strong>tensity. Faces scales may notrequire the ability to seriate or estimate quantitiesbecause the task can be h<strong>and</strong>led by match<strong>in</strong>g how onefeels to one of the faces, which is presumed to be easierthan quantitative estimation (41). However, self-reportis subject to <strong>in</strong>dividual response biases, reflect<strong>in</strong>g theperson’s appraisal of the consequences of the pa<strong>in</strong> report(36). Although children of preschool age are often askedto confirm or deny that they are feel<strong>in</strong>g <strong>in</strong>ternal statessuch as hunger or thirst, they are rarely, if at all, askedto make quantitative estimates of these states. Thus,us<strong>in</strong>g a self-report pa<strong>in</strong> scale is an unusual experiencefor most young children (15). Alternative strategies foranswer<strong>in</strong>g confus<strong>in</strong>g questions are frequently adoptedby young children. Response bias is a propensity torespond systematically to test items <strong>in</strong> ways unrelated tothe item content. Response biases that have been documented<strong>in</strong> the pediatric literature <strong>in</strong>clude:l Anchor effects which refer to the <strong>in</strong>fluence of surround<strong>in</strong>gconditions or prior experience on the estimationof a quantity. For example, pa<strong>in</strong> rat<strong>in</strong>gs on facesscales are <strong>in</strong>fluenced by whether the lower anchor faceis smil<strong>in</strong>g or not.l Sequence bias such as the child select<strong>in</strong>g (for example)the leftmost face to answer the first question, <strong>and</strong>then picks the adjacent face to the right <strong>in</strong> response toeach successive question, <strong>in</strong> a sequence of responsesthat would be scored <strong>in</strong> an ascend<strong>in</strong>g or descend<strong>in</strong>gseries (e.g., 0–2–4–6–8).l Giv<strong>in</strong>g the same answer to all questions (15,42–44).In experimental situations where children were askedto rate hypothetical pa<strong>in</strong> situations, it has been demonstratedthat young children from four to seven cannotdist<strong>in</strong>guish as many faces as proposed by the majorityof available faces scales (45). These results stronglyrecommend a reduction <strong>in</strong> the number of response levelsof faces scales for pa<strong>in</strong> assessment <strong>in</strong> children.It should be noted that not all <strong>in</strong>accurate responses<strong>in</strong>dicate the occurrence of response biases as <strong>in</strong>accurateresponses can occur for other reasons such as failureto underst<strong>and</strong> the question, deliberate r<strong>and</strong>om or<strong>in</strong>correct respond<strong>in</strong>g, lack of motivation <strong>and</strong> attentionto the task, or undetected learn<strong>in</strong>g or cognitive difficulties(15). Cl<strong>in</strong>icians should be aware that young children’spa<strong>in</strong> scores can be mislead<strong>in</strong>g, particularly whena pa<strong>in</strong> scale is used only once to measure pa<strong>in</strong> on as<strong>in</strong>gle occasion, mak<strong>in</strong>g it difficult for the cl<strong>in</strong>ician todetect any underly<strong>in</strong>g response bias. Therefore, selfreportpa<strong>in</strong> scores from children below 5 years of ageshould generally be treated with caution <strong>and</strong> should becorroborated by observational measures.ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 11


Choice of assessment tool: No <strong>in</strong>dividual observational(14), self-report (13), or physiological measure isbroadly recommended for pa<strong>in</strong> assessment across allchildren or all contexts. Some validated pa<strong>in</strong> measures,primarily developed for use with<strong>in</strong> pa<strong>in</strong> research studies,do not transition easily <strong>in</strong> everyday practice as they canbe challeng<strong>in</strong>g to use <strong>in</strong> cl<strong>in</strong>ical sett<strong>in</strong>gs (46). Therefore,healthcare professionals need to make <strong>in</strong>formed choicesabout which tool to use to assess each <strong>in</strong>dividual child’spa<strong>in</strong>. Composite measures us<strong>in</strong>g self-report <strong>and</strong> at leastone other measure may be a better approach (13).Table 3 provides guidance, as a function of a child’schronological age, on measures that have good psychometricproperties <strong>and</strong> can be used for the assessment ofprocedural <strong>and</strong> postoperative pa<strong>in</strong>.Education: Healthcare professionals require appropriatelevels of education about pa<strong>in</strong> (27,47–49). They alsoneed adequate tra<strong>in</strong><strong>in</strong>g/preparation <strong>in</strong> the use of pa<strong>in</strong>assessment tools <strong>and</strong> proficiency <strong>in</strong> us<strong>in</strong>g them(23,50,51). Improved work<strong>in</strong>g practices (52), organizationalcommitment (23), quality improvement strategies(23), <strong>and</strong> one-to-one coach<strong>in</strong>g (53) have been shown toenhance pa<strong>in</strong> assessment. Studies have demonstratedthat health professionals’ assessment of children’s pa<strong>in</strong>is subject to a range of <strong>in</strong>dividual, social, <strong>and</strong> contextual<strong>in</strong>fluences (54–57). Professionals need to be flexible <strong>and</strong>will<strong>in</strong>g to develop more positive attitudes <strong>and</strong> beliefsregard<strong>in</strong>g the attributes of children’s pa<strong>in</strong> (19). Perceptionsabout the pa<strong>in</strong> experienced by particular groups ofchildren, such as children with neurological impairmentmay need to be challenged (58,59).Parents <strong>and</strong> other carers should also be given appropriate<strong>in</strong>formation about their child’s pa<strong>in</strong> (55,60–62)<strong>and</strong> emotional support <strong>and</strong> clarification of their role <strong>in</strong>their child’s pa<strong>in</strong> (61,63). Their beliefs about theirchild’s pa<strong>in</strong> need to be taken <strong>in</strong>to consideration asthese beliefs may impact their child’s care. Parents/Table 2 Recommended measures for procedural <strong>and</strong> postoperativepa<strong>in</strong> assessment as a function of the child’s chronological ageChild’s age*MeasureNewborn–3 years oldCOMFORT or FLACC4 years old FPS-R +COMFORT or FLACC5–7 years old FPS-R7 years old + VAS or NRS or FPS-R*with normal or assumed normal cognitive developmentNote: Reliance on chronological age as the sole <strong>in</strong>dicator of achild’s capacity to self-report will <strong>in</strong>evitably generate both falsepositives (<strong>in</strong>valid scores from children who do not underst<strong>and</strong>the scale) <strong>and</strong> false negatives (not obta<strong>in</strong><strong>in</strong>g valid scores fromchildren who do underst<strong>and</strong> the scale but were not asked).carers of children with cognitive impairment may havemistaken beliefs about their child’s pa<strong>in</strong>, which need tobe carefully explored (59). Parents/carers also needappropriate <strong>in</strong>formation <strong>and</strong> teach<strong>in</strong>g <strong>in</strong> the use ofpa<strong>in</strong> assessment tools if they are to be effective <strong>in</strong>assess<strong>in</strong>g <strong>and</strong> manag<strong>in</strong>g their child’s pa<strong>in</strong> (59,63,64).3.2 Pa<strong>in</strong> measurement toolsA bewilder<strong>in</strong>g number of acute pa<strong>in</strong> measurementtools exist. Tools vary <strong>in</strong> relation to three broadgroups of factors: child-related, user-related, <strong>and</strong> structural.For example, the age, cognitive level, language,ethnic/cultural background of the child, the sett<strong>in</strong>g forwhich they are to be used, <strong>and</strong> the tool’s psychometricproperties (e.g., validity <strong>and</strong> reliability) <strong>in</strong> that context(13,14,35,65–67). Such factors should be taken <strong>in</strong>toconsideration when mak<strong>in</strong>g choices about which acutepa<strong>in</strong> measurement tool to use.Despite the proliferation <strong>and</strong> availability of tools,they are not always used consistently or well (68–70)<strong>and</strong> <strong>in</strong>consistencies have been identified betweenreported assessment practice <strong>and</strong> documented practice(3,26,27,29,71).The follow<strong>in</strong>g provides a brief guide to some of thebest evaluated <strong>and</strong> commonly used tools <strong>in</strong> currentcl<strong>in</strong>ical practice. The tools are broadly divided <strong>in</strong>toself-report <strong>and</strong> observational/behavioral tools <strong>and</strong> thenfurther subdivided <strong>in</strong>to their suitability for type of pa<strong>in</strong>(acute procedural, postoperative, or disease-related)<strong>and</strong>/or sett<strong>in</strong>g. Brief <strong>in</strong>formation of the <strong>in</strong>tended ageranges for which the tool has been developed <strong>and</strong>/or<strong>in</strong>formation on the ages for which the tool has beenvalidated are presented (look at the data extractiontables for more <strong>in</strong>formation on each measure’s psychometricproperties <strong>and</strong> relevant studies).3.2.1 Self-report tools (5 years <strong>and</strong> above)The most psychometrically sound <strong>and</strong> feasible selfreporttools, based on age/developmental level <strong>and</strong> typeof pa<strong>in</strong>, have been recommended for use <strong>in</strong> cl<strong>in</strong>ical trials(marked * below) (13). However, other tools, while notnecessarily suitable for cl<strong>in</strong>ical trials, have been shownto have good cl<strong>in</strong>ical utility <strong>and</strong> have been validated.<strong>Procedural</strong> pa<strong>in</strong>l Wong <strong>and</strong> Baker FACES Pa<strong>in</strong> Scale (72): <strong>in</strong>tendedfor 3–18 year olds.l Faces Pa<strong>in</strong> Scale-Revised* (44): see also (43,73):<strong>in</strong>tended for 4–12 year olds.12 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


<strong>Postoperative</strong> pa<strong>in</strong>l NCCPC-PV (Non-Communicat<strong>in</strong>g Children’s Pa<strong>in</strong>Checklist – <strong>Postoperative</strong> Version) (100): <strong>in</strong>tended for3–19 year olds.l PPP (The Pediatric Pa<strong>in</strong> Profile) (101): <strong>in</strong>tended for1–18 year olds.• Revised FLACC (50): <strong>in</strong>tended for 4–19 year olds.Parent report of their child’s postoperative pa<strong>in</strong><strong>in</strong>tensityThe most psychometrically sound <strong>and</strong> feasible parentreport tool, based on age/developmental level <strong>and</strong> typeof pa<strong>in</strong>, has been recommended for use <strong>in</strong> cl<strong>in</strong>ical trials(13). However, this may not necessarily directly transferto cl<strong>in</strong>ical utility <strong>and</strong> more research is needed.• PPPM (Parents <strong>Postoperative</strong> Pa<strong>in</strong> Measure) (95);see also (96,97).3.2.3 Physiological measuresPhysiological parameters such as heart rate variability,sk<strong>in</strong> conductance, <strong>and</strong> changes <strong>in</strong> salivary cortisol canbe used <strong>in</strong>directly to <strong>in</strong>dicate the presence of pa<strong>in</strong> (103–106). However, blood pressure, heart rate, <strong>and</strong> respiratoryrate have been shown to be unreliable <strong>in</strong>dicators <strong>in</strong>newborns, <strong>in</strong>fants, <strong>and</strong> young children with wide <strong>in</strong>ter<strong>in</strong>dividualbehavior–physiology correlations after majorsurgery <strong>in</strong> 0–3-year-old <strong>in</strong>fants (16). More recently, themagnitude of evoked cortical activity has been suggestedas a possible <strong>in</strong>dicator of pa<strong>in</strong> (107). While the methodappears promis<strong>in</strong>g <strong>and</strong> correlations with other pa<strong>in</strong>measures have been found to be good, similarly to themeasurement of other physiological parameters such ascortisol changes, it has limited cl<strong>in</strong>ical utility. It is questionablewhether the pa<strong>in</strong> experience can be mean<strong>in</strong>gfullyreduced to physiological activation alone;therefore, physiological measures should be used <strong>in</strong> conjunctionwith other tools/measures to determ<strong>in</strong>e thepresence <strong>and</strong> <strong>in</strong>tensity of pa<strong>in</strong>.References1 F<strong>in</strong>ley GA, Franck L, Grunau R et al. WhyChildren’s Pa<strong>in</strong> Matters. Seattle, WA: IASP,2005.2 Howard R. Current status of pa<strong>in</strong> management<strong>in</strong> children. JAMA 2003; 290: 2464–2469.3 Taylor EM, Boyer K, Campbell FA. Pa<strong>in</strong> <strong>in</strong>hospitalized children: a prospective crosssectionalsurvey of pa<strong>in</strong> prevalence, <strong>in</strong>tensity,assessment <strong>and</strong> management <strong>in</strong> a Canadianpediatric teach<strong>in</strong>g hospital. Pa<strong>in</strong> ResManag 2008; 13: 25–32.4 Walter-Nicolet E, Annequ<strong>in</strong> D, Biran V etal. Pa<strong>in</strong> management <strong>in</strong> newborns: fromprevention to treatment. Paediatr Drugs2010; 12: 353–365.5 An<strong>and</strong> KJ, Ar<strong>and</strong>a JV, Berde CB et al. Summaryproceed<strong>in</strong>gs from the neonatal pa<strong>in</strong>controlgroup. Pediatrics 2006; 117: S9–S22.6 Prevention <strong>and</strong> <strong>Management</strong> of Pa<strong>in</strong> <strong>and</strong>Stress <strong>in</strong> the Newborn. Committee on Fetus<strong>and</strong> Newborn Canadian Pediatric Society.Pediatrics 2000; 105: 454–461.7 Improv<strong>in</strong>g Services for Children <strong>in</strong> Hospital.London: Commission for Healthcare Audit<strong>and</strong> Inspection UK, 2007.8 Mac<strong>in</strong>tyre PE, Schug SA, Scott DA et al.Acute Pa<strong>in</strong> <strong>Management</strong>: Scientific Evidence(3rd edition). 3rd edition edn. Melbourne:Work<strong>in</strong>g Group of the Australian <strong>and</strong> NewZeal<strong>and</strong> College of Anaesthetists <strong>and</strong>Faculty of Pa<strong>in</strong> Medic<strong>in</strong>e, 2010.9 Stapelkamp C, Carter B, Gordon J et al.Assessment of acute pa<strong>in</strong> <strong>in</strong> children:development of evidence-based guidel<strong>in</strong>es.Int J Evid Based Healthc 2011; 9: 39–50.10 Cl<strong>in</strong>ical Guidel<strong>in</strong>es for the Recognition <strong>and</strong>Assessment of Acute Pa<strong>in</strong> <strong>in</strong> Children.Royal College of Nurs<strong>in</strong>g Institute, 2009.Available at: www.rcn.org.uk/childrenspa<strong>in</strong>guidel<strong>in</strong>e.11 Guidel<strong>in</strong>es for <strong>Good</strong> <strong>Practice</strong>: Recognition<strong>and</strong> Assessment of Acute Pa<strong>in</strong> <strong>in</strong> Children.London: RCPCH, 2001.12 Cohen LL, La Greca AM, Blount RL et al.Introduction to special issue: evidence-basedassessment <strong>in</strong> pediatric psychology. J PediatrPsychol 2008; 33: 911–915.13 St<strong>in</strong>son J, Kavanagh T, Yamada J et al.Systematic review of the psychometric properties,<strong>in</strong>terpretability <strong>and</strong> feasibility of selfreportpa<strong>in</strong> <strong>in</strong>tensity measures for use <strong>in</strong>cl<strong>in</strong>ical trials <strong>in</strong> children <strong>and</strong> adolescents.Pa<strong>in</strong> 2006; 125: 143–157.14 von Baeyer C, Spagrud L. Systematic reviewof observational (behavioral) measures ofpa<strong>in</strong> for children <strong>and</strong> adolescents aged 3 to18 years. Pa<strong>in</strong> 2007; 127: 140–150.15 von Baeyer CL, Forsyth SJ, Stanford EAet al. Response biases <strong>in</strong> preschoolchildren’s rat<strong>in</strong>gs of pa<strong>in</strong> <strong>in</strong> hypotheticalsituations. Eur J Pa<strong>in</strong> 2009; 13: 209–213.16 Buttner W, F<strong>in</strong>cke W. Analysis of behavioural<strong>and</strong> physiological parameters for theassessment of postoperative analgesicdem<strong>and</strong> <strong>in</strong> newborns, <strong>in</strong>fants <strong>and</strong> young children.Paediatr Anaesth 2000; 10: 303–318.17 van Dijk M, de Boer JB, Koot HM et al.The association between physiological <strong>and</strong>behavioral pa<strong>in</strong> measures <strong>in</strong> 0-to 3-year-old<strong>in</strong>fants after major surgery. J Pa<strong>in</strong> SymptomManage 2001; 22: 600–609.18 Howard R. Plann<strong>in</strong>g for pa<strong>in</strong> relief. In: L<strong>in</strong>dahlS, ed. Cl<strong>in</strong>ical Anaesthesiology: PaediatricAnaesthesia. London: Bailliere T<strong>in</strong>dall,1996: 657–676.19 Salantera S, Lauri S, Salmi T et al. Nurses’knowledge about pharmacological <strong>and</strong> nonpharmacologicalpa<strong>in</strong> management <strong>in</strong> children.J Pa<strong>in</strong> Symptom Manage 1999; 18:289–299.20 Samuels JG, Fetzer S. Development of theSamuels scale to rate pa<strong>in</strong> management documentation.Pa<strong>in</strong> Manag Nurs 2008; 9: 166–170.21 Furyk J, Sumner M. Pa<strong>in</strong> score documentation<strong>and</strong> analgesia: a comparison of children<strong>and</strong> adults with appendicitis. Emerg MedAustralas 2008; 20: 482–487.22 Faries JE, Mills DS, Goldsmith KW et al.Systematic pa<strong>in</strong> records <strong>and</strong> their impact onpa<strong>in</strong> control – a pilot-study. Cancer Nurs1991; 14: 306–313.23 Treadwell MJ, Franck LS, Vich<strong>in</strong>sky E.Us<strong>in</strong>g quality improvement strategies toenhance pediatric pa<strong>in</strong> assessment. IntJ Qual Health Care 2002; 14: 39–47.24 Stomberg WM, Lorentzen P, Joelsson H etal. <strong>Postoperative</strong> pa<strong>in</strong> management on surgicalwards-impact of database documentation14 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


of anesthesia organized services. Pa<strong>in</strong>Manag Nurs 2003; 4: 155–164.25 McJunk<strong>in</strong>s A, Green A, An<strong>and</strong> KJS. Pa<strong>in</strong>assessment <strong>in</strong> cognitively impaired, functionallyimpaired children: pilot study results.J Pediatr Nurs 2010; 25: 307–309.26 Harrison D, Loughnan P, Johnston L. Pa<strong>in</strong>assessment <strong>and</strong> procedural pa<strong>in</strong> managementpractices <strong>in</strong> neonatal units <strong>in</strong> Australia.J Paediatr Child Health 2006; 42: 6–9.27 Smyth W, Toombes J, Usher K. Children’spostoperative pro re nata (PRN) analgesia:nurses’ adm<strong>in</strong>istration practices. ContempNurse 2011; 37: 160–172.28 Price A, Ong J, Isedale G et al. Document<strong>in</strong>g<strong>and</strong> treat<strong>in</strong>g acute pa<strong>in</strong> <strong>in</strong> children.Emerg Nurse 2011; 19: 18–20.29 Stevens BJ, Abbott LK, Yamada J et al.Epidemiology <strong>and</strong> management of pa<strong>in</strong>fulprocedures <strong>in</strong> children <strong>in</strong> Canadian hospitals.Can Med Assoc J 2011; 183: E403–E410.30 Kohler H, Schulz S, Wiebalck A. Pa<strong>in</strong> management<strong>in</strong> children: assessment <strong>and</strong> documentation<strong>in</strong> burn units. Eur J Pediatr Surg2001; 11: 40–43.31 Simons J, Moseley L. Influences on nurses’scor<strong>in</strong>g of children’s post-operative pa<strong>in</strong>.J Child Health Care 2009; 13: 101–115.32 Shrestha-Ranjit JM, Manias E. Pa<strong>in</strong> assessment<strong>and</strong> management practices <strong>in</strong> childrenfollow<strong>in</strong>g surgery of the lower limb. J Cl<strong>in</strong>Nurs 2010; 19: 118–128.33 Falanga IJ, Lafrenaye S, Mayer SK et al.<strong>Management</strong> of acute pa<strong>in</strong> <strong>in</strong> children:safety <strong>and</strong> efficacy of a nurse-controlledalgorithm for pa<strong>in</strong> relief. Acute Pa<strong>in</strong> 2006;8: 45–54.34 Rajasagaram U, Taylor DM, Braitberg G etal. Paediatric pa<strong>in</strong> assessment: differencesbetween triage nurse, child <strong>and</strong> parent.J Paediatr Child Health 2009; 45: 199–203.35 von Baeyer CL. Children’s self-report ofpa<strong>in</strong> <strong>in</strong>tensity: scale selection, limitations<strong>and</strong> <strong>in</strong>terpretation. Pa<strong>in</strong> Res Manage 2006;11: 157–162.36 Stanford E, Chambers C, Craig K. The roleof developmental factors <strong>in</strong> predict<strong>in</strong>gyoung children’s use of a self-report scalefor pa<strong>in</strong>. Pa<strong>in</strong> 2006; 120: 16–23.37 de C Williams AC, Davies HT, Chadury Y.Simple pa<strong>in</strong> rat<strong>in</strong>g scales hide complex idiosyncraticmean<strong>in</strong>gs. Pa<strong>in</strong> 2000; 85: 457–463.38 Azize PM, Humphreys A, Cattani A. Theimpact of language on the expression <strong>and</strong>assessment of pa<strong>in</strong> <strong>in</strong> children. Intensive CritCare Nurs 2011; 27: 235–243.39 Fortier MA, Anderson CT, Ka<strong>in</strong> ZN. Ethnicitymatters <strong>in</strong> the assessment <strong>and</strong> treatmentof children’s pa<strong>in</strong>. Pediatrics 2009;124: 378–380.40 Hodg<strong>in</strong>s MJ. Interpret<strong>in</strong>g the mean<strong>in</strong>g ofpa<strong>in</strong> severity scores. [Review] [59 refs]. Pa<strong>in</strong>Res Manage 2002; 7: 192–198.41 Champion D, <strong>Good</strong>enough B, von BaeyerC et al. In: F<strong>in</strong>ley G, McGrath P, eds.Measurement of Pa<strong>in</strong> <strong>in</strong> Infants <strong>and</strong>Children. Seattle, WA: IASP Press, 1998:123–155.42 Chambers C, Johnston C. Developmentaldifferences <strong>in</strong> children’s use of rat<strong>in</strong>g scales.J Pediatr Psychol 2002; 27: 27–36.43 <strong>Good</strong>enough B, Addicoat L, Champion Get al. Pa<strong>in</strong> <strong>in</strong> 4- to 6-year-old childrenreceiv<strong>in</strong>g <strong>in</strong>tramuscular <strong>in</strong>jections: a comparisonof the Faces Pa<strong>in</strong> Scale with otherself-report <strong>and</strong> behavioral measures. Cl<strong>in</strong> JPa<strong>in</strong> 1997; 13: 60–73.44 Hicks C, von BC, Spafford P et al. TheFaces Pa<strong>in</strong> Scale-Revised: toward a commonmetric <strong>in</strong> pediatric pa<strong>in</strong> measurement.Pa<strong>in</strong> 2001; 93: 173–183.45 Decruynaere C, Thonnard JL, Plaghki L.How many response levels do children dist<strong>in</strong>guishon faces scales for pa<strong>in</strong> assessment?Eur J Pa<strong>in</strong> 2009; 13: 641–648.46 Voepel-Lewis T, Burke CN, Jeffreys N et al.Do 0-10 numeric rat<strong>in</strong>g scores translate <strong>in</strong>tocl<strong>in</strong>ically mean<strong>in</strong>gful pa<strong>in</strong> measures for children?Anesth Analg 2011; 112: 415–421.47 Simons J, Roberson E. Poor communication<strong>and</strong> knowledge deficits: obstacles to effectivemanagement of children’s postoperativepa<strong>in</strong>. J Adv Nurs 2002; 40: 78–86.48 Schultz M, Loughran-Fowlds A, Spence K.Neonatal pa<strong>in</strong>: a comparison of the beliefs<strong>and</strong> practices of junior doctors <strong>and</strong> currentbest evidence. J Paediatr Child Health 2010;46: 23–28.49 Polkki T, Korhonen A, Laukkala H et al.Nurses’ attitudes <strong>and</strong> perceptions of pa<strong>in</strong>assessment <strong>in</strong> neonatal <strong>in</strong>tensive care. Sc<strong>and</strong>J Car<strong>in</strong>g Sci 2010; 24: 49–55.50 Malviya S, Voepel-Lewis T, Burke C et al.The revised FLACC observational pa<strong>in</strong>tool: improved reliability <strong>and</strong> validity forpa<strong>in</strong> assessment <strong>in</strong> children with cognitiveimpairment. Pediatr Anesth 2006; 16: 258–265.51 Zhou H, Roberts P, Horgan L. Associationbetween self-report pa<strong>in</strong> rat<strong>in</strong>gs of child <strong>and</strong>parent, child <strong>and</strong> nurse <strong>and</strong> parent <strong>and</strong>nurse dyads: meta-analysis. J Adv Nurs2008; 63: 334–342.52 Boyd RJ, Stuart P. The efficacy of structuredassessment <strong>and</strong> analgesia provision <strong>in</strong>the paediatric emergency department. EmergMed J 2005; 22: 30–32.53 Johnston CC, Gagnon A, Rennick J et al.One-on-one coach<strong>in</strong>g to improve pa<strong>in</strong>assessment <strong>and</strong> management practices ofpediatric nurses. J Pediatr Nurs 2007; 22:467–478.54 Craig KD, Lilley CM, Gilbert CA. Socialbarriers to optimal pa<strong>in</strong> management <strong>in</strong><strong>in</strong>fants <strong>and</strong> children. Cl<strong>in</strong> J Pa<strong>in</strong> 1996; 12:232–242.55 Pillai Riddell RR, Horton RE, Hillgrove Jet al. Underst<strong>and</strong><strong>in</strong>g caregiver judgments of<strong>in</strong>fant pa<strong>in</strong>: contrasts of parents, nurses <strong>and</strong>pediatricians. Pa<strong>in</strong> Res Manag 2008; 13:489–496.56 Walker SM, Franck LS, Fitzgerald M et al.Long-term impact of neonatal <strong>in</strong>tensive care<strong>and</strong> surgery on somatosensory perception <strong>in</strong>children born extremely preterm. Pa<strong>in</strong> 2009;141: 79–87.57 Cignacco E, Hamers JPH, Stoffel L et al.Rout<strong>in</strong>e procedures <strong>in</strong> NICUs: factors <strong>in</strong>fluenc<strong>in</strong>gpa<strong>in</strong> assessment <strong>and</strong> rank<strong>in</strong>g by pa<strong>in</strong><strong>in</strong>tensity. Swiss Med Wkly 2008; 138: 484–491.58 Breau L, McGrath P, Stevens B et al. Judgmentsof pa<strong>in</strong> <strong>in</strong> the neonatal <strong>in</strong>tensive caresett<strong>in</strong>g: a survey of direct care staffs’ perceptionsof pa<strong>in</strong> <strong>in</strong> <strong>in</strong>fants at risk for neurologicalimpairment. Cl<strong>in</strong> J Pa<strong>in</strong> 2006; 22: 122–129.59 Breau L, MacLaren J, McGrath P et al.Caregivers’ beliefs regard<strong>in</strong>g pa<strong>in</strong> <strong>in</strong> childrenwith cognitive impairment: relation betweenpa<strong>in</strong> sensation <strong>and</strong> reaction <strong>in</strong>creases withseverity of impairment. Cl<strong>in</strong> J Pa<strong>in</strong> 2003;19: 335–344.60 Kankkunen P, Vehvila<strong>in</strong>en-Julkunen K, PietilaA et al. Parents’ perceptions <strong>and</strong> use ofanalgesics at home after children’s day surgery.Paediatr Anaesth 2003; 13: 132–140.61 Polkki T, Vehvila<strong>in</strong>en-Julkunen K, PietilaA. Parents’ roles <strong>in</strong> us<strong>in</strong>g non-pharmacologicalmethods <strong>in</strong> their child’s postoperativepa<strong>in</strong> alleviation. J Cl<strong>in</strong> Nurs 2002; 11: 526–536.62 Simons J, Franck L, Roberson E. Parent<strong>in</strong>volvement <strong>in</strong> children’s pa<strong>in</strong> care: views ofparents <strong>and</strong> nurses. J Adv Nurs 2001; 36:591–599.63 Rony RYZ, Fortier MA, Chorney JM et al.Parental postoperative pa<strong>in</strong> management:attitudes, assessment, <strong>and</strong> management.Pediatrics 2010; 125: e1372–e1378.64 Voepel-Lewis T, Malviya S, Tait A. Validityof parent rat<strong>in</strong>gs as proxy measures of pa<strong>in</strong><strong>in</strong> children with cognitive impairment. Pa<strong>in</strong>Manag Nurs 2005; 6: 168–174.65 Merkel SMS, Voepel-Lewis T, MalviyaSMD. Pa<strong>in</strong> assessment <strong>in</strong> <strong>in</strong>fants <strong>and</strong> youngchildren: the FLACC Scale: a behavioraltool to measure pa<strong>in</strong> <strong>in</strong> young children.Am J Nurs 2002; 102: 55–58.66 Mathew PJ, Mathew JL. Assessment <strong>and</strong>management of pa<strong>in</strong> <strong>in</strong> <strong>in</strong>fants. PostgradMed J 2003; 79: 438–443.67 Breau LM, Burkitt C. Assess<strong>in</strong>g pa<strong>in</strong> <strong>in</strong>children with <strong>in</strong>tellectual disabilities. Pa<strong>in</strong>Res Manage 2009; 14: 116–120.ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 15


68 Broome ME, Richtsmeier A, Maikler V etal. Pediatric pa<strong>in</strong> practices: a national surveyof health professionals. J Pa<strong>in</strong> SymptomManage 1996; 11: 312–320.69 Franck LS, Bruce E. Putt<strong>in</strong>g pa<strong>in</strong> assessment<strong>in</strong>to practice: why is it so pa<strong>in</strong>ful? Pa<strong>in</strong>Res Manag 2009; 14: 13–20.70 Karl<strong>in</strong>g M, Renstrom M, Ljungman G.Acute <strong>and</strong> postoperative pa<strong>in</strong> <strong>in</strong> children:a Swedish nationwide survey. Acta Paediatr2002; 91: 660–666.71 Simons J, MacDonald LM. Chang<strong>in</strong>g practice:implement<strong>in</strong>g validated paediatric pa<strong>in</strong>assessment tools. J Child Health Care 2006;10: 160–176.72 Wong D, Baker C. Pa<strong>in</strong> <strong>in</strong> children: comparisonof assessment scales. Pediatr Nurs1988; 14: 9–17.73 Hunter M, McDowell L, Hennessy R et al.An evaluation of the Faces Pa<strong>in</strong> Scale withyoung children. J Pa<strong>in</strong> Symptom Manage2000; 20: 122–129.74 Hester N. The preoperational child’s reactionto immunizations. Nurs Res 1979; 28:250–255.75 Hester NO, Foster R, Kristensen K. Measurementof pa<strong>in</strong> <strong>in</strong> children – generalizability<strong>and</strong> validity of the pa<strong>in</strong> ladder <strong>and</strong> thepoker chip tool. Adv Pa<strong>in</strong> Res Ther 1990;15: 79–84.76 St-Laurent-Gagnon T, Bernard-Bonn<strong>in</strong> A,Villeneuve E. Pa<strong>in</strong> evaluation <strong>in</strong> preschoolchildren <strong>and</strong> by their parents. Acta Paediatr1999; 88: 422–427.77 Blount RL, Loiselle KA. Behaviouralassessment of pediatric pa<strong>in</strong>. Pa<strong>in</strong> ResManag 2009; 14: 47–52.78 Stevens B, Gibb<strong>in</strong>s S. Cl<strong>in</strong>ical utility <strong>and</strong>cl<strong>in</strong>ical significance <strong>in</strong> the assessment <strong>and</strong>management of pa<strong>in</strong> <strong>in</strong> vulnerable <strong>in</strong>fants.Cl<strong>in</strong> Per<strong>in</strong>atol 2002; 29: 459.79 Stevens B, Johnston C, Petryshen P et al.Premature <strong>in</strong>fant pa<strong>in</strong> profile:development<strong>and</strong> <strong>in</strong>itial validation. Cl<strong>in</strong> J Pa<strong>in</strong> 1996; 12:13–22.80 Ballantyne M, Stevens B, McAllister Met al. Validation of the premature <strong>in</strong>fantpa<strong>in</strong> profile <strong>in</strong> the cl<strong>in</strong>ical sett<strong>in</strong>g. Cl<strong>in</strong>J Pa<strong>in</strong> 1999; 15: 297–303.81 Jonsdottir RB, Kristjansdottir G. The sensitivityof the premature <strong>in</strong>fant pa<strong>in</strong> profile- PIPP to measure pa<strong>in</strong> <strong>in</strong> hospitalizedneonates. J Eval Cl<strong>in</strong> Pract 2005; 11: 598–605.82 Krechel S, Bildner J. CRIES: a new neonatalpostoperative pa<strong>in</strong> measurement score:<strong>in</strong>itial test<strong>in</strong>g of validity <strong>and</strong> relaibility.Anesthesiology 1995; 5: 53.83 Grunau RE, Oberl<strong>and</strong>er T, Holsti L et al.Bedside application of the Neonatal FacialCod<strong>in</strong>g System <strong>in</strong> pa<strong>in</strong> assessment of prematureneonates. Pa<strong>in</strong> 1998; 76: 277–286.84 Grunau R, Craig K. Pa<strong>in</strong> expression <strong>in</strong> neonates:facial action <strong>and</strong> cry. Pa<strong>in</strong> 1987; 28:395–410.85 McNair C, Ballantyne M, Dionne K et al.<strong>Postoperative</strong> pa<strong>in</strong> assessment <strong>in</strong> the neonatal<strong>in</strong>tensive care unit. Arch Dis Child FetalNeonatal Ed 2004; 89: F537–F541.86 Ambuel B, Hamlett K, Marx C et al.Assess<strong>in</strong>g distress <strong>in</strong> pediatric <strong>in</strong>tensive careenvironments: the COMFORT scale. J PediatrPsychol 1992; 17: 95–109.87 Caljouw MAA, Kloos MAC, Olivier MYet al. Measurement of pa<strong>in</strong> <strong>in</strong> premature<strong>in</strong>fants with a gestational age between 28 to37 weeks: validation of the adapted COM-FORT scale. J Neonatal Nurs 2007; 13: 13–18.88 van Dijk M, de Boer J, Koot H et al. Thereliability <strong>and</strong> validity of the COMFORTscale as a postoperative pa<strong>in</strong> <strong>in</strong>strument <strong>in</strong> 0to 3-year-old <strong>in</strong>fants. Pa<strong>in</strong> 2000; 84: 367–377.89 Merkel S, Voepel-Lewis T, Shayevitz J et al.The FLACC: a behavioral scale for scor<strong>in</strong>gpostoperative pa<strong>in</strong> <strong>in</strong> young children. PediatrNurs 1997; 23: 293–297.90 Manworren RCB, Hynan LS. Cl<strong>in</strong>ical validationof FLACC: preverbal patient pa<strong>in</strong>scale. Pediatr Nurs 2003; 29: 140–146.91 Voepel-Lewis T, Malviya S, Merkel S et al.Behavioral pa<strong>in</strong> assessment <strong>and</strong> the face,legs, activity, cry <strong>and</strong> consolability <strong>in</strong>strument.Expert Rev Pharmacoecon OutcomesRes 2003; 3: 317–325.92 Voepel-Lewis TMSN, Malviya SMD, MerkelSMSN et al. Reliability <strong>and</strong> validity ofthe FLACC behavioral scale as a measureof pa<strong>in</strong> <strong>in</strong> cognitively impaired children.[Miscellaneous]. ASA Annual Meet<strong>in</strong>gAbstracts Pediatric Anesthesia 2001; 95:A1229.93 McGrath P, Johnson G, <strong>Good</strong>man J et al.CHEOPS: a behavioral scale for rat<strong>in</strong>g postoperativepa<strong>in</strong> <strong>in</strong> children. Adv Pa<strong>in</strong> ResTher 1985; 9: 395–402.94 Spl<strong>in</strong>ter WM, Semelhago LC, Chou S. Thereliability <strong>and</strong> validity of a modified cheopspa<strong>in</strong> score. Anesth Analg 1994; 78: U220.95 Chambers C, Reid G, McGrath P et al.Development <strong>and</strong> prelim<strong>in</strong>ary validation ofa postoperative pa<strong>in</strong> measure for parents.Pa<strong>in</strong> 1996; 68: 307–313.96 Chambers CT, F<strong>in</strong>ley GA, McGrath PJet al. The parents’ postoperative pa<strong>in</strong> measure:replication <strong>and</strong> extension to 2-6-yearoldchildren. Pa<strong>in</strong> 2003; 105: 437–443.97 F<strong>in</strong>ley GA, Chambers CT, McGrath PJet al. Construct validity of the parents’ postoperativepa<strong>in</strong> measure. Cl<strong>in</strong> J Pa<strong>in</strong> 2003;19: 329–334.98 Breau L, McGrath P, Camfield C et al. Prelim<strong>in</strong>aryvalidation of an observational pa<strong>in</strong>checklist for persons with cognitive impairments<strong>and</strong> <strong>in</strong>ability to communicate verbally.Dev Med Child Neurol 2000; 42: 609–616.99 Breau LM, Camfield C, McGrath PJ et al.Measur<strong>in</strong>g pa<strong>in</strong> accurately <strong>in</strong> children withcognitive impairments: ref<strong>in</strong>ement of a caregiverscale. J Pediatr 2001; 138: 721–727.100 Breau L, F<strong>in</strong>ley G, McGrath P et al. Validationof the non-communicat<strong>in</strong>g children’spa<strong>in</strong> checklist-postoperative version. Anesthesiology2002; 96: 528–535.101 Hunt A, Goldman A, Seers K et al. Cl<strong>in</strong>icalvalidation of the paediatric pa<strong>in</strong> profile. DevMed Child Neurol 2004; 46: 9–18.102 Whitelaw A, Evans D, Carter M et al. R<strong>and</strong>omizedcl<strong>in</strong>ical trial of prevention ofhydrocephalus after <strong>in</strong>traventricular hemorrhage<strong>in</strong> preterm <strong>in</strong>fants: bra<strong>in</strong>-wash<strong>in</strong>g versustapp<strong>in</strong>g fluid. Pediatrics 2007; 119:e1071–e1078.103 Choo EK, Magruder W, Montgomery CJet al. Sk<strong>in</strong> conductance fluctuations correlatepoorly with postoperative self-reportpa<strong>in</strong> measures <strong>in</strong> school-aged children.Anesthesiology 2010; 113: 175–182.104 Hunt A, Wisbeach A, Seers K et al. Developmentof the paediatric pa<strong>in</strong> profile: roleof video analysis <strong>and</strong> saliva cortisol <strong>in</strong> validat<strong>in</strong>ga tool to assess pa<strong>in</strong> <strong>in</strong> children withsevere neurological disability. J Pa<strong>in</strong> SymptomManage 2007; 33: 276–289.105 Sweet S, McGrath P. Physiological measuresof pa<strong>in</strong>. In: F<strong>in</strong>ley GA, McGrath PJ, eds.Measurement of Pa<strong>in</strong> <strong>in</strong> Infants <strong>and</strong> Children.Seattle, WA: IASP Press, 1998: 59–81.106 Walco GA, Conte PM, Labay LE et al.<strong>Procedural</strong> distress <strong>in</strong> children with cancer:self-report, behavioral observations, <strong>and</strong>physiological parameters. Cl<strong>in</strong> J Pa<strong>in</strong> 2005;21: 484–490.107 Slater R, Cantarella A, Franck L et al. Howwell do cl<strong>in</strong>ical pa<strong>in</strong> assessment tools reflectpa<strong>in</strong> <strong>in</strong> <strong>in</strong>fants? PLoS Med 2008; 5: e129.108 Fitzpatrick R, Davey C, Buxton MJ et al.Evaluat<strong>in</strong>g patient-based outcome measuresfor use <strong>in</strong> cl<strong>in</strong>ical trials. Health TechnolAssess 1998; 2: i–iv. 1–74.109 Stre<strong>in</strong>er DL, Norman GR. Health MeasurementScales: A Practical Guide to TheirDevelopment <strong>and</strong> Use, 3rd edn. Oxford:Oxford University Press, 2005: 327–330.110 Guyatt GH, Deyo RA, Charlson M et al.Responsiveness <strong>and</strong> validity <strong>in</strong> health statusmeasurement: a clarification. J Cl<strong>in</strong> Epidemiol1989; 42: 403–408.111 Portney GL, Watk<strong>in</strong>s MP. Statistical Measuresof Reliability, 2nd edn. Upper SaddleRiver, NJ: Prentice-Hall, 2000: 570–586112 Liang MH. Longitud<strong>in</strong>al construct validity:establishment of cl<strong>in</strong>ical mean<strong>in</strong>g <strong>in</strong> patientevaluative <strong>in</strong>struments. Med Care 2000; 38:II84–II90.16 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


Section 4.0Medical ProceduresContents4.1 General considerations4.2 <strong>Procedural</strong> pa<strong>in</strong> <strong>in</strong> the neonate4.2.1 Blood sampl<strong>in</strong>g4.2.2 Ocular exam<strong>in</strong>ation for ret<strong>in</strong>opathy of prematurity4.2.3 Lumbar puncture4.2.4 Ur<strong>in</strong>e sampl<strong>in</strong>g4.2.5 Chest dra<strong>in</strong> (tube) <strong>in</strong>sertion <strong>and</strong> removal (see 4.3.3)4.2.6 Nasogastric tube placement (see 4.3.5)4.2.7 Immunization <strong>and</strong> <strong>in</strong>tramuscular <strong>in</strong>jection4.3 <strong>Procedural</strong> pa<strong>in</strong> <strong>in</strong> <strong>in</strong>fants <strong>and</strong> older children4.3.1 Blood sampl<strong>in</strong>g <strong>and</strong> <strong>in</strong>travenous cannulation4.3.2 Lumbar puncture4.3.3 Chest dra<strong>in</strong> (tube) <strong>in</strong>sertion <strong>and</strong> removal4.3.4 Bladder catheterization <strong>and</strong> ur<strong>in</strong>e sampl<strong>in</strong>g procedures4.3.5 Insertion of nasogastric tubes4.3.6 Immunization <strong>and</strong> <strong>in</strong>tramuscular <strong>in</strong>jection4.3.7 Repair of lacerations4.3.8 Change of dress<strong>in</strong>gs <strong>in</strong> children with burns4.3.9 Botul<strong>in</strong>um <strong>in</strong>jections for children with muscle spasm4.1 General considerationsRout<strong>in</strong>e medical care <strong>in</strong>volv<strong>in</strong>g blood sampl<strong>in</strong>g <strong>and</strong>other pa<strong>in</strong>ful diagnostic <strong>and</strong> therapeutic procedurescan cause great distress for children <strong>and</strong> their families.When such procedures are essential, it is importantthat they should be achieved with as little pa<strong>in</strong> as possible.For many children who have chronic illness,these procedures often need to be repeated, <strong>and</strong> thiscan generate very high levels of anxiety <strong>and</strong> distress iftheir previous experience has been poor. The 10 generalpr<strong>in</strong>ciples, which apply to the management of allprocedures at any age, are listed below. Further advicefor use <strong>in</strong> specific age-groups, <strong>and</strong> specifically for someof the most common procedures, is described <strong>in</strong> sections4.2 <strong>and</strong> 4.3.1. Infants <strong>and</strong> children of all ages, <strong>in</strong>clud<strong>in</strong>g prematureneonates, are capable of feel<strong>in</strong>g pa<strong>in</strong> <strong>and</strong> require analgesiafor pa<strong>in</strong>ful procedures.2. Developmental differences <strong>in</strong> the response to pa<strong>in</strong><strong>and</strong> analgesic efficacy should be considered whenplann<strong>in</strong>g analgesia.3. Consider whether the planned procedure is necessary,<strong>and</strong> how the <strong>in</strong>formation it will provide might<strong>in</strong>fluence care? Avoid multiple procedures if possible.4. Plan the tim<strong>in</strong>g of procedures to m<strong>in</strong>imize the frequencyof a pa<strong>in</strong>ful procedure.5. Are sedation or even general anesthesia likely to berequired for a safe <strong>and</strong> satisfactory outcome?6. Would modification of the procedure reduce pa<strong>in</strong>?For example, venepuncture is less pa<strong>in</strong>ful than heellance.7. Is the planned environment suitable? Ideally, thisshould be a quiet, calm place with suitable toys <strong>and</strong>distractions.8. Ensure that appropriate personnel who possess thenecessary skills are available, <strong>and</strong> enlist experiencedhelp when necessary.9. Allow sufficient time for analgesic drugs <strong>and</strong> otheranalgesic measures to be effective.10. Formulate a clear plan of action should the procedurefail or pa<strong>in</strong> become unmanageable us<strong>in</strong>g the techniquesselected.<strong>Good</strong> practice po<strong>in</strong>tPa<strong>in</strong> management for procedures should <strong>in</strong>clude bothpharmacological <strong>and</strong> nonpharmacological strategieswhenever possible.4.2 <strong>Procedural</strong> pa<strong>in</strong> <strong>in</strong> the neonatePremature neonates are able to perceive pa<strong>in</strong>, but theresponse to both pa<strong>in</strong> <strong>and</strong> analgesia is dependant ondevelopmental age. Because of this, pa<strong>in</strong> assessment <strong>in</strong>this age-group is particularly difficult (see section 3),<strong>and</strong> the low sensitivity of many pa<strong>in</strong> measurementtools can complicate the <strong>in</strong>terpretation of evidence.Cl<strong>in</strong>ically, neonates appear to be sensitive to theadverse effects of many drugs, <strong>in</strong>clud<strong>in</strong>g analgesics;ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 17


however, reductions <strong>in</strong> the response to pa<strong>in</strong> have beenobserved follow<strong>in</strong>g nontraditional analgesia such assucrose <strong>and</strong> physical <strong>and</strong> environmental measures, forexample, suckl<strong>in</strong>g or tactile stimulation, which are currentlynot known to have potentially harmful effects.A number of documents <strong>in</strong>clud<strong>in</strong>g reviews, guidel<strong>in</strong>e,<strong>and</strong> policy statements have been published recently onthe subject of procedural pa<strong>in</strong> management <strong>in</strong> the neonate(1–4). On the basis of the currently available evidence,the follow<strong>in</strong>g measures can be generallyrecommended for the management of procedural pa<strong>in</strong><strong>in</strong> the neonate:RecommendationsBreast-feed<strong>in</strong>g should be encouraged dur<strong>in</strong>g the procedure,if feasible: Grade A (5–9).Nonpharmacological measures <strong>in</strong>clud<strong>in</strong>g non-nutritivesuck<strong>in</strong>g, ‘kangaroo care’, swaddl<strong>in</strong>g/facilitated tuck<strong>in</strong>g,tactile stimulation, <strong>and</strong> heel massage can be used forbrief procedures: Grade A (5,6,10–30).4.2.1 Blood sampl<strong>in</strong>g <strong>in</strong> the neonate(<strong>in</strong>cludes peripheral venous, arterial, <strong>and</strong>percutaneous central venous cannulation)Blood sampl<strong>in</strong>g is a necessary <strong>and</strong> rout<strong>in</strong>e part of neonatalcare. Where an <strong>in</strong>dwell<strong>in</strong>g arterial catheter is notavailable, then venepuncture (VP) or heel prick bloodsampl<strong>in</strong>g (HPBS) is used. All newborn babies <strong>in</strong> theUK have a HPBS as part of the UK screen<strong>in</strong>g regime.Neonates admitted to <strong>in</strong>tensive care or who are caredfor on postnatal wards will require frequent bloodsampl<strong>in</strong>g that has been identified <strong>in</strong> many studies as asignificant cause of pa<strong>in</strong> <strong>and</strong> morbidity. HPBS requiresappropriate tra<strong>in</strong><strong>in</strong>g <strong>and</strong> is used to collect small bloodsamples such as blood glucose, bilirub<strong>in</strong> newbornscreen<strong>in</strong>g tests, <strong>and</strong> capillary blood gases. VP alsorequires tra<strong>in</strong><strong>in</strong>g but is technically more difficult <strong>and</strong> isused to collect larger blood samples. The pr<strong>in</strong>ciples<strong>and</strong> techniques of pa<strong>in</strong> relief are applicable to other<strong>in</strong>vasive procedures such as peripheral arterial l<strong>in</strong>e<strong>in</strong>sertion <strong>and</strong> percutaneous central venous catheters(i.e., long l<strong>in</strong>e). Please also see sections 4.0 <strong>and</strong> 4.1 onthe general management of procedural pa<strong>in</strong>.RecommendationsSucrose or other sweet solutions can be used: Grade A(5,6,10–18,22,29,31–40).Nonpharmacological measures <strong>in</strong>clud<strong>in</strong>g tactile stimulation,breast-feed<strong>in</strong>g, non-nutritive suck<strong>in</strong>g, ‘kangaroocare’, <strong>and</strong> massage of the heel can be used for heel prickblood sampl<strong>in</strong>g: Grade A (12,19–28,30).Venepuncture (by a tra<strong>in</strong>ed practitioner) is preferred toheel lance for larger samples as it is less pa<strong>in</strong>ful: GradeA (18,41–43).Topical local anesthetics alone are <strong>in</strong>sufficient for heellance pa<strong>in</strong>: Grade A (44,45).Topical local anesthetics can be used for venepuncturepa<strong>in</strong>: Grade B (44–47).Us<strong>in</strong>g the whole plantar surface of the heel reduces thepa<strong>in</strong> of heel prick blood sampl<strong>in</strong>g: Grade B (48,49).Remifentanil <strong>and</strong> sucrose decreased central venous catheterpa<strong>in</strong>: Grade B: (36).Topical tetraca<strong>in</strong>e plus morph<strong>in</strong>e is superior to topicalanalgesia alone for central venous catheter pa<strong>in</strong> <strong>in</strong> ventilated<strong>in</strong>fants: Grade B (50,51).EvidenceA large number of studies have demonstrated thatsucrose before VP or HPBS reduces the behavioralpa<strong>in</strong> scores measured by a range of validated assessments(5,6,10–18,22,29,31–40,52). The dose of sucrosediffered across these studies.Reliev<strong>in</strong>g the pa<strong>in</strong> of HPBS has been challeng<strong>in</strong>gwith pharmacological methods. However, nonpharmacologicalmethods <strong>in</strong>clud<strong>in</strong>g breast-feed<strong>in</strong>g, non-nutritivesuck<strong>in</strong>g, kangaroo care, <strong>and</strong> premassage of theheel before <strong>and</strong> dur<strong>in</strong>g HPBS have consistently demonstratedreduced behavioral pa<strong>in</strong> scores <strong>and</strong> physiologicalmarkers (12,19–28).VP appears to be less pa<strong>in</strong>ful than HPBS so is thepreferred option whenever practical (18,41,43). Topicallocal anesthesia (LA) can reduce the pa<strong>in</strong> of VP <strong>and</strong><strong>in</strong>sertion of central venous catheters (44–46,51,53).However, topical LA is not effective for HPBS (45).Morph<strong>in</strong>e with topical LA was more effective than LAalone for central venous l<strong>in</strong>e placement <strong>in</strong> ventilatedneonates (50,51). In addition, low-dose remifentanilcomb<strong>in</strong>ed with sucrose reduced the pa<strong>in</strong> of <strong>in</strong>sertion ofcentral venous catheters (36).HPBS pa<strong>in</strong> can be reduced with procedure modificationsuch as us<strong>in</strong>g an automated spr<strong>in</strong>g-loaded device,avoid<strong>in</strong>g squeez<strong>in</strong>g the heel, <strong>and</strong> us<strong>in</strong>g a wider area ofthe plantar surface of the heel (48,49,54–56).18 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


Analgesia Table 4.2.1aBlood sampl<strong>in</strong>g <strong>and</strong> peripheral cannulation <strong>in</strong> the neonateDirectevidenceLocal anesthesia Topical 1+Sucrose 1++Nonpharmacological 1+Procedure modifications 1+Analgesia Table 4.2.1bPercutaneous central venous catheter <strong>in</strong>sertionDirectevidenceIndirectevidenceIndirectevidenceLocal anesthesia a Topical 1+Opioids Intravenous 1+Sucrose a 1+ 1++a Comb<strong>in</strong>ed with Opioids.4.2.2 Ocular exam<strong>in</strong>ation for ret<strong>in</strong>opathy of prematurityPreterm <strong>in</strong>fants ‘at risk’ of ret<strong>in</strong>opathy of prematurity(ROP) should have regular ocular exam<strong>in</strong>ation. Aneyelid speculum is <strong>in</strong>serted to hold the eye open, <strong>and</strong>the ret<strong>in</strong>a is exam<strong>in</strong>ed by <strong>in</strong>direct fundoscopy througha dilated pupil. In addition, a small proportion willrequire laser ablation of significant disease.RecommendationsSucrose may contribute to pa<strong>in</strong> response reduction <strong>in</strong>exam<strong>in</strong>ation for ret<strong>in</strong>opathy: Grade A (57–60).Infants undergo<strong>in</strong>g exam<strong>in</strong>ation for ret<strong>in</strong>opathy shouldreceive local anesthetic drops <strong>in</strong> comb<strong>in</strong>ation with othermeasures if an eyelid speculum is used: Grade B (61–65).Swaddl<strong>in</strong>g, developmental care, non-nutritive suck<strong>in</strong>g,<strong>and</strong> pacifier should be considered for neonates undergo<strong>in</strong>gexam<strong>in</strong>ation for ret<strong>in</strong>opathy: Grade B(57,60,63,66).Laser treatment should be with general anesthesia iftimely treatment is needed: Grade D (63).EvidenceA comb<strong>in</strong>ed analgesic approach us<strong>in</strong>g LA, a pacifier,swaddl<strong>in</strong>g, <strong>and</strong> the addition of a sweet solution islikely to be most effective for ROP screen<strong>in</strong>g exam<strong>in</strong>ationpa<strong>in</strong> (57,65). Oral sucrose prior to the screenreduced the behavioral pa<strong>in</strong> scores <strong>in</strong> small groupsof <strong>in</strong>fants (59,60). Laser treatment is pa<strong>in</strong>ful, <strong>and</strong>appropriate pa<strong>in</strong>-reliev<strong>in</strong>g strategies should beemployed (63). Laser treatment may be more rapidlyavailable if sedation, analgesia, ventilation, <strong>and</strong>muscle relaxation are possible on the neonatal unit(63). See section 6.7 for further <strong>in</strong>formation on theuse of sucrose.Analgesia Table 4.2.2 Ret<strong>in</strong>opathy of prematurityLocal anesthesia Topical 1+Sucrose 1+Non-nutritive suck<strong>in</strong>g 1+Comfort care package 1)Directevidence4.2.3 Lumbar puncture (LP) <strong>in</strong> the neonateIndirectevidenceSampl<strong>in</strong>g of cerebrosp<strong>in</strong>al fluid is often regarded as am<strong>in</strong>or procedure <strong>in</strong> <strong>in</strong>fants; nevertheless, it is associatedwith pa<strong>in</strong> that can be reduced by suitable analgesia(67).RecommendationTopical local anesthesia is effective <strong>in</strong> reduc<strong>in</strong>g lumbarpuncture pa<strong>in</strong>: Grade A (67,68).EvidenceThere have been few studies directly <strong>in</strong>vestigat<strong>in</strong>g LPpa<strong>in</strong> <strong>in</strong> the neonate. Topical local anesthetic hasbeen found to be effective (67). Indirect evidencesuggests that subcutaneous <strong>in</strong>filtration of LA wouldalso be effective, but it has not been ‘consistently’shown to be superior to placebo <strong>in</strong> the neonate, <strong>in</strong>contrast to positive effects <strong>in</strong> older children <strong>and</strong>adults (69). A nomogram of weight to midsp<strong>in</strong>aldepth allows estimation of the depth of <strong>in</strong>sertion ofan LP needle (70,71). This has been correlated withª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 19


<strong>in</strong>creased success rate (i.e., less red cell contam<strong>in</strong>ation).Analgesia Table 4.2.3 Lumbar puncture <strong>in</strong> the neonateDirectevidenceIndirectevidenceLocal anesthesia Topical 1+Infiltration a 1+Sucrose 1++Non-nutritive suck<strong>in</strong>g 1+Nonpharmacological 1+Procedure Modification 2+Analgesia Table 4.2.4 Ur<strong>in</strong>e sampl<strong>in</strong>g <strong>in</strong> the neonateDirectevidenceIndirectevidence1+Local anesthesia Topicallubricant gel aSucrose 1) 1++Non-nutritive suck<strong>in</strong>g 1+Nonpharmacological 1+Procedure modification a 1+a Urethral catheterization.a Older children <strong>and</strong> adults.4.2.4 Ur<strong>in</strong>e sampl<strong>in</strong>g <strong>in</strong> the neonateUr<strong>in</strong>e sampl<strong>in</strong>g can be important to detect ur<strong>in</strong>arytract <strong>in</strong>fection <strong>in</strong> neonates <strong>and</strong> must be collectedavoid<strong>in</strong>g sample contam<strong>in</strong>ation. Direct catheterizationof the urethra or catheterization of the bladderby the percutaneous suprapubic route is often preferredbecause some types of ur<strong>in</strong>e collection bagshave a high rate of contam<strong>in</strong>ation, <strong>and</strong> ‘clean catch’specimens can be difficult or time-consum<strong>in</strong>g to collect.RecommendationsTransurethral catheterization with local anesthetic gel ispreferred as it is less pa<strong>in</strong>ful than suprapubic catheterizationwith topical local anesthesia: Grade B (72,73).Sucrose reduces the pa<strong>in</strong> response to urethral catheterization:Grade C (74).EvidencePa<strong>in</strong> responses were observed <strong>in</strong> neonates <strong>and</strong> <strong>in</strong>fantshav<strong>in</strong>g either urethral or suprapubic catheterizationwith local anesthesia (72). Transurethral catheterizationappeared to be less pa<strong>in</strong>ful (72). Sucrose analgesiaimmediately before bladder catheterization <strong>in</strong> neonates<strong>and</strong> <strong>in</strong>fants up to 3 months old was not effective atabolish<strong>in</strong>g pa<strong>in</strong> responses; however, a reduction <strong>in</strong>response was observed <strong>in</strong> the subgroup of those


Analgesia Table 4.2.6 Nasogastric tube <strong>in</strong>sertionDirect evidenceSucrose 1+ 1++Non-nutritive suck<strong>in</strong>g 1+Nonpharmacological 1+Indirect evidence4.2.7 Immunization <strong>and</strong> <strong>in</strong>tramuscular <strong>in</strong>jectionThe management of this procedure is also discussedwith that of older children <strong>in</strong> section 4.3.6. There aretwo <strong>in</strong>dications for IM <strong>in</strong>jections: rout<strong>in</strong>e immunization<strong>and</strong> adm<strong>in</strong>istration of vitam<strong>in</strong> K. In any other situation,an alternative route of adm<strong>in</strong>istration shouldbe used. The UK rout<strong>in</strong>e immunization scheduleadvises that vacc<strong>in</strong>ations are given at 2, 3, <strong>and</strong>4 months of age. A premature neonate born at


Newer preparations such as liposomal encapsulatedLA or newer LA delivery systems may offeradvantages <strong>in</strong> some situations. Buffered <strong>in</strong>jected LA,for example, lidoca<strong>in</strong>e + bicarbonate 10:1, adm<strong>in</strong>isteredwith a f<strong>in</strong>e 30-g needle subcutaneously prior tocannulation is faster <strong>in</strong> onset <strong>and</strong> may be as acceptable<strong>and</strong> effective as topical preparations (81,82,88).Nitrous oxide (50–70%) <strong>in</strong>halation has been used <strong>in</strong>children older than 6 years who can self-adm<strong>in</strong>isterdur<strong>in</strong>g venepuncture <strong>in</strong> some circumstances. 70%nitrous oxide is not rout<strong>in</strong>ely available for selfadm<strong>in</strong>istration<strong>in</strong> the UK. 50% nitrous oxide <strong>and</strong>EMLA have been shown to be equally effective forvenepuncture with further improvements <strong>in</strong> pa<strong>in</strong> reductionus<strong>in</strong>g a comb<strong>in</strong>ation of the two (79,89).The efficacy of vapocoolant topical spray has notbeen clearly established. Vapocoolant spray was noteffective <strong>in</strong> reduc<strong>in</strong>g pa<strong>in</strong> <strong>in</strong> one study of <strong>in</strong>travenouscannulation but did show a modest reduction <strong>in</strong> pa<strong>in</strong> <strong>in</strong>a later study (90,91). In a study of children’s preferences,children who had experienced both methodsselected both ethyl chloride <strong>and</strong> Ametop Ò equally (92).A comb<strong>in</strong>ation of cool<strong>in</strong>g <strong>and</strong> vibration (Buzzy Ò ) withor without LA reduced pa<strong>in</strong> <strong>and</strong> distress of venepuncture<strong>in</strong> one study (93).Psychological approaches such as distraction shouldbe offered to all children as it is easy to adm<strong>in</strong>ister.Hypnosis can also be very effective for children requir<strong>in</strong>grepeated <strong>in</strong>terventions (83,86).Analgesia Table 4.3.1Blood sampl<strong>in</strong>g <strong>and</strong> IV cannulation <strong>in</strong> childrenDirectevidenceLocal anesthesia Topical 1++Infiltration 1++50% nitrous oxide/oxygen 1+Psychological preparation 1)Psychological <strong>in</strong>tervention 1++4.3.2 Lumbar puncture <strong>in</strong> childrenLumbar puncture (LP) is necessary <strong>in</strong> acutely ill children<strong>in</strong> whom men<strong>in</strong>gitis is suspected. These childrenare likely to be unwell <strong>and</strong> anxious, <strong>and</strong> they may alsoundergo other pa<strong>in</strong>ful procedures such as venepunctureas part of diagnosis <strong>and</strong> treatment.Other children require ‘elective’ or ‘planned’ LP:This may be for diagnostic reasons, such as evaluationof possible raised <strong>in</strong>tracranial pressure, or for <strong>in</strong>trathecaltreatments such as chemotherapy.Position<strong>in</strong>g of the child is very important for success,<strong>and</strong> it is helpful to have assistance from tra<strong>in</strong>edstaff with experience of correct position<strong>in</strong>g. Childrenwho require multiple LPs may cope better with theaddition of sedation (see NICE Guidel<strong>in</strong>e CG112‘Sedation <strong>in</strong> Children <strong>and</strong> Young People’ available at:http://www.nice.org.uk/CG112) or general anesthesia.See also section 4.0 <strong>and</strong> 4.2 on the general managementof pa<strong>in</strong>ful procedures.RecommendationsBehavioral techniques of pa<strong>in</strong> management should beused to reduce LP pa<strong>in</strong>: Grade A (85,94).Topical LA <strong>and</strong> LA <strong>in</strong>filtration are effective for LP pa<strong>in</strong><strong>and</strong> do not decrease success rates: Grade B (82,95,96).50% nitrous oxide/oxygen should be offered to childrenwill<strong>in</strong>g <strong>and</strong> able to cooperate: Grade C (97).EvidenceFew studies have directly exam<strong>in</strong>ed the efficacy of analgesics<strong>in</strong> awake children undergo<strong>in</strong>g lumbar puncture.Most commonly, local anesthesia is comb<strong>in</strong>ed with sedativeagents, such as midazolam, or biobehavioral techniques,such as distraction or other cognitive–behavioral<strong>in</strong>terventions (85,94,95,98), is effective for LP pa<strong>in</strong>, <strong>and</strong>may also be used <strong>in</strong> comb<strong>in</strong>ation with LA (either topicalor <strong>in</strong>filtration) <strong>and</strong> other strategies (97). Ketam<strong>in</strong>e analgesia/sedationor general anesthesia is sometimes used <strong>in</strong>emergency departments <strong>and</strong> oncology units with appropriatefacilities (99–101). However, recent studies <strong>in</strong>dicatethat analgesia practice for LP <strong>in</strong> emergencydepartments could be improved (102,103). It seemslikely that older children, especially those who may onlyneed to undergo this procedure once, may tolerate LPwith appropriate behavioral techniques <strong>and</strong> local anesthesia,whereas children requir<strong>in</strong>g multiple LPs shouldbe offered sedation or GA (98).There is some evidence that technique modificationus<strong>in</strong>g pencil po<strong>in</strong>t needles <strong>in</strong>stead of st<strong>and</strong>ard needlesmay reduce the <strong>in</strong>cidence of post-LP headaches(104).Analgesia Table 4.3.2 Lumbar puncture <strong>in</strong> childrenDirectevidenceLocal anesthesia Topical 1+Infiltration 1)50% nitrous oxide/oxygen 2+Psychological <strong>in</strong>terventions 1++Indirectevidence22 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


4.3.3 Chest dra<strong>in</strong> (tube) <strong>in</strong>sertion <strong>and</strong> removalChest dra<strong>in</strong>s are necessary <strong>in</strong> children with pneumothorax,empyema, pleural effusions, follow<strong>in</strong>g chest trauma<strong>and</strong> surgery. Pediatricians are most likely to need to<strong>in</strong>sert chest dra<strong>in</strong>s <strong>in</strong> the Neonatal Intensive Care Unitto <strong>in</strong>fants with pneumothorax. This procedure isbecom<strong>in</strong>g <strong>in</strong>creas<strong>in</strong>gly rare because of improvements <strong>in</strong>the management of Respiratory Distress Syndrome, e.g.the use of surfactant <strong>and</strong> ventilat<strong>in</strong>g <strong>in</strong>fants at lowerpressures. Older children require dra<strong>in</strong>s for managementof empyema or for pneumothorax. Chest dra<strong>in</strong>shave become easier to <strong>in</strong>sert recently with the developmentof small-bore Seld<strong>in</strong>ger-type dra<strong>in</strong>s that reducethe need for blunt dissection of the chest wall: They areavailable for both neonates <strong>and</strong> older children.Sedation (see NICE Guidel<strong>in</strong>e CG112 ‘Sedation <strong>in</strong>Children <strong>and</strong> Young People’ available at: http://www.nice.org.uk/CG112) or general anesthesia shouldbe considered for chest dra<strong>in</strong> <strong>in</strong>sertion; however, <strong>in</strong> anemergency, some children may tolerate this procedureus<strong>in</strong>g <strong>in</strong>filtration of buffered LA.Studies agree that chest dra<strong>in</strong> removal also causessignificant pa<strong>in</strong>. No s<strong>in</strong>gle analgesic strategy has beenshown to satisfactorily alleviate this pa<strong>in</strong> <strong>in</strong> children,<strong>and</strong> it is likely that the optimum effects will beachieved us<strong>in</strong>g a comb<strong>in</strong>ation of strategies.See also section 4.0 <strong>and</strong> 4.2 for advice on the generalmanagement of pa<strong>in</strong>ful procedures.<strong>Good</strong> practice po<strong>in</strong>tsFor chest dra<strong>in</strong> <strong>in</strong>sertion, consider general anesthesiaor sedation comb<strong>in</strong>ed with subcutaneous <strong>in</strong>filtration ofbuffered lidoca<strong>in</strong>e. Selection of appropriate dra<strong>in</strong> typemay reduce pa<strong>in</strong> by facilitat<strong>in</strong>g easy <strong>in</strong>sertion.For chest dra<strong>in</strong> removal, consider a comb<strong>in</strong>ation oftwo or more strategies known to be effective for pa<strong>in</strong>fulprocedures such as psychological <strong>in</strong>terventions,sucrose or pacifier (<strong>in</strong> neonates), opioids, nitrousoxide, <strong>and</strong> NSAIDs. 1EvidenceThere is little published evidence look<strong>in</strong>g at analgesicoptions for chest dra<strong>in</strong> <strong>in</strong>sertion or removal. Chestdra<strong>in</strong> <strong>in</strong>sertion may require general anesthesia or sedation<strong>in</strong> comb<strong>in</strong>ation with LA <strong>in</strong>filtration. Analgesia forremoval of chest dra<strong>in</strong>s has <strong>in</strong>cluded IV opioid, localanesthetics, <strong>and</strong> NSAIDs, but despite the use of these1 It is important to allow enough time for the chosen agent to reach theirpeak effect <strong>and</strong> to use adequate doses (105).analgesics, significant pa<strong>in</strong> is still reported (106,107).Inhalation agents such as nitrous oxide or isofluranemay have a role <strong>in</strong> these procedures, but further studyis needed (108,109). N.B. Nitrous oxide is contra<strong>in</strong>dicated<strong>in</strong> the presence of pneumothorax. Multimodaltherapy, for example, IV morph<strong>in</strong>e, nitrous oxide, topicalLA, <strong>and</strong> NSAID, is likely to be superior to a s<strong>in</strong>gleagent, but such comb<strong>in</strong>ations, although <strong>in</strong> cl<strong>in</strong>icaluse, have not been studied.Analgesia Table 4.3.3 Chest dra<strong>in</strong> <strong>in</strong>sertion <strong>and</strong> removalDirectevidenceIndirectevidenceLA: buffered lidoca<strong>in</strong>e <strong>in</strong>filtration (<strong>in</strong>sertion) 1++LA: topicala (removal) 1+Opioids a (removal) 1+NSAIDS a (removal) 1+50% nitrous oxide a,b (removal) 1)Psychological <strong>in</strong>terventions 1++Procedure modification (<strong>in</strong>sertion) 3a May reduce but not abolish pa<strong>in</strong> of chest dra<strong>in</strong> removal.b Contra<strong>in</strong>dicated <strong>in</strong> the presence of pneumothorax.4.3.4 Bladder catheterization <strong>and</strong> related ur<strong>in</strong>esampl<strong>in</strong>g proceduresUr<strong>in</strong>e specimens are usually obta<strong>in</strong>ed by ‘clean catch’ ormidstream specimen (MSU). Ur<strong>in</strong>e may be obta<strong>in</strong>edfrom young <strong>in</strong>fants by means of suprapubic aspirate(SPA). Sampl<strong>in</strong>g by urethral catheterization appears tobe less pa<strong>in</strong>ful than SPA (72,110). Bladder catheterizationmay be required for radiological or other <strong>in</strong>vestigationof the renal tract, for example, micturat<strong>in</strong>gcystourethrogram (MCUG) also known as void<strong>in</strong>g cystourethrogram(VCUG). Consider whether MCUG isreally necessary – it is a distress<strong>in</strong>g procedure for thechild <strong>and</strong> other less <strong>in</strong>vasive techniques, such as dynamicrenal scann<strong>in</strong>g may provide the same <strong>in</strong>formation.Bladder catheterization may also be required <strong>in</strong> childrenwho develop ur<strong>in</strong>ary retention, particularly thosereceiv<strong>in</strong>g epidural analgesia postoperatively. Very illpatients <strong>in</strong> ICU may also require catheterization tomonitor ur<strong>in</strong>e output. For children who are to receivepostoperative epidural opioids after major surgery,consider ‘prophylactic’ bladder catheterization undergeneral anesthesia at the time of surgery.Sedation may also be <strong>in</strong>dicated for some children; seeNICE Guidel<strong>in</strong>e CG112 ‘Sedation <strong>in</strong> Children <strong>and</strong>Young People’ available at http://www.nice.org.uk/CG112 for advice on sedation practice, <strong>and</strong> sections 4.0<strong>and</strong> 4.2 on the general management of procedural pa<strong>in</strong>.ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 23


<strong>Good</strong> practice po<strong>in</strong>tLubricant conta<strong>in</strong><strong>in</strong>g local anesthesia should beapplied to the urethral mucosa prior to bladdercatheterization.RecommendationsPsychological preparation <strong>and</strong> psychological <strong>and</strong> behavioral<strong>in</strong>terventions should be used dur<strong>in</strong>g bladder catheterization<strong>and</strong> <strong>in</strong>vasive <strong>in</strong>vestigations of the renal tract:Grade B (111,112).Infants: Consider procedure modification as urethralcatheterization is less pa<strong>in</strong>ful than SPA for ur<strong>in</strong>e sampl<strong>in</strong>g:Grade B (72,73).EvidenceBladder catheterization has been shown to cause significantpa<strong>in</strong> <strong>and</strong> distress, but analgesia is not part of rout<strong>in</strong>ecare <strong>in</strong> many <strong>in</strong>stitutions (113). More complex<strong>in</strong>terventions, which <strong>in</strong>clude bladder catheterizationssuch as MCUG or VCUG, have also been shown tocause significant distress, which can be reduced by psychologicalpreparation <strong>and</strong> behavioral pa<strong>in</strong> managementtechniques such as distraction or hypnosis(111,112,114). Local anesthetics <strong>in</strong>corporated <strong>in</strong>to lubricantgels are frequently used <strong>in</strong> adults to reduce the pa<strong>in</strong><strong>and</strong> discomfort of catheterization, but this has not beenwell studied <strong>in</strong> children. Pretreatment of the urethrawith lidoca<strong>in</strong>e 10 m<strong>in</strong> before catheterization reducedpa<strong>in</strong> <strong>in</strong> a group of children (16 girls, four boys) with amean age of 7.7 years (115). However, <strong>in</strong> younger children(mean age 2 years), application of lidoca<strong>in</strong>e gel tothe ‘genital mucosa’ for only 2–3 m<strong>in</strong> before the procedure<strong>and</strong> its subsequent use as a lubricant did notdecrease pa<strong>in</strong> (113). Techniques comb<strong>in</strong><strong>in</strong>g adequatepreparation, local anesthesia, <strong>and</strong> behavioral <strong>in</strong>terventionsare likely to be more effective (116).Analgesia Table 4.3.4Bladder catheterization <strong>and</strong> ur<strong>in</strong>e sampl<strong>in</strong>g <strong>in</strong> childrenDirectevidenceLocal anesthesia Topical gel a 1+50% nitrous oxide 1+Psychological preparation 1+Psychological <strong>in</strong>tervention 1+Procedure modification b 1+a Applied 10 m<strong>in</strong> before catheterization.b Urethral catheterization <strong>in</strong>stead of SPA.Indirectevidence4.3.5 Nasogastric tube <strong>in</strong>sertionSee also sections 4.1, 4.2 <strong>and</strong> 4.3 for advice on the generalmanagement of pa<strong>in</strong>ful procedures <strong>in</strong> neonates,<strong>in</strong>fants, <strong>and</strong> children <strong>and</strong> 4.2.7 for NGT <strong>in</strong>sertion <strong>in</strong>neonates. NGT <strong>in</strong>sertion is a pa<strong>in</strong>ful <strong>and</strong> distress<strong>in</strong>gprocedure frequently performed with little attention topa<strong>in</strong>-reliev<strong>in</strong>g strategies (75). Infants who are unwell<strong>and</strong> unable to feed, particularly those with respiratoryproblems such as bronchiolitis, may need to be ‘tubefed’ for a short period. NGT is often ma<strong>in</strong>ta<strong>in</strong>ed <strong>in</strong> thepostoperative period <strong>and</strong> may need to be re-<strong>in</strong>serted ifthey become displaced. Older children may also be fedvia NGT, for example, <strong>in</strong> patients with cystic fibrosiswho sometimes require supplementary feed<strong>in</strong>g on multipleoccasions. Clearly, it is particularly important tooptimize pa<strong>in</strong> management <strong>in</strong> those patients who arelikely to need repeated NGT placement.Pass<strong>in</strong>g a NGT is a skilled procedure, <strong>and</strong> <strong>in</strong> theUK, the Department of Health has published guidel<strong>in</strong>es(CMO Update no.39, publ DoH, UK; NPSA/2007/19), which should be followed.<strong>Good</strong> practice po<strong>in</strong>tTopical local anesthetics such as lubricant gel conta<strong>in</strong><strong>in</strong>glidoca<strong>in</strong>e, applied prior to placement, are likely toreduce the pa<strong>in</strong> <strong>and</strong> discomfort of NGT <strong>in</strong>sertion.EvidenceNGT <strong>in</strong>sertion has been little studied <strong>in</strong> children. In theadult, topical local anesthesia <strong>and</strong> lubricants have beenshown to reduce pa<strong>in</strong> <strong>and</strong> facilitate placement (117–119). 10% nebulized lidoca<strong>in</strong>e is also effective <strong>in</strong> adultsbut may also slightly <strong>in</strong>crease the <strong>in</strong>cidence of epistaxis(120). A recent RCT did not f<strong>in</strong>d any benefit from nebulizedlidoca<strong>in</strong>e <strong>in</strong> children between 1 <strong>and</strong> 5 years (121).The additional use of vasoconstrictors such as topicalphenylephr<strong>in</strong>e or coca<strong>in</strong>e may reduce this risk, f<strong>in</strong>d<strong>in</strong>gsthat have not been confirmed <strong>in</strong> children. Indirect evidencealso suggests that the use of psychological/behavioraltechniques may be of benefit <strong>in</strong> older children.Analgesia Table 4.3.5 Nasogastric tube <strong>in</strong>sertionDirectevidenceTopical LA 1++Non-nutritive suck<strong>in</strong>g a 1+Tactile stimulation a 1+Psychological preparation 1+Psychological <strong>in</strong>tervention 1+a Infants.Indirectevidence24 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


4.3.6 Immunization <strong>and</strong> <strong>in</strong>tramuscular <strong>in</strong>jectionImmunization schedules result <strong>in</strong> <strong>in</strong>creas<strong>in</strong>g numbersof <strong>in</strong>tramuscular <strong>in</strong>jections be<strong>in</strong>g adm<strong>in</strong>istered to<strong>in</strong>fants <strong>and</strong> children. At 2 <strong>and</strong> 3 months, <strong>in</strong>fants areoffered diphtheria, tetanus, pertussis, hemophilus(Hib), <strong>and</strong> polio immunization as one vacc<strong>in</strong>ation,with a separate men<strong>in</strong>gococcal or pneumococcal vacc<strong>in</strong>e.All 3 are given at 4 months. Children receive furtherimmunizations at 1 year <strong>and</strong> 15 months, aga<strong>in</strong> atpreschool, <strong>and</strong> f<strong>in</strong>ally at school leav<strong>in</strong>g. Intramuscularadm<strong>in</strong>istration of asparag<strong>in</strong>ase to children with leukemia,<strong>and</strong> long-act<strong>in</strong>g penicill<strong>in</strong> therapy are other examples.The pa<strong>in</strong> of these <strong>in</strong>jections is widelyacknowledged <strong>and</strong> contributes to anxiety <strong>in</strong> patients<strong>and</strong> their parents/carers, particularly regard<strong>in</strong>g vacc<strong>in</strong>ations.There is now evidence that such pa<strong>in</strong> may bereduced by a number of strategies. Knowledge thatpractitioners have considered the use of these strategiesmay help parents <strong>in</strong> their decisions about immunization.It is important that treatable pa<strong>in</strong> is not a barrierto the childhood immunization program.See also sections 4.0, 4.1, <strong>and</strong> 4.2 on the generalmanagement of procedural pa<strong>in</strong>.<strong>Good</strong> practice po<strong>in</strong>tIntramuscular <strong>in</strong>jections should be avoided <strong>in</strong> childrenas part of rout<strong>in</strong>e care. If <strong>in</strong>tramuscular <strong>in</strong>jection isunavoidable, pharmacological <strong>and</strong> nonpharmacologicalstrategies should be employed to reduce pa<strong>in</strong>.RecommendationsPsychological strategies such as distraction should beused for <strong>in</strong>fants <strong>and</strong> children undergo<strong>in</strong>g vacc<strong>in</strong>ation:Grade A (85,122–124).Consider additional procedure modifications such as vacc<strong>in</strong>eformulation, order of vacc<strong>in</strong>es (least pa<strong>in</strong>ful first)needle size, depth of <strong>in</strong>jection (25 mm 25 gauge needle),or the use of vapocoolant spay: Grade A (125–132).Swaddl<strong>in</strong>g, breast-feed<strong>in</strong>g or pacifier, <strong>and</strong> sucrose shouldbe considered <strong>in</strong> <strong>in</strong>fants undergo<strong>in</strong>g vacc<strong>in</strong>ation: GradeA (7,78,133,134).EvidenceThere are two phases of immunization pa<strong>in</strong>: the <strong>in</strong>itialpa<strong>in</strong> of the needle pierc<strong>in</strong>g the sk<strong>in</strong> <strong>and</strong> <strong>in</strong>jection of avolume of vacc<strong>in</strong>e <strong>in</strong>to the muscle or subcutaneous tissue,followed by a later phase of soreness <strong>and</strong> swell<strong>in</strong>g atthe vacc<strong>in</strong>ation site because of subsequent <strong>in</strong>flammatoryreaction. Studies have generally <strong>in</strong>vestigated strategiesdesigned to deal with the former, presumably becausethis is perceived to be the most unpleasant component.Children typically dread needle-related pa<strong>in</strong>; the use ofeither nonpharmacological or pharmacological pa<strong>in</strong>reduction strategies may reduce subsequent negativerecall (123). There is good evidence that nonpharmacologicalmethods, particularly distraction, can reduceimmunization pa<strong>in</strong> (85,122,123,135). There is also evidenceof benefit from nonpharmacological strategies <strong>in</strong>neonates <strong>and</strong> young <strong>in</strong>fants


most effective. There are a number of less pa<strong>in</strong>fulalternatives to simple wound suture <strong>in</strong> the awakepatient: Tissue adhesives <strong>in</strong> simple low-tension wounds<strong>and</strong> the hair apposition technique (HAT) <strong>in</strong> scalp lacerationsare examples.Also see section 4.0 <strong>and</strong> 4.2 for general considerations<strong>in</strong> procedural pa<strong>in</strong> management.<strong>Good</strong> practice po<strong>in</strong>tFor extensive wounds or children who are very anxiousconsider sedation or general anesthesia.RecommendationsFor repair of simple low-tension lacerations, tissue adhesivesshould be considered as they are less pa<strong>in</strong>ful, quickto use, <strong>and</strong> have a similar cosmetic outcome to sutures oradhesive sk<strong>in</strong> closures (steri-strips): Grade A (146–148).Topical anesthetic preparations, for example, LAT (lidoca<strong>in</strong>e–adrenal<strong>in</strong>e–tetraca<strong>in</strong>e)if available, can be used <strong>in</strong>preference to <strong>in</strong>jected LA, as they are less pa<strong>in</strong>ful toapply; it is not necessary to use a preparation conta<strong>in</strong><strong>in</strong>gcoca<strong>in</strong>e: Grade A (149–153).Buffer<strong>in</strong>g <strong>in</strong>jected lidoca<strong>in</strong>e with sodium bicarbonateshould be considered: Grade A (88).‘HAT’ should be considered for scalp lacerations. It isless pa<strong>in</strong>ful than sutur<strong>in</strong>g, does not require shav<strong>in</strong>g, <strong>and</strong>produces a similar outcome: Grade B (154).If <strong>in</strong>jected lidoca<strong>in</strong>e is used, pretreatment of the woundwith a topical anesthetic preparation, for example, lidoca<strong>in</strong>e–adrenal<strong>in</strong>e–tetraca<strong>in</strong>e(LAT) gel, reduces the pa<strong>in</strong>of subsequent <strong>in</strong>jection: Grade B (155,156).50% nitrous oxide reduces pa<strong>in</strong> <strong>and</strong> anxiety dur<strong>in</strong>g lacerationrepair: Grade B (157–159).EvidenceLaceration repair has been relatively well studied <strong>in</strong>children. There are a number of alternatives to simplewound suture <strong>in</strong> the awake patient. Tissue adhesives <strong>in</strong>simple low-tension wounds <strong>and</strong> the hair appositiontechnique (HAT) <strong>in</strong> scalp lacerations are less pa<strong>in</strong>fulalternatives (147,154). A number of topical local anestheticmixtures are available; they can give equivalentanalgesia to <strong>in</strong>filtrated local anesthetic <strong>and</strong> are lesspa<strong>in</strong>ful to apply although a recent systematic review <strong>in</strong>adults <strong>and</strong> children concluded that there was <strong>in</strong>sufficientevidence to unreservedly recommend topical LA<strong>in</strong> preference to <strong>in</strong>jected LA (82,153). A systematicreview <strong>in</strong>clud<strong>in</strong>g trials <strong>in</strong> adults <strong>and</strong> children found that‘buffer<strong>in</strong>g’ local anesthetics with sodium bicarbonatesignificantly reduces the pa<strong>in</strong> of <strong>in</strong>jection (88). Nitrousoxide has been shown to be effective <strong>in</strong> reduc<strong>in</strong>g pa<strong>in</strong>,anxiety, <strong>and</strong> distress <strong>in</strong> cooperative children (157,158).See section 6.7 for <strong>in</strong>formation on the use of nitrousoxide. Psychological techniques such as distraction <strong>and</strong>relaxation are also likely to be useful (85).Analgesia Table 4.3.7 Repair of lacerations <strong>in</strong> childrenDirectevidenceIndirectevidenceLocal anesthesia Topical 1++Infiltration 1++Buffered 1++<strong>in</strong>filtration50% nitrous oxide 1+Procedure modification 1++Psychological <strong>in</strong>tervention 1++4.3.8 Dress<strong>in</strong>g changes <strong>in</strong> the burned childChildren with burns often require repeated, oftenextremely pa<strong>in</strong>ful, dress<strong>in</strong>g changes. Children withsevere burns are normally cared for <strong>in</strong> a specialist unit,but some children will be seen <strong>in</strong> Emergency Departments.Initial dress<strong>in</strong>g changes are likely to be performedunder general anesthesia, <strong>and</strong> if childrenrema<strong>in</strong> very distressed, this option may be favored forsubsequent procedures. Sedation is sometimes used tosupplement analgesia for burns dress<strong>in</strong>gs, see NICEGuidel<strong>in</strong>e CG112 ‘Sedation <strong>in</strong> Children <strong>and</strong> YoungPeople’ available at: http://www.nice.org.uk/CG112. Inthe early stages of burn pa<strong>in</strong> management, childrenmay require cont<strong>in</strong>uous <strong>in</strong>fusion of potent opioidssuch as morph<strong>in</strong>e, <strong>and</strong> additional analgesia will berequired prior to dress<strong>in</strong>g changes (160).Both pharmacological <strong>and</strong> nonpharmacological techniquesshould be used <strong>in</strong> the management of pa<strong>in</strong>fuldress<strong>in</strong>g changes, see section 4.0, 4.1, <strong>and</strong> 4.2 for adviceon the general management of pa<strong>in</strong>ful procedures.RecommendationsPotent opioid analgesia given by oral, transmucosal, ornasal routes accord<strong>in</strong>g to patient preference <strong>and</strong> availabilityof suitable preparations should be considered fordress<strong>in</strong>g changes <strong>in</strong> burned children: Grade A (161–164).Nonpharmacological therapies such as distraction <strong>and</strong>relaxation should be considered as part of pa<strong>in</strong> managementfor dress<strong>in</strong>g changes <strong>in</strong> burned children: Grade B(165–170).26 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


EvidenceThe evidence base for manag<strong>in</strong>g burn pa<strong>in</strong> <strong>in</strong> childrenis small <strong>and</strong> <strong>in</strong>complete. Opioids are used extensively<strong>and</strong> should be given as necessary by <strong>in</strong>travenous orother routes (160). There are a number of small studiescompar<strong>in</strong>g different opioid formulations <strong>and</strong> routes ofadm<strong>in</strong>istration, such as transmucosal or <strong>in</strong>tranasal fentanyl,hydromorphone, oxycodone <strong>and</strong> morph<strong>in</strong>e bythe oral route (161–164).There is evidence for distraction with children us<strong>in</strong>ga variety of devices – such as helmet Visual Realitydevices or h<strong>and</strong>-held multimodal devices where thechild is an active participant <strong>in</strong> the game they are play<strong>in</strong>gbe<strong>in</strong>g more effective than st<strong>and</strong>ard distractionwhen burns dress<strong>in</strong>gs are be<strong>in</strong>g changed (168–173).Small studies have <strong>in</strong>vestigated different creams ordress<strong>in</strong>gs with some be<strong>in</strong>g less pa<strong>in</strong>ful – more researchis needed <strong>in</strong> this area (174–176). Nitrous oxide is usedextensively for s<strong>in</strong>gle pa<strong>in</strong>ful procedure <strong>in</strong> childrenwho are able to cooperate; multiple or frequent adm<strong>in</strong>istrationmay lead to bone marrow toxicity. Nitrousoxide has not been directly studied <strong>in</strong> this patientgroup, although there is one small cohort study assess<strong>in</strong>gparent <strong>and</strong> patient satisfaction (177). See section6.7 for more <strong>in</strong>formation on the use of nitrous oxide.4.3.9 Botul<strong>in</strong>um <strong>in</strong>jections for children withmuscle spasmBotul<strong>in</strong>um tox<strong>in</strong> is used to relieve muscle spasm; <strong>in</strong>pediatric practice, this is most often the spasticity associatedwith cerebral palsy. These <strong>in</strong>jections can take along time – usually, multiple sites are chosen, <strong>and</strong>there are three phases to the procedure: <strong>in</strong>itial puncture,localization of correct muscle po<strong>in</strong>t, <strong>and</strong> then<strong>in</strong>jection. There is very little evidence for pa<strong>in</strong> managementstrategies: In practice, many children are likely tobe offered general anesthesia or sedation.One observational study was identified, which <strong>in</strong>vestigatedthe level of pa<strong>in</strong> felt by children undergo<strong>in</strong>gthis procedure with local anesthetic cream <strong>and</strong> 50%nitrous oxide. In this study, half the children experiencedsevere pa<strong>in</strong>, but the rest of the children managedwell with this comb<strong>in</strong>ation (178). Further research isneeded.<strong>Good</strong> practice po<strong>in</strong>t50% nitrous oxide/oxygen should be considered <strong>in</strong> childrenwho are able to cooperate with self-adm<strong>in</strong>istration.Analgesia Table 4.3.9 Botul<strong>in</strong>um tox<strong>in</strong> <strong>in</strong>jectionsAnalgesia Table 4.3.8 Dress<strong>in</strong>g changes <strong>in</strong> burned childDirectevidenceIndirectevidenceDirectevidenceIndirectevidenceOpioids 1++Nitrous oxide a 1++Psychological preparation 1+Psychological <strong>in</strong>tervention 1+50% nitrous oxide 1+Topical LA 1+Psychological preparation 1+Psychological <strong>in</strong>tervention 1+a No data for multiple adm<strong>in</strong>istrations.References1 An<strong>and</strong> KJ, Ar<strong>and</strong>a JV, Berde CB et al.Summary proceed<strong>in</strong>gs from the neonatalpa<strong>in</strong>-control group. Pediatrics 2006; 117:S9–S22.2 Mackenzie A, Acworth J, Norden M et al.Guidel<strong>in</strong>e Statement: <strong>Management</strong> of Procedure-RelatedPa<strong>in</strong> <strong>in</strong> Neonates. Sydney,NSW, Australia: Paediatrics <strong>and</strong> ChildHealth Division RACP, 2005: 24.3 Batton DG, Barr<strong>in</strong>gton KJ, Wallman C.Prevention <strong>and</strong> management of pa<strong>in</strong> <strong>in</strong> theneonate: an update. Pediatrics 2006; 118:2231–2241.4 Lago P, Garetti E, Merazzi D et al. Guidel<strong>in</strong>esfor procedural pa<strong>in</strong> <strong>in</strong> the newborn.Acta Paediatr 2009; 98: 932–939.5 Carbajal R, Veerapen S, Couderc S et al.Analgesic effect of breast feed<strong>in</strong>g <strong>in</strong> termneonates: r<strong>and</strong>omised controlled trial. BMJ2003; 326: 13.6 Shah P, Aliwalas L, Shah V. Breastfeed<strong>in</strong>gor breast milk for procedural pa<strong>in</strong> <strong>in</strong> neonates.Cochrane Database Syst Rev 2006; 3:CD004950.7 Shah V, Taddio A, Rieder MJ. Effectiveness<strong>and</strong> tolerability of pharmacologic <strong>and</strong> comb<strong>in</strong>ed<strong>in</strong>terventions for reduc<strong>in</strong>g <strong>in</strong>jectionpa<strong>in</strong> dur<strong>in</strong>g rout<strong>in</strong>e childhood immunizations:systematic review <strong>and</strong> meta-analyses.Cl<strong>in</strong> Ther 2009; 31(Suppl. 2): S104–S151.8 Agarwal R. Breastfeed<strong>in</strong>g or Breast Milkfor <strong>Procedural</strong> Pa<strong>in</strong> <strong>in</strong> Neonates : RHLCommentary (last revised: 1 June 2011).The WHO Reproductive Health Library.Geneva: World Health Organization(WHO): 2011.9 Holsti L, Oberl<strong>and</strong>er TF, Brant R. Doesbreastfeed<strong>in</strong>g reduce acute procedural pa<strong>in</strong><strong>in</strong> preterm <strong>in</strong>fants <strong>in</strong> the neonatal <strong>in</strong>tensivecare unit? A r<strong>and</strong>omized cl<strong>in</strong>ical trial. Pa<strong>in</strong>2011; 152: 2575–2581.10 Skogsdal Y, Eriksson M, Scholl<strong>in</strong> J. Analgesia<strong>in</strong> newborns given oral glucose. ActaPaediatr 1997; 86: 217–220.11 Carbajal R, Chauvet X, Couderc S et al.R<strong>and</strong>omised trial of analgesic effects ofsucrose, glucose, <strong>and</strong> pacifiers <strong>in</strong> term neonates.BMJ 1999; 319: 1393–1397.ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 27


12 Bellieni C, Bagnoli F, Perrone S et al. Effectof multisensory stimulation on analgesia <strong>in</strong>term neonates: a r<strong>and</strong>omized controlledtrial. Pediatr Res 2002; 51: 460–463.13 Carbajal R, Lenclen R, Gajdos V et al.Crossover trial of analgesic efficacy of glucose<strong>and</strong> pacifier <strong>in</strong> very preterm neonatesdur<strong>in</strong>g subcutaneous <strong>in</strong>jections. Pediatrics2002; 110: 389–393.14 Bauer K, Kettler J, Hellwig M et al. Oralglucose before venepuncture relieves neonatesof pa<strong>in</strong> but stress is still evidenced by<strong>in</strong>crease <strong>in</strong> oxygen consumption, energyexpenditure, <strong>and</strong> heart rate. Pediatr Res2004; 55: 695–700.15 Grad<strong>in</strong> M, F<strong>in</strong>nstrom O, Scholl<strong>in</strong> J. Feed<strong>in</strong>g<strong>and</strong> oral glucose – additive effects onpa<strong>in</strong> reduction <strong>in</strong> newborns. Early Hum Dev2004; 77: 57–65.16 Stevens B, Yamada J, Ohlsson A. Sucrosefor analgesia <strong>in</strong> newborn <strong>in</strong>fants undergo<strong>in</strong>gpa<strong>in</strong>ful procedures. Cochrane Database SystRev 2004; 3: CD001069.17 L<strong>in</strong>g J, Qhah B, Van Rostenberghe H. Thesafety <strong>and</strong> efficacy of oral dextrose forreliev<strong>in</strong>g pa<strong>in</strong> follow<strong>in</strong>g venepuncture <strong>in</strong>neonates. Med J Malaysia 2005; 60: 140–145.18 Ogawa SOT, Fujiwara E, Ito K et al. Venepunctureis preferable to heel lance forblood sampl<strong>in</strong>g <strong>in</strong> term neonates. Arch DisChild Fetal Neonatal Ed 2005; 90: F432–F436.19 Johnston CC, Filion F, Campbell-Yeo Met al. Kangaroo mother care dim<strong>in</strong>ishespa<strong>in</strong> from heel lance <strong>in</strong> very preterm neonates:a crossover trial. BMC Pediatr2008; 8: 13.20 Ferber SG, Makhoul IR. Neurobehaviouralassessment of sk<strong>in</strong>-to-sk<strong>in</strong> effects on reactionto pa<strong>in</strong> <strong>in</strong> preterm <strong>in</strong>fants: a r<strong>and</strong>omized,controlled with<strong>in</strong>-subject trial. ActaPaediatr 2008; 97: 171–176.21 Castrale C, Evans D, Verger C et al. Peritonealdialysis <strong>in</strong> elderly patients: report fromthe French Peritoneal Dialysis Registry(RDPLF). Nephrol Dial Transplant 2010;25: 255–262.22 Weissman A, Aranovitch M, Blazer S et al.Heel-lanc<strong>in</strong>g <strong>in</strong> newborns: behavioral <strong>and</strong>spectral analysis assessment of pa<strong>in</strong> controlmethods. Pediatrics 2009; 124: e921–e926.23 Codipietro L, Ceccarelli M, Ponzone A.Breastfeed<strong>in</strong>g or oral sucrose solution <strong>in</strong>term neonates receiv<strong>in</strong>g heel lance: a r<strong>and</strong>omized,controlled trial. Pediatrics 2008;122: e716–e721.24 Kashan<strong>in</strong>ia Z, Sajedi F, Rahgozar M et al.The effect of Kangaroo Care on behavioralresponses to pa<strong>in</strong> of an <strong>in</strong>tramuscular <strong>in</strong>jection<strong>in</strong> neonates. J Spec Pediatr Nurs 2008;13: 275–280.25 Ja<strong>in</strong> S, Kumar P, McMillan DD. Prior legmassage decreases pa<strong>in</strong> responses to heelstick <strong>in</strong> preterm babies. J Paediatr ChildHealth 2006; 42: 505–508.26 Cong X, Lud<strong>in</strong>gton-Hoe SM, McCa<strong>in</strong> G etal. Kangaroo Care modifies preterm <strong>in</strong>fantheart rate variability <strong>in</strong> response to heelstick pa<strong>in</strong>: pilot study. Early Hum Dev 2009;85: 561–567.27 Ozdogan T, Akman I, Cebeci D et al. Comparisonof two doses of breast milk <strong>and</strong>sucrose dur<strong>in</strong>g neonatal heel prick. PediatrInt 2010; 52: 175–179.28 Kost<strong>and</strong>y RR, Lud<strong>in</strong>gton-Hoe SM, Cong Xet al. Kangaroo Care (sk<strong>in</strong> contact) reducescry<strong>in</strong>g response to pa<strong>in</strong> <strong>in</strong> preterm neonates:pilot results. Pa<strong>in</strong> Manag Nurs 2008; 9: 55–65.29 Stevens B, Yamada J, Ohlsson A. Sucrosefor analgesia <strong>in</strong> newborn <strong>in</strong>fants undergo<strong>in</strong>gpa<strong>in</strong>ful procedures. Cochrane Database SystRev 2010; 1: CD001069.30 Pillai Riddell RR, Rac<strong>in</strong>e NM, Turcotte Ket al. Non-pharmacological management of<strong>in</strong>fant <strong>and</strong> young child procedural pa<strong>in</strong>.Cochrane Database Syst Rev 2011; 10:CD006275.31 Curtis SJ, Jou H, Ali S et al. A r<strong>and</strong>omizedcontrolled trial of sucrose <strong>and</strong>/or pacifier asanalgesia for <strong>in</strong>fants receiv<strong>in</strong>g venipuncture<strong>in</strong> a pediatric emergency department. BMCPediatr 2007; 7: 27.32 Taddio A, Shah V, Katz J. Reduced <strong>in</strong>fantresponse to a rout<strong>in</strong>e care procedure aftersucrose analgesia. Pediatrics 2009; 123:e425–e429.33 Liu MF, L<strong>in</strong> KC, Chou YH et al. Us<strong>in</strong>gnon-nutritive suck<strong>in</strong>g <strong>and</strong> oral glucose solutionwith neonates to relieve pa<strong>in</strong>: a r<strong>and</strong>omisedcontrolled trial. J Cl<strong>in</strong> Nurs 2010; 19:1604–1611.34 Taddio A, Shah V, Hancock R et al. Effectivenessof sucrose analgesia <strong>in</strong> newbornsundergo<strong>in</strong>g pa<strong>in</strong>ful medical procedures.CMAJ 2008; 179: 37–43.35 Hatfield LA. Sucrose decreases <strong>in</strong>fant biobehavioralpa<strong>in</strong> response to immunizations: ar<strong>and</strong>omized controlled trial. J Nurs Scholarsh2008; 40: 219–225.36 Lago P, Tiozzo C, Boccuzzo G et al. Remifentanilfor percutaneous <strong>in</strong>travenous centralcatheter placement <strong>in</strong> preterm <strong>in</strong>fant: a r<strong>and</strong>omizedcontrolled trial. Pediatr Anesth2008; 18: 736–744.37 Gaspardo CM, Miyase CI, Chimello JT etal. Is pa<strong>in</strong> relief equally efficacious <strong>and</strong> freeof side effects with repeated doses of oralsucrose <strong>in</strong> preterm neonates? Pa<strong>in</strong> 2008;137: 16–25.38 Saththasivam P, Umadevan D, Ramli N etal. Venipuncture versus heel prick for bloodglucose monitor<strong>in</strong>g <strong>in</strong> neonates. S<strong>in</strong>gaporeMed J 2009; 50: 1004–1007.39 Elserafy FA, Alsaedi SA, Louwrens J et al.Oral sucrose <strong>and</strong> a pacifier for pa<strong>in</strong> reliefdur<strong>in</strong>g simple procedures <strong>in</strong> preterm <strong>in</strong>fants:a r<strong>and</strong>omized controlled trial. Ann SaudiMed 2009; 29: 184–188.40 Okan F, Coban A, Ince Z et al. Analgesia<strong>in</strong> preterm newborns: the comparativeeffects of sucrose <strong>and</strong> glucose. Eur J Pediatr2007; 166: 1017–1024.41 Logan P. Venepuncture versus heel prickfor the collection of the Newborn Screen<strong>in</strong>gTest. Aust J Adv Nurs 1999; 17: 30–36.42 Shah V, Ohlsson A. Venepuncture versusheel lance for blood sampl<strong>in</strong>g <strong>in</strong> term neonates.Cochrane Database Syst Rev 2004; 4:CD001452.43 Shah VS, Ohlsson A. Venepuncture versusheel lance for blood sampl<strong>in</strong>g <strong>in</strong> term neonates.Cochrane Database Syst Rev 2011; 10:CD001452.44 Taddio A, Ohlsson A, E<strong>in</strong>arson TR et al. Asystematic review of lidoca<strong>in</strong>e-priloca<strong>in</strong>ecream (EMLA) <strong>in</strong> the treatment of acutepa<strong>in</strong> <strong>in</strong> neonates. Pediatrics 1998; 101: E1.45 Ja<strong>in</strong> A, Rutter N. Does topical amethoca<strong>in</strong>egel reduce the pa<strong>in</strong> of venepuncture <strong>in</strong> newborn<strong>in</strong>fants? A r<strong>and</strong>omised double bl<strong>in</strong>dcontrolled trial. Arch Dis Child Fetal NeonatalEd 2000; 83: F207–F210.46 Grad<strong>in</strong> M, Eriksson MGH et al. Pa<strong>in</strong>reduction at venepuncture <strong>in</strong> newborns: oralglucose compared with local anaestheticcream. Paediatrics 2002; 110: 1053–1057.47 Taddio A, Lee C, Yip A et al. Intravenousmorph<strong>in</strong>e <strong>and</strong> topical tetraca<strong>in</strong>e for treatmentof pa<strong>in</strong> <strong>in</strong> [corrected] neonates undergo<strong>in</strong>gcentral l<strong>in</strong>e placement. JAMA 2006;295: 793–800.48 Ja<strong>in</strong> A, Rutter N. Ultrasound study of heelto calcaneum depth <strong>in</strong> neonates. Arch DisChild Fetal Neonatal Ed 1999; 80: F243–F245.49 Arena J, Emparanza JI, Nogues A et al.Sk<strong>in</strong> to calcaneus distance <strong>in</strong> the neonate.Arch Dis Child Fetal Neonatal Ed 2005; 90:F328–f331.50 Lemyre B, Sherlock R, Hogan D et al. Howeffective is tetraca<strong>in</strong>e 4% gel, before aperipherally <strong>in</strong>serted central catheter, <strong>in</strong>reduc<strong>in</strong>g procedural pa<strong>in</strong> <strong>in</strong> <strong>in</strong>fants: a r<strong>and</strong>omizeddouble-bl<strong>in</strong>d placebo controlledtrial [ISRCTN75884221]. BMC Med 2006;4: 11.51 Taddio A, Lee C, Yip A et al. Intravenousmorph<strong>in</strong>e <strong>and</strong> topical tetraca<strong>in</strong>e for treatmentof pa<strong>in</strong> <strong>in</strong> [corrected] neonates undergo<strong>in</strong>gcentral l<strong>in</strong>e placement.[erratumappears <strong>in</strong> JAMA. 2006 Apr]5;295(13):1518]. JAMA 2006; 295: 793–800.52 Taddio A, Shah V, Stephens D et al.Effect of liposomal lidoca<strong>in</strong>e <strong>and</strong> sucrosealone <strong>and</strong> <strong>in</strong> comb<strong>in</strong>ation for venipuncture28 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


pa<strong>in</strong> <strong>in</strong> newborns. Pediatrics 2011; 127:e940–e947.53 Biran V, Gourrier E, Cimerman P et al.Analgesic effects of EMLA cream <strong>and</strong> oralsucrose dur<strong>in</strong>g venipuncture <strong>in</strong> preterm<strong>in</strong>fants. Pediatrics 2011; 128: e63–e70.54 Paes B, Janes M, Vegh P et al. A comparativestudy of heel-stick devices for <strong>in</strong>fantblood collection. Am J Dis Child 1993; 147:346–348.55 Shah V, Taddio A, Kulasekaran K et al.Evaluation of a new lancet device (BDQuikHeel) on pa<strong>in</strong> response <strong>and</strong> success ofprocedure <strong>in</strong> term neonates. ArchPediatr Adolesc Med 2003; 157:1075–1078.56 Barker DP, Latty BW, Rutter N. Heelblood sampl<strong>in</strong>g <strong>in</strong> preterm <strong>in</strong>fants: whichtechnique? Arch Dis Child Fetal Neonatal Ed1994; 71: F206–F208.57 Mitchell A, Stevens B, Mungan N et al.Analgesic effects of oral sucrose <strong>and</strong> pacifierdur<strong>in</strong>g eye exam<strong>in</strong>ations for ret<strong>in</strong>opathy ofprematurity. Pa<strong>in</strong> Manag Nurs 2004; 5: 160–168.58 Gal P, Kissl<strong>in</strong>g GE, Young WO et al. Efficacyof sucrose to reduce pa<strong>in</strong> <strong>in</strong> premature<strong>in</strong>fants dur<strong>in</strong>g eye exam<strong>in</strong>ations for ret<strong>in</strong>opathyof prematurity. Ann Pharmacother2005; 39: 1029–1033.59 Boyle EM, Freer Y, Khan-Orakzai Z et al.Sucrose <strong>and</strong> non-nutritive suck<strong>in</strong>g for therelief of pa<strong>in</strong> <strong>in</strong> screen<strong>in</strong>g for ret<strong>in</strong>opathy ofprematurity: a r<strong>and</strong>omised controlled trial.Arch Dis Child Fetal Neonatal Ed 2006; 91:F166–F168.60 O’Sullivan A, O’Connor M, Brosnahan D etal. Sweeten, soother <strong>and</strong> swaddle for ret<strong>in</strong>opathyof prematurity screen<strong>in</strong>g: a r<strong>and</strong>omisedplacebo controlled trial. Arch DisChild Fetal Neonatal Ed 2010; 95: F419–F422.61 Marsh VA, Young WO, Dunaway KK etal. Efficacy of topical anesthetics to reducepa<strong>in</strong> <strong>in</strong> premature <strong>in</strong>fants dur<strong>in</strong>g eye exam<strong>in</strong>ationsfor ret<strong>in</strong>opathy of prematurity. AnnPharmacother 2005; 39: 829–833.62 Lichtenste<strong>in</strong> S. Screen<strong>in</strong>g exam<strong>in</strong>ation ofpremature <strong>in</strong>fants for ret<strong>in</strong>opathy of prematurity.Pediatrics 2006; 117: 572–576.63 Health RCoPaC. UK Ret<strong>in</strong>opathy of PrematurityGuidel<strong>in</strong>e. London: RCPCH, 2008.64 Sun X, Lemyre B, Barrowman N et al. Pa<strong>in</strong>management dur<strong>in</strong>g eye exam<strong>in</strong>ations forret<strong>in</strong>opathy of prematurity <strong>in</strong> preterm<strong>in</strong>fants: a systematic review. Acta Paediatr2010; 99: 329–334.65 Dempsey E, McCreery K. Local anaestheticeye drops for prevention of pa<strong>in</strong> <strong>in</strong> preterm<strong>in</strong>fants undergo<strong>in</strong>g screen<strong>in</strong>g for ret<strong>in</strong>opathyof prematurity. Cochrane Database Syst Rev2011; 9: CD007645.66 Kleberg A, Warren I, Norman E et al.Lower stress responses after Newborn IndividualizedDevelopmental Care <strong>and</strong> AssessmentProgram care dur<strong>in</strong>g eye screen<strong>in</strong>gexam<strong>in</strong>ations for ret<strong>in</strong>opathy of prematurity:a r<strong>and</strong>omized study. Pediatrics 2008;121: e1267–e1278.67 Kaur G, Gupta P, Kumar A. A r<strong>and</strong>omizedtrial of eutectic mixture of local anestheticsdur<strong>in</strong>g lumbar puncture <strong>in</strong> newborns. ArchPediatr Adolesc Med 2003; 157: 1065–1070.68 Baxter AL, Fisher RG, Burke BL et al.Local anesthetic <strong>and</strong> stylet styles: factorsassociated with resident lumbar puncturesuccess. Pediatrics 2006; 117: 876–881.69 An<strong>and</strong> KJ, Johnston CC, Oberl<strong>and</strong>er TF etal. Analgesia <strong>and</strong> local anesthesia dur<strong>in</strong>g<strong>in</strong>vasive procedures <strong>in</strong> the neonate. Cl<strong>in</strong>Ther 2005; 27: 844–876.70 Murray MJ, Arthurs OJ, Hills MH et al. Ar<strong>and</strong>omized study to validate a midsp<strong>in</strong>alcanal depth nomogram <strong>in</strong> neonates. Am JPer<strong>in</strong>atol 2009; 26: 733–738.71 Arthurs OJ, Murray M, Zubier M et al.Ultrasonographic determ<strong>in</strong>ation of neonatalsp<strong>in</strong>al canal depth. Arch Dis Child FetalNeonatal Ed 2008; 93: F451–F454.72 Kozer E, Rosenbloom E, Goldman D et al.Pa<strong>in</strong> <strong>in</strong> <strong>in</strong>fants who are younger than2 months dur<strong>in</strong>g suprapubic aspiration <strong>and</strong>transurethral bladder catheterization: a r<strong>and</strong>omized,controlled study. Pediatrics 2006;118: e51–e56.73 El-Naggar W, Yiu A, Mohamed A et al.Comparison of pa<strong>in</strong> dur<strong>in</strong>g two methods ofur<strong>in</strong>e collection <strong>in</strong> preterm <strong>in</strong>fants. Pediatrics2010; 125: 1224–1229.74 Rogers A, Greenwald M, Deguzman M etal. A r<strong>and</strong>omized, controlled trial of sucroseanalgesia <strong>in</strong> <strong>in</strong>fants younger than 90 days ofage who require bladder catheterization <strong>in</strong>the pediatric emergency department. AcadEmerg Med 2006; 13: 617–622.75 Juhl GA, Conners GP. Emergency physicians’practices <strong>and</strong> attitudes regard<strong>in</strong>g proceduralanaesthesia for nasogastric tube<strong>in</strong>sertion. Emerg Med J 2005; 22: 243–245.76 McCullough S, Halton T, Mowbray D et al.L<strong>in</strong>gual sucrose reduces the pa<strong>in</strong> responseto nasogastric tube <strong>in</strong>sertion: a r<strong>and</strong>omisedcl<strong>in</strong>ical trial. Arch Dis Child Fetal NeonatalEd 2008; 93: F100–F103.77 Efe E, Ozer ZC. The use of breast-feed<strong>in</strong>gfor pa<strong>in</strong> relief dur<strong>in</strong>g neonatal immunization<strong>in</strong>jections. Appl Nurs Res 2007; 20: 10–16.78 Hatfield LA, Gusic ME, Dyer AM et al.Analgesic properties of oral sucrose dur<strong>in</strong>grout<strong>in</strong>e immunizations at 2 <strong>and</strong> 4 months ofage. Pediatrics 2008; 121: e327–e334.79 Hee HI, Goy RW, Ng AS. Effective reductionof anxiety <strong>and</strong> pa<strong>in</strong> dur<strong>in</strong>g venouscannulation <strong>in</strong> children: a comparison ofanalgesic efficacy conferred by nitrousoxide, EMLA <strong>and</strong> comb<strong>in</strong>ation. PaediatrAnaesth 2003; 13: 210–216.80 Koh J, Harrison D, Myers R et al. A r<strong>and</strong>omized,double-bl<strong>in</strong>d comparison study ofEMLA <strong>and</strong> ELA-Max for topical anesthesia<strong>in</strong> children undergo<strong>in</strong>g <strong>in</strong>travenous <strong>in</strong>sertion.Pediatr Anesth 2004; 14: 977–982.81 Luhmann J, Hurt S, Shootman M et al. Acomparison of buffered lidoca<strong>in</strong>e versusELA-Max before peripheral <strong>in</strong>travenouscatheter <strong>in</strong>sertions <strong>in</strong> children. Pediatrics2004; 113: e217–e220.82 Eidelman A, Weiss JM, Lau J et al. Topicalanesthetics for dermal <strong>in</strong>strumentation: asystematic review of r<strong>and</strong>omized, controlledtrials. Ann Emerg Med 2005; 46: 343–351.83 St<strong>in</strong>son J, Yamada J, Dickson A et al.Review of systematic reviews on acute proceduralpa<strong>in</strong> <strong>in</strong> children <strong>in</strong> the hospital sett<strong>in</strong>g.Pa<strong>in</strong> Res Manag 2008; 13: 51–57.84 Newbury C, Herd DW. Amethoca<strong>in</strong>e versusEMLA for successful <strong>in</strong>travenous cannulation<strong>in</strong> a children’s emergency department: ar<strong>and</strong>omised controlled study. Emerg Med J2009; 26: 487–491.85 Uman LS, Chambers CT, McGrath PJ et al.Psychological <strong>in</strong>terventions for needlerelatedprocedural pa<strong>in</strong> <strong>and</strong> distress <strong>in</strong> children<strong>and</strong> adolescents. Cochrane DatabaseSyst Rev 2006; 4: CD005179.86 Liossi C, White P, Hatira P. A r<strong>and</strong>omizedcl<strong>in</strong>ical trial of a brief hypnosis <strong>in</strong>terventionto control venepuncture-related pa<strong>in</strong> of paediatriccancer patients. Pa<strong>in</strong> 2009; 142: 255–263.87 L<strong>and</strong>er JA, Weltman BJ, So SS. EMLA <strong>and</strong>amethoca<strong>in</strong>e for reduction of children’s pa<strong>in</strong>associated with needle <strong>in</strong>sertion. CochraneDatabase Syst Rev 2006; 3: CD004236.88 Davies RJ. Buffer<strong>in</strong>g the pa<strong>in</strong> of local anaesthetics:a systematic review. Emerg Med(Fremantle) 2003; 15: 81–88.89 Ekbom K, Jakobsson J, Marcus C. Nitrousoxide <strong>in</strong>halation is a safe <strong>and</strong> effective wayto facilitate procedures <strong>in</strong> paediatric outpatientdepartments. Arch Dis Child 2005; 90:1073–1076.90 Costello M, Ramundo M, Christopher NCet al. Ethyl v<strong>in</strong>yl chloride vapocoolant sprayfails to decrease pa<strong>in</strong> associated with <strong>in</strong>travenouscannulation <strong>in</strong> children. Cl<strong>in</strong> Pediatr(Phila) 2006; 45: 628–632.91 Farion KJ, Spl<strong>in</strong>ter KL, Newhook K et al.The effect of vapocoolant spray on pa<strong>in</strong> dueto <strong>in</strong>travenous cannulation <strong>in</strong> children: ar<strong>and</strong>omized controlled trial. CMAJ 2008;179: 31–36.92 Davies EH, Molloy A. Comparison of ethylchloride spray with topical anaesthetic <strong>in</strong>children experienc<strong>in</strong>g venepuncture. PaediatrNurs 2006; 18: 39–43.93 Baxter AL, Cohen LL, McElvery HL et al.An <strong>in</strong>tegration of vibration <strong>and</strong> cold relievesª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 29


venipuncture pa<strong>in</strong> <strong>in</strong> a pediatric emergencydepartment. Pediatr Emerg Care 2011; 27:1151–1156.94 Liossi C, White P, Hatira P. R<strong>and</strong>omizedcl<strong>in</strong>ical trial of local anesthetic versus acomb<strong>in</strong>ation of local anesthetic with selfhypnosis<strong>in</strong> the management of pediatricprocedure-related pa<strong>in</strong>. Health Psychol2006; 25: 307–315.95 Carraccio C, Fe<strong>in</strong>berg P, Hart LS et al.Lidoca<strong>in</strong>e for lumbar punctures. A help nota h<strong>in</strong>drance. Arch Pediatr Adolesc Med1996; 150: 1044–1046.96 Juarez Gimenez J, Oliveras M, Hidalgo E etal. Anesthetic efficacy of eutectic priloca<strong>in</strong>elidoca<strong>in</strong>ecream <strong>in</strong> pediatric oncologypatients undergo<strong>in</strong>g lumbar puncture. AnnPharmacother 1996; 30: 1235–1237.97 Kanagasundaram SA, Lane LJ, CavallettoBP et al. Efficacy <strong>and</strong> safety of nitrousoxide <strong>in</strong> alleviat<strong>in</strong>g pa<strong>in</strong> <strong>and</strong> anxiety dur<strong>in</strong>gpa<strong>in</strong>ful procedures. Arch Dis Child 2001; 84:492–495.98 Crock C, Olsson C, Phillips R et al. Generalanaesthesia or conscious sedation for pa<strong>in</strong>fulprocedures <strong>in</strong> childhood cancer: the family’sperspective. Arch Dis Child 2003; 88:253–257.99 Ljungman G, Gordh T, Sorensen S et al.Lumbar puncture <strong>in</strong> pediatric oncology:conscious sedation vs. general anesthesia.Med Pediatr Oncol 2001; 36: 372–379.100 Evans D, Turnham L, Barbour K et al.Intravenous ketam<strong>in</strong>e sedation for pa<strong>in</strong>fuloncology procedures. Pediatr Anesth 2005;15: 131–138.101 Iannalfi A, Bern<strong>in</strong>i G, Caprilli S et al. Pa<strong>in</strong>fulprocedures <strong>in</strong> children with cancer: comparisonof moderate sedation <strong>and</strong> generalanesthesia for lumbar puncture <strong>and</strong> bonemarrow aspiration. Pediatr Blood Cancer2005; 45: 933–938.102 Fe<strong>in</strong> D, Avner JR, Kh<strong>in</strong>e H. Pattern of pa<strong>in</strong>management dur<strong>in</strong>g lumbar puncture <strong>in</strong>children. Pediatr Emerg Care 2010; 26: 357–360.103 Hoyle JD Jr, Rogers AJ, Reischman DE etal. Pa<strong>in</strong> <strong>in</strong>tervention for <strong>in</strong>fant lumbarpuncture <strong>in</strong> the emergency department: physicianpractice <strong>and</strong> beliefs. Acad Emerg Med2011; 18: 140–144.104 Apiliogullari S, Duman A, Gok F et al.Sp<strong>in</strong>al needle design <strong>and</strong> size affect the <strong>in</strong>cidenceof postdural puncture headache <strong>in</strong>children. Pediatr Anesth 2010; 20: 177–182.105 Bruce EA, Howard RF, Franck LS. Chestdra<strong>in</strong> removal pa<strong>in</strong> <strong>and</strong> its management: aliterature review. J Cl<strong>in</strong> Nurs 2006; 15: 145–154.106 Rosen DA, Morris JL, Rosen KR et al.Analgesia for pediatric thoracostomy tuberemoval. Anesth Analg 2000; 90: 1025–1028.107 Bruce E, Franck L, Howard RF. The efficacyof morph<strong>in</strong>e <strong>and</strong> Entonox analgesiadur<strong>in</strong>g chest dra<strong>in</strong> removal <strong>in</strong> children. PediatrAnesth 2006; 16: 302–308.108 Bruce E, Franck L. Self-adm<strong>in</strong>isterednitrous oxide (Entonox) for the managementof procedural pa<strong>in</strong>. Paediatr Nurs 2000; 12:15–19.109 Akrofi M, Miller S, Colfar S et al. A r<strong>and</strong>omizedcomparison of three methods ofanalgesia for chest dra<strong>in</strong> removal <strong>in</strong> postcardiacsurgical patients. Anesth Analg 2005;100: 205–209.110 Charlton J. Pa<strong>in</strong> <strong>in</strong> children. Core Curriculumfor Professional Education <strong>in</strong> Pa<strong>in</strong>.Seattle: IASP Press, 2005: 113–117.111 Phillips DA, Watson AR, MacK<strong>in</strong>lay D.Distress <strong>and</strong> the micturat<strong>in</strong>g cystourethrogram:does preparation help? Acta Paediatr1998; 87: 175–179.112 Butler L, Symons B, Henderson S et al.Hypnosis reduces distress <strong>and</strong> duration ofan <strong>in</strong>vasive medical procedure for children.Pediatrics 2005; 115: e77–e85.113 Vaughan M, Paton EA, Bush A et al. Doeslidoca<strong>in</strong>e gel alleviate the pa<strong>in</strong> of bladdercatheterization <strong>in</strong> young children? A r<strong>and</strong>omized,controlled trial. Pediatrics 2005;116: 917–920.114 S<strong>and</strong>y NS, Nguyen HT, Z<strong>in</strong>iel SI et al.Assessment of parental satisfaction <strong>in</strong> childrenundergo<strong>in</strong>g void<strong>in</strong>g cystourethrographywithout sedation. J Urol 2011; 185: 658–662.115 Gerard LL, Cooper CS, Duethman KS etal. Effectiveness of lidoca<strong>in</strong>e lubricant fordiscomfort dur<strong>in</strong>g pediatric urethral catheterization.The Journal of urology 2003; 170:564–567.116 Stevens B. Use of 2% lidoca<strong>in</strong>e gel dur<strong>in</strong>gbladder catheterisation did not reduce procedurerelated pa<strong>in</strong> <strong>in</strong> young children. EvidBased Nurs 2006; 9: 41.117 S<strong>in</strong>ger AJ, Konia N. Comparison of topicalanesthetics <strong>and</strong> vasoconstrictors vs lubricantsprior to nasogastric <strong>in</strong>tubation: a r<strong>and</strong>omized,controlled trial. Acad Emerg Med1999; 6: 184–190.118 Wolfe TR, Fosnocht DE, L<strong>in</strong>scott MS.Atomized lidoca<strong>in</strong>e as topical anesthesia fornasogastric tube placement: a r<strong>and</strong>omized,double-bl<strong>in</strong>d, placebo-controlled trial. AnnEmerg Med 2000; 35: 421–425.119 Ozucelik DN, Karaca MA, Sivri B. Effectivenessof pre-emptive metoclopramide<strong>in</strong>fusion <strong>in</strong> alleviat<strong>in</strong>g pa<strong>in</strong>, discomfort <strong>and</strong>nausea associated with nasogastric tube<strong>in</strong>sertion: a r<strong>and</strong>omised, double-bl<strong>in</strong>d, placebo-controlledtrial. Int J Cl<strong>in</strong> Pract 2005;59: 1422–1427.120 Cullen L, Taylor D, Taylor S et al. Nebulizedlidoca<strong>in</strong>e decreases the discomfort ofnasogastric tube <strong>in</strong>sertion: a r<strong>and</strong>omized,double-bl<strong>in</strong>d trial. Ann Emerg Med 2004;44: 131–137.121 Babl FE, Goldf<strong>in</strong>ch C, M<strong>and</strong>rawa C et al.Does nebulized lidoca<strong>in</strong>e reduce the pa<strong>in</strong><strong>and</strong> distress of nasogastric tube <strong>in</strong>sertion <strong>in</strong>young children? A r<strong>and</strong>omized, doublebl<strong>in</strong>d,placebo-controlled trial. Pediatrics2009; 123: 1548–1555.122 Cohen L, Blount R, Cohen R et al. Comparativestudy of distraction versus topicalanesthesia for pediatric pa<strong>in</strong> managementdur<strong>in</strong>g immunizations. Health Psychol 1999;18: 591–598.123 Cohen LL, MacLaren JE, Fortson BL et al.R<strong>and</strong>omized cl<strong>in</strong>ical trial of distraction for<strong>in</strong>fant immunization pa<strong>in</strong>. Pa<strong>in</strong> 2006; 125:165–171.124 Chambers CT, Taddio A, Uman LS et al.Psychological <strong>in</strong>terventions for reduc<strong>in</strong>gpa<strong>in</strong> <strong>and</strong> distress dur<strong>in</strong>g rout<strong>in</strong>e childhoodimmunizations: a systematic review. Cl<strong>in</strong>Ther 2009; 31(Suppl. 2): S77–S103.125 Cohen Reis E, Holubkov R. Vapocoolantspray is equally effective as EMLA cream <strong>in</strong>reduc<strong>in</strong>g immunization pa<strong>in</strong> <strong>in</strong> school-agedchildren. Pediatrics 1997; 100: E5.126 Mark A, Carlsson RM, Granstrom M. Subcutaneousversus <strong>in</strong>tramuscular <strong>in</strong>jection forbooster DT vacc<strong>in</strong>ation of adolescents. Vacc<strong>in</strong>e1999; 17: 2067–2072.127 Ipp M, Cohen E, Goldbach M et al. Effectof choice of measles-mumps-rubella vacc<strong>in</strong>eon immediate vacc<strong>in</strong>ation pa<strong>in</strong> <strong>in</strong> <strong>in</strong>fants.Arch Pediatr Adolesc Med 2004; 158: 323–326.128 Wood C, von Baeyer CL, Bourrillon A etal. Self-assessment of immediate post-vacc<strong>in</strong>ationpa<strong>in</strong> after two different MMR vacc<strong>in</strong>esadm<strong>in</strong>istered as a second dose <strong>in</strong> 4- to6-year-old children. Vacc<strong>in</strong>e 2004; 23: 127–131.129 Scheifele D, Halper<strong>in</strong> S, Ochnio J et al. Amodified vacc<strong>in</strong>e reduces the rate of large<strong>in</strong>jection site reactions to the pre schoolbooster dose of diphtheria-tetanus-acellularpertussis vacc<strong>in</strong>e: results of a r<strong>and</strong>omizedcontrolled trial. Pediatr Infect Dis J 2005;24: 1059–1066.130 Diggle L, Deeks JJ, Pollard AJ. Effect ofneedle size on immunogenicity <strong>and</strong> reactogenicityof vacc<strong>in</strong>es <strong>in</strong> <strong>in</strong>fants: r<strong>and</strong>omisedcontrolled trial. BMJ 2006; 333:571.131 Taddio A, Ilersich AL, Ipp M et al. Physical<strong>in</strong>terventions <strong>and</strong> <strong>in</strong>jection techniques forreduc<strong>in</strong>g <strong>in</strong>jection pa<strong>in</strong> dur<strong>in</strong>g rout<strong>in</strong>e childhoodimmunizations: systematic review ofr<strong>and</strong>omized controlled trials <strong>and</strong> quasi-r<strong>and</strong>omizedcontrolled trials. Cl<strong>in</strong> Ther 2009;31(Suppl. 2): S48–S76.132 Ipp M, Park<strong>in</strong> PC, Lear N et al. Order ofvacc<strong>in</strong>e <strong>in</strong>jection <strong>and</strong> <strong>in</strong>fant pa<strong>in</strong> response.30 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


Arch Pediatr Adolesc Med 2009; 163: 469–472.133 Lew<strong>in</strong>don PJ, Harkness L, Lew<strong>in</strong>don N.R<strong>and</strong>omised controlled trial of sucrose bymouth for the relief of <strong>in</strong>fant cry<strong>in</strong>g afterimmunisation. Arch Dis Child 1998; 78:453–456.134 Reis E, Roth E, Syphan J et al. Effectivepa<strong>in</strong> reduction for multiple immunization<strong>in</strong>jections <strong>in</strong> young <strong>in</strong>fants. Arch PediatrAdolesc Med 2003; 157: 1115–1120.135 Cohen LL, Blount RL, Panopoulos G.Nurse coach<strong>in</strong>g <strong>and</strong> cartoon distraction: aneffective <strong>and</strong> practical <strong>in</strong>tervention to reducechild, parent, <strong>and</strong> nurse distress dur<strong>in</strong>gimmunizations. J Pediatr Psychol 1997; 22:355–370.136 Kassab M, Sheehy A, K<strong>in</strong>g M et al. A double-bl<strong>in</strong>dr<strong>and</strong>omised controlled trial of25% oral glucose for pa<strong>in</strong> relief <strong>in</strong> 2-monthold <strong>in</strong>fants undergo<strong>in</strong>g immunisation. Int JNurs Stud 2012; 49: 249–246.137 Harrison D, Yamada J, Adams-Webber Tet al. Sweet tast<strong>in</strong>g solutions for reductionof needle-related procedural pa<strong>in</strong> <strong>in</strong> childrenaged one to 16 years. Cochrane DatabaseSyst Rev 2011; Oct 5;(10): CD008408.138 Ipp M, Cohen E, Goldbach M et al. Pa<strong>in</strong>response to M-M-R vacc<strong>in</strong>ation <strong>in</strong> 4–6 yearold children. Can J Cl<strong>in</strong> Pharmacol 2006;13: e296–e299.139 Hanson D, Hall W, Mills LL et al. Comparisonof distress <strong>and</strong> pa<strong>in</strong> <strong>in</strong> <strong>in</strong>fants r<strong>and</strong>omizedto groups receiv<strong>in</strong>g st<strong>and</strong>ard versusmultiple immunizations. Infant Behav Dev2010; 33: 289–296.140 Taddio A, Nulman I, Goldbach M et al.Use of lidoca<strong>in</strong>e-priloca<strong>in</strong>e cream for vacc<strong>in</strong>ationpa<strong>in</strong> <strong>in</strong> <strong>in</strong>fants. J Pediatr 1994; 124:643–648.141 Cassidy KL, Reid GJ, McGrath PJ et al. Ar<strong>and</strong>omized double-bl<strong>in</strong>d, placebo-controlledtrial of the EMLA patch for the reductionof pa<strong>in</strong> associated with <strong>in</strong>tramuscular <strong>in</strong>jection<strong>in</strong> four to six-year-old children. ActaPaediatr 2001; 90: 1329–1336.142 L<strong>in</strong>dh V, Wiklund U, Blomquist HK et al.EMLA cream <strong>and</strong> oral glucose for immunizationpa<strong>in</strong> <strong>in</strong> 3-month-old <strong>in</strong>fants. Pa<strong>in</strong>2003; 104: 381–388.143 O’Brien L, Taddio A, Ipp M et al. Topical4% amethoca<strong>in</strong>e gel reduces the pa<strong>in</strong> ofsubcutaneous measle-mumps-rubella vacc<strong>in</strong>ation.Paediatrics 2004; 114: 720–724.144 Amir J, G<strong>in</strong>at S, Cohen YH et al. Lidoca<strong>in</strong>eas a diluent for adm<strong>in</strong>istration of benzath<strong>in</strong>epenicill<strong>in</strong> G. Pediatr Infect Dis J 1998; 17:890–893.145 Albertsen BK, Hasle H, Clausen N et al.Pa<strong>in</strong> <strong>in</strong>tensity <strong>and</strong> bioavailability of <strong>in</strong>tramuscularasparag<strong>in</strong>ase <strong>and</strong> a local anesthetic:a double-bl<strong>in</strong>ded study. Pediatr BloodCancer 2005; 44: 255–258.146 Barnett P, Jarman FC, <strong>Good</strong>ge J et al.R<strong>and</strong>omised trial of histoacryl blue tissueadhesive glue versus sutur<strong>in</strong>g <strong>in</strong> the repairof paediatric lacerations. J Paediatr ChildHealth 1998; 34: 548–550.147 Farion KJ, Osmond MH, Hartl<strong>in</strong>g L et al.Tissue adhesives for traumatic lacerations: asystematic review of r<strong>and</strong>omized controlledtrials. Acad Emerg Med 2003; 10: 110–118.148 Zempsky WT, Parrotti D, Grem C et al.R<strong>and</strong>omized controlled comparison of cosmeticoutcomes of simple facial lacerationsclosed with Steri Strip Sk<strong>in</strong> Closures orDermabond tissue adhesive. Pediatr EmergCare 2004; 20: 519–524.149 Ernst AA, Marvez-Valls E, Nick TG et al.Topical lidoca<strong>in</strong>e adrenal<strong>in</strong>e tetraca<strong>in</strong>e(LAT gel) versus <strong>in</strong>jectable buffered lidoca<strong>in</strong>efor local anesthesia <strong>in</strong> lacerationrepair. West J Med 1997; 167: 79–81.150 Smith GA, Strausbaugh SD, Harbeck-Weber C et al. Tetraca<strong>in</strong>e-lidoca<strong>in</strong>e-phenylephr<strong>in</strong>etopical anesthesia compared withlidoca<strong>in</strong>e <strong>in</strong>filtration dur<strong>in</strong>g repair ofmucous membrane lacerations <strong>in</strong> children.Cl<strong>in</strong> Pediatr (Phila) 1998; 37: 405–412.151 White NJ, Kim MK, Brousseau DC et al.The anesthetic effectiveness of lidoca<strong>in</strong>eadrenal<strong>in</strong>e-tetraca<strong>in</strong>egel on f<strong>in</strong>ger lacerations.Pediatr Emerg Care 2004; 20: 812–815.152 Eidelman A, Weiss JM, Enu IK et al. Comparativeefficacy <strong>and</strong> costs of various topicalanesthetics for repair of dermal lacerations:a systematic review of r<strong>and</strong>omized, controlledtrials. J Cl<strong>in</strong> Anesth 2005; 17: 106–116.153 Eidelman A, Weiss JM, Baldw<strong>in</strong> CL et al.Topical anaesthetics for repair of dermallaceration. Cochrane Database Syst Rev2011; 10: CD005364.154 Hock MO, Ooi SB, Saw SM et al. A r<strong>and</strong>omizedcontrolled trial compar<strong>in</strong>g the hairapposition technique with tissue glue tost<strong>and</strong>ard sutur<strong>in</strong>g <strong>in</strong> scalp lacerations (HATstudy). Ann Emerg Med 2002; 40: 19–26.155 S<strong>in</strong>ger AJ, Stark MJ. Pretreatment of lacerationswith lidoca<strong>in</strong>e, ep<strong>in</strong>ephr<strong>in</strong>e, <strong>and</strong> tetraca<strong>in</strong>eat triage: a r<strong>and</strong>omized double-bl<strong>in</strong>dtrial. Acad Emerg Med 2000; 7: 751–756.156 S<strong>in</strong>ger AJ, Stark MJ. LET versus EMLAfor pretreat<strong>in</strong>g lacerations: a r<strong>and</strong>omizedtrial. Acad Emerg Med 2001; 8: 223–230.157 Burton JH, Auble TE, Fuchs SM. Effectivenessof 50% nitrous oxide/50% oxygen dur<strong>in</strong>glaceration repair <strong>in</strong> children. AcadEmerg Med 1998; 5: 112–117.158 Luhmann JD, Kennedy RM, Porter FL etal. A r<strong>and</strong>omized cl<strong>in</strong>ical trial of cont<strong>in</strong>uous-flownitrous oxide <strong>and</strong> midazolam forsedation of young children dur<strong>in</strong>g lacerationrepair. Ann Emerg Med 2001; 37: 20–27.159 Babl FE, Oakley E, Puspitadewi A et al.Limited analgesic efficacy of nitrous oxidefor pa<strong>in</strong>ful procedures <strong>in</strong> children. EmergMed J 2008; 25: 717–721.160 Henry D, Foster R. Burn pa<strong>in</strong> management<strong>in</strong> children. Pediatr Cl<strong>in</strong> North Am 2000; 47:681–698, ix–x.161 Sharar SR, Bratton SL, Carrougher GJ etal. A comparison of oral transmucosal fentanylcitrate <strong>and</strong> oral hydromorphone for<strong>in</strong>patient pediatric burn wound care analgesia.J Burn Care Rehabil 1998; 19: 516–521.162 Sharar SR, Carrougher GJ, Selzer K et al.A comparison of oral transmucosal fentanylcitrate <strong>and</strong> oral oxycodone for pediatric outpatientwound care. J Burn Care Rehabil2002; 23: 27–31.163 Robert R, Brack A, Blakeney P et al. Adouble-bl<strong>in</strong>d study of the analgesic efficacyof oral transmucosal fentanyl citrate <strong>and</strong>oral morph<strong>in</strong>e <strong>in</strong> pediatric patients undergo<strong>in</strong>gburn dress<strong>in</strong>g change <strong>and</strong> tubb<strong>in</strong>g. JBurn Care Rehabil 2003; 24: 351–355.164 Borl<strong>and</strong> ML, Bergesio R, Pascoe EM et al.Intranasal fentanyl is an equivalent analgesicto oral morph<strong>in</strong>e <strong>in</strong> paediatric burnspatients for dress<strong>in</strong>g changes: a r<strong>and</strong>omiseddouble bl<strong>in</strong>d crossover study. Burns 2005;31: 831–837.165 Fratianne RB, Prensner JD, Huston MJ etal. The effect of music-based imagery <strong>and</strong>musical alternate engagement on the burndebridement process. J Burn Care Rehabil2001; 22: 47–53.166 Hern<strong>and</strong>ez-Reif M, Field T, Largie S et al.Childrens’ distress dur<strong>in</strong>g burn treatment isreduced by massage therapy. J Burn CareRehabil 2001; 22: 191–195; ; discussion 190.167 Das DA, Grimmer KA, Sparnon AL et al.The efficacy of play<strong>in</strong>g a virtual realitygame <strong>in</strong> modulat<strong>in</strong>g pa<strong>in</strong> for children withacute burn <strong>in</strong>juries: a r<strong>and</strong>omized controlledtrial [ISRCTN87413556]. BMC Pediatr2005; 5: 1.168 Miller K, Rodger S, Bucolo S et al. Multimodaldistraction. Us<strong>in</strong>g technology tocombat pa<strong>in</strong> <strong>in</strong> young children with burn<strong>in</strong>juries. Burns 2010; 36: 647–658.169 Miller K, Rodger S, Kipp<strong>in</strong>g B et al. Anovel technology approach to pa<strong>in</strong> management<strong>in</strong> children with burns: a prospectiver<strong>and</strong>omized controlled trial. Burns 2011; 37:395–405.170 Schmitt YS, Hoffman HG, Blough DK etal. A r<strong>and</strong>omized, controlled trial of immersivevirtual reality analgesia, dur<strong>in</strong>g physicaltherapy for pediatric burns. Burns 2011; 37:61–68.171 Mott J, Bucolo S, Cuttle L et al. The efficacyof an augmented virtual reality systemto alleviate pa<strong>in</strong> <strong>in</strong> children undergo<strong>in</strong>gburns dress<strong>in</strong>g changes: a r<strong>and</strong>omised controlledtrial. Burns 2008; 34: 803–808.ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 31


172 van Twillert B, Bremer M, Faber AW.Computer-generated virtual reality to controlpa<strong>in</strong> <strong>and</strong> anxiety <strong>in</strong> pediatric <strong>and</strong> adultburn patients dur<strong>in</strong>g wound dress<strong>in</strong>gchanges. J Burn Care Res 2007; 28: 694–702.173 Sharar SR, Carrougher GJ, Nakamura D etal. Factors <strong>in</strong>fluenc<strong>in</strong>g the efficacy of virtualreality distraction analgesia dur<strong>in</strong>g postburnphysical therapy: prelim<strong>in</strong>ary results from 3ongo<strong>in</strong>g studies. Arch Phys Med Rehabil2007; 88: S43–S49.174 Glat PM, Kubat WD, Hsu JF et al. R<strong>and</strong>omizedcl<strong>in</strong>ical study of SilvaSorb gel <strong>in</strong>comparison to Silvadene silver sulfadiaz<strong>in</strong>ecream <strong>in</strong> the management of partial-thicknessburns. J Burn Care Res 2009; 30: 262–267.175 Saba SC, Tsai R, Glat P. Cl<strong>in</strong>ical evaluationcompar<strong>in</strong>g the efficacy of aquacel ag hydrofiberdress<strong>in</strong>g versus petrolatum gauze withantibiotic o<strong>in</strong>tment <strong>in</strong> partial-thicknessburns <strong>in</strong> a pediatric burn center. J BurnCare Res 2009; 30: 380–385.176 Kargi E, Tekerekoglu B. Usage of lidoca<strong>in</strong>e-priloca<strong>in</strong>ecream <strong>in</strong> the treatment ofpostburn pa<strong>in</strong> <strong>in</strong> pediatric patients. UlusTravma Acil Cerrahi Derg 2010; 16: 229–232.177 Ozil C, Vialle R, Theven<strong>in</strong>-Lemo<strong>in</strong>e C et al.Use of a comb<strong>in</strong>ed oxygen/nitrous oxide/morph<strong>in</strong>e chlorydrate protocol for analgesia<strong>in</strong> burned children requir<strong>in</strong>g pa<strong>in</strong>ful localcare. Pediatr Surg Int 2010; 26: 263–267.178 Brochard S, Blajan V, Lempereur M et al.Effectiveness of nitrous oxide <strong>and</strong> analgesiccream (lidoca<strong>in</strong>e <strong>and</strong> priloca<strong>in</strong>e) for preventionof pa<strong>in</strong> dur<strong>in</strong>g <strong>in</strong>tramuscular botul<strong>in</strong>umtox<strong>in</strong> <strong>in</strong>jections <strong>in</strong> children. Ann Phys RehabilMed 2009; 52: 704–716.32 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


Section 5.0<strong>Postoperative</strong> pa<strong>in</strong>Contents5.1 General pr<strong>in</strong>ciples of postoperative pa<strong>in</strong> management5.2 ENT surgery5.2.1 Myr<strong>in</strong>gotomy5.2.2 Tonsillectomy5.2.3 Mastoid <strong>and</strong> middle ear surgery5.3 Opthalmology5.3.1 Strabismus surgery5.3.2 Vitreoret<strong>in</strong>al surgery5.4 Dental procedures5.5 General surgery <strong>and</strong> urology (m<strong>in</strong>or <strong>and</strong> Intermediate)5.5.1 Sub-umbilical surgery5.5.2 Circumcision5.5.3 Neonatal circumcision5.5.4 Hypospadias repair5.5.5 Orchidopexy5.5.6 Open <strong>in</strong>gu<strong>in</strong>al hernia repair5.5.7 Umbilical hernia repair5.6 General surgery <strong>and</strong> urology (major)5.6.1 Intra-abdom<strong>in</strong>al surgery5.6.2 Appendicectomy (open)5.6.3 Fundoplication (open)5.6.4 Major urology5.7 Laparoscopic surgery5.8 Orthopaedics, sp<strong>in</strong>al <strong>and</strong> plastic surgery5.8.1 Lower limb surgery5.8.2 Upper limb surgery5.8.3 Sp<strong>in</strong>al surgery5.8.4 Cleft lip <strong>and</strong> palate <strong>and</strong> related procedures5.9 Cardiothoracic surgery5.9.1 Cardiac surgery (sternotomy)5.9.2 Thoracotomy5.10 Neurosurgery5.10.1 Craniotomy <strong>and</strong> major neurosurgery5.1 General pr<strong>in</strong>ciples of postoperativepa<strong>in</strong> management<strong>Good</strong> practice po<strong>in</strong>tsProviders of postoperative care should underst<strong>and</strong> thegeneral pr<strong>in</strong>ciples of good pa<strong>in</strong> management <strong>in</strong> children;this <strong>in</strong>cludes knowledge of assessment techniques<strong>and</strong> the use of analgesics at different developmentalages.Pediatric anesthetists are responsible for <strong>in</strong>itiat<strong>in</strong>gpostoperative analgesia. They should liaise withpatients <strong>and</strong> their families/carers, surgeons, <strong>and</strong> othermembers of the team provid<strong>in</strong>g postoperative care toensure that pa<strong>in</strong> is assessed <strong>and</strong> suitable ongo<strong>in</strong>ganalgesia is adm<strong>in</strong>istered.<strong>Postoperative</strong> analgesia should be appropriate todevelopmental age, surgical procedure, <strong>and</strong> cl<strong>in</strong>icalsett<strong>in</strong>g to provide safe, sufficiently potent, <strong>and</strong> flexiblepa<strong>in</strong> relief with a low <strong>in</strong>cidence of side effects.Comb<strong>in</strong>ations of analgesics should be used unlessthere are specific contra-<strong>in</strong>dications, for example;local anesthetics, opioids, NSAIDs, <strong>and</strong> paracetamolcan be given <strong>in</strong> conjunction, not exceed<strong>in</strong>g maximumrecommended doses.Introduction<strong>Postoperative</strong> care is frequently shared between heathprofessionals from different discipl<strong>in</strong>es: they should besuitably qualified, <strong>in</strong>clud<strong>in</strong>g an awareness of the generalpr<strong>in</strong>ciples of pa<strong>in</strong> assessment <strong>and</strong> pa<strong>in</strong> management<strong>in</strong> children. <strong>Postoperative</strong> analgesia should beplanned <strong>and</strong> organised prior to surgery <strong>in</strong> consultationwith patients <strong>and</strong> their families or carers, <strong>and</strong> othermembers of the perioperative team. The pediatric anesthetistis responsible for <strong>in</strong>itiat<strong>in</strong>g suitable postoperativeanalgesia; this should be considered to be part ofthe overall plan of anesthesia.Analgesia is an <strong>in</strong>tegral part of surgical anesthesia,<strong>and</strong> therefore, potent analgesics are adm<strong>in</strong>istered dur<strong>in</strong>ggeneral anesthesia <strong>in</strong> the form of opioids, localanesthetics, <strong>and</strong> other drugs. Patients <strong>and</strong> carersshould be made aware that the effects of these analgesicswill wear off <strong>in</strong> the postoperative period, lead<strong>in</strong>gto an <strong>in</strong>crease <strong>in</strong> pa<strong>in</strong> <strong>and</strong> the need for further analgesia.Patients should not be discharged from the <strong>Postoperative</strong>Care Unit (postanesthesia recovery area)until satisfactory pa<strong>in</strong> control is established <strong>and</strong> ongo<strong>in</strong>ganalgesia is available.Prior to discharge from the hospital, patients <strong>and</strong>their families should be given clearly presented <strong>in</strong>formation<strong>and</strong> advice regard<strong>in</strong>g the assessment of pa<strong>in</strong><strong>and</strong> the adm<strong>in</strong>istration of analgesia at home. It is alsoª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 33


necessary to ensure that the patient will have access tosuitable analgesia.Pa<strong>in</strong> after surgery is usually most severe <strong>in</strong> the first24–72 h but may persist for several days or weeks.Analgesia can be given regularly (by the clock) <strong>in</strong> theearly postoperative period <strong>and</strong> then ‘as required’accord<strong>in</strong>g to assessed pa<strong>in</strong>. Drugs to counteractunwanted effects of analgesia or other side effects ofsurgery such as PONV should also be available <strong>and</strong>adm<strong>in</strong>istered when necessary.<strong>Postoperative</strong> pa<strong>in</strong> should be assessed frequently: seesection 3.0 for further <strong>in</strong>formation. Analgesic regimensshould be sufficiently flexible to allow for <strong>in</strong>ter-<strong>in</strong>dividualdifferences <strong>in</strong> the response to analgesics <strong>and</strong> thevariation <strong>in</strong> the requirement for pa<strong>in</strong> relief that occursdur<strong>in</strong>g the postoperative period.5.2 ENT surgery5.2.1 Myr<strong>in</strong>gotomyDra<strong>in</strong>age of the middle ear, usually with <strong>in</strong>sertion of atube, is a treatment for otitis media. Myr<strong>in</strong>gotomy isusually considered to be a m<strong>in</strong>or procedure, undertakenon a day-case basis. See also section 5.1 for thegeneral pr<strong>in</strong>ciples of postoperative pa<strong>in</strong> management.<strong>Good</strong> practice po<strong>in</strong>tAs myr<strong>in</strong>gotomy is a brief procedure, oral paracetamolor NSAID should be adm<strong>in</strong>istered preoperativelyto ensure adequate analgesia at the end of surgery.RecommendationsOral paracetamol or NSAIDS (ibuprofen, diclofenac, orketorolac) <strong>in</strong> suitable doses can achieve adequate earlypostoperative analgesia: Grade B (1–4).Opioids are effective but not recommended for rout<strong>in</strong>euse because of side effects: Grade B (1,5–8).EvidenceParacetamol (oral) produces dose-related analgesia;10 mgÆkg )1 is no better than placebo (3) or is associatedwith higher supplemental requirements (8), whereas pa<strong>in</strong>scores are lower with 15–20 mgÆkg )1 (1,2,4,5,9).Ibuprofen <strong>and</strong> diclofenac appear to provide similaranalgesia to paracetamol (2,10), but the comb<strong>in</strong>ationhas not been tested.Ketorolac 1 mgÆkg )1 (<strong>in</strong>travenous) provides m<strong>in</strong>orimprovements <strong>in</strong> analgesia when compared with lowdoses of paracetamol, 10 mgÆkg )1 (3,8); paracetamol10 mgÆkg )1 + code<strong>in</strong>e 1 mgÆkg )1 (8); paracetamol15 mgÆkg )1 (but only first 10 m<strong>in</strong> there was no differenceat 20 m<strong>in</strong>) (4). See section 6.5 for recommendeddoses of ketorolac <strong>and</strong> other NSAIDS.Opioids, for example code<strong>in</strong>e, butorphanol, orfentanyl, have been associated with <strong>in</strong>creased sideeffects when compared with NSAIDs or paracetamol,without cl<strong>in</strong>ically significant improvements <strong>in</strong> analgesia;therefore, their use is not warranted for rout<strong>in</strong>emyr<strong>in</strong>gotomy:i. <strong>in</strong>creased sedation <strong>and</strong> time to discharge for oralcode<strong>in</strong>e: (1), nasal fentanyl (7) <strong>and</strong> nasal butorphanol (6)ii. <strong>in</strong>creased vomit<strong>in</strong>g with oral code<strong>in</strong>e or nasal butorphanol(8).LA block of the auricular branch of the vagus providedequivalent analgesia to <strong>in</strong>tranasal fentanyl (11).Analgesia Table 5.2.1Opioid a 1)NSAID 1)Paracetamol 1)Directevidencea Not rout<strong>in</strong>ely recommended because of side effects: see text.5.2.2 TonsillectomyTonsillectomy (±adenoidectomy) is one of the mostfrequently performed procedures <strong>in</strong> children. Chronicor recurrent tonsillitis with tonsillar hyperplasia lead<strong>in</strong>gto upper airway obstruction, for example <strong>in</strong> sleepapnea syndromes, is the most frequent <strong>in</strong>dication fortonsillectomy. The choice of analgesia, postoperativemonitor<strong>in</strong>g, <strong>and</strong> duration of hospital admission is<strong>in</strong>fluenced by the potential for serious complicationssuch as apnea, perioperative bleed<strong>in</strong>g, <strong>and</strong> postoperativenausea <strong>and</strong> vomit<strong>in</strong>g (PONV). Pa<strong>in</strong> after tonsillectomycan persist for many days. See also section 5.1for the general management of postoperative pa<strong>in</strong>.<strong>Good</strong> practice po<strong>in</strong>tAs significant levels of pa<strong>in</strong>, behavioral disturbance, sleepdisruption, <strong>and</strong> altered activity can persist for 5–8 daysfollow<strong>in</strong>g tonsillectomy, regular adm<strong>in</strong>istration of analgesiamay be necessary dur<strong>in</strong>g this period. Information forfamilies about pa<strong>in</strong> assessment <strong>and</strong> medication use follow<strong>in</strong>gdischarge is particularly important.34 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


RecommendationsA comb<strong>in</strong>ation of <strong>in</strong>dividually titrated <strong>in</strong>traoperative opioids,dexamethasone, <strong>and</strong> regularly adm<strong>in</strong>istered perioperativemild analgesics (NSAIDS <strong>and</strong>/or paracetamol) isrecommended for management of tonsillectomy pa<strong>in</strong>:Grade A (12,13).Topical application or <strong>in</strong>jection of local anesthetic <strong>in</strong> thetonsillar fossa improves early pa<strong>in</strong> scores follow<strong>in</strong>g tonsillectomy:Grade A (14,15).Tramadol can produce similar analgesia to morph<strong>in</strong>e orpethid<strong>in</strong>e: Grade B (16–18).Peritonsillar <strong>in</strong>jection of tramadol has no advantage oversystemic adm<strong>in</strong>istration: Grade B (19,20).Intraoperative <strong>in</strong>travenous ketam<strong>in</strong>e does not providesignificant postoperative advantage compared with opioid:Grade B (16,17,21,22).Implementation of st<strong>and</strong>ardised protocols <strong>in</strong>clud<strong>in</strong>g <strong>in</strong>traoperativeopioid ± anti-emetic, perioperative NSAID(diclofenac or ibuprofen), <strong>and</strong> paracetamol is associatedwith acceptable pa<strong>in</strong> relief <strong>and</strong> low rates of PONV:Grade C (23,24).EvidenceSignificant levels of pa<strong>in</strong>, behavioral disturbance, sleepdisruption, <strong>and</strong> altered activity can persist for 5–8 daysfollow<strong>in</strong>g tonsillectomy (25–28). Regular adm<strong>in</strong>istrationof paracetamol <strong>and</strong> NSAID is necessary for severaldays postoperatively, <strong>and</strong> adequate parentaleducation about pa<strong>in</strong> assessment <strong>and</strong> medication use isrequired.Opioids: Intraoperative opioids are given dur<strong>in</strong>g tonsillectomy<strong>and</strong> may be required <strong>in</strong> the postoperativeperiod (12). Morph<strong>in</strong>e is the prototype opioid, butthere has been some <strong>in</strong>terest <strong>in</strong> the use of tramadol follow<strong>in</strong>gtonsillectomy.Tramadol produces similar analgesia <strong>and</strong> side effectsto morph<strong>in</strong>e (29) <strong>and</strong> pethid<strong>in</strong>e (16). Tramadol1mgÆkg )1 was equianalgesic with IV paracetamol15 mgÆkg )1 <strong>in</strong> one study (30). One study reported lessnausea with tramadol than morph<strong>in</strong>e (18). In patientswith sleep apnea tramadol was associated with fewerepisodes of oxygen desaturation at one time po<strong>in</strong>tpostoperatively (1–2 h, no difference at earlier or latertime po<strong>in</strong>ts to 6 h) (29). Comparison of <strong>in</strong>travenous<strong>and</strong> peritonsillar <strong>in</strong>jection of tramadol 2 mgÆkg )1reported m<strong>in</strong>or improvements with peritonsillar <strong>in</strong>jection(19), but effects are likely to be related to systemicabsorption. Tramadol 1 mgÆkg )1 (IV), 2 mgÆkg )1 (IM),or 3 mgÆkg )1 by peri-tonsillar <strong>in</strong>jection reduced pa<strong>in</strong>scores when compared with placebo (20,31). Of particularconcern, children <strong>in</strong> these placebo groups receivedno <strong>in</strong>tra-operative analgesia. However, tramadol wasless effective than ketoprofen (higher pa<strong>in</strong> scores <strong>and</strong>higher postoperative PCA fentanyl) <strong>and</strong> did not differfrom placebo <strong>in</strong> one study (32).NSAIDS improve analgesia when compared withplacebo (10/11 studies) <strong>and</strong> provide similar analgesiato opioids (7/8 studies) <strong>and</strong> paracetamol (3/3 studies)(33). A systematic review found that heterogeneity ofthe data precluded meta-analysis, <strong>and</strong> many studiescompar<strong>in</strong>g two active treatments were not sensitiveenough to show a difference (12). Subsequent studieshave reported similar analgesia with ketorolac <strong>and</strong>fentanyl (34), no improvement with addition of rofecoxibto opioid <strong>and</strong> paracetamol (35), <strong>and</strong> no difference<strong>in</strong> pa<strong>in</strong> scores but <strong>in</strong>creased rescue analgesicrequirements with IV paracetamol compared withpethid<strong>in</strong>e (36). Ketoprofen improved analgesia <strong>in</strong> thefirst 6 h postoperatively <strong>in</strong> comparison with tramadolor placebo (32).Paracetamol is more effective given orally prior tosurgery than rectally after <strong>in</strong>duction of anesthesia, itreduces opioid requirements <strong>and</strong> PONV (37–39).Local anesthesia: Two recent meta-analyses reportedstatistically significant reductions <strong>in</strong> postoperative pa<strong>in</strong>scores with local anesthetic techniques for up to 48 h,but the effect size decreased after the first 4–6 h(14,15). Topical application <strong>and</strong> <strong>in</strong>filtration wereequally effective (14), <strong>and</strong> no difference was foundbetween LA <strong>in</strong>filtration before or after removal of thetonsils (15). <strong>Postoperative</strong> analgesic requirements werereduced (15), but there was no significant difference <strong>in</strong>adverse events (14) or PONV (15). In additional studies,bupivaca<strong>in</strong>e <strong>in</strong>filtration <strong>and</strong> topical levobupivaca<strong>in</strong>eswabs improved pa<strong>in</strong> scores but did not alterPONV (40,41). Others reported no benefit with peritonsillarLA <strong>in</strong>filtration (42) <strong>and</strong> similar analgesiawhen topical 2% viscous lignocane was compared withrectal diclofenac (43).Ketam<strong>in</strong>e (IV) improves analgesia when comparedwith placebo (21,44,45) but provides no advantagewhen compared with equianalgesic opioid (17,46) <strong>and</strong>may <strong>in</strong>crease side effects (22). Addition of ketam<strong>in</strong>e0.25 mgÆkg )1 to morph<strong>in</strong>e 0.1 mgÆkg )1 did not significantlyimprove analgesia (47). Topical application onswabs (ketam<strong>in</strong>e 20 mg <strong>in</strong> children aged 3–12 years)(48) or peritonsillar <strong>in</strong>filtration reduced very earlypa<strong>in</strong> scores <strong>and</strong> opioid requirements (49), effects mayrelate to systemic absorption. The comb<strong>in</strong>ation of ketam<strong>in</strong>e0.5 mgÆkg )1 IV <strong>and</strong> topical bupivaca<strong>in</strong>e <strong>in</strong>filtrationresulted <strong>in</strong> m<strong>in</strong>or reductions <strong>in</strong> pa<strong>in</strong> scoresª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 35


when compared with LA alone <strong>and</strong> sal<strong>in</strong>e controlgroups (41).Dexmedetomid<strong>in</strong>e (IV) may reduce opioid requirements<strong>and</strong> respiratory side effects <strong>in</strong> children after tonsillectomy,this may particularly benefit those withobstructive sleep apnea (OSA) or respiratory compromise.One microgram per kilogram produced less respiratorydepression than 100 lgÆkg )1 morph<strong>in</strong>e but lesseffective analgesia (50). Higher doses, 2 <strong>and</strong> 4 lgÆkg )1 ,lengthened time to rescue opioid analgesia but<strong>in</strong>creased sedation <strong>in</strong> the early postoperative periodwhen compared to fentanyl 1 or 2 lgÆkg )1 IV (51).Dexmedetomid<strong>in</strong>e 2 lgÆkg )1 + 0.7 lgÆkg )1 Æh )1 <strong>in</strong>traoperativereduced early postoperative opioid requirements<strong>and</strong> agitation <strong>in</strong> children with OSA comparedwith fentanyl 1 lgÆkg )1 (52).Dexamethasone reduces PONV <strong>and</strong> postoperativepa<strong>in</strong> scores follow<strong>in</strong>g tonsillectomy (13,53).Most meta-analyses of posttonsillectomy analgesiahave focused on PONV <strong>and</strong> bleed<strong>in</strong>g rather than analgesicefficacy. PONV follow<strong>in</strong>g tonsillectomy is reducedby NSAID presumably because of a reduction <strong>in</strong>opioid requirement (33,54), <strong>and</strong> by <strong>in</strong>traoperative dexamethasone(see above). As posttonsillectomy bleed<strong>in</strong>gis relatively rare, meta-analyses have <strong>in</strong>cluded differenttrials <strong>and</strong> reached different conclusions:l Bleed<strong>in</strong>g is <strong>in</strong>creased by aspir<strong>in</strong> but not ibuprofen ordiclofenac (seven trials) (55).l Risk of bleed<strong>in</strong>g <strong>and</strong> reoperation <strong>in</strong>creased (NNH29), <strong>and</strong> NSAIDS should not be used (seven trials)(56).l Risk of reoperation (NNH 60) but not bleed<strong>in</strong>g<strong>in</strong>creased, <strong>and</strong> NSAIDS should be used cautiously (25trials) (33)l NSAIDS do not <strong>in</strong>crease risk of bleed<strong>in</strong>g or reoperationbut further studies required (13 pediatric trials)(54).Although meta-analyses are currently <strong>in</strong>conclusive,perioperative diclofenac <strong>and</strong> ibuprofen appear to beassociated with m<strong>in</strong>imal risk of posttonsillectomybleed<strong>in</strong>g. Early studies us<strong>in</strong>g high doses of ketorolachave been <strong>in</strong>cluded <strong>in</strong> the meta-analyses, but there are<strong>in</strong>sufficient data to assess the risks associated with differentNSAIDS.Analgesia Table 5.2.2AgentTechniqueDirectevidenceLA a Tonsillar fossa <strong>in</strong>jection 1+*Topical 1+*Opioid 1+Tramadol 1+Dexamethasone 1+Ketam<strong>in</strong>e 1+NSAIDS 1+Paracetamol 1+a No differences have been demonstrated based on route (topicalvs <strong>in</strong>filtration), type of LA, or time of <strong>in</strong>jection (pre- vs postremoval).5.2.3 Mastoid <strong>and</strong> middle ear surgeryMastoidectomy may be performed to remove <strong>in</strong>fectedtissue or cholesteatoma. As the <strong>in</strong>cidence of chronicsuppurative otitis media is decl<strong>in</strong><strong>in</strong>g <strong>in</strong> many populations,this surgery is now less frequently required <strong>in</strong>the UK. Middle ear surgery, such as reconstruction ofa damaged tympanic membrane by placement of surgicalgrafts, may be associated with significant PONV.See also section 5.1 for the general management ofpostoperative pa<strong>in</strong>.RecommendationsGreat auricular nerve block can provide similar analgesia<strong>and</strong> reduced PONV compared with morph<strong>in</strong>e. Pre<strong>in</strong>cisiontim<strong>in</strong>g of the block confers no additional benefit:Grade B (57,58).EvidenceThere are relatively few controlled trials specifically<strong>in</strong>vestigat<strong>in</strong>g pa<strong>in</strong> dur<strong>in</strong>g <strong>and</strong> after mastoidectomy <strong>and</strong><strong>in</strong>vasive middle ear surgery, <strong>and</strong> no further studiess<strong>in</strong>ce the last edition of this guidel<strong>in</strong>e. As NSAIDS<strong>and</strong> paracetamol improve analgesia for middle ear procedures,there is <strong>in</strong>direct evidence that they providebeneficial supplemental analgesia for mastoid surgery.However, compared with middle ear surgery, mastoidsurgery is associated with <strong>in</strong>creased pa<strong>in</strong>: patients aretherefore more likely to require opioids, treatment forPONV <strong>and</strong> hospital admission (59). In procedures thatrequire a postauricular <strong>in</strong>cision, LA block of the greatauricular nerve can provide similar analgesia <strong>and</strong>reduced PONV compared with morph<strong>in</strong>e (57). No differencewas found between perform<strong>in</strong>g the block pre<strong>in</strong>cisionvs prior to the end of surgery (58).36 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


Analgesia Table 5.2.3AgentTechniqueDirectevidenceLAGreater auricular 1)nerve blockOpioid 1)NSAID 1)Paracetamol 1)5.3 Opthalmology5.3.1 Strabismus surgeryIndirectevidenceStrabismus surgery (correction of squ<strong>in</strong>t) is associatedwith a high <strong>in</strong>cidence of PONV, <strong>and</strong> <strong>in</strong>traoperativetension on ocular muscles may provoke a vagalresponse (oculocardiac reflex). See also section 5.1 forthe general management of postoperative pa<strong>in</strong>.RecommendationsIntraoperative LA blocks (subtenon’s or peribulbar)reduce PONV <strong>and</strong> may improve perioperative analgesia<strong>in</strong> comparison with IV opioid but provide no benefit overtopical LA: Grade B (60–64).Topical NSAIDS do not improve pa<strong>in</strong> scores or postoperativeanalgesic requirements when compared with topicalLA or placebo: Grade B (65–67).Intraoperative opioid <strong>and</strong> NSAID provide similar postoperativeanalgesia, but opioid use is associated with<strong>in</strong>creased PONV: Grade B (68–71).EvidenceIn many trials, reduction of PONV rather thanimprovement <strong>in</strong> analgesia has been the primary outcome.The duration of surgery varies from 25 to80 m<strong>in</strong> <strong>in</strong> the reported studies, <strong>and</strong> many do not discrim<strong>in</strong>atebetween unilateral or bilateral surgery orprocedures <strong>in</strong>volv<strong>in</strong>g s<strong>in</strong>gle or multiple muscles. Thismay contribute to the variability across studies <strong>in</strong> the<strong>in</strong>cidence of side effects <strong>and</strong> analgesic requirements.Peribulbar or subtenon’s LA blocks reduce <strong>in</strong>traoperativeoculocardiac reflex responses (60,62,63) <strong>and</strong> PONV(60,62,63) when compared with <strong>in</strong>traoperative opioid.Peribulbar or subtenon blocks reduce perioperative analgesicrequirements when compared with opioid <strong>in</strong> some(60,63) but not all (61,62) trials. No complications of LA<strong>in</strong>jections were reported <strong>in</strong> these studies, but patientnumbers are small. Sub-tenon’s block provided no benefitcompared with less <strong>in</strong>vasive topical tetraca<strong>in</strong>e application(64). Topical LA applied prior to <strong>and</strong> at thecompletion of surgery reduced early distress (first30 m<strong>in</strong>) but did not <strong>in</strong>fluence pa<strong>in</strong> at later time po<strong>in</strong>ts orreduce supplemental analgesic requirements (72).No difference <strong>in</strong> postoperative pa<strong>in</strong> scores or analgesicrequirement has been detected between topical LAdrops <strong>and</strong> topical NSAIDS (65,67). Pa<strong>in</strong> scores (CHE-OPS) were not reduced by topical NSAIDS when comparedwith placebo (66,67), but the authors questionedthe sensitivity of this measure for ocular pa<strong>in</strong>.Direct comparisons of <strong>in</strong>traoperative NSAID <strong>and</strong>opioid (PR diclofenac vs IV morph<strong>in</strong>e) (71) (IV ketorolacvs IV pethid<strong>in</strong>e) (70) (IV ketorolac vs IV fentanyl)(68) have reported no difference <strong>in</strong> postoperative pa<strong>in</strong>scores or supplemental analgesic requirements but<strong>in</strong>creases <strong>in</strong> PONV <strong>in</strong> patients given opioids. Comparisonof <strong>in</strong>traoperative remifentanil <strong>and</strong> fentanyl reportedhigher early pa<strong>in</strong> scores but less PONV with remifentanil(73). Comparisons of NSAID <strong>and</strong> placebo haveshown m<strong>in</strong>or improvements <strong>in</strong> pa<strong>in</strong> score <strong>and</strong> reductions<strong>in</strong> supplemental analgesic requirements (69,74).Analgesia Table 5.3.1AgentTechniqueDirectevidenceLA Subtenon block a 1)LA Peribulbar a 1)LA Topical a 1+Opioid Parenteral b 1)NSAID Topical 1)Systemic b 1)Paracetamol 1)Indirectevidencea Few comparisons, but no advantage of subtenon over topical<strong>in</strong> one trial.b Similar analgesia with systemic NSAID <strong>and</strong> opioid but<strong>in</strong>creased PONV with opioid; oral or rectal paracetamol givenas part of multimodal analgesia to all patients <strong>in</strong> several trialsbut efficacy not directly compared with other agents.5.3.2 Vitreoret<strong>in</strong>al surgeryVitreoret<strong>in</strong>al <strong>and</strong> ret<strong>in</strong>al detachment surgery are associatedwith significant postoperative pa<strong>in</strong> <strong>and</strong> PONV.Supplemental local anesthetic techniques may have arole, but the relative benefit vs risk has not been fullyevaluated. See also section 5.1 for the general managementof postoperative pa<strong>in</strong>.RecommendationsIn vitreoret<strong>in</strong>al surgery, NSAID can provide similaranalgesia but lower rates of PONV compared with opioid:Grade C (75).ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 37


Peribulbar block improves early analgesia <strong>and</strong>may reduce PONV compared with opioid: Grade C(60,76–78).EvidenceKetoprofen <strong>and</strong> pethid<strong>in</strong>e provided similar levels ofanalgesia, but PONV was less with ketoprofen (75).Peribulbar LA block appears to be effective (60,76).Concerns have been expressed that peribulbar blockmay present a higher risk <strong>in</strong> children than subtenon’sblock as the eye occupies a relatively greater volume ofthe bony orbit <strong>in</strong> a child, <strong>and</strong> large volumes of LA havebeen used <strong>in</strong> trials of peribulbar block (79). Comparedwith fentanyl, subtenon’s LA block reduces the <strong>in</strong>cidenceof <strong>in</strong>tra-operative oculo-cardiac reflexes <strong>and</strong>improves early analgesia (77,80), but only one trialshowed a reduction <strong>in</strong> analgesic requirements <strong>and</strong>PONV (77). There has been no evaluation of the risk vsbenefit of these procedures <strong>in</strong> children.Topical LA gel at the beg<strong>in</strong>n<strong>in</strong>g of surgery reduced<strong>in</strong>tra-operative, but not postoperative, analgesicrequirements (81).Analgesia Table 5.3.2AgentTechniqueDirectevidenceLA Peribulbar block a 2+Subtenon block 1)Opioid 1)NSAID 1)Paracetamol 1)a No analysis of risk–benefit for peribulbar block.5.4 Dental proceduresIndirectevidenceDental procedures <strong>in</strong> children may range from m<strong>in</strong>orrestoration <strong>and</strong> conservation requir<strong>in</strong>g little or nopostoperative analgesia, to variable numbers of extractions,<strong>and</strong> sometimes more extensive surgery lead<strong>in</strong>g tosignificant postoperative pa<strong>in</strong>. See also section 5.1 forthe general management of postoperative pa<strong>in</strong>.RecommendationsNSAIDS with or without paracetamol reduce pa<strong>in</strong> follow<strong>in</strong>gdental extractions: Grade B (82–84).Swabs soaked with bupivaca<strong>in</strong>e on exposed tooth socketsfollow<strong>in</strong>g extraction produce no or m<strong>in</strong>or improvements<strong>in</strong> pa<strong>in</strong> <strong>in</strong> the immediate postoperative period: Grade B(85,86).Intraoperative LA <strong>in</strong>filtration reduces postoperative pa<strong>in</strong>follow<strong>in</strong>g dental extractions, but provides little additionalbenefit over NSAIDS <strong>and</strong> paracetamol alone:Grade B (83,84,87,88).EvidenceThe degree of postoperative pa<strong>in</strong> follow<strong>in</strong>g dentalextractions <strong>in</strong>creases with the number of teeth removed(89,90).NSAIDS (82,91,92) <strong>and</strong> comb<strong>in</strong>ations of NSAID<strong>and</strong> paracetamol (83,84,88) reduce pa<strong>in</strong> follow<strong>in</strong>g dentalextractions. However, add<strong>in</strong>g paracetamol to ibuprofendid not improve early analgesia (15 m<strong>in</strong>postoperatively) compared with ibuprofen alone <strong>in</strong> onestudy (82).Opioids: no differences <strong>in</strong> analgesia were shown <strong>in</strong>comparisons with NSAIDS for extractions (93,94), butopioids may produce <strong>in</strong>creased PONV (94). Similarly,for dental restorations without extractions, paracetamolprovided adequate analgesia, pa<strong>in</strong> scores wereslightly lower with pethid<strong>in</strong>e, but sedation was<strong>in</strong>creased (95).LA <strong>in</strong>filtration (2% lignoca<strong>in</strong>e with adrenal<strong>in</strong>e)added to NSAID ± paracetamol (83,84,88,92) provideslittle additional benefit follow<strong>in</strong>g dental extractions,but less postoperative bleed<strong>in</strong>g <strong>in</strong> the recoveryroom (reduced need for suction<strong>in</strong>g rather than quantifiedlosses) was noted <strong>in</strong> one trial (88). Addition ofmorph<strong>in</strong>e (25 lgÆkg )1 ) to the local anesthetic <strong>in</strong>jectiondid not improve analgesia (96). The soft tissue numbnessassociated with LA <strong>in</strong>filtration may produce distress<strong>and</strong> <strong>in</strong>crease bit<strong>in</strong>g of lips <strong>and</strong> cheeks <strong>in</strong> youngchildren (92). Distress<strong>in</strong>g numbness was avoided by <strong>in</strong>traligamental<strong>in</strong>jection of LA, but add<strong>in</strong>g this toNSAID <strong>and</strong> paracetamol provided no additional benefit(83) or m<strong>in</strong>or improvements <strong>in</strong> early analgesia(5 m<strong>in</strong>) only (84). No improvements <strong>in</strong> analgesia ordistress were found when bupivaca<strong>in</strong>e-soaked swabs <strong>in</strong>the dental socket were added to paracetamol15 mgÆkg )1 (86) or diclofenac (85).Analgesia Table 5.4AgentTechniqueLA Local <strong>in</strong>filtration a 1+Soaked swabs a 1)Opioid 1)NSAID 1+Paracetamol 1)DirectEvidencea Improvements <strong>in</strong> early analgesia <strong>and</strong> no additional benefit overNSAID ± paracetamol.38 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


5.5 General surgery <strong>and</strong> urology (m<strong>in</strong>or<strong>and</strong> <strong>in</strong>termediate)5.5.1 Sub-umbilical surgeryThis category has been <strong>in</strong>cluded because many studieshave used a comb<strong>in</strong>ation of different surgical proceduresfrom the sub-umbilical area as the operativemodel, for example, repair of <strong>in</strong>gu<strong>in</strong>al hernia, orchidopexy,orchidectomy, circumcision, phimosis, hypospadias,hydrocoele, vesico-ureteric reflux, testiculartortion, appendicectomy. <strong>Postoperative</strong> pa<strong>in</strong> is unlikelyto be equivalent follow<strong>in</strong>g each of these different procedures(97), but they are not uniformly distributedbetween studies <strong>and</strong> the numbers of <strong>in</strong>dividual procedures<strong>in</strong> each study are often low, thereby mak<strong>in</strong>g itimpractical to look at each procedure <strong>in</strong> isolation.Refer to other pages <strong>in</strong> this section for more <strong>in</strong>formationon specific procedures, see also section 5.1 for thegeneral management of postoperative pa<strong>in</strong>.RecommendationLA should be used when feasible: wound <strong>in</strong>filtration,transversus abdom<strong>in</strong>is plane (TAP) block, ilio-<strong>in</strong>gu<strong>in</strong>alnerve block, <strong>and</strong> caudal analgesia are effective <strong>in</strong> theearly postoperative period follow<strong>in</strong>g sub-umbilical surgery:Grade A (98–103).EvidenceThe majority of studies compared differ<strong>in</strong>g drug comb<strong>in</strong>ations<strong>in</strong> central or peripheral nerve blockade. Caudalepidural neuraxial block was the most commonlystudied technique <strong>and</strong> demonstrated good efficacy <strong>in</strong>all studies with a low failure <strong>and</strong> serious complicationrate. This is <strong>in</strong> agreement with large case series of thistechnique (104–107). Efficacy was equivalent irrespectiveof the local anesthetic agent used, <strong>and</strong> there waslittle difference <strong>in</strong> the rate of side effects, caudal analgesiahas been used with either general anesthesia orsedation for surgery (100,102,107–109). The optimalconcentration <strong>and</strong> volume of LA has not been elucidated,but concentrations of levobupivaca<strong>in</strong>e <strong>and</strong> ropivaca<strong>in</strong>ebelow 0.2% have been associated with lowerefficacy <strong>in</strong> some studies (110–112).Caudal neuraxial analgesic additives 1 : with LA: theaddition of caudal S-ketam<strong>in</strong>e, neostigm<strong>in</strong>e, clonid<strong>in</strong>e,dexmedetomid<strong>in</strong>e, midazolam, buprenorph<strong>in</strong>e, fentanyl,<strong>and</strong> morph<strong>in</strong>e <strong>in</strong>creased analgesic efficacy <strong>and</strong> prolongedthe duration of the block, with little reported <strong>in</strong>crease <strong>in</strong>side effects <strong>in</strong> most studies (113–123). In contrast, otherstudies show that there is no benefit to add<strong>in</strong>g midazolam,magnesium, or sufentanil to LA via the caudal route(124–126). Clonid<strong>in</strong>e, S-ketam<strong>in</strong>e, <strong>and</strong> buprenorph<strong>in</strong>ewere more effective when given by the caudal route comparedwith the <strong>in</strong>travenous route (115,120,127). In directcomparisons, either caudal clonid<strong>in</strong>e or midazolam werebetter than morph<strong>in</strong>e (113,128).Without LA: a comb<strong>in</strong>ation of S-ketam<strong>in</strong>e <strong>and</strong>clonid<strong>in</strong>e demonstrated better analgesic efficacy thanS-ketam<strong>in</strong>e alone via the caudal route (129). The useof such adjunctive analgesia requires further researchto better identify safety profile, risk–benefit <strong>and</strong> dose;see also section 6.3 for a further discussion of neuraxialanalgesia.Ilio-<strong>in</strong>gu<strong>in</strong>al nerve block was shown to be effective,but overall efficacy was generally lower than <strong>in</strong> studiesof caudal block (98,130). The use of ultrasound toplace the ilio-<strong>in</strong>gu<strong>in</strong>al block improved the quality ofthe block, decreased supplementary opioid use, <strong>and</strong>decreased the amount of local anesthetic used (131).No benefit was seen from add<strong>in</strong>g clonid<strong>in</strong>e to the localanesthetic <strong>in</strong> ilio-<strong>in</strong>gu<strong>in</strong>al nerve block (100,132).TAP block is feasible with <strong>in</strong>itial reports of goodefficacy. An ultrasound-guided technique was shownto be effective <strong>in</strong> the <strong>in</strong>traoperative <strong>and</strong> early postoperativeperiod, though efficacy was less when comparedwith ultrasound-guided ilio-<strong>in</strong>gu<strong>in</strong>al nerve block for<strong>in</strong>gu<strong>in</strong>al surgery (103).LA wound <strong>in</strong>filtration/<strong>in</strong>stillation is effective <strong>in</strong> theearly postoperative period, it was equivalent to ilio<strong>in</strong>gu<strong>in</strong>alblock with no further benefit from us<strong>in</strong>g them<strong>in</strong> comb<strong>in</strong>ation <strong>in</strong> one study (98,101).1 Note on caudal additives: not all additives have undergone rigoroussafety test<strong>in</strong>g <strong>and</strong> concerns regard<strong>in</strong>g potential toxic effects have beenexpressed. See Section 6. 3ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 39


Analgesia Table 5.5.1 Sub-umbilical SurgeryAgentTechniqueDirectevidenceLA Wound <strong>in</strong>filtration a 1+LA Ilio-<strong>in</strong>gu<strong>in</strong>al nerve block a 1+LA TAP Block 1)LA Caudal epidural 1+LA + Ketam<strong>in</strong>e b Caudal epidural 1+LA + Clonid<strong>in</strong>e b Caudal epidural 1+Opioid c 1+NSAID c 1+Paracetamol c 1+Indirectevidencea Possibly lower efficacy than caudal block: more studies arerequired.b Note on caudal additives: not all additives have undergone rigoroussafety test<strong>in</strong>g, <strong>and</strong> concerns regard<strong>in</strong>g potential toxiceffects have been expressed. See Section 6.c As part of a multi-modal technique5.5.2 CircumcisionCircumcision is regarded as a relatively m<strong>in</strong>or surgicalprocedure, but it may be associated with significantpostoperative pa<strong>in</strong> <strong>and</strong> distress. It is usually undertakenon an out-patient or day-case basis. Circumcision<strong>in</strong> the neonate is considered separately <strong>in</strong> section5.5.3. See sections 5.1 for the general management ofpostoperative pa<strong>in</strong> <strong>and</strong> 5.5.1 for a discussion of subumbilicalsurgery.<strong>Good</strong> practice po<strong>in</strong>tAnalgesia with opioid alone should be avoided if possiblebecause of lower efficacy <strong>and</strong> higher <strong>in</strong>cidence ofside effects <strong>in</strong> comparison with LA techniques.RecommendationCaudal epidural <strong>and</strong> dorsal nerve block are effective <strong>in</strong>the early postoperative period, with low rates of complications<strong>and</strong> side effects: Grade A (133).EvidenceLocal anesthetic techniques <strong>in</strong>volv<strong>in</strong>g a regional blockor topical application can provide good analgesic efficacy<strong>in</strong> the early postoperative period (133–135).Analgesia follow<strong>in</strong>g caudal or dorsal nerve block wasequivalent <strong>and</strong> was superior to subcutaneous ‘r<strong>in</strong>g’block (133,136–139). Caudal <strong>and</strong> dorsal nerve blockdemonstrated a low failure <strong>and</strong> serious complicationrate <strong>in</strong> all studies. This is <strong>in</strong> agreement with largercase series of both techniques (104,140). In somestudies, a caudal block reportedly <strong>in</strong>creased the timeto micturition <strong>and</strong> <strong>in</strong>cidence of motor blockcompared with dorsal nerve block <strong>and</strong> subcutaneousr<strong>in</strong>g block, but this f<strong>in</strong>d<strong>in</strong>g was not seen <strong>in</strong> other<strong>in</strong>vestigations (133,136–139). The ideal agent, dose, orconcentration for a caudal block has not been elucidated.The use of ultrasound for dorsal nerve block hasbeen shown to improve the efficacy <strong>and</strong> decrease the<strong>in</strong>cidence of failed blocks (141) The use of subcutaneousr<strong>in</strong>g block was associated with a higher failure <strong>and</strong> complicationrate than caudal or dorsal nerve block(136,137). Pundendal nerve block has also been shownto provide effective perioperative analgesia for circumcision(142,143). One study compared topical local anesthesiawith dorsal nerve block for 6 h postoperatively<strong>and</strong> showed no difference <strong>in</strong> analgesia (144).Caudal neuraxial analgesic additives 1 : Ketam<strong>in</strong>e+ LA showed <strong>in</strong>creased analgesic efficacy butalso <strong>in</strong>creased motor block when compared with a LAdorsal nerve block (145). The addition of ketam<strong>in</strong>e orclond<strong>in</strong>e conferred no additional benefit comparedwith LA alone <strong>in</strong> other studies (146,147).Parenteral opioids are associated with lower analgesicefficacy <strong>and</strong> <strong>in</strong>creased postoperative nausea <strong>and</strong>vomit<strong>in</strong>g compared with LA techniques (135).NSAID (Diclofenac) as a sole agent was <strong>in</strong>ferior todorsal nerve block, but the comb<strong>in</strong>ation may decreasesupplementary analgesic use compared with eithertechnique <strong>in</strong> isolation (134).Analgesia Table 5.5.2 CircumcisionAgentTechniqueLA Topical a 1+LA Subcutaneous ‘r<strong>in</strong>g’ block a 1)LA Pudendal nerve block 1)LA Dorsal n. block 1+LA Caudal epidural 1+Opioid b 1+NSAIDS b 1+Paracetamol b 1+a lower efficacy than caudal epidural or dorsal nerve block.b As part of a multi-modal technique.5.5.3 Neonatal CircumcisionDirectevidenceNeonatal circumcision is considered separately fromcircumcision <strong>in</strong> older children because of differences <strong>in</strong>cl<strong>in</strong>ical practice <strong>and</strong> evidence base. Premature neonatescan experience pa<strong>in</strong> <strong>and</strong> therefore require good1 Note on caudal additives: not all additives have undergone rigoroussafety test<strong>in</strong>g, <strong>and</strong> concerns regard<strong>in</strong>g potential toxic effects have beenexpressed. See Section 6.3.40 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


perioperative analgesia for surgical <strong>in</strong>terventions.Many circumcisions are done <strong>in</strong> the awake neonate <strong>in</strong>the first few hours or days of life; this is reflected <strong>in</strong>the literature as studies have generally evaluated pa<strong>in</strong>dur<strong>in</strong>g the procedure. However, for neonatal circumcision,no s<strong>in</strong>gle technique has been shown to reliablyalleviate pa<strong>in</strong> <strong>in</strong> the awake patient, which thereforepresents a cl<strong>in</strong>ical challenge. Circumcision <strong>in</strong> <strong>in</strong>fants<strong>and</strong> older children is <strong>in</strong>variably performed under generalanesthesia (see section 5.5.1), the debate regard<strong>in</strong>gthe necessity for general anesthesia <strong>in</strong> the neonaterema<strong>in</strong>s unresolved. See sections 5.1 for the generalmanagement of postoperative pa<strong>in</strong> <strong>and</strong> 5.5.1 for afurther discussion of sub-umbilical surgery.<strong>Good</strong> practice po<strong>in</strong>tGeneral anesthesia should be considered for neonatalcircumcision. A multi-modal analgesic approachshould <strong>in</strong>clude a local anesthetic technique at the timeof the procedure <strong>in</strong> comb<strong>in</strong>ation with sucrose <strong>and</strong> paracetamol.RecommendationsLA should be used as it is superior to other techniquesfor circumcision pa<strong>in</strong>: Grade A (148).Dorsal nerve block is more effective than subcutaneousr<strong>in</strong>g block or topical LA: Grade A (148).When us<strong>in</strong>g topical local anesthetic, it must be appliedcorrectly <strong>and</strong> sufficient time allowed for it to becomeeffective: Grade A (148).Evidence<strong>Postoperative</strong> pa<strong>in</strong> after circumcision <strong>in</strong> the neonatehas not been well <strong>in</strong>vestigated, <strong>and</strong> available studieshave all exam<strong>in</strong>ed pa<strong>in</strong> dur<strong>in</strong>g the procedure <strong>in</strong> awakeneonates. It has been suggested that the procedure beperformed <strong>in</strong> awake <strong>in</strong>fants only dur<strong>in</strong>g the first weekof life as pa<strong>in</strong> scores dur<strong>in</strong>g the procedure have beenshown to <strong>in</strong>crease to unacceptable levels with <strong>in</strong>creas<strong>in</strong>gneonatal age (149). For all techniques studied,there was a significant failure rate (148,150). The useof LA was superior to either placebo or simple analgesics<strong>and</strong> sucrose (148). Dorsal nerve block appears tobe superior to subcutaneous r<strong>in</strong>g block or topical localanesthesia (caudal epidural analgesia has not beenstudied, see (107)) <strong>and</strong> was associated with lower cortisollevels <strong>in</strong> one study, but was operator dependent<strong>and</strong> not totally reliable (148,150). Efficacy of topicallocal anesthetic agents was very dependent on the techniqueof application <strong>and</strong> time allowed (148,151,152).No <strong>in</strong>creased <strong>in</strong>cidence of complications was seen <strong>in</strong>one technique compared with another (148). The durationof surgery (<strong>and</strong> therefore duration of <strong>in</strong>tra-operativepa<strong>in</strong>) was dependent on the surgical techniquewith the ‘Mogen Clamp’ associated with faster procedures(148,150).Analgesia Table 5.5.3 Neonatal CircumcisionAgentTechniqueDirectevidenceLA Topical 1++LA Subcutaneous ‘r<strong>in</strong>g’ block 1++LA Dorsal nerve block 1++LA Caudal epidural 1+Paracetamol a 1+Sucrose b 1+a For postprocedure pa<strong>in</strong>.b As part of multimodal technique.5.5.4 Hypospadias repairIndirectevidenceHypospadias surgery may be either relatively superficial<strong>and</strong> m<strong>in</strong>or, or more major reconstructive surgery<strong>in</strong>volv<strong>in</strong>g the entire penile urethra may be undertaken,which will <strong>in</strong>fluence postoperative analgesia requirements.Some procedures are suitable for day-case surgerywhilst others require hospital admission overnightor longer, with the possibility of prolonged urethralcatheterisation <strong>and</strong> pa<strong>in</strong>ful postoperative dress<strong>in</strong>gchanges. See sections 5.1 <strong>and</strong> 5.5.1 for the generalmanagement of postoperative pa<strong>in</strong> <strong>and</strong> for a furtherdiscussion of sub-umbilical surgery.RecommendationLA central neuraxial or dorsal nerve block is effectivereduc<strong>in</strong>g the need for postoperative supplementary opioidadm<strong>in</strong>istration follow<strong>in</strong>g hypospadias surgery: Grade A(153–158).EvidenceCaudal LA was most commonly <strong>in</strong>vestigated for hypospadiasrepair. <strong>Good</strong> efficacy for the technique wasdemonstrated with a low failure <strong>and</strong> serious complicationrate; this is <strong>in</strong> agreement with large case series ofthis technique (104–106). Bupivaca<strong>in</strong>e 0.25%,0.5 mlÆkg )1 was most frequently studied, but therewere few comparisons with other local anesthetics orbetween different concentrations or volumes. Onestudy found that caudal ropivaca<strong>in</strong>e 0.1%, 1.8 mlÆkg )1 ,ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 41


was more effective with less motor block than ropivaca<strong>in</strong>e0.375%, 0.5 mlÆkg )1 (159).Caudal neuraxial analgesic additives a : With LA: theaddition of neostigm<strong>in</strong>e or diamorph<strong>in</strong>e to caudal bupivaca<strong>in</strong>e<strong>in</strong>creased analgesic efficacy (154,157,160) butalso <strong>in</strong>creased the rate of nausea <strong>and</strong> vomit<strong>in</strong>g <strong>in</strong> twoof the studies (154,160). Add<strong>in</strong>g tramadol to bupivavca<strong>in</strong>e<strong>in</strong>creased the analgesic efficacy <strong>in</strong> the first 24 hpostoperatively (161). In other studies, the addition oftramadol, clonid<strong>in</strong>e, or sufent<strong>in</strong>il did not <strong>in</strong>crease efficacy(153,162,163).Without LA: ketam<strong>in</strong>e or mixture of ketam<strong>in</strong>e/alfentanilwas superior to alfentanil alone, <strong>and</strong> higher dosesof neostigm<strong>in</strong>e <strong>in</strong>creased efficacy but also <strong>in</strong>creasednausea <strong>and</strong> vomit<strong>in</strong>g (164,165). In general, the use ofneuraxial analgesics has not been comprehensivelystudied, further research to identify safety profile, risk–benefit <strong>and</strong> dose are required (see also section 6.0).Only one study compared different techniques <strong>and</strong>showed that tramadol given by the caudal routedemonstrated better analgesic efficacy <strong>and</strong> lesspostoperative nausea <strong>and</strong> vomit<strong>in</strong>g than when given bythe <strong>in</strong>travenous route (166).Epidural analgesia was shown to provide goodanalgesia both <strong>in</strong>tra- <strong>and</strong> postoperatively irrespectiveof the local anesthetic agent used: bupivaca<strong>in</strong>e, levobupivaca<strong>in</strong>e,or ropivaca<strong>in</strong>e, there was an exclusionrate of 10% <strong>in</strong> one study (167) <strong>and</strong> patients hav<strong>in</strong>gan abdom<strong>in</strong>al <strong>in</strong>cision were <strong>in</strong>cluded <strong>in</strong> another (168).The addition of fentanyl to ropivaca<strong>in</strong>e demonstrated<strong>in</strong>creased analgesic efficacy for postoperative epidural<strong>in</strong>fusions at low (0.125%) concentrations of ropivaca<strong>in</strong>e(158).Dorsal nerve block is effective for distal hypospadiasrepair. An <strong>in</strong>vestigation of the tim<strong>in</strong>g of dorsal nerveblock either pre or postsurgery found that plac<strong>in</strong>g theblock prior to surgery improved analgesic efficacy(169).Sp<strong>in</strong>al <strong>in</strong>trathecal neuraxial analgesia us<strong>in</strong>g hyperbaric0.5% bupivaca<strong>in</strong>e is effective both <strong>in</strong>tra- <strong>and</strong>postoperatively. The addition of morph<strong>in</strong>e to the LA<strong>in</strong>creased the efficacy with no <strong>in</strong>crease <strong>in</strong> adverseeffects <strong>in</strong> one study (170).Paracetamol given alongside caudal block did notimprove analgesia <strong>in</strong> the first six postoperative hourscompared with a caudal block alone <strong>in</strong> one study(171). Overall, there are <strong>in</strong>sufficient data to evaluatethe use of supplementary analgesia <strong>in</strong> either the earlyor late postoperative period. In cl<strong>in</strong>ical practice, amulti-modal analgesic technique for this procedure issuggested, with regular supplementary analgesia given<strong>in</strong> the postoperative period.Analgesia Table 5.5.4 Hypospadias RepairAgentTechniqueDirectevidenceLA Dorsal n. block 1+LA Caudal epidural 1+LA Lumbar epidural 1+LA Sp<strong>in</strong>al 1)LA + neostigm<strong>in</strong>e a,b Caudal epidural 1+LA + opioid b Caudal epidural 1+LA + opioid Intrathecal 1)Opioid c 1+NSAID c 1+Paracetamol c 1+Indirectevidencea Note on caudal additives: not all additives have undergone rigoroussafety test<strong>in</strong>g, <strong>and</strong> concerns regard<strong>in</strong>g potential toxiceffects have been expressed. See Section 6.3.b Small improvements <strong>in</strong> efficacy must be balanced aga<strong>in</strong>st<strong>in</strong>creased PONV.c As part of a multi-modal technique.5.5.5 OrchidopexyOrchidopexy usually <strong>in</strong>volves surgical exploration ofthe <strong>in</strong>gu<strong>in</strong>al region, dissection, <strong>and</strong> traction of thespermatic cord <strong>and</strong> scrotal <strong>in</strong>cision may also berequired. Orchidopexy is generally performed on aday-case basis. See sections 5.1 <strong>and</strong> 5.5.1 for the generalmanagement of postoperative pa<strong>in</strong> <strong>and</strong> for a furtherdiscussion of sub-umbilical surgery.RecommendationCaudal block is effective <strong>in</strong> the early postoperative periodfor orchidopexy with low rates of complications <strong>and</strong>side effects: Grade A (172–174).EvidenceThere are few studies <strong>in</strong>vestigat<strong>in</strong>g analgesia for orchidopexyalone. <strong>Postoperative</strong> analgesic requirementsmay be greater than that required for <strong>in</strong>gu<strong>in</strong>al herniarepair (97).LA caudal block us<strong>in</strong>g 1 mlÆkg )1 of 0.125–0.25%bupivaca<strong>in</strong>e or 1–1.5 mlÆkg )1 of ropivaca<strong>in</strong>e 0.15–0.225% has shown good efficacy <strong>and</strong> low complicationrates (172–175). This is <strong>in</strong> agreement with large caseseries of this technique (104–106). It was associatedwith greater efficacy, less supplementary analgesic use<strong>and</strong> lower levels of stress hormones when comparedwith ilio<strong>in</strong>gu<strong>in</strong>al nerve block plus local <strong>in</strong>filtration(172,173). There was also no difference <strong>in</strong> time to micturition,motor block or nausea <strong>and</strong> vomit<strong>in</strong>g betweenthe two techniques (172). A higher volume of localanesthetic (1 mlÆkg )1 ) was associated with less response42 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


to cord traction, but not with improved postoperativeanalgesia (174).Neuraxial analgesic additives: the addition of ketam<strong>in</strong>e0.25–1 mgÆkg )1 as an adjunct to bupivaca<strong>in</strong>e<strong>in</strong>creased analgesic efficacy but was associated with‘short-lived psychomotor effects’ at higher doses (176).The addition of IV dexamethasone with ropivavca<strong>in</strong>ecaudal block was associated with <strong>in</strong>creased analgesicefficacy (177).Transverse abdom<strong>in</strong>al plane (TAP) block us<strong>in</strong>g pla<strong>in</strong>LA, as part of a multi-modal analgesic technique, hasdemonstrated perioperative analgesic efficacy with nocomplications <strong>in</strong> a small case series (178).Analgesia Table 5.5.5 OrchidopexyAgentTechniqueDirectevidenceLA Wound <strong>in</strong>filtration a 1+LA Ilio<strong>in</strong>gu<strong>in</strong>al block a 1+LA Caudal epidural 1+LA TAP block 3Opioid b 1+NSAID b 1+Paracetamol b 1+a Less effective than caudal block.b As part of a multi-modal technique.5.5.6 Ingu<strong>in</strong>al hernia repair (open)IndirectevidenceSurgical repair of <strong>in</strong>gu<strong>in</strong>al hernia is generally performedon a day-case basis. The follow<strong>in</strong>g refers to theconventional ‘open’ technique, rather than laparoscopicrepair that is becom<strong>in</strong>g more popular. See sections5.1 <strong>and</strong> 5.5.1 for the general management ofpostoperative pa<strong>in</strong> <strong>and</strong> for a further discussion of subumbilicalsurgery.<strong>Good</strong> practice po<strong>in</strong>tThe use of an ultrasound-guided technique for theplacement of an ilio-<strong>in</strong>gu<strong>in</strong>al nerve block may decreasethe failure rate <strong>and</strong> improve analgesic efficacy.RecommendationsLA wound <strong>in</strong>filtration, ilio-<strong>in</strong>gu<strong>in</strong>al nerve block, paravertebralblock, or caudal analgesia are effective <strong>in</strong> theearly postoperative period: Grade A (179–184).EvidenceCaudal block was the most commonly studied techniquewith good efficacy <strong>and</strong> a low failure complication rate <strong>in</strong>all studies. This is <strong>in</strong> agreement with large case series ofthis technique (104–106). Bupivaca<strong>in</strong>e 0.25% was themost studied <strong>and</strong> compared LA, ropivaca<strong>in</strong>e 0.25% wasfound to be equivalent <strong>in</strong> one study (185). Anotherstudy compar<strong>in</strong>g different concentrations of bupivaca<strong>in</strong>ewith <strong>and</strong> without adjunctive opioid showed lowerefficacy for 0.125% bupivaca<strong>in</strong>e (186). In a study ofbupivaca<strong>in</strong>e 0.175% (+adrenal<strong>in</strong>e 1 : 10 000), therewas no difference <strong>in</strong> efficacy or side effects at volumes ofbetween 0.7 <strong>and</strong> 1.3 mlÆkg )1 (187).Neuraxial analgesic additives: With LA; midazolam,ketam<strong>in</strong>e, clonid<strong>in</strong>e, fentanyl, neostigm<strong>in</strong>e, adrenal<strong>in</strong>e,morph<strong>in</strong>e <strong>and</strong> tramadol have all been studied asadjuncts to local anesthesia for caudal block. They allshow good efficacy, but evidence of overall benefit isequivocal as <strong>in</strong> most studies few patients required furtheranalgesia follow<strong>in</strong>g caudal block with pla<strong>in</strong> LA(166,175,181,188–195). In studies where no comparisonwas made with pla<strong>in</strong> LA: <strong>in</strong>creas<strong>in</strong>g the dose of ketam<strong>in</strong>ealso <strong>in</strong>creased efficacy, but neuro-behavioral sideeffects were seen at higher doses (196). Increas<strong>in</strong>g clonid<strong>in</strong>edose from 1 to 2 lgÆkg )1 had limited or noeffects on efficacy, time to 1st analgesia was prolonged<strong>in</strong> one study, but not <strong>in</strong> another (188,197).Without LA: S (+) ketam<strong>in</strong>e without local anestheticwas equivalent to bupivaca<strong>in</strong>e + adrenal<strong>in</strong>emixture, <strong>and</strong> S (+) ketam<strong>in</strong>e + clonid<strong>in</strong>e mixtureshowed <strong>in</strong>creased efficacy over ketam<strong>in</strong>e alone(198,199). Another study compar<strong>in</strong>g caudal with<strong>in</strong>tramuscular S-ketam<strong>in</strong>e showed <strong>in</strong>creased efficacy <strong>in</strong>the caudal group (200). Tramadol without local anestheticshowed reduced efficacy compared with pla<strong>in</strong>bupivaca<strong>in</strong>e or a bupivaca<strong>in</strong>e + tramadol mixture(191).Placement of caudal block prior to surgery was alsoshown to have better efficacy <strong>in</strong> the postoperative periodthan placement at the end of surgery <strong>in</strong> one study(201).Comparison of paravertebral block with caudal LAor <strong>in</strong>traoperative opioid (fentanyl) showed <strong>in</strong>creasedpostoperative analgesic efficacy, patient satisfaction,<strong>and</strong> earlier hospital discharge with the paravertebralblock (184,202).Ilio<strong>in</strong>gu<strong>in</strong>al nerve block shows good efficacy <strong>and</strong>safety, although a preferred agent, dose, or volume hasnot been demonstrated, although Levobupivaca<strong>in</strong>econcentrations below 0.25% show decreased efficacy(182,203–205). High failure rates have been associatedª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 43


with us<strong>in</strong>g l<strong>and</strong>mark techniques (205,206). Ultrasoundguidedtechniques may <strong>in</strong>crease the success rate <strong>and</strong>allow placement of the LA closer to the nerves withlower volumes be<strong>in</strong>g required for efficacy therebydecreas<strong>in</strong>g the potential for systemic toxicity (206–208). No advantage was seen postoperatively with theaddition of genitofemoral nerve block or by us<strong>in</strong>g a‘double shot technique’ (182,203). In one study, thesuccess rate of the block us<strong>in</strong>g surface l<strong>and</strong>marks wasquoted as only 72% (203).Wound <strong>in</strong>filtration is effective when compared tocaudal block with pla<strong>in</strong> LA or placebo, although <strong>in</strong>one study postoperative opioid use was comparativelyhigh (179,180,209). The tim<strong>in</strong>g of wound <strong>in</strong>filtration,either pre or postsurgery, did not <strong>in</strong>fluence efficacy(180,209,210). The use of Tramadol without LA for<strong>in</strong>filtration was effective <strong>in</strong> one study (211).When us<strong>in</strong>g a perioperative opioid-based regimen(without LA block), multi-modal analgesia add<strong>in</strong>gboth paracetamol <strong>and</strong> a NSAID is more effective thaneither opioid alone or opioid plus either paracetamolor NSAID (212,213).Analgesia Table 5.5.6 Ingu<strong>in</strong>al Hernia Repair (Open)AgentTechniqueDirectevidenceLA Wound <strong>in</strong>filtration 1+LA Ilio<strong>in</strong>gu<strong>in</strong>al Block 1+LA Paravertebral Block 1)LA Caudal Epidural 1+Opioid Wound <strong>in</strong>filtration 1)Opioid a 1) 1+NSAID a 1) 1+Paracetamol a 1) 1+a As part of a multi-modal technique.5.5.7 Umbilical hernia repairIndirectevidenceUmbilical hernia repair is usually regarded as a relativelym<strong>in</strong>or surgical procedure, but it may be associatedwith significant postoperative pa<strong>in</strong>. It is oftenundertaken on an out-patient or day-case basis. Seesections 5.1 for the general management of postoperativepa<strong>in</strong>.<strong>Good</strong> practice po<strong>in</strong>tA multi-modal analgesic regimen comb<strong>in</strong><strong>in</strong>g localanesthesia <strong>and</strong> simple analgesics perioperatively isrecommended, opioid supplementation may berequired. Paracetamol <strong>and</strong>/or NSAID should be cont<strong>in</strong>uedpostoperatively for at least 48 h.EvidenceLocal anesthesia techniques <strong>in</strong>clud<strong>in</strong>g wound <strong>in</strong>filtration,rectus sheath block, <strong>and</strong> paraumbilical block areeffective with few complications. Ultrasound-guidedrectus sheath block showed <strong>in</strong>creased <strong>in</strong>traoperativeanalgesic efficacy when compared with wound <strong>in</strong>filtration(214). Either bupivaca<strong>in</strong>e or levobupivaca<strong>in</strong>e0.25% were used <strong>in</strong> the studies, but there has been nocomparison between these agents or concentrations orvolumes (215–218). Ultrasound demonstrates the <strong>in</strong>ter<strong>in</strong>dividualvariability <strong>in</strong> umbilical anatomy, its use may<strong>in</strong>crease the rate of correct needle placement, improvedefficacy <strong>and</strong> reduce the volume of LA required(216,218).Analgesia Table 5.5.7 Umbilical Hernia RepairAgentTechniqueDirectevidenceLA Wound <strong>in</strong>filtration 2)LA Paraumbilical block 3LA Rectus sheath block 2)Opioid a 1+NSAID a 1+Paracetamol a 1+a As part of a multi-modal technique.Indirectevidence5.6 General surgery <strong>and</strong> urology (major)5.6.1 Intra-abdom<strong>in</strong>al surgeryThis group <strong>in</strong>cludes a heterogeneous mixture ofabdom<strong>in</strong>al procedures on the gastro-<strong>in</strong>test<strong>in</strong>al (GI)<strong>and</strong> genitour<strong>in</strong>ary (GU) tracts <strong>in</strong>clud<strong>in</strong>g nephrectomy,pyeloplasty, ureteric reimplantation, <strong>and</strong> cystoplastyfor all of which a significant level of postoperative pa<strong>in</strong>is expected. Intravenous opioid techniques or epiduralanalgesia are acceptable for postoperative pa<strong>in</strong> management;<strong>in</strong> cl<strong>in</strong>ical practice, supplementary analgesiawith NSAID <strong>and</strong> paracetamol is usually also adm<strong>in</strong>istered.Appendicectomy <strong>and</strong> fundoplication are consideredseparately <strong>in</strong> sections 5.6.2, 5.6.3 <strong>and</strong> laparoscopictechniques <strong>in</strong> section 5.7. See also section 5.1 for generalmanagement of postoperative pa<strong>in</strong>.<strong>Good</strong> practice po<strong>in</strong>tMultimodal analgesia us<strong>in</strong>g parenteral opioids, centralneuraxial analgesia together with systemic NSAIDs44 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


<strong>and</strong> paracetamol should be used unless specificallycontra<strong>in</strong>dicated.RecommendationsIntravenous opioids either as cont<strong>in</strong>uous <strong>in</strong>fusion, NCAor PCA are effective follow<strong>in</strong>g major abdom<strong>in</strong>al surgery:Grade A (219–223).Epidural analgesia with LA should be considered formajor abdom<strong>in</strong>al surgery. The addition of neuraxial clonid<strong>in</strong>eor opioid may further improve analgesia, but sideeffects may also be <strong>in</strong>creased: Grade B (168,224–229).EvidenceThere is a considerable descriptive literature (predat<strong>in</strong>gthe time limits of this guidel<strong>in</strong>e 1996–2011) describ<strong>in</strong>gthe use of opioid <strong>in</strong>fusions, PCA, NCA, <strong>and</strong> LA epidural<strong>in</strong>fusion with or without opioid for major surgerysuch that these techniques have become part of everydaypractice. For suitable regimens, see section 6. ParavertebralLA block has also been described <strong>and</strong> is a feasiblealternative. There are very few well-designed cl<strong>in</strong>ical trialscompar<strong>in</strong>g these analgesic techniques. A variety ofsurgical procedures are <strong>in</strong>cluded <strong>in</strong> most studies, theexact surgical <strong>in</strong>cision employed is frequently not stated.Intravenous opioids as a cont<strong>in</strong>uous <strong>in</strong>fusion, PCAor NCA are effective follow<strong>in</strong>g abdom<strong>in</strong>al surgery: theanalgesic response is a function of dose <strong>and</strong> developmentalage (219–223). See Section 6.1 for <strong>in</strong>formationon doses <strong>and</strong> regimens.Cont<strong>in</strong>uous epidural analgesia with LA is acceptable.Bupivaca<strong>in</strong>e, ropivaca<strong>in</strong>e, <strong>and</strong> levobupivaca<strong>in</strong>ehave been shown to be effective <strong>in</strong> a variety of <strong>in</strong>fusionconcentrations <strong>and</strong> dose rates (168,224,226,230,231).Epidural LA + opioid also provides good analgesia.Morph<strong>in</strong>e, fentanyl, hydromorphone, <strong>and</strong> diamorph<strong>in</strong>ehave been the most frequently described; the side effectprofile depends on the dose <strong>and</strong> particular opioid thatis used (168,226,228,232).S<strong>in</strong>gle-shot caudal epidural LA + clonid<strong>in</strong>e has beencompared to LA alone, LA + opioid, LA + dexmedetomid<strong>in</strong>e<strong>and</strong> clonid<strong>in</strong>e alone. Clonid<strong>in</strong>e causes dosedependantsedation <strong>and</strong> hypotension. Clonid<strong>in</strong>e or clonid<strong>in</strong>e+ LA were equally effective as part of a multimodalstrategy <strong>in</strong> comb<strong>in</strong>ation with ketoprofen (233).Clonid<strong>in</strong>e (1)2 lgÆkg )1 ) + LA has fewer side effectscompared to opioid + LA, efficacy may also be lower(228,234). Caudal epidural clonid<strong>in</strong>e 2 lgÆkg )1 or dexmedetomid<strong>in</strong>e2 lgÆkg )1 with LA prolonged the durationof LA without <strong>in</strong>creas<strong>in</strong>g side effects (235).Epidural opioid (without LA):S<strong>in</strong>gle doses of epidural opioid can improve postoperativeanalgesia <strong>and</strong> reduce requirements for ongo<strong>in</strong>ganalgesia (236,237). Intermittent epidural morph<strong>in</strong>ewas superior to <strong>in</strong>tramuscular morph<strong>in</strong>e <strong>in</strong> one study(238), but is less effective than LA conta<strong>in</strong><strong>in</strong>g (bupivaca<strong>in</strong>e+ fentanyl) <strong>in</strong>fusion (224).Peripheral nerve blocks (PNB): There is an<strong>in</strong>creas<strong>in</strong>g <strong>in</strong>terest <strong>in</strong> the use of s<strong>in</strong>gle-shot <strong>and</strong> cont<strong>in</strong>uousperipheral nerve blocks. Paravertebral blockis feasible for abdom<strong>in</strong>al surgery <strong>and</strong> has beenshown to decrease opioid requirements follow<strong>in</strong>gappendicectomy, see Section 5.6.2 (239,240). Transversusabdom<strong>in</strong>is plane (TAP) block is feasible forabdom<strong>in</strong>al surgery <strong>in</strong> neonates <strong>and</strong> children <strong>and</strong>appears to provide satisfactory analgesia <strong>in</strong> some circumstances(241–243). A systematic review <strong>in</strong> adults<strong>and</strong> children that <strong>in</strong>cluded TAP <strong>and</strong> rectus sheathblock did not draw conclusions regard<strong>in</strong>g the efficacyof these techniques because of the small number ofstudies available (244). See also Sections 5.5.1, 5.6.2<strong>and</strong> 5.7.Analgesia Table 5.6.1 Abdom<strong>in</strong>al surgeryAgentTechniqueDirectevidenceLA Epidural 1+LA Paravertebral block 1+TAP block 2)LA + opioid Epidural 1+LA + clonid<strong>in</strong>e Epidural 1+Opioid Epidural 1+Clonid<strong>in</strong>e Epidural 1)Opioid Intravenous 1+NSAID a 1)Paracetamol a 1+a As part of a multimodal technique.5.6.2 Appendicectomy (open)IndirectevidenceAppendicectomy is the most common <strong>in</strong>dication forlaparotomy <strong>in</strong> children. Under normal circumstances,this procedure is performed through an <strong>in</strong>cision <strong>in</strong> theright lower quadrant. In the majority of cases, appendicectomywill be performed as an emergency orunplanned procedure. See also sections 5.6 <strong>and</strong> 5.6.1for <strong>in</strong>formation on the general management of postoperativepa<strong>in</strong>, <strong>and</strong> a further discussion of analgesia follow<strong>in</strong>gabdom<strong>in</strong>al surgery.ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 45


<strong>Good</strong> practice po<strong>in</strong>tWound <strong>in</strong>filtration with LA follow<strong>in</strong>g appendicectomyis a simple procedure that may be of benefit <strong>in</strong> theearly postoperative period as part of a multimodalanalgesic technique.RecommendationPCA comb<strong>in</strong>ed with NSAID is effective for postappendicectomypa<strong>in</strong>: grade B (245).Analgesia Table 5.6.2 AppendicectomyAgentTechniqueDirectevidenceLA* Wound <strong>in</strong>filtration 1)Paravertebral 1+TAP Block 1+Opioid Intravenous 1+NSAID a 1+Paracetamol a 1+a As part of a multimodal technique.IndirectevidenceEvidenceIntravenous opioids as a cont<strong>in</strong>uous <strong>in</strong>fusion, PCA orNCA, together with a multimodal analgesic strategy<strong>in</strong>clud<strong>in</strong>g LA wound <strong>in</strong>filtration, NSAID <strong>and</strong> paracetamolis currently suggested practice follow<strong>in</strong>g appendicectomy(245–250).Morph<strong>in</strong>e PCA has been previously shown to beeffective, supplementation with NSAID improvesanalgesia, particularly for pa<strong>in</strong> on movement (245).The addition of ketam<strong>in</strong>e to morph<strong>in</strong>e did notimprove analgesia <strong>in</strong> one study <strong>and</strong> neurobehavioralside effects were <strong>in</strong>creased (248). Antiemetic additivesto the opioid such as droperidol or ondansetronoffered no advantage but may <strong>in</strong>crease side effects(247,251).Wound <strong>in</strong>filtration with LA has previously beenfound to be of benefit (252), but results from morerecent studies are <strong>in</strong>conclusive. Neither pre nor post<strong>in</strong>cisionbupivaca<strong>in</strong>e 0.25–0.5% reduced postoperative morph<strong>in</strong>erequirement <strong>in</strong> the first 24 h when compared withplacebo or no <strong>in</strong>filtration (250,253). Bupivaca<strong>in</strong>e 0.25%0.5 mlÆkg )1 may not confer additional benefit <strong>in</strong> childrenreceiv<strong>in</strong>g effective multi-modal analgesia with opioid,NSAID, <strong>and</strong> paracetamol (254). However,pre<strong>in</strong>cision bupivaca<strong>in</strong>e followed by <strong>in</strong>filtration of themuscle layer on closure reduced pa<strong>in</strong> scores for up to48 h <strong>in</strong> another study that <strong>in</strong>cluded children <strong>and</strong> adults(255).Paravertebral block reduced time to first dose <strong>and</strong>total postoperative opioid requirements compared toplacebo (240).TAP block reduced pa<strong>in</strong> scores <strong>and</strong> morph<strong>in</strong>erequirements <strong>in</strong> first 24 h compared to placebo (243).5.6.3 Fundoplication (open)This procedure usually <strong>in</strong>volves an <strong>in</strong>cision of the upperabdomen utilis<strong>in</strong>g either a midl<strong>in</strong>e, transverse supraumbilical,or left sub-costal approach. Increas<strong>in</strong>gly laparoscopictechniques have been used for fundoplication,see section 5.7. The patient population is diverse, <strong>in</strong>clud<strong>in</strong>gsignificant numbers of children with neurodevelopmentaldelay <strong>and</strong> communication difficulties, whichmay <strong>in</strong>fluence the choice of analgesic regime. See alsosections 5.1 <strong>and</strong> 5.6.1 for <strong>in</strong>formation on the generalmanagement of postoperative pa<strong>in</strong>, <strong>and</strong> a further discussionof analgesia follow<strong>in</strong>g abdom<strong>in</strong>al surgery.<strong>Good</strong> practice po<strong>in</strong>tMultimodal analgesia us<strong>in</strong>g parenteral opioids or epiduralanalgesia together with systemic NSAIDs <strong>and</strong>paracetamol should be used unless specifically contra<strong>in</strong>dicated.RecommendationEpidural LA + opioid is effective <strong>and</strong> may be associatedwith improved cl<strong>in</strong>ical outcome <strong>in</strong> selected patientsfollow<strong>in</strong>g fundoplication: grade D (256–258).EvidenceSome of the studies quoted have <strong>in</strong>cluded other majorprocedures as well as fundoplication. There are noprospective studies compar<strong>in</strong>g analgesic techniques follow<strong>in</strong>gopen fundoplication.Epidural analgesia has been favored follow<strong>in</strong>gfundoplication as this group of patients is at high riskof respiratory complications <strong>and</strong> <strong>in</strong>cludes significantnumbers with neurodevelopmental delay (258–260).Epidural LA: Ropivaca<strong>in</strong>e without opioid providedsatisfactory analgesia for neonates <strong>and</strong> <strong>in</strong>fants aftermajor thoracic <strong>and</strong> abdom<strong>in</strong>al surgery <strong>in</strong>clud<strong>in</strong>g fourpatients follow<strong>in</strong>g fundoplication (231).46 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


Epidural LA + opioid: buivaca<strong>in</strong>e + fentanylappears to be effective; higher pa<strong>in</strong> scores were noted<strong>in</strong> patients who had had fundoplication <strong>in</strong> one of thestudies but overall the regimen was considered to be‘satisfactory’ (257,260).Epidural clonid<strong>in</strong>e or LA + clonid<strong>in</strong>e: both werefound to be effective for a mixed surgical group aspart of a multimodal strategy <strong>in</strong>clud<strong>in</strong>g ketoprofen,although after fundoplication (n = 9) there was an<strong>in</strong>creased need for supplementary opioid on the firstpostoperative night (233).Intravenous opioid by cont<strong>in</strong>uous <strong>in</strong>fusion PCA orNCA appears to be effective, but may be <strong>in</strong>ferior fornonpa<strong>in</strong> outcomes: see ‘epidural analgesia vs parenteralopioid’ below (256,261,262).Epidural analgesia vs parenteral opioid.Two retrospective observational studies have foundthat duration of hospital stay is prolonged <strong>in</strong> patientsselected for opioid analgesia even when sp<strong>in</strong>al deformitypatients (scoliosis) were excluded <strong>in</strong> one study(256,258).Analgesia Table 5.6.3 Fundoplication (open)AgentTechniqueLA Epidural 3LA + opioid Epidural 3LA + clonid<strong>in</strong>e a Epidural 3Clonid<strong>in</strong>e a Epidural 3Opioid a Intravenous 1+NSAID a 1+Paracetamol a 1+a As part of a multimodal technique.5.6.4 Major urologyDirectevidenceIndirectevidenceThis category has been <strong>in</strong>cluded because studies haveused a comb<strong>in</strong>ation of different urological proceduresas the operative model, for example pyeloplasty,nephrectomy, hem<strong>in</strong>ephrectomy, hypospadias, bladderaugmentation/reconstruction, ureteric reimplantation.<strong>Postoperative</strong> pa<strong>in</strong> is unlikely to be equivalent follow<strong>in</strong>geach of these different procedures, but they are notuniformly distributed between studies, <strong>and</strong> the numbersof <strong>in</strong>dividual procedures <strong>in</strong> each study are oftenlow, thereby mak<strong>in</strong>g it impractical to look at each procedure<strong>in</strong> isolation. See section 5.1 for the generalmanagement of postoperative pa<strong>in</strong>.<strong>Good</strong> practice po<strong>in</strong>tMultimodal analgesia us<strong>in</strong>g parenteral opioids orregional analgesia together with systemic NSAIDs<strong>and</strong> paracetamol should be used unless specificallycontra<strong>in</strong>dicated.EvidenceLA techniques are commonly used perioperatively formajor urological surgery. Comparison with parenteralopioid techniques is limited, <strong>and</strong> little good evidenceexists with regard to the optimum analgesic regimen.Epidural LA± opioid: For a variety of urologicalprocedures, perioperative ropivaca<strong>in</strong>e <strong>in</strong>fusions, withor without opioid, have shown good analgesic efficacywith low pa<strong>in</strong> scores <strong>and</strong> complication rates (263,264).Comparisons of fentanyl or sufentanil added to ropivaca<strong>in</strong>e,<strong>and</strong> fentanyl or butorphanol added to bupivaca<strong>in</strong>eshowed no difference <strong>in</strong> efficacy or pa<strong>in</strong> scoresbetween these regimens (229,263).Epidural LA vs Parenteral Opioid: Comparison ofpostoperative epidural ropivaca<strong>in</strong>e <strong>in</strong>fusions with regularbolus tramadol or oxycodone plus paracetamol <strong>and</strong>NSAID showed no difference <strong>in</strong> pa<strong>in</strong> scores up to 48 hbut <strong>in</strong>creased rescue analgesia between 48 <strong>and</strong> 72 h(264).Caudal neuraxial analgesic additives: In childrenundergo<strong>in</strong>g ureteric reimplantation, caudal analgesiawith LA + clonid<strong>in</strong>e or opioid was effective. Therewas no difference <strong>in</strong> efficacy or pa<strong>in</strong> scores from add<strong>in</strong>gclonid<strong>in</strong>e, morph<strong>in</strong>e, or hydromorphone to caudalropivaca<strong>in</strong>e 0.2% + ep<strong>in</strong>ephr<strong>in</strong>e, patients receiv<strong>in</strong>gclonid<strong>in</strong>e experienced fewer side effects (234).Paravertebral Block: Use of a ‘s<strong>in</strong>gle-shot’ <strong>in</strong>traoperativeparavertebral block with levobupivaca<strong>in</strong>e <strong>and</strong>regular paracetamol postoperatively was associatedwith low pa<strong>in</strong> scores <strong>and</strong> low opioid use <strong>in</strong> the earlypostoperative period <strong>in</strong> patients undergo<strong>in</strong>g majorrenal surgery (239).Wound Infiltration: A multimodal analgesic techniqueus<strong>in</strong>g LA <strong>in</strong>filtration alongside opioids, NSAID,<strong>and</strong> paracetamol was associated with low pa<strong>in</strong> scores<strong>in</strong> children undergo<strong>in</strong>g pyeloplasty <strong>and</strong> ureteric reimplantation(265,266).ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 47


Analgesia Table 5.6.4 Urological SurgeryAgentTechniqueDirectevidenceLA Epidural 1)LA + opioid Epidural 1)LA Caudal epidural 1)LA Paravertebral block 2)LA a Wound <strong>in</strong>filtration 3Opioid a Intravenous 3 1+NSAID a 3 1+Paracetamol a 3 1+a As part of a multimodal technique.5.7 Laparoscopic surgeryIndirectevidenceThere has been a dramatic <strong>in</strong>crease <strong>in</strong> the amount ofpediatric laparoscopic surgery <strong>in</strong> the last decade. Thisis performed ma<strong>in</strong>ly through the body cavities (chest<strong>and</strong> abdomen) or potential spaces. Ingu<strong>in</strong>al herniarepair, appendicectomy, fundoplication, urological <strong>and</strong>adrenal surgery are examples. For general managementof postoperative pa<strong>in</strong>, see section 5.1.<strong>Good</strong> practice po<strong>in</strong>tsInfiltration of port sites with LA as part of a multimodalanalgesic strategy may reduce postoperativepa<strong>in</strong> follow<strong>in</strong>g laparoscopy.Although overall postoperative analgesic requirementsappear to be reduced follow<strong>in</strong>g laparoscopy, pa<strong>in</strong> maybe equivalent to the equivalent open procedure <strong>in</strong>some circumstances, particularly dur<strong>in</strong>g the first 24 h.EvidenceAdvantages of laparoscopic surgery may <strong>in</strong>clude fasterrecovery <strong>and</strong> overall reduction <strong>in</strong> pa<strong>in</strong> <strong>and</strong> use of opioidanalgesia <strong>in</strong> comparison with the open surgicalcounterpart (246,267–272). Although the overall durationof postoperative pa<strong>in</strong> appears to be reduced, analgesicrequirements may be at least as great on the firstpostoperative day as the equivalent open procedure(261,267,273–275). The use of robotic laparoscopictechniques may also decrease postoperative opioidrequirements after ureteric reimplantation surgery(276). The anatomical approach to laparoscopic surgeryhas not been shown to effect analgesic requirements(277,278).Multimodal analgesia <strong>in</strong>clud<strong>in</strong>g LA <strong>in</strong>filtration, opioid,NSAID, <strong>and</strong> paracetamol is suitable, <strong>and</strong> the useof carefully designed protocols may improve efficacy(279). Dem<strong>and</strong>-led opioid regimens such as PCA orNCA are feasible <strong>and</strong> effective for some procedures<strong>and</strong> require further evaluation (246,262).LA <strong>in</strong>filtration of port sites when comb<strong>in</strong>ed withNSAID provided equivalent analgesia to caudal blockfor m<strong>in</strong>or diagnostic <strong>and</strong> therapeutic laparoscopic procedures<strong>and</strong> to TAP block follow<strong>in</strong>g appendicectomy(280,281). Use of aerosolised bupivaca<strong>in</strong>e after port<strong>in</strong>sertion, as part of a multimodal analgesic regimen,demonstrated some opioid spar<strong>in</strong>g effect (282).Perioperative regional LA techniques have also beenshown to be effective <strong>and</strong> aga<strong>in</strong> require further evaluation(271,279). Little good evidence exists with regardto the optimum analgesic regimen.Analgesia Table 5.7 Laparoscopic surgeryAgentTechniqueLA* Infiltration 1)LA* Aerosolised 3LA Caudal 1)Opioid Parenteral/oral 3NSAID a 1)Paracetamol a 3a As part of a multimodal technique.DirectevidenceIndirectevidence5.8 Orthopedics, sp<strong>in</strong>al <strong>and</strong> plastic surgery5.8.1 Lower limb surgeryThe surgery covered <strong>in</strong> this section ranges from relativelym<strong>in</strong>or s<strong>in</strong>gle site orthopedic surgery to moremajor procedures such as multiple level osteotomies.The population of patients requir<strong>in</strong>g femoral <strong>and</strong>pelvic osteotomies <strong>in</strong>cludes those suffer<strong>in</strong>g from cerebralpalsy; pa<strong>in</strong> <strong>in</strong> this population can also precipitatepa<strong>in</strong>ful muscle spasm requir<strong>in</strong>g specific managementwith benzodiazep<strong>in</strong>es.Multimodal analgesia is suitable: there is particularlyextensive experience of the use of local anesthetic techniquesfor this type of surgery. Concerns have beenexpressed that NSAIDs may <strong>in</strong>hibit new bone growthfollow<strong>in</strong>g orthopedic surgery; this is addressed below.<strong>Good</strong> practice po<strong>in</strong>tThere is no evidence from studies <strong>in</strong> children thatNSAIDs have a deleterious effect on bone fusion. Theanalgesic benefit of short-term NSAID use has beendemonstrated <strong>and</strong> may frequently outweigh any hypotheticalrisk.48 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


RecommendationsPeripheral nerve blocks provide superior analgesia <strong>and</strong>are associated with fewer adverse effects compared with<strong>in</strong>travenous opioids: Grade B (283,284).Epidural opioids are effective, reduce the dose requirementsof local anesthetic, <strong>and</strong> rescue IV opioids but<strong>in</strong>crease the <strong>in</strong>cidence of side effects: Grade B(259,285,286).Cont<strong>in</strong>uous peripheral nerve blocks are feasible, effective,<strong>and</strong> safe <strong>and</strong> are associated with lower pa<strong>in</strong> scores:Grade B (287–295).Epidural techniques are associated with lower pa<strong>in</strong>scores than <strong>in</strong>travenous opioid analgesia: Grade C(237,257,296,297).Systemic paracetamol <strong>and</strong> NSAID reduce <strong>in</strong>travenousopioid requirements: Grade C (298,299).EvidenceStudies have shown epidural analgesia us<strong>in</strong>g opioids,local anesthesia or a mixture of the two are effectivebut differences <strong>in</strong> efficacy <strong>and</strong> side effects between regimensare observed. Epidural opioids improve analgesiabut side effects are more frequent. The side effectprofile may be related to the <strong>in</strong>dividual properties ofspecific opioids: morph<strong>in</strong>e, fentanyl, <strong>and</strong> hydromorphonewere of comparable analgesic efficacy <strong>in</strong> onestudy; respiratory depression, somnolence, <strong>and</strong> retentionof ur<strong>in</strong>e were higher <strong>in</strong> the morph<strong>in</strong>e group;PONV <strong>and</strong> ur<strong>in</strong>ary retention had the lowest <strong>in</strong>cidencewith hydromorphone (285). S<strong>in</strong>gle-dose epidural morph<strong>in</strong>ewas equianalgesic with <strong>in</strong>creas<strong>in</strong>g dose (11.2, 15,<strong>and</strong> 20 lgÆkg )1 ), but the <strong>in</strong>cidence of PONV <strong>in</strong>creasedwith dose (300). In a study compar<strong>in</strong>g bupivaca<strong>in</strong>e+ fentanyl with bupivaca<strong>in</strong>e (both with adrenal<strong>in</strong>e),the fentanyl group had superior analgesia <strong>and</strong>did not require rescue opioid but had a higher <strong>in</strong>cidenceof PONV, whereas the bupivaca<strong>in</strong>e grouprequired more bupivaca<strong>in</strong>e <strong>and</strong> 10/26 (38%) requiredrescue opiates <strong>and</strong> antiemetic therapy, itch<strong>in</strong>g onlyoccurred <strong>in</strong> the fentanyl group (286).Epidural vs peripheral nerve blockA comparison of cont<strong>in</strong>uous epidural block with cont<strong>in</strong>uouspopliteal nerve block for major foot surgery showedno difference <strong>in</strong> pa<strong>in</strong> or rescue analgesia, but adverseeffects <strong>and</strong> patient satisfaction were improved withperipheral nerve block (290). In congenital club foot surgery,a comparison of s<strong>in</strong>gle-shot caudal anesthesia withs<strong>in</strong>gle-shot peripheral nerve blocks (comb<strong>in</strong>ed sciatic femoral,comb<strong>in</strong>ed sciatic saphenous, <strong>and</strong> saphenous comb<strong>in</strong>edwith local <strong>in</strong>filtration) showed no difference <strong>in</strong> theduration of analgesia <strong>and</strong> no difference <strong>in</strong> morph<strong>in</strong>e consumptionwith<strong>in</strong> the first 24 h, there was no difference <strong>in</strong>the <strong>in</strong>cidence of nausea <strong>and</strong> vomit<strong>in</strong>g between any of thegroups (301). S<strong>in</strong>gle-shot Psoas Compartment Blockshowed moderate reduction <strong>in</strong> postoperative opioidrequirements compared to caudal epidural follow<strong>in</strong>gopen hip reduction or osteotomy (302).Epidural compared with Intravenous techniquesIn a comparison between patient-controlled epiduralanalgesia (PCEA) with lidoca<strong>in</strong>e, <strong>and</strong> nurse-controlledIV fentanyl, pa<strong>in</strong> scores (unvalidated method), <strong>and</strong>PONV were lower <strong>in</strong> the epidural group (297). A s<strong>in</strong>gledose of epidural morph<strong>in</strong>e 30 lgÆkg )1 reduced postoperativePCA morph<strong>in</strong>e use, <strong>and</strong> VAS scores were also lower<strong>in</strong> the epidural morph<strong>in</strong>e group, <strong>and</strong> there was no difference<strong>in</strong> the <strong>in</strong>cidence of severe pruritus or PONV (237).Peripheral nerve block vs <strong>in</strong>travenous techniquesComparisons between peripheral nerve blocks <strong>and</strong><strong>in</strong>travenous morph<strong>in</strong>e <strong>in</strong> pelvic osteotomy (283) <strong>and</strong>patella realignment surgery (284) demonstrate reducedpa<strong>in</strong> scores, reduced morph<strong>in</strong>e consumption <strong>and</strong> areduction <strong>in</strong> the <strong>in</strong>cidence of sedation with the use ofperipheral nerve blocks.A number of successful series of peripheral nerveblocks have been described, <strong>in</strong>clud<strong>in</strong>g popliteal nerveblock (288,290,292–294,303), fascia iliaca compartmentblock (288,303,304), sciatic nerve block(289,291,295,305),psoas compartment block (287,293), <strong>and</strong> femoral nerveblock (284,304).Cont<strong>in</strong>uous LA <strong>in</strong>fusion vs PCRA/PCEAPCRA (Ropivaca<strong>in</strong>e 0.2%) showed similar efficacy toa cont<strong>in</strong>uous regional technique, with a lower totaldose of LA for popliteal <strong>and</strong> fascia iliaca blocks (303).In a comparison of PCEA vs CEA, aga<strong>in</strong> efficacy wassimilar <strong>and</strong> a lower dose of LA used (306).Systemic analgesia with NSAID <strong>and</strong> paracetamolcan be comb<strong>in</strong>ed with <strong>in</strong>travenous opioid or regionalanalgesia. In one study, a comb<strong>in</strong>ation of paracetamol<strong>and</strong> ketoprofen significantly decreased pa<strong>in</strong> scores <strong>and</strong>IV morph<strong>in</strong>e requirements compared to either drugalone (299). In a case series of patients undergo<strong>in</strong>gclub foot surgery <strong>and</strong> long bone osteotomy, ketorolacreduced IV morph<strong>in</strong>e usage <strong>and</strong> associated GI effectsª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 49


(298). Ketorolac did not <strong>in</strong>fluence bony union <strong>in</strong> a caseseries of lower limb osteotomies (307).Adjuvant analgesicsThe use of <strong>in</strong>travenous magnesium (50 mgÆkg )1 bolusfollowed by an <strong>in</strong>fusion of 15 mgÆkg )1 Æh )1 ) reducedpostoperative pa<strong>in</strong> scores <strong>and</strong> analgesic consumption<strong>in</strong> children with cerebral palsy undergo<strong>in</strong>g femoral osteotomy.Analgesia Table 5.8.1 Lower Limb surgeryAgentTechniqueDirectevidenceLA Peripheral nerve block 1+Caudal Epidural 1) 1)Lumbar Epidural 1+Opioid IV <strong>in</strong>fusion 1+NSAID a 1+Paracetamol a 1+Clonid<strong>in</strong>e Peripheral nerve block 3a As part of a multi-modal technique.IndirectevidenceAxillary brachial plexus block was the most studiedapproach; postoperatively patients were generally managedwith oral analgesia. There was no difference <strong>in</strong>postoperative efficacy (time to 1st analgesia, analgesicconsumption, pa<strong>in</strong> score) between 0.2% ropivaca<strong>in</strong>e<strong>and</strong> 0.25% bupivaca<strong>in</strong>e when used for axillary brachialplexus block (312). There was no benefit to us<strong>in</strong>g afractionated dose of LA compared to a s<strong>in</strong>gle <strong>in</strong>jectionfor axillary brachial plexus block, nor <strong>in</strong> plac<strong>in</strong>g theblock prior to or after surgery (309,316).Other studies have exam<strong>in</strong>ed the feasibility of thedifferent approaches to brachial plexus block. The <strong>in</strong>fraclavicular(311,313,315), the supraclavicularapproach (310), <strong>and</strong> the <strong>in</strong>terscalene approach (291)are effective, <strong>and</strong> there were no <strong>in</strong>cidences of pneumothorax<strong>in</strong> these studies (412 patients).A comparison between peripheral nerve block at thewrist <strong>and</strong> <strong>in</strong>travenous alfentanil demonstrated superioranalgesia <strong>and</strong> a reduction <strong>in</strong> adverse events <strong>in</strong> theblock group (317).Analgesia Table 5.8.2 Upper Limb surgery5.8.2 Upper limb surgeryAgentTechniqueDirectevidenceIndirectevidenceSurgery on the upper limb is most commonly performedfor plastic <strong>and</strong> orthopedic procedures of h<strong>and</strong> <strong>and</strong> forearm,often follow<strong>in</strong>g trauma. Local anesthesia of thebrachial plexus prior to surgery is frequently used.There is some controversy regard<strong>in</strong>g the most safe <strong>and</strong>reliable approach to the brachial plexus. See section 5.1for the general management of postoperative pa<strong>in</strong>.RecommendationsBrachial plexus blocks provide satisfactory analgesia forh<strong>and</strong> <strong>and</strong> forearm surgery extend<strong>in</strong>g <strong>in</strong>to the postoperativeperiod: Grade B (308–313).The axillary, <strong>in</strong>fraclavicular, supraclavicular, <strong>and</strong> <strong>in</strong>terscaleneapproach are feasible <strong>and</strong> effective: Grade B(291,294,308,310–315).EvidenceAnalgesia follow<strong>in</strong>g upper limb surgery has not beenwell studied, <strong>and</strong> few <strong>in</strong>vestigations of postoperativepa<strong>in</strong> management have been undertaken. Brachialplexus block appears to be effective, but differencesbetween techniques have not been <strong>in</strong>vestigated. Theaxillary approach to the brachial plexus is theoreticallyless likely to lead to accidental pneumothorax. Thereare no comparisons between brachial plexus block <strong>and</strong>other alternatives such as <strong>in</strong>travenous opioid.LA Brachial plexus block 1+Opioid Intravenous 1+Oral 1+NSAID a 1+Paracetamol a 1+Clonid<strong>in</strong>e Brachial plexus block 3a As part of a multi-modal technique.5.8.3 Sp<strong>in</strong>al surgerySurgery to correct sp<strong>in</strong>al deformity requires extensiveexposure of the sp<strong>in</strong>e which may be achieved posteriorly,anteriorly via thoracotomy or thoraco-abdom<strong>in</strong>alapproach, or by a comb<strong>in</strong>ed anterior–posteriorapproach. <strong>Postoperative</strong> pa<strong>in</strong> can be severe <strong>and</strong> prolonged,necessitat<strong>in</strong>g the use of potent <strong>in</strong>travenous orneuraxial analgesic techniques for 3–5 days postoperatively.The use of <strong>in</strong>travenous opioid analgesia hasnot been well studied; however, the success of neuraxialtechniques <strong>in</strong> controll<strong>in</strong>g postoperative pa<strong>in</strong> <strong>in</strong>children has led to an <strong>in</strong>terest <strong>in</strong> their use for sp<strong>in</strong>alsurgery.The patient population requir<strong>in</strong>g sp<strong>in</strong>al surgery<strong>in</strong>cludes healthy adolescents <strong>and</strong> patients with severeunderly<strong>in</strong>g medical conditions such as Duchenne’smuscular dystrophy <strong>and</strong> cerebral palsy. The choice ofanalgesic technique will be <strong>in</strong>fluenced by both patient50 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


<strong>and</strong> surgical factors <strong>in</strong> addition to local circumstances,for example, neuraxial techniques are not suitable forsome patients. The <strong>in</strong>volvement of the surgeon <strong>in</strong> thechoice of analgesic technique is especially important <strong>in</strong>sp<strong>in</strong>al surgery as it must also enable early <strong>and</strong> frequentassessment of neurological function, <strong>and</strong> epidural LAis not usually adm<strong>in</strong>istered follow<strong>in</strong>g surgery until normalneurological function has been demonstrated. Seesection 5.1 for the general management of postoperativepa<strong>in</strong>.<strong>Good</strong> practice po<strong>in</strong>tThere is no evidence from studies <strong>in</strong> children thatNSAIDs have a deleterious effect on bone fusion. Theanalgesic benefit of short-term NSAID use has beendemonstrated <strong>and</strong> may frequently outweigh any hypotheticalrisk.RecommendationsEpidural techniques produce a modest improvement <strong>in</strong>pa<strong>in</strong> control, compared with <strong>in</strong>travenous opioids <strong>in</strong>patients undergo<strong>in</strong>g corrective surgery for adolescent idiopathicscoliosis: Grade B (318–322).Intrathecal opioids decrease <strong>in</strong>tra-operative blood loss<strong>and</strong> IV opioid consumption postoperatively. The durationof action is 18–24 h: Grade C (318,323–326).Dual catheter epidural techniques should be considered,as this permits coverage of multiple sp<strong>in</strong>al levels: GradeC (319,327–329).The use of LA + lipophilic opioid <strong>in</strong> the epidural spacewith a s<strong>in</strong>gle epidural catheter does not show an analgesicbenefit over <strong>in</strong>travenous opioid techniques: Grade C(330,331).The use of LA + hydrophilic opioids <strong>in</strong> the epiduralspace has a favorable analgesic profile compared withIV opioid, but at the expense of <strong>in</strong>crease adverse effects:Grade D (332,333).EvidenceThe majority of studies have been conducted <strong>in</strong> adolescents,<strong>and</strong> some studies have also <strong>in</strong>cluded young adultsup to the age of 22 years. Neuraxial techniques havebeen the most <strong>in</strong>vestigated. Intrathecal (IT) opioids: s<strong>in</strong>gledoses of IT opioids can reduce <strong>in</strong>traoperative bloodloss <strong>and</strong> postoperative analgesic requirements. IT morph<strong>in</strong>eplus sufentanil decreased <strong>in</strong>tra-operative bloodloss compared with IV sufentanil (323). IT morph<strong>in</strong>e5 lgÆkg )1 also decreased <strong>in</strong>tra-operative blood losscompared with 2 lgÆkg )1 IT or sal<strong>in</strong>e controls (324).The time to first analgesic use, 6–24 h postoperatively,was significantly <strong>in</strong>creased <strong>in</strong> proportion to dose of ITmorph<strong>in</strong>e <strong>in</strong> these studies (323,324,334). Pa<strong>in</strong> scoreswere also lower with <strong>in</strong>trathecal morph<strong>in</strong>e (318,324).However, the use of a high-dose <strong>in</strong>trathecal opioidregime (15 lgÆkg )1 morph<strong>in</strong>e + 1 lgÆkg )1 sufentanil)did not improve analgesic efficacy or enhance the reduction<strong>in</strong> blood loss compared with a low-dose regimen(5 lgÆkg )1 morph<strong>in</strong>e + 1 lgÆkg )1 sufentanil) (325).Several studies have found no <strong>in</strong>crease <strong>in</strong> respiratorydepression with IT opioids up to a maximum dose of20 lgÆkg )1 of morph<strong>in</strong>e compared with <strong>in</strong>travenoustechniques (323,324), <strong>and</strong> no difference <strong>in</strong> level ofsedation, nausea <strong>and</strong> vomit<strong>in</strong>g or pruritus (324). However,<strong>in</strong>trathecal morph<strong>in</strong>e <strong>in</strong> excess of 20 lgÆkg )1 wasassociated with respiratory depression (326). IT opiatesdid not affect the ability to monitor sp<strong>in</strong>al sensoryevoked potentials (SSEPs) (335).A meta-analysis of epidural analgesia <strong>in</strong> adolescentscoliosis surgery demonstrated a statistical, but cl<strong>in</strong>icallymodest improvement <strong>in</strong> pa<strong>in</strong> scores <strong>in</strong> patients receiv<strong>in</strong>gepidural analgesia compared with <strong>in</strong>travenous opioidson all first three postoperative days. One hundred <strong>and</strong>twenty patients from four studies were <strong>in</strong>cluded <strong>in</strong> theanalysis which also concluded that patient satisfactionwas higher <strong>in</strong> the epidural group. The papers <strong>in</strong>cluded <strong>in</strong>the meta-analysis differ <strong>in</strong> the regimens used: two papersreport the use of a s<strong>in</strong>gle catheter midthoracic epidural<strong>in</strong>fusion of bupivaca<strong>in</strong>e <strong>and</strong> fentanyl <strong>and</strong> show no difference<strong>in</strong> pa<strong>in</strong> sores compared PCA morph<strong>in</strong>e(330,331). The rema<strong>in</strong><strong>in</strong>g two papers report the use of adual catheter technique <strong>in</strong>fus<strong>in</strong>g ropivaca<strong>in</strong>e withoutopiod <strong>in</strong> patients follow<strong>in</strong>g posterior (329) <strong>and</strong> anterior(319) sp<strong>in</strong>al surgery. Significantly lower pa<strong>in</strong> scores wererecorded compared with cont<strong>in</strong>uous IV morph<strong>in</strong>e <strong>in</strong>fusion.A prospective comparison between PCEA with bipvaca<strong>in</strong>e0.1% <strong>and</strong> hydromorphone 10 lg/ml )1 <strong>and</strong>PCA hydromorphone demonstrated a reduction <strong>in</strong> pa<strong>in</strong>scores <strong>in</strong> the epidural group. There have also been severalretrospective series demonstrat<strong>in</strong>g reduced pa<strong>in</strong>scores with epidural analgesia compared with IV opioid:A s<strong>in</strong>gle epidural catheter <strong>in</strong>fus<strong>in</strong>g bupivaca<strong>in</strong>e withhydromorphone compared with a group receiv<strong>in</strong>g PCAmorph<strong>in</strong>e (613 patients); the epidural group had ahigher <strong>in</strong>cidence of side effects (333). Dual epiduralcatheters <strong>in</strong>fus<strong>in</strong>g 0.1% bupivaca<strong>in</strong>e with fentanyl2 lgÆml )1 compared with an opioid PCA, no difference<strong>in</strong> adverse effects (322). S<strong>in</strong>gle epidural <strong>in</strong>fus<strong>in</strong>g bupivaca<strong>in</strong>e0.1% <strong>and</strong> hydromorphone compared with PCAmorph<strong>in</strong>e compared with <strong>in</strong>trathecal <strong>and</strong> PCA morph<strong>in</strong>e:<strong>in</strong>trathecal morph<strong>in</strong>e controlled pa<strong>in</strong> equally asª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 51


well as the epidural technique for the first 24 h, but epiduralwas superior at 36 <strong>and</strong> 48 h (138 patients) (318).Case series have demonstrated effective analgesia withthe follow<strong>in</strong>g regimes: bupivaca<strong>in</strong>e 0.0625–0.1% withfentanyl, hydromorphone or morph<strong>in</strong>e, 0.1% ropivaca<strong>in</strong>ewith hydromorphone, bupivaca<strong>in</strong>e 0.0625–0.125%with morph<strong>in</strong>e, bupivaca<strong>in</strong>e 0.0625% with fentanyl <strong>and</strong>clonid<strong>in</strong>e (332,336–339). Several authors commentedthat placement of the epidural catheter by direct visualisationdur<strong>in</strong>g surgery was important.Both 0.0625% bupivaca<strong>in</strong>e with fentanyl <strong>and</strong> withclonid<strong>in</strong>e <strong>and</strong> ropivaca<strong>in</strong>e with hydromorphone havealso been reported as successful us<strong>in</strong>g a dual cathetertechnique (327,328). Epidural analgesia may be associatedwith a more rapid return <strong>in</strong> GI function(318,330). The use of an epidural technique did notcompromise neurological assessment (336). There wasone report of a wound <strong>in</strong>fection occurr<strong>in</strong>g <strong>in</strong> a patientreceiv<strong>in</strong>g epidural analgesia (330) but no reports ofepidural hematoma or abscess.NSAIDS: There have been two retrospective reviewslook<strong>in</strong>g at the use of NSAIDS follow<strong>in</strong>g sp<strong>in</strong>al surgery.There was no difference <strong>in</strong> the <strong>in</strong>cidence of nonunion <strong>in</strong>patients who had received ketorolac (221 patients) comparedto controls (306 patients) (333,340).Adjuvant analgesics: The use of gabapent<strong>in</strong>(15 mgÆkg )1 preoperatively followed by 5 mgÆkg )1 tdsfor 5 days) reduced opioid consumption on postoperativedays 1 <strong>and</strong> 2 <strong>and</strong> reduced pa<strong>in</strong> scores on day 1compared with placebo, no difference was seen beyondday 2 <strong>and</strong> no difference was seen <strong>in</strong> side effects (341).No difference was seen <strong>in</strong> pa<strong>in</strong> scores or morph<strong>in</strong>econsumption when low-dose ketam<strong>in</strong>e was adm<strong>in</strong>istered<strong>in</strong>tra-operatively (0.5 mgÆkg )1 load<strong>in</strong>g dose followedby an <strong>in</strong>fusion of 4 lgÆkg )1 Æm<strong>in</strong> )1 ) comparedwith placebo (342). A retrospective review of the additionof dexmedetomid<strong>in</strong>e (0.4 lgÆkg )1 Æh )1 ) to PCAmorph<strong>in</strong>e was unable to demonstrate a significantdifference <strong>in</strong> pa<strong>in</strong> scores or morph<strong>in</strong>e consumptioncompared with PCA morph<strong>in</strong>e alone (343).Analgesia Table 5.8.3 Sp<strong>in</strong>al surgeryAgentTechniqueDirectevidenceLA Thoracic Epidural 1+LA Lumbo-thoracic 2 Catheter 1+Opioid Intrathecal 1+Opioid IV <strong>in</strong>fusion 1+Clonid<strong>in</strong>e Epidural 3NSAID a 1+Paracetamol a 1+Gabapent<strong>in</strong> 1+Indirectevidence5.8.4 Cleft lip <strong>and</strong> palate <strong>and</strong> related proceduresThis section <strong>in</strong>cludes a range of procedures such asrepair of Cleft Lip <strong>and</strong> Palate, Otoplasty, <strong>and</strong> Alveolarbone graft<strong>in</strong>g. See section 5.1 for the general managementof postoperative pa<strong>in</strong>.RecommendationInfraorbital nerve block provides effective analgesiafor cleft lip repair <strong>in</strong> the early postoperative period:Grade A (344–348).EvidenceThe evidence base support<strong>in</strong>g the efficacy of analgesicstrategies is weak for this group of procedures <strong>and</strong>postoperative analgesic requirements are not clear.Many patients appear to be successfully managed with<strong>in</strong>traoperative local anesthesia followed by NSAIDs,paracetamol, <strong>and</strong> low doses of opioid postoperatively.Cleft Lip Repair: <strong>in</strong>fra-orbital nerve block for cleft lipsurgery is feasible, <strong>and</strong> studies have demonstrated lowerpa<strong>in</strong> scores <strong>in</strong> patients who received <strong>in</strong>fra-orbital nerveblock compared with IV fentanyl (347,348) peri-<strong>in</strong>cisional<strong>in</strong>filtration of local anesthetic (344,345) <strong>and</strong> rectalParacetamol (346). Blocks were performed with 0.25%bupivaca<strong>in</strong>e <strong>in</strong> all these studies. The addition of opioidspethid<strong>in</strong>e or fentanyl significantly prolonged the durationof the block <strong>in</strong> two studies (349,350). Clonid<strong>in</strong>eadded to bupivaca<strong>in</strong>e resulted <strong>in</strong> a moderate improvement<strong>in</strong> postoperative analgesia <strong>in</strong> another (351).Cleft Palate Surgery: Local <strong>in</strong>filtration (352), palat<strong>in</strong>enerve block (353), <strong>and</strong> bilateral suprazygomaticmaxillary nerve block (354) have been associated withlow pa<strong>in</strong> scores follow<strong>in</strong>g cleft palate repair. The effectof NSAIDs on peri-operative bleed<strong>in</strong>g was reviewed <strong>in</strong>one small case series (20 patients), <strong>and</strong> there was noeffect associated with diclofenac 1 mgÆkg )1 b.d. (355).Alveolar Bone Graft: Morph<strong>in</strong>e PCA requirementsare low (


Analgesia Table 5.8.4 Plastic surgery procedures of head <strong>and</strong> neckAgentTechniqueDirectevidenceLA Local <strong>in</strong>filtration 1+LA Infraorbital nerve block a 1+Opioid b 1+NSAID b 1+Paracetamol b 1+a Repair of cleft lip alone.b As part of a multi-modal technique.5.9 Cardiothoracic surgery5.9.1 Cardiac surgery (sternotomy)IndirectevidenceClassically, cardiac surgery with cardiopulmonary bypass(CPB) will <strong>in</strong>volve division of the bony sternumto obta<strong>in</strong> access to the heart <strong>and</strong> great vessels. Anticoagulationwith hepar<strong>in</strong> is ma<strong>in</strong>ta<strong>in</strong>ed throughout CPB,which has implications for the use of regional techniques.<strong>Postoperative</strong> patients are nursed <strong>in</strong> ICU areas,often with a short period of mechanical ventilationprior to extubation of the trachea. <strong>Postoperative</strong> analgesiawith <strong>in</strong>travenous opioids, most frequently morph<strong>in</strong>eor fentanyl, has been st<strong>and</strong>ard practice for morethan 20 years <strong>in</strong> many <strong>in</strong>stitutions. See section 5.1 forthe general management of postoperative pa<strong>in</strong>.RecommendationEpidural <strong>and</strong> <strong>in</strong>trathecal techniques with opioid <strong>and</strong>/orLA are effective for sternotomy pa<strong>in</strong>, but only marg<strong>in</strong>albenefits have been demonstrated, <strong>and</strong> there are <strong>in</strong>sufficientdata concern<strong>in</strong>g the <strong>in</strong>cidence of serious complications:Grade B (360–368).EvidenceIntravenous opioids are the st<strong>and</strong>ard to which otheranalgesic techniques are to be compared. A comparisonof morph<strong>in</strong>e <strong>and</strong> tramadol NCA found no difference <strong>in</strong>efficacy between the two, although tramadol caused lesssedation <strong>in</strong> the early postoperative period (369).There has been an <strong>in</strong>creas<strong>in</strong>g <strong>in</strong>terest <strong>in</strong> regionalanalgesic techniques because of their potential toreduce stress responses <strong>and</strong> facilitate earlier trachealextubation with possible improvements <strong>in</strong> cl<strong>in</strong>ical outcome<strong>and</strong> economic cost reduction. The relativelysmall size of studies precludes accurate prediction ofvery rare but serious side effects such as epiduralhematoma <strong>and</strong> consequent neurological damage.Intrathecal opioid: morph<strong>in</strong>e or fentanyl produceequivalent analgesia (<strong>and</strong> side effects) to <strong>in</strong>travenousmorph<strong>in</strong>e with lower overall analgesic consumption(364,365).Intrathecal opioid + LA: improved pa<strong>in</strong> scorescompared with bolus IV fentanyl alone with loweroverall fentanyl consumption but no difference <strong>in</strong> opioidrelated side effects (366).Epidural: case series have demonstrated the feasibility<strong>and</strong> efficacy of epidural catheter techniques fromcaudal, lumbar or thoracic approaches with few <strong>and</strong>modest improvements <strong>in</strong> outcomes (360–362,368).There is a s<strong>in</strong>gle case report of epidural hematomarequir<strong>in</strong>g surgical decompression <strong>in</strong> an 18-year-oldwith TEB who rema<strong>in</strong>ed anticoagulated follow<strong>in</strong>g aorticvalve surgery (370).NSAIDS: ketorolac commenced 6 h postoperativelydid not <strong>in</strong>crease postoperative bleed<strong>in</strong>g, nor affect IVmorph<strong>in</strong>e requirements or reduce time to extubation <strong>in</strong>one study (371).Analgesia Table 5.9.1 Cardiac Surgery (sternotomy)AgentTechniqueDirectevidenceLA Caudal epidural catheter 3LA Thoracic epidural (TEB) 1)LA Intrathecal (SAB) 1)Opioid IV <strong>in</strong>fusion 1+Opioid Caudal 2)Opioid Thoracic epidural (TEB) 2)Opioid Intrathecal 1+NSAID a 1+Paracetamol a 1+a As part of a multi-modal technique.5.9.2 ThoracotomyIndirectevidenceAccess to the lungs, pleura, <strong>and</strong> <strong>in</strong>trathoracic structuresis obta<strong>in</strong>ed by an <strong>in</strong>tercostal <strong>in</strong>cision <strong>and</strong> separation <strong>and</strong>retraction of the ribs. Typical procedures <strong>in</strong>clude ligationof patent ductus arteriosus (PDA) resection of aorticcoarctation, lung biopsy, or partial resection, pneumonectomy,repair of tracheoesphageal fistula. Considerablepa<strong>in</strong> can be expected follow<strong>in</strong>g classical thoracotomy<strong>in</strong>cision. Recently, VATS (video assisted thoracoscopicsurgery), a m<strong>in</strong>imally <strong>in</strong>vasive technique, has been usedfor some relatively m<strong>in</strong>or thoracic procedures, for examplelung biopsy or smaller lung resections.ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 53


<strong>Good</strong> practice po<strong>in</strong>tA multi-modal analgesic approach, <strong>in</strong>clud<strong>in</strong>g a localanesthetic technique <strong>and</strong>/or opioid with NSAID <strong>and</strong>paracetamol, is suitable for postthoracotomy pa<strong>in</strong>.RecommendationEpidural analgesia is effective for postthoracotomy pa<strong>in</strong>:Grade D (225,226,231,257,372).EvidenceThoracotomy is frequently <strong>in</strong>cluded <strong>in</strong> studies ofanalgesia for major surgery <strong>in</strong> comb<strong>in</strong>ation withother procedures such as abdom<strong>in</strong>al <strong>and</strong> sp<strong>in</strong>al surgery,mak<strong>in</strong>g <strong>in</strong>terpretation of f<strong>in</strong>d<strong>in</strong>gs difficult.Either epidural analgesia or <strong>in</strong>travenous opioids aspart of a multimodal strategy <strong>in</strong>clud<strong>in</strong>g NSAID <strong>and</strong>paracetamol have been used extensively for postthoracotomypa<strong>in</strong>. Paravertebral block has also beendescribed.There are few studies compar<strong>in</strong>g regional <strong>and</strong> systemictechniques directly, or with other more novelregimens. Although it might be anticipated that pa<strong>in</strong>follow<strong>in</strong>g VATS would differ from classical thoracotomy,there are no studies explor<strong>in</strong>g this issue.Epidural analgesia is frequently recommended forpostthoracotomy pa<strong>in</strong>; however, there is no conclusiveevidence that any particular regimen is more effective.Epidural LA: pla<strong>in</strong> bupivaca<strong>in</strong>e <strong>and</strong> ropivaca<strong>in</strong>esolutions have been found to be effective for majorabdom<strong>in</strong>al <strong>and</strong> thoracic surgery <strong>in</strong> neonates <strong>and</strong><strong>in</strong>fants (225,231). Analgesia was reported as equivalent<strong>in</strong> a case series (272 patients, 29 thoracic) compar<strong>in</strong>gchildren who received either pla<strong>in</strong> ropivaca<strong>in</strong>e or bupivaca<strong>in</strong>e+ diamorph<strong>in</strong>e as part of a multimodal analgesicstrategy (226).LA + opioid: bupivaca<strong>in</strong>e with fentanyl, morph<strong>in</strong>e,diamorph<strong>in</strong>e, or other opioids is effective for postthoracotomypa<strong>in</strong>, by cont<strong>in</strong>uous <strong>in</strong>fusion or PCEA(226,257,372,373).Epidural opioid without LA: s<strong>in</strong>gle-dose thoracicepidural morph<strong>in</strong>e was equivalent to <strong>in</strong>travenous morph<strong>in</strong>e<strong>in</strong>fusion <strong>in</strong> the first 24 h after thoracotomy(374). S<strong>in</strong>gle-dose caudal morph<strong>in</strong>e with or withoutLA was less effective than thoracic epidural Morph<strong>in</strong>e+ LA <strong>in</strong>fusion; <strong>in</strong>fusion patients also had betternonpa<strong>in</strong> outcomes, for example earlier oral <strong>in</strong>take, lessPONV, <strong>and</strong> shorter ICU stay (373).Intrathecal opioid as part of a multimodal techniquehas been described <strong>in</strong> a small case series (375).Paravertebral block has been described as effective<strong>in</strong> a number of small case series of neonates, <strong>in</strong>fants,<strong>and</strong> children (376–382). There have been no comparisonswith other techniques.Intercostal nerve block: <strong>in</strong>creased the time to furtheranalgesia when compared with a s<strong>in</strong>gle dose of pethid<strong>in</strong>eat sk<strong>in</strong> closure (383).Opioids: <strong>in</strong>travenous <strong>in</strong>fusion of opioid is frequentlyused for severe postoperative pa<strong>in</strong> <strong>in</strong>clud<strong>in</strong>g postthoracotomy(384,385). PCA/NCA has been described <strong>in</strong>studies that have <strong>in</strong>cluded a small number of postthoracotomypatients (220,221,223). Data on the efficacyof opioids for thoracotomy are <strong>in</strong>adequate to allowconclusive evaluation, <strong>and</strong> the role of multimodal analgesiahas also not been sufficiently evaluated. In acomparison of PCA <strong>and</strong> cont<strong>in</strong>uous <strong>in</strong>fusion of morph<strong>in</strong>ewithout supplementary NSAID <strong>and</strong> paracetamol,there was no difference between the groups, but20–40% of patients <strong>in</strong> each group had pa<strong>in</strong> scores <strong>in</strong>the ‘severe’ range on the first postoperative day (220).Analgesia Table 5.9.2 ThoracotomyAgentTechniqueDirectevidenceLA Thoracic epidural a 3LA Paravertebral block 3LA Intercostal block b 3LA + opioid Thoracic epidural a 3Opioid Thoracic epidural c 1)Opioid Intrathecal b 3Opioid Intravenous 2)NSAID b 1+Paracetamol b 1+a Caudal, lumbar <strong>and</strong> thoracic catheter <strong>in</strong>sertion sites.b As part of a multi-modal technique.c 1st 24 h.5.10 NeurosurgeryIndirectevidenceNeurosurgical procedures <strong>in</strong> children <strong>in</strong>clude dra<strong>in</strong>ageof hydrocephalus <strong>and</strong> <strong>in</strong>sertion or replacement of anextra cranial shunt, craniotomy, craniofacial surgery,<strong>and</strong> surgery for <strong>in</strong>tracranial aneurism or other vascularmalformation. There has been little <strong>in</strong>vestigation ofanalgesic requirements or analgesia for this group ofpatients, but it is frequently asserted that severe postoperativepa<strong>in</strong> is not a prom<strong>in</strong>ent feature, even follow<strong>in</strong>gmajor neurosurgical <strong>in</strong>terventions, this has beendisputed (386). <strong>Postoperative</strong>ly, many neurosurgicalpatients are admitted to ICU or high dependency areasfor monitor<strong>in</strong>g; opioid analgesia must be used judiciouslyas excessive sedation may mask signs of acutechanges <strong>in</strong> <strong>in</strong>tracranial pressure or <strong>in</strong>terfere with thepatient’s ability to co-operate with neurological assessments.As the risk of postoperative bleed<strong>in</strong>g is rela-54 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


tively high <strong>and</strong> potentially disastrous follow<strong>in</strong>g someprocedures, NSAIDs are sometimes withheld dur<strong>in</strong>gthe first 24 h. See also section 5.1 on the general managementof postoperative pa<strong>in</strong>, <strong>and</strong> section 5.10.1 forthe management of craniotomy <strong>and</strong> major neurosurgery.<strong>Good</strong> practice po<strong>in</strong>tAnalgesia follow<strong>in</strong>g neurosurgery requires goodcommunication <strong>and</strong> close co-operation betweenmembers of the peri-operative team. Frequent pa<strong>in</strong>assessments should be a rout<strong>in</strong>e part of postoperativecare. A multi-modal analgesic approach is suitable,which may <strong>in</strong>clude the use of LA <strong>in</strong>filtration,paracetamol, NSAID (when not contra<strong>in</strong>dicated),<strong>and</strong> parenteral or oral opioid as determ<strong>in</strong>ed byassessed analgesic requirements.EvidenceThe literature <strong>in</strong>form<strong>in</strong>g the management of postoperativepa<strong>in</strong> after neurosurgery is limited. There have beenfew studies compar<strong>in</strong>g st<strong>and</strong>ard analgesic regimens.Opioids: the use of parenteral opioids follow<strong>in</strong>g craniotomy<strong>and</strong> major neurosurgery has been described(387–390). PCA with fentanyl plus a cont<strong>in</strong>uous<strong>in</strong>fusion of midazolam has been described (391). NCAwas reportedly used successfully <strong>in</strong> a small numberof patients


14 Gra<strong>in</strong>ger J, Saravanappa N. Local anaestheticfor post-tonsillectomy pa<strong>in</strong>: a systematicreview <strong>and</strong> meta-analysis. Cl<strong>in</strong>Otolaryngol 2008; 33: 411–419.15 Sun J, Wu X, Meng Y et al. Bupivaca<strong>in</strong>eversus normal sal<strong>in</strong>e for relief of post-adenotonsillectomypa<strong>in</strong> <strong>in</strong> children: a metaanalysis.Int J Pediatr Otorh<strong>in</strong>olaryngol2010; 74: 369–373.16 Ozer Z, Gorur K, Altunkan A et al. Efficacyof tramadol versus meperid<strong>in</strong>e for pa<strong>in</strong>relief <strong>and</strong> safe recovery after adenotonsillectomy.Eur J Anaesthesiol 2003; 20: 920–924.17 Umuroglu T, Eti Z, Ciftci H et al. Analgesiafor adenotonsillectomy <strong>in</strong> children: a comparisonof morph<strong>in</strong>e, ketam<strong>in</strong>e <strong>and</strong> tramadol.Paediatr Anaesth 2004; 14: 568–573.18 Ozalevli M, Unlugenc H, Tuncer U et al.Comparison of morph<strong>in</strong>e <strong>and</strong> tramadol bypatient-controlled analgesia for postoperativeanalgesia after tonsillectomy <strong>in</strong> children.Paediatr Anaesth 2005; 15: 979–984.19 Akkaya T, Bedirli N, Ceylan T et al. Comparisonof <strong>in</strong>travenous <strong>and</strong> peritonsillar<strong>in</strong>filtration of tramadol for postoperativepa<strong>in</strong> relief <strong>in</strong> children follow<strong>in</strong>g adenotonsillectomy.Eur J Anaesthesiol 2009; 26: 333–337.20 Ugur MB, Yilmaz M, Altunkaya H et al.Effects of <strong>in</strong>tramuscular <strong>and</strong> peritonsillar<strong>in</strong>jection of tramadol before tonsillectomy: adouble bl<strong>in</strong>d, r<strong>and</strong>omized, placebo-controlledcl<strong>in</strong>ical trial. Int J Pediatr Otorh<strong>in</strong>olaryngol2008; 72: 241–248.21 Elhakim M, Khalafallah Z, El-Fattah H etal. Ketam<strong>in</strong>e reduces swallow<strong>in</strong>g-evokedpa<strong>in</strong> after paediatric tonsillectomy. ActaAnaesthesiol Sc<strong>and</strong> 2003; 47: 604–609.22 O’Flaherty J, L<strong>in</strong> C. Does ketam<strong>in</strong>e or magnesiumaffect posttonsillectomy pa<strong>in</strong> <strong>in</strong> children?Paediatr Anaesth 2003; 13: 413–421.23 White M, Nolan J. An evaluation of pa<strong>in</strong><strong>and</strong> postoperative nausea <strong>and</strong> vomit<strong>in</strong>g follow<strong>in</strong>gthe <strong>in</strong>troduction of guidel<strong>in</strong>es fortonsillectomy. Paediatr Anaesth 2005; 15:683–688.24 Ewah BN, Robb PJ, Raw M. <strong>Postoperative</strong>pa<strong>in</strong>, nausea <strong>and</strong> vomit<strong>in</strong>g follow<strong>in</strong>g paediatricday-case tonsillectomy. Anaesthesia2006; 61: 116–122.25 Warnock F, L<strong>and</strong>er J. Pa<strong>in</strong> progression,<strong>in</strong>tensity <strong>and</strong> outcomes follow<strong>in</strong>g tonsillectomy.Pa<strong>in</strong> 1998; 75: 37–45.26 Giannoni C, White S, Ennek<strong>in</strong>g FK et al.Ropivaca<strong>in</strong>e with or without clonid<strong>in</strong>eimproves pediatric tonsillectomy pa<strong>in</strong>. ArchOtolaryngol Head Neck Surg 2001; 127:1265–1270.27 Park AH, Pappas AL, Fluder E et al. Effectof perioperative adm<strong>in</strong>istration of ropivaca<strong>in</strong>ewith ep<strong>in</strong>ephr<strong>in</strong>e on postoperativepediatric adenotonsillectomy recovery. ArchOtolaryngol Head Neck Surg 2004; 130:459–464.28 Owczarzak V, Haddad JJr. Comparison oforal versus rectal adm<strong>in</strong>istration of acetam<strong>in</strong>ophenwith code<strong>in</strong>e <strong>in</strong> postoperative pediatricadenotonsillectomy patients.Laryngoscope 2006; 116: 1485–1488.29 Hullett BJ, Chambers NA, Pascoe EM et al.Tramadol vs morph<strong>in</strong>e dur<strong>in</strong>g adenotonsillectomyfor obstructive sleep apnea <strong>in</strong> children.Paediatr Anaesth 2006; 16: 648–653.30 Uysal HY, Takmaz SA, Yaman F et al. Theefficacy of <strong>in</strong>travenous paracetamol versustramadol for postoperative analgesia afteradenotonsillectomy <strong>in</strong> children. J Cl<strong>in</strong>Anesth 2011; 23: 53–57.31 Atef A, Fawaz AA. Peritonsillar <strong>in</strong>filtrationwith tramadol improves pediatric tonsillectomypa<strong>in</strong>. Eur Arch Otorh<strong>in</strong>olaryngol 2008;265: 571–574.32 Antila H, Manner T, Kuurila K et al. Ketoprofen<strong>and</strong> tramadol for analgesia dur<strong>in</strong>gearly recovery after tonsillectomy <strong>in</strong> children.Paediatr Anaesth 2006; 16: 548–553.33 Mo<strong>in</strong>iche S, Roms<strong>in</strong>g J, Dahl J et al. Nonsteroidalanti<strong>in</strong>flammatory drugs <strong>and</strong> therisk of operative site bleed<strong>in</strong>g after tonsillectomy:a quantitative systematic review.Anesth Analg 2003; 96: 68–77.34 Keidan I, Zaslansky R, Eviatar E et al. Intraoperativeketorolac is an effective substitutefor fentanyl <strong>in</strong> children undergo<strong>in</strong>goutpatient adenotonsillectomy. PaediatrAnaesth 2004; 14: 318–323.35 Sheeran PW, Rose JB, Fazi LM et al. Rofecoxibadm<strong>in</strong>istration to paediatric patientsundergo<strong>in</strong>g adenotonsillectomy. PaediatrAnaesth 2004; 14: 579–583.36 Alhashemi JA, Daghistani MF. Effects of<strong>in</strong>traoperative i.v. acetam<strong>in</strong>ophen vs i.m.meperid<strong>in</strong>e on post-tonsillectomy pa<strong>in</strong><strong>in</strong> children. Br J Anaesth 2006; 96: 790–795.37 Anderson B, Kanagasundarum S, WoollardG. Analgesic efficacy of paracetamol <strong>in</strong> childrenus<strong>in</strong>g tonsillectomy as a pa<strong>in</strong> model.Anaesth Intensive Care 1996; 24: 669–673.38 Anderson B, Holford N, Woollard G et al.Perioperative pharmacodynamics of acetam<strong>in</strong>ophenanalgesia <strong>in</strong> children. Anesthesiology1999; 90: 411–421.39 Anderson BJ, Ralph CJ, Stewart AW et al.The dose–effect relationship for morph<strong>in</strong>e<strong>and</strong> vomit<strong>in</strong>g after day-stay tonsillectomy <strong>in</strong>children. Anaesth Intensive Care 2000; 28:155–160.40 Karaaslan K, Yilmaz F, Gulcu N et al. Theeffects of levobupivaca<strong>in</strong>e versus levobupivaca<strong>in</strong>eplus magnesium <strong>in</strong>filtration on postoperativeanalgesia <strong>and</strong> laryngospasm <strong>in</strong>pediatric tonsillectomy patients. Int J PediatrOtorh<strong>in</strong>olaryngol 2008; 72: 675–681.41 Inanoglu K, Ozbakis Akkurt BC, TurhanogluS et al. Intravenous ketam<strong>in</strong>e <strong>and</strong> localbupivaca<strong>in</strong>e <strong>in</strong>filtration are effective as partof a multimodal regime for reduc<strong>in</strong>g posttonsillectomypa<strong>in</strong>. Med Sci Monit 2009; 15:CR539–CR543.42 Gemma M, Piccioni LO, Gioia L et al.Ropivaca<strong>in</strong>e peritonsillar <strong>in</strong>filtration foranalgesia after adenotonsillectomy <strong>in</strong> children:a r<strong>and</strong>omized, double-bl<strong>in</strong>d, placebocontrolledstudy. Ann Otol Rh<strong>in</strong>ol Laryngol2009; 118: 227–231.43 Rhendra Hardy MZ, Zayuah MS, Baharud<strong>in</strong>A et al. The effects of topical viscouslignoca<strong>in</strong>e 2% versus per-rectal diclofenac<strong>in</strong> early post-tonsillectomy pa<strong>in</strong> <strong>in</strong> children.Int J Pediatr Otorh<strong>in</strong>olaryngol 2010; 74:374–377.44 Da Conceicao M, Da Conceicao D, CarneiroLeao C. Effect of an <strong>in</strong>travenous s<strong>in</strong>gledose of ketam<strong>in</strong>e on postoperative pa<strong>in</strong> <strong>in</strong>tonsillectomy patients. Paediatr Anaesth2006; 16: 962–967.45 Ayd<strong>in</strong> ON, Ugur B, Ozgun S et al. Pa<strong>in</strong>prevention with <strong>in</strong>traoperative ketam<strong>in</strong>e <strong>in</strong>outpatient children undergo<strong>in</strong>g tonsillectomyor tonsillectomy <strong>and</strong> adenotomy. JCl<strong>in</strong> Anesth 2007; 19: 115–119.46 Taheri R, Seyedhejazi M, Ghojazadeh M etal. Comparison of ketam<strong>in</strong>e <strong>and</strong> fentanylfor postoperative pa<strong>in</strong> relief <strong>in</strong> children follow<strong>in</strong>gadenotonsillectomy. Pak J Biol Sci2011; 14: 572–577.47 Abu-Shahwan I. Ketam<strong>in</strong>e does not reducepostoperative morph<strong>in</strong>e consumption aftertonsillectomy <strong>in</strong> children. Cl<strong>in</strong> J Pa<strong>in</strong> 2008;24: 395–398.48 Canbay O, Celebi N, Uzun S et al. Topicalketam<strong>in</strong>e <strong>and</strong> morph<strong>in</strong>e for post-tonsillectomypa<strong>in</strong>. Eur J Anaesthesiol 2008; 25:287–292.49 Dahmani S, Michelet D, Abback PS et al.Ketam<strong>in</strong>e for perioperative pa<strong>in</strong> management<strong>in</strong> children: a meta-analysis of publishedstudies. Paediatr Anaesth 2011; 21:636–652.50 Zhuang PJ, Wang X, Zhang XF et al. <strong>Postoperative</strong>respiratory <strong>and</strong> analgesic effects ofdexmedetomid<strong>in</strong>e or morph<strong>in</strong>e for adenotonsillectomy<strong>in</strong> children with obstructivesleep apnoea. Anaesthesia 2011; 66: 989–993.51 Pestieau SR, Quezado ZM, Johnson YJ etal. High-dose dexmedetomid<strong>in</strong>e <strong>in</strong>creasesthe opioid-free <strong>in</strong>terval <strong>and</strong> decreases opioidrequirement after tonsillectomy <strong>in</strong> children.Can J Anaesth 2011; 58: 540–550.52 Patel A, Davidson M, Tran MC et al. Dexmedetomid<strong>in</strong>e<strong>in</strong>fusion for analgesia <strong>and</strong>prevention of emergence agitation <strong>in</strong> childrenwith obstructive sleep apnea syndromeundergo<strong>in</strong>g tonsillectomy <strong>and</strong> adenoidectomy.Anesth Analg 2010; 111: 1004–1010.56 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


53 Steward DL, Welge JA, Myer CM. Steroidsfor improv<strong>in</strong>g recovery follow<strong>in</strong>g tonsillectomy<strong>in</strong> children. Cochrane Database SystRev 2011; Aug 10;(8): CD003997.54 Cardwell M, Siviter G, Smith A. Non-steroidalanti-<strong>in</strong>flammatory drugs <strong>and</strong> perioperativebleed<strong>in</strong>g <strong>in</strong> paediatric tonsillectomy.Cochrane Database Syst Rev 2005; Apr 18;(2): CD003591.55 Krishna S, Hughes L, L<strong>in</strong> S. <strong>Postoperative</strong>hemorrhage with nonsteroidal anti-<strong>in</strong>flammatorydrug use after tonsillectomy: a metaanalysis.Arch Otolaryngol Head Neck Surg2003; 129: 1086–1089.56 Marret E, Flahault A, Samama C et al.Effects of postoperative, nonsteroidal, anti<strong>in</strong>flammatorydrugs on bleed<strong>in</strong>g risk aftertonsillectomy: meta-analysis of r<strong>and</strong>omized,controlled trials. Anesthesiology 2003; 98:1497–1502.57 Suresh S, Barcelona S, Young N et al. <strong>Postoperative</strong>pa<strong>in</strong> relief <strong>in</strong> children undergo<strong>in</strong>gtympanomastoid surgery: is a regional blockbetter than opioids? Anesth Analg 2002; 94:859–862.58 Suresh S, Barcelona SL, Young NM et al.Does a preemptive block of the great auricularnerve improve postoperative analgesia<strong>in</strong> children undergo<strong>in</strong>g tympanomastoid surgery?Anesth Analg 2004; 98: 330–333,tableof contents.59 Hasan RA, LaRouere MJ, Kartush J et al.Ambulatory tympanomastoid surgery <strong>in</strong>children: factors affect<strong>in</strong>g hospital admission.Arch Otolaryngol Head Neck Surg2004; 130: 1158–1162.60 Deb K, Subramaniam R, Dehran M et al.Safety <strong>and</strong> efficacy of peribulbar block asadjunct to general anaesthesia for paediatricophthalmic surgery. Paediatr Anaesth 2001;11: 161–167.61 Sheard RM, Mehta JS, Barry JS et al. Subtenonslidoca<strong>in</strong>e <strong>in</strong>jection for postoperativepa<strong>in</strong> relief after strabismus surgery <strong>in</strong> children:a prospective r<strong>and</strong>omized controlledtrial. J AApos 2004; 8: 314–317.62 Chhabra A, P<strong>and</strong>ey R, Kh<strong>and</strong>elwal M et al.Anesthetic techniques <strong>and</strong> postoperativeemesis <strong>in</strong> pediatric strabismus surgery. RegAnesth Pa<strong>in</strong> Med 2005; 30: 43–47.63 Steib A, Karcenty A, Calache E et al.Effects of subtenon anesthesia comb<strong>in</strong>edwith general anesthesia on perioperativeanalgesic requirements <strong>in</strong> pediatric strabismussurgery. Reg Anesth Pa<strong>in</strong> Med 2005;30: 478–483.64 Morris B, Watts P, Zatman T et al. Pa<strong>in</strong>relief for strabismus surgery <strong>in</strong> children: ar<strong>and</strong>omised controlled study of the use ofpreoperative sub-Tenon levobupivaca<strong>in</strong>e. BrJ Ophthalmol 2009; 93: 329–332.65 Morton N, Benham S, Lawson R et al. Diclofenacvs oxybuproca<strong>in</strong>e eyedrops for analgesia<strong>in</strong> paediatric strabismus surgery.Paediatr Anaesth 1997; 7: 221–226.66 Bridge HS, Montgomery CJ, Kennedy RAet al. Analgesic efficacy of ketorolac 0.5%ophthalmic solution (Accular) <strong>in</strong> paediatricstrabismus surgery. Paediatr Anaesth 2000;10: 521–526.67 Kim J, Azavedo L, Bhananker S et al.Amethoca<strong>in</strong>e or ketorolac eyedrops provide<strong>in</strong>adequate analgesia <strong>in</strong> pediatric strabismussurgery. Can J Anaesth 2003; 50: 819–823.68 Mendel H, Guarnieri K, Sundt L et al. Theeffects of ketorolac <strong>and</strong> fentanyl on postoperativevomit<strong>in</strong>g <strong>and</strong> analgesic requirements<strong>in</strong> children undergo<strong>in</strong>g strabismus surgery.Anesth Analg 1995; 80: 1129–1133.69 Kokki H, Homan E, Tuov<strong>in</strong>en K et al. Preoperativetreatment with i.v. ketoprofenreduces pa<strong>in</strong> <strong>and</strong> vomit<strong>in</strong>g <strong>in</strong> children afterstrabismus surgery. Acta Anaesthesiol Sc<strong>and</strong>1999; 43: 13–18.70 Shende D, Das K. Comparative effects of<strong>in</strong>travenous ketorolac <strong>and</strong> pethid<strong>in</strong>e on perioperativeanalgesia <strong>and</strong> postoperative nausea<strong>and</strong> vomit<strong>in</strong>g (PONV) for paediatricstrabismus surgery. Acta Anaesthesiol Sc<strong>and</strong>1999; 43: 265–269.71 Wennstrom B, Re<strong>in</strong>sfelt B. Rectally adm<strong>in</strong>istereddiclofenac (Voltaren) reduces vomit<strong>in</strong>gcompared with opioid (morph<strong>in</strong>e) afterstrabismus surgery <strong>in</strong> children. Acta AnaesthesiolSc<strong>and</strong> 2002; 46: 430–434.72 Ann<strong>in</strong>ger W, Forbes B, Qu<strong>in</strong>n G et al. Theeffect of topical tetraca<strong>in</strong>e eye drops onemergence behavior <strong>and</strong> pa<strong>in</strong> relief afterstrabismus surgery. J AAPOS 2007; 11:273–276.73 Eltzschig H, Schroeder T, Eissler B et al.The effect of remifentanil or fentanyl onpostoperative vomit<strong>in</strong>g <strong>and</strong> pa<strong>in</strong> <strong>in</strong> childrenundergo<strong>in</strong>g strabismus surgery. AnesthAnalg 2002; 94: 1173–1177.74 Mikawa K, Nish<strong>in</strong>a K, Maekawa N et al.Dose–response of flurbiprofen on postoperativepa<strong>in</strong> <strong>and</strong> emesis after paediatric strabismussurgery. Can J Anaesth 1997; 44: 95–98.75 Subramaniam R, Ghai B, Khetarpal M etal. A comparison of <strong>in</strong>travenous ketoprofenversus pethid<strong>in</strong>e on peri-operative analgesia<strong>and</strong> post-operative nausea <strong>and</strong> vomit<strong>in</strong>g <strong>in</strong>paediatric vitreoret<strong>in</strong>al surgery. J PostgradMed 2003; 49: 123–126.76 Subramaniam R, Subbarayudu S, Rewari Vet al. Usefulness of pre-emptive peribulbarblock <strong>in</strong> pediatric vitreoret<strong>in</strong>al surgery: aprospective study. Reg Anesth Pa<strong>in</strong> Med2003; 28: 43–47.77 Chhabra A, S<strong>in</strong>ha R, Subramaniam R et al.Comparison of sub-Tenon’s block with i.v.fentanyl for paediatric vitreoret<strong>in</strong>al surgery.Br J Anaesth 2009; 103: 739–743.78 Ghai B, Ram J, Makkar JK et al. Subtenonblock compared to <strong>in</strong>travenous fentanyl forperioperative analgesia <strong>in</strong> pediatric cataractsurgery. Anesth Analg 2009; 108: 1132–1138.79 Parulekar MV, Berg S, Elston JS. Adjunctiveperibulbar anaesthesia for paediatricophthalmic surgery: are the risks justified?Paediatr Anaesth 2002; 12: 85–86.80 Ghai B, Makkar JK, Chari P et al. Additionof midazolam to cont<strong>in</strong>uous postoperativeepidural bupivaca<strong>in</strong>e <strong>in</strong>fusion reducesrequirement for rescue analgesia <strong>in</strong> childrenundergo<strong>in</strong>g upper abdom<strong>in</strong>al <strong>and</strong> flank surgery.J Cl<strong>in</strong> Anesth 2009; 21: 113–119.81 S<strong>in</strong>ha R, Subramaniam R, Chhabra A et al.Comparison of topical lignoca<strong>in</strong>e gel <strong>and</strong>fentanyl for perioperative analgesia <strong>in</strong> childrenundergo<strong>in</strong>g cataract surgery. PaediatrAnaesth 2009; 19: 371–375.82 Gazal G, Mackie IC. A comparison of paracetamol,ibuprofen or their comb<strong>in</strong>ationfor pa<strong>in</strong> relief follow<strong>in</strong>g extractions <strong>in</strong> childrenunder general anaesthesia: a r<strong>and</strong>omizedcontrolled trial. Int J Paediatr Dent2007; 17: 169–177.83 Leong KJ, Roberts GJ, Ashley PF. Perioperativelocal anaesthetic <strong>in</strong> young paediatricpatients undergo<strong>in</strong>g extractions under outpatient‘short-case’ general anaesthesia. Adouble-bl<strong>in</strong>d r<strong>and</strong>omised controlled trial. BrDent J 2007; 203: E11;discussion 334–335.84 Sammons HM, Unsworth V, Gray C et al.R<strong>and</strong>omized controlled trial of the <strong>in</strong>traligamentaluse of a local anaesthetic (lignoca<strong>in</strong>e2%) versus controls <strong>in</strong> paediatric toothextraction. Int J Paediatr Dent 2007; 17:297–303.85 Andrzejowski J, Lamb L. The effect ofswabs soaked <strong>in</strong> bupivaca<strong>in</strong>e <strong>and</strong> ep<strong>in</strong>ephr<strong>in</strong>efor pa<strong>in</strong> relief follow<strong>in</strong>g simple dentalextractions <strong>in</strong> children. Anaesthesia 2002;57: 281–283.86 Gazal G, Bowman R, Worth<strong>in</strong>gton HV etal. A double-bl<strong>in</strong>d r<strong>and</strong>omized controlledtrial <strong>in</strong>vestigat<strong>in</strong>g the effectiveness of topicalbupivaca<strong>in</strong>e <strong>in</strong> reduc<strong>in</strong>g distress <strong>in</strong> childrenfollow<strong>in</strong>g extractions under generalanaesthesia. Int J Paediatr Dent 2004; 14:425–431.87 An<strong>and</strong> P, Wilson R, Sheehy EC. Intraligamentalanalgesia for post-operative pa<strong>in</strong>control <strong>in</strong> children hav<strong>in</strong>g dental extractionsunder general anaesthesia. Eur J PaediatrDent 2005; 6: 10–15.88 McWilliams PA, Rutherford JS. Assessmentof early postoperative pa<strong>in</strong> <strong>and</strong> haemorrhage<strong>in</strong> young children undergo<strong>in</strong>g dentalextractions under general anaesthesia. Int JPaediatr Dent 2007; 17: 352–357.89 Atan S, Ashley P, Gilthorpe MS et al. Morbidityfollow<strong>in</strong>g dental treatment of childrenunder <strong>in</strong>tubation general anaesthesia <strong>in</strong> aª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 57


day-stay unit. Int J Paediatr Dent 2004; 14:9–16.90 Gazal G, Mackie IC. Distress related todental extraction for children under generalanaesthesia <strong>and</strong> their parents. Eur J PaediatrDent 2007; 8: 7–12.91 O’Donnell A, Henderson M, Fearne J et al.<strong>Management</strong> of postoperative pa<strong>in</strong> <strong>in</strong> childrenfollow<strong>in</strong>g extractions of primary teethunder general anaesthesia: a comparison ofparacetamol, Voltarol <strong>and</strong> no analgesia. IntJ Paediatr Dent 2007; 17: 110–115.92 Townsend JA, Ganzberg S, Thikkurissy S.The effect of local anesthetic on quality ofrecovery characteristics follow<strong>in</strong>g dentalrehabilitation under general anesthesia <strong>in</strong>children. Anesth Prog 2009; 56: 115–122.93 Littlejohn IH, Tarl<strong>in</strong>g MM, Flynn PJ et al.Post-operative pa<strong>in</strong> relief <strong>in</strong> children follow<strong>in</strong>gextraction of carious deciduous teethunder general anaesthesia: a comparison ofnalbuph<strong>in</strong>e <strong>and</strong> diclofenac. Eur J Anaesthesiol1996; 13: 359–363.94 Purday J, Reichert C, Merrick P. Comparativeeffects of three doses of <strong>in</strong>travenousketorolac or morph<strong>in</strong>e on emesis <strong>and</strong> analgesiafor restorative dental surgery <strong>in</strong> children.Can J Anaesth 1996; 43: 221–225.95 Alhashemi JA, Daghistani MF. Effect of <strong>in</strong>traoperative<strong>in</strong>travenous acetam<strong>in</strong>ophen vs.<strong>in</strong>tramuscular meperid<strong>in</strong>e on pa<strong>in</strong> <strong>and</strong> dischargetime after paediatric dental restoration.Eur J Anaesthesiol 2007; 24: 128–133.96 Bhananker SM, Azavedo LF, Spl<strong>in</strong>ter WM.Addition of morph<strong>in</strong>e to local anesthetic<strong>in</strong>filtration does not improve analgesia afterpediatric dental extractions. Paediatr Anaesth2008; 18: 140–144.97 Ho D, Keneally J. Analgesia follow<strong>in</strong>g paediatricday-surgical orchidopexy <strong>and</strong> herniotomy.Paediatr Anaesth 2000; 10: 627–631.98 Anatol TI, Pitt-Miller P, Holder Y. Trial ofthree methods of <strong>in</strong>traoperative bupivaca<strong>in</strong>eanalgesia for pa<strong>in</strong> after paediatric gro<strong>in</strong> surgery.Can J Anaesth 1997; 44: 1053–1059.99 Ivani G, DeNegri P, Conio A et al. Comparisonof racemic bupivaca<strong>in</strong>e, ropivaca<strong>in</strong>e,<strong>and</strong> levo-bupivaca<strong>in</strong>e for pediatric caudalanesthesia: effects on postoperative analgesia<strong>and</strong> motor block. Reg Anesth Pa<strong>in</strong> Med2002; 27: 157–161.100 Ivani G, Conio A, De NP et al. Sp<strong>in</strong>al versusperipheral effects of adjunct clonid<strong>in</strong>e:comparison of the analgesic effect of a ropivaca<strong>in</strong>e-clonid<strong>in</strong>emixture when adm<strong>in</strong>isteredas a caudal or ilio<strong>in</strong>gu<strong>in</strong>aliliohypogastricnerve blockade for <strong>in</strong>gu<strong>in</strong>alsurgery <strong>in</strong> children. Paediatr Anaesth 2002;12: 680–684.101 Suraseranivongse S, Chowvanayot<strong>in</strong> S, PirayavarapornS et al. Effect of bupivaca<strong>in</strong>ewith ep<strong>in</strong>ephr<strong>in</strong>e wound <strong>in</strong>stillation for pa<strong>in</strong>relief after pediatric <strong>in</strong>gu<strong>in</strong>al herniorrhaphy<strong>and</strong> hydrocelectomy. Reg Anesth Pa<strong>in</strong> Med2003; 28: 24–28.102 Ivani G, De Negri P, Lonnqvist PA et al.Caudal anesthesia for m<strong>in</strong>or pediatric surgery:a prospective r<strong>and</strong>omized comparisonof ropivaca<strong>in</strong>e 0.2% vs levobupivaca<strong>in</strong>e0.2%. Paediatr Anaesth 2005; 15: 491–494.103 Fredrickson MJ, Pa<strong>in</strong>e C, Hamill J.Improved analgesia with the ilio<strong>in</strong>gu<strong>in</strong>alblock compared to the transversus abdom<strong>in</strong>isplane block after pediatric <strong>in</strong>gu<strong>in</strong>al surgery:a prospective r<strong>and</strong>omized trial.Paediatr Anaesth 2010; 20: 1022–1027.104 Giaufre E, Dalens B, Gombert A. Epidemiology<strong>and</strong> morbidity of regional anesthesia<strong>in</strong> children: a one-year prospective survey ofthe French-Language Society of PediatricAnesthesiologists. Anesth Analg 1996; 83:904–912.105 Cook TM, Counsell D, Wildsmith JA.Major complications of central neuraxialblock: report on the Third National AuditProject of the Royal College of Anaesthetists.Br J Anaesth 2009; 102: 179–190.106 Ecoffey C, Lacroix F, Giaufre E et al. Epidemiology<strong>and</strong> morbidity of regional anesthesia<strong>in</strong> children: a follow-up one-yearprospective survey of the French-LanguageSociety of Paediatric Anaesthesiologists(ADARPEF). Paediatr Anaesth 2010; 20:1061–1069.107 Brenner L, Kettner SC, Marhofer P et al.Caudal anaesthesia under sedation: a prospectiveanalysis of 512 <strong>in</strong>fants <strong>and</strong> children.Br J Anaesth 2010; 104: 751–755.108 Breschan C, Jost R, Krumpholz R et al. Aprospective study compar<strong>in</strong>g the analgesicefficacy of levobupivaca<strong>in</strong>e, ropivaca<strong>in</strong>e <strong>and</strong>bupivaca<strong>in</strong>e <strong>in</strong> pediatric patients undergo<strong>in</strong>gcaudal blockade. Paediatr Anaesth 2005; 15:301–306.109 Ingelmo P, Frawley G, Astuto M et al. Relativeanalgesic potencies of levobupivaca<strong>in</strong>e<strong>and</strong> ropivaca<strong>in</strong>e for caudal anesthesia <strong>in</strong>children. Anesth Analg 2009; 108: 805–813.110 Luz G, Innerhofer P, Haussler B et al.Comparison of ropivaca<strong>in</strong>e 0.1% <strong>and</strong> 0.2%with bupivaca<strong>in</strong>e 0.2% for s<strong>in</strong>gle-shot caudalanaesthesia <strong>in</strong> children. Paediatr Anaesth2000; 10: 499–504.111 Bosenberg A, Thomas J, Lopez T et al. Theefficacy of caudal ropivaca<strong>in</strong>e 1, 2 <strong>and</strong>3mg· l()1) for postoperative analgesia <strong>in</strong>children. Paediatr Anaesth 2002; 12: 53–58.112 Ivani G, De NP, Lonnqvist P et al. A comparisonof three different concentrations oflevobupivaca<strong>in</strong>e for caudal block <strong>in</strong> children.Anesth Analg 2003; 97: 368–371.113 Gulec S, Buyukkidan B, Oral N et al. Comparisonof caudal bupivaca<strong>in</strong>e, bupivaca<strong>in</strong>emorph<strong>in</strong>e<strong>and</strong> bupivaca<strong>in</strong>e-midazolam mixturesfor post-operative analgesia <strong>in</strong> children.Eur J Anaesthesiol 1998; 15: 161–165.114 Ivani G, De Negri P, Conio A et al. Ropivaca<strong>in</strong>e-clonid<strong>in</strong>ecomb<strong>in</strong>ation for caudalblockade <strong>in</strong> children. Acta AnaesthesiolSc<strong>and</strong> 2000; 44: 446–449.115 Khan F, Memon G, Kamal R. Effect ofroute of buprenorph<strong>in</strong>e on recovery <strong>and</strong>postoperative analgesic requirement <strong>in</strong> paediatricpatients. Paediatr Anaesth 2002; 12:786–790.116 Anserm<strong>in</strong>o M, Basu R, V<strong>and</strong>ebeek C et al.Nonopioid additives to local anaestheticsfor caudal blockade <strong>in</strong> children: a systematicreview. Paediatr Anaesth 2003; 13: 561–573.117 Turan A, Memis D, Basaran UN et al. Caudalropivaca<strong>in</strong>e <strong>and</strong> neostigm<strong>in</strong>e <strong>in</strong> pediatricsurgery. Anesthesiology 2003; 98: 719–722.118 Weber F, Wulf H. Caudal bupivaca<strong>in</strong>e <strong>and</strong>s(+)-ketam<strong>in</strong>e for postoperative analgesia<strong>in</strong> children. Paediatr Anaesth 2003; 13: 244–248.119 Bano F, Haider S, Sultan ST. Comparisonof caudal bupivaca<strong>in</strong>e <strong>and</strong> bupivaca<strong>in</strong>e-midazolamfor peri <strong>and</strong> postoperative analgesia<strong>in</strong> children. J Coll Physicians Surg Pak2004; 14: 65–68.120 Mart<strong>in</strong>dale S, Dix P, Stoddart P. Doublebl<strong>in</strong>dr<strong>and</strong>omized controlled trial of caudalversus <strong>in</strong>travenous S(+)-ketam<strong>in</strong>e for supplementationof caudal analgesia <strong>in</strong> children.Br J Anaesth 2004; 92: 344–347.121 Saadawy I, Boker A, Elshahawy MA et al.Effect of dexmedetomid<strong>in</strong>e on the characteristicsof bupivaca<strong>in</strong>e <strong>in</strong> a caudal block <strong>in</strong>pediatrics. Acta Anaesthesiol Sc<strong>and</strong> 2009; 53:251–256.122 Shukla U, Prabhakar T, Malhotra K. <strong>Postoperative</strong>analgesia <strong>in</strong> children when us<strong>in</strong>gclonid<strong>in</strong>e or fentanyl with ropivaca<strong>in</strong>e givencaudally. J Anaesthesiol Cl<strong>in</strong> Pharmacol2011; 27: 205–210.123 Disma N, Frawley G, Mameli L et al. Effectof epidural clonid<strong>in</strong>e on m<strong>in</strong>imum localanesthetic concentration (ED50) of levobupivaca<strong>in</strong>efor caudal block <strong>in</strong> children. PaediatrAnaesth 2011; 21: 128–135.124 Pradhan B, Bajracharya GR. Midazolamfor caudal analgesia <strong>in</strong> children: comparisonwith caudal bupivaca<strong>in</strong>e. Kathm<strong>and</strong>u UnivMed J (KUMJ) 2008; 6: 166–172.125 Birbicer H, Doruk N, C<strong>in</strong>el I et al. Couldadd<strong>in</strong>g magnesium as adjuvant to ropivaca<strong>in</strong>e<strong>in</strong> caudal anaesthesia improve postoperativepa<strong>in</strong> control ? Pediatr Surg Int 2007;23: 195–198.126 Erol A, Tavlan A, Tuncer S et al. Caudalanesthesia for m<strong>in</strong>or subumbilical pediatricsurgery: a comparison of levobupivaca<strong>in</strong>ealone <strong>and</strong> levobupivaca<strong>in</strong>e plus sufentanil. JCl<strong>in</strong> Anesth 2008; 20: 442–446.127 Ak<strong>in</strong> A, Ocalan S, Esmaoglu A et al. Theeffects of caudal or <strong>in</strong>travenous clonid<strong>in</strong>e onpostoperative analgesia produced by caudal58 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


levobupivaca<strong>in</strong>e <strong>in</strong> children. Paediatr Anaesth2010; 20: 350–355.128 Luz G, Innerhofer P, Oswald E et al. Comparisonof clonid<strong>in</strong>e 1 microgram kg-1 withmorph<strong>in</strong>e 30 micrograms kg-1 for post-operativecaudal analgesia <strong>in</strong> children. Eur JAnaesthesiol 1999; 16: 42–46.129 Passariello M, Almenrader N, Canneti A etal. Caudal analgesia <strong>in</strong> children: S(+)-ketam<strong>in</strong>evs S(+)-ketam<strong>in</strong>e plus clonid<strong>in</strong>e. PaediatrAnaesth 2004; 14: 851–855.130 Dalens B, Ecoffey C, Joly A et al. Pharmacok<strong>in</strong>etics<strong>and</strong> analgesic effect of ropivaca<strong>in</strong>efollow<strong>in</strong>g ilio<strong>in</strong>gu<strong>in</strong>al/iliohypogastricnerve block <strong>in</strong> children. Paediatr Anaesth2001; 11: 415–420.131 Willschke H, Marhofer P, Bosenberg A etal. Ultrasonography for ilio<strong>in</strong>gu<strong>in</strong>al/iliohypogastricnerve blocks <strong>in</strong> children. Br J Anaesth2005; 95: 226–230.132 Kaabachi O, Zerelli Z, Methamem M et al.Clonid<strong>in</strong>e adm<strong>in</strong>istered as adjuvant for bupivaca<strong>in</strong>e<strong>in</strong> ilio<strong>in</strong>gu<strong>in</strong>al-iliohypogastric nerveblock does not prolong postoperative analgesia.Paediatr Anaesth 2005; 15: 586–590.133 Cyna AM, Middleton P. Caudal epiduralblock versus other methods of postoperativepa<strong>in</strong> relief for circumcision <strong>in</strong> boys. CochraneDatabase Syst Rev 2008; CD003005.134 McGowan P, May H, Molnar Z et al. Acomparison of three methods of analgesia <strong>in</strong>children hav<strong>in</strong>g day case circumcision. PaediatrAnaesth 1998; 8: 403–407.135 Matsota P, Papageorgiou-Brousta M. Intraoperative<strong>and</strong> postoperative analgesia withsubcutaneous r<strong>in</strong>g block of the penis withlevobupivaca<strong>in</strong>e for circumcision <strong>in</strong> children.Eur J Pediatr Surg 2004; 14: 198–202.136 Irw<strong>in</strong> M, Cheng W. Comparison of subcutaneousr<strong>in</strong>g block of the penis with caudalepidural block for post-circumcision analgesia<strong>in</strong> children. Anaesth Intensive Care 1996;24: 365–367.137 Holder K, Peutrell J, Weir P. Regionalanaesthesia for circumcision. Subcutaneousr<strong>in</strong>g block of the penis <strong>and</strong> subpubic penileblock compared. Eur J Anaesthesiol 1997;14: 495–498.138 Gauntlett I. A comparison between localanaesthetic dorsal nerve block <strong>and</strong> caudalbupivaca<strong>in</strong>e with ketam<strong>in</strong>e for paediatriccircumcision. Paediatr Anaesth 2003; 13: 38–42.139 Weksler N, Atias I, Kle<strong>in</strong> M et al. Is penileblock better than caudal epidural block forpostcircumcision analgesia? J Anesth 2005;19: 36–39.140 Soh CR, Ng SB, Lim SL. Dorsal penilenerve block. Paediatr Anaesth 2003; 13:329–333.141 S<strong>and</strong>eman DJ, Re<strong>in</strong>er D, Dilley AV et al. Aretrospective audit of three different regionalanaesthetic techniques for circumcision<strong>in</strong> children. Anaesth Intensive Care 2010; 38:519–524.142 Naja Z, Al-Tannir MA, Faysal W et al. Acomparison of pudendal block vs dorsalpenile nerve block for circumcision <strong>in</strong> children:a r<strong>and</strong>omised controlled trial. Anaesthesia2011; 66: 802–807.143 Kargi E, Isikdemir A, Tokgoz H et al.Comparison of local anesthetic effects oftramadol with priloca<strong>in</strong>e dur<strong>in</strong>g circumcisionprocedure. Urology 2010; 75: 672–675.144 Choi W, Irw<strong>in</strong> M, Hui T et al. EMLAcream versus dorsal penile nerve block forpostcircumcision analgesia <strong>in</strong> children.Anesth Analg 2003; 96: 396–399.145 Margetts L, Carr A, McFadyen G et al. Acomparison of caudal bupivaca<strong>in</strong>e <strong>and</strong> ketam<strong>in</strong>ewith penile block for paediatric circumcision.Eur J Anaesthesiol 2008; 25:1009–1013.146 Lee HM, S<strong>and</strong>ers GM. Caudal ropivaca<strong>in</strong>e<strong>and</strong> ketam<strong>in</strong>e for postoperative analgesia <strong>in</strong>children. Anaesthesia 2000; 55: 806–810.147 Sharpe P, Kle<strong>in</strong> JR, Thompson JP et al.Analgesia for circumcision <strong>in</strong> a paediatricpopulation: comparison of caudal bupivaca<strong>in</strong>ealone with bupivaca<strong>in</strong>e plus two dosesof clonid<strong>in</strong>e. Paediatr Anaesth 2001; 11:695–700.148 Brady-Fryer B, Wiebe N, L<strong>and</strong>er JA. Pa<strong>in</strong>relief for neonatal circumcision. CochraneDatabase Syst Rev 2004; CD004217.149 Banieghbal B. Optimal time for neonatalcircumcision: an observation-based study. JPediatr Urol 2009; 5: 359–362.150 Taeusch HW, Mart<strong>in</strong>ez AM, Partridge JC etal. Pa<strong>in</strong> dur<strong>in</strong>g Mogen or PlastiBell circumcision.J Per<strong>in</strong>atol 2002; 22: 214–218.151 Taddio A, Ohlsson A, E<strong>in</strong>arson TR et al. Asystematic review of lidoca<strong>in</strong>e-priloca<strong>in</strong>ecream (EMLA) <strong>in</strong> the treatment of acutepa<strong>in</strong> <strong>in</strong> neonates. Pediatrics 1998; 101: E1.152 Lehr VT, Cepeda E, Frattarelli DA et al.Lidoca<strong>in</strong>e 4% cream compared with lidoca<strong>in</strong>e2.5% <strong>and</strong> priloca<strong>in</strong>e 2.5% or dorsalpenile block for circumcision. Am J Per<strong>in</strong>atol2005; 22: 231–237.153 Prosser D, Davis A, Booker P et al. Caudaltramadol for postoperative analgesia <strong>in</strong>pediatric hypospadias surgery. Br J Anaesth1997; 79: 293–296.154 Abdulatif M, El-Sanabary M. Caudal neostigm<strong>in</strong>e,bupivaca<strong>in</strong>e, <strong>and</strong> their comb<strong>in</strong>ationfor postoperative pa<strong>in</strong> managementafter hypospadias surgery <strong>in</strong> children.Anesth Analg 2002; 95: 1215–1218,table ofcontents.155 Gunes Y, Gunduz M, Unlugenc H et al.Comparison of caudal vs <strong>in</strong>travenous tramadoladm<strong>in</strong>istered either preoperatively orpostoperatively for pa<strong>in</strong> relief <strong>in</strong> boys. PaediatrAnaesth 2004; 14: 324–328.156 Hansen TG, Henneberg SW, Walther-LarsenS et al. Caudal bupivaca<strong>in</strong>e supplementedwith caudal or <strong>in</strong>travenous clonid<strong>in</strong>e<strong>in</strong> children undergo<strong>in</strong>g hypospadias repair:a double-bl<strong>in</strong>d study. Br J Anaesth 2004; 92:223–227.157 Mahajan R, Grover V, Chari P. Caudalneostigm<strong>in</strong>e with bupivaca<strong>in</strong>e produces adose-<strong>in</strong>dependent analgesic effect <strong>in</strong> children.Can J Anaesth 2004; 51: 702–706.158 Cho JE, Kim JY, Hong JY et al. The additionof fentanyl to 1.5 mg/ml ropivaca<strong>in</strong>ehas no advantage for paediatric epiduralanalgesia. Acta Anaesthesiol Sc<strong>and</strong> 2009; 53:1084–1087.159 Silvani P, Camporesi A, Agost<strong>in</strong>o MR et al.Caudal anesthesia <strong>in</strong> pediatrics: an update.M<strong>in</strong>erva Anestesiol 2006; 72: 453–459.160 Kelleher A, Black A, Penman S et al. Comparisonof caudal bupivaca<strong>in</strong>e <strong>and</strong> diamorph<strong>in</strong>ewith caudal bupivaca<strong>in</strong>e alone forrepair of hypospadias. Br J Anaesth 1996;77: 586–590.161 Laiq N, Khan MN, Tahmeedullah K. et al.Comparison of caudal bupivaca<strong>in</strong>e <strong>and</strong> bupivaca<strong>in</strong>e-tramadolfor postoperative analgesia<strong>in</strong> children undergo<strong>in</strong>g hypospadiassurgery. J Coll Physicians Surg Pak 2009;19: 678–681.162 De Mey JC, Strobbet J, Poelaert J et al.The <strong>in</strong>fluence of sufentanil <strong>and</strong>/or clonid<strong>in</strong>eon the duration of analgesia after a caudalblock for hypospadias repair surgery <strong>in</strong>children. Eur J Anaesthesiol 2000; 17: 379–382.163 Hansen T, Henneberg S. Caudal clonid<strong>in</strong>e<strong>in</strong> neonates <strong>and</strong> small <strong>in</strong>fants <strong>and</strong> respiratorydepression. Paediatr Anaesth 2004; 14:529–530.164 Ozbek H, Bilen A, Ozcengiz D et al. Thecomparison of caudal ketam<strong>in</strong>e, alfentanil<strong>and</strong> ketam<strong>in</strong>e plus alfentanil adm<strong>in</strong>istrationfor postoperative analgesia <strong>in</strong> children. PaediatrAnaesth 2002; 12: 610–616.165 Batra YK, Arya VK, Mahajan R et al.Dose response study of caudal neostigm<strong>in</strong>efor postoperative analgesia <strong>in</strong> paediatricpatients undergo<strong>in</strong>g genitour<strong>in</strong>ary surgery.Paediatr Anaesth 2003; 13: 515–521.166 Gunes Y, Secen M, Ozcengiz D et al. Comparisonof caudal ropivaca<strong>in</strong>e, ropivaca<strong>in</strong>eplus ketam<strong>in</strong>e <strong>and</strong> ropivaca<strong>in</strong>e plus tramadoladm<strong>in</strong>istration for postoperative analgesia<strong>in</strong> children. Paediatr Anaesth 2004; 14:557–563.167 De Negri P, Ivani G, Tirri T et al. A comparisonof epidural bupivaca<strong>in</strong>e, levobupivaca<strong>in</strong>e,<strong>and</strong> ropivaca<strong>in</strong>e on postoperativeanalgesia <strong>and</strong> motor blockade. Anesth Analg2004; 99: 45–48.168 Lerman J, Nolan J, Eyres R et al. Efficacy,safety, <strong>and</strong> pharmacok<strong>in</strong>etics of levobupivaca<strong>in</strong>ewith <strong>and</strong> without fentanyl after con-ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 59


t<strong>in</strong>uous epidural <strong>in</strong>fusion <strong>in</strong> children: a multicentertrial. Anesthesiology 2003; 99: 1166–1174.169 Chhibber A, Perk<strong>in</strong>s F, Rab<strong>in</strong>owitz R et al.Penile block tim<strong>in</strong>g for postoperative analgesiaof hypospadias repair <strong>in</strong> children. JUrol 1997; 158: 1156–1159.170 Apiliogullari S, Duman A, Gok F et al.Sp<strong>in</strong>al needle design <strong>and</strong> size affect the <strong>in</strong>cidenceof postdural puncture headache <strong>in</strong>children. Paediatr Anaesth 2010; 20: 177–182.171 Ozyuvaci E, Altan A, Yucel M et al. Evaluationof add<strong>in</strong>g preoperative or postoperativerectal paracetamol to caudalbupivaca<strong>in</strong>e for postoperative analgesia <strong>in</strong>children. Paediatr Anaesth 2004; 14: 661–665.172 F<strong>in</strong>dlow D, Aldridge L, Doyle E. Comparisonof caudal block us<strong>in</strong>g bupivaca<strong>in</strong>e <strong>and</strong>ketam<strong>in</strong>e with ilio<strong>in</strong>gu<strong>in</strong>al nerve block fororchidopexy <strong>in</strong> children. Anaesthesia 1997;52: 1110–1113.173 Somri M, Gait<strong>in</strong>i LA, Vaida SJ et al. Effectof ilio<strong>in</strong>gu<strong>in</strong>al nerve block on the catecholam<strong>in</strong>eplasma levels <strong>in</strong> orchidopexy: comparisonwith caudal epidural block. PaediatrAnaesth 2002; 12: 791–797.174 Verghese S, Hannallah R, Rice L et al. Caudalanesthesia <strong>in</strong> children: effect of volumeversus concentration of bupivaca<strong>in</strong>e onblock<strong>in</strong>g spermatic cord traction responsedur<strong>in</strong>g orchidopexy. Anesth Analg 2002; 95:1219–1223.175 Hong JY, Han SW, Kim WO et al. A comparisonof high volume/low concentration<strong>and</strong> low volume/high concentration ropivaca<strong>in</strong>e<strong>in</strong> caudal analgesia for pediatricorchiopexy. Anesth Analg 2009; 109: 1073–1078.176 Semple D, F<strong>in</strong>dlow D, Aldridge L et al. Theoptimal dose of ketam<strong>in</strong>e for caudal epiduralblockade <strong>in</strong> children. Anaesthesia 1996;51: 1170–1172.177 Hong JY, Han SW, Kim WO et al. Effectof dexamethasone <strong>in</strong> comb<strong>in</strong>ation with caudalanalgesia on postoperative pa<strong>in</strong> control<strong>in</strong> day-case paediatric orchiopexy. Br J Anaesth2010; 105: 506–510.178 Fitzgerald M, McG<strong>in</strong>ley J. The use of transverseabdom<strong>in</strong>al plane block for orchidopexy.Paediatr Anaesth 2009; 19: 810–811.179 Machotta A, Risse A, Bercker S et al. Comparisonbetween <strong>in</strong>stillation of bupivaca<strong>in</strong>eversus caudal analgesia for postoperativeanalgesia follow<strong>in</strong>g <strong>in</strong>gu<strong>in</strong>al herniotomy <strong>in</strong>children. Paediatr Anaesth 2003; 13: 397–402.180 Sakellaris G, Petrakis I, Makatounaki K etal. Effects of ropivaca<strong>in</strong>e <strong>in</strong>filtration on cortisol<strong>and</strong> prolact<strong>in</strong> responses to postoperativepa<strong>in</strong> after <strong>in</strong>gu<strong>in</strong>al hernioraphy <strong>in</strong>children. J Pediatr Surg 2004; 39: 1400–1403.181 Kumar P, Rudra A, Pan A et al. Caudaladditives <strong>in</strong> pediatrics: a comparison amongmidazolam, ketam<strong>in</strong>e, <strong>and</strong> neostigm<strong>in</strong>e coadm<strong>in</strong>isteredwith bupivaca<strong>in</strong>e. AnesthAnalg 2005; 101: 69–73.182 Sasaoka N, Kawaguchi M, Yoshitani K etal. Evaluation of genitofemoral nerve block,<strong>in</strong> addition to ilio<strong>in</strong>gu<strong>in</strong>al <strong>and</strong> iliohypogastricnerve block, dur<strong>in</strong>g <strong>in</strong>gu<strong>in</strong>al herniarepair <strong>in</strong> children. Br J Anaesth 2005; 94:243–246.183 Naja ZM, Raf M, El-Rajab M et al. A comparisonof nerve stimulator guided paravertebralblock <strong>and</strong> ilio-<strong>in</strong>gu<strong>in</strong>al nerve blockfor analgesia after <strong>in</strong>gu<strong>in</strong>al herniorrhaphy <strong>in</strong>children. Anaesthesia 2006; 61: 1064–1068.184 Tug R, Ozcengiz D, Gunes Y. S<strong>in</strong>gle levelparavertebral versus caudal block <strong>in</strong> paediatric<strong>in</strong>gu<strong>in</strong>al surgery. Anaesth IntensiveCare 2011; 39: 909–913.185 Ko<strong>in</strong>ig H, Krenn CG, Glaser C et al. Thedose–response of caudal ropivaca<strong>in</strong>e <strong>in</strong> children.Anesthesiology 1999; 90: 1339–1344.186 Joshi W, Connelly N, Dwyer M et al. Acomparison of two concentrations of bupivaca<strong>in</strong>e<strong>and</strong> adrenal<strong>in</strong>e with <strong>and</strong> withoutfentanyl <strong>in</strong> paediatric <strong>in</strong>gu<strong>in</strong>al herniorrhaphy.Paediatr Anaesth 1999; 9: 317–320.187 Schrock C, Jones M. The dose of caudalepidural analgesia <strong>and</strong> duration of postoperativeanalgesia. Paediatr Anaesth 2003; 13:403–408.188 Klimscha W, Chiari A, Michalek-SaubererA et al. The efficacy <strong>and</strong> safety of a clonid<strong>in</strong>e/bupivaca<strong>in</strong>ecomb<strong>in</strong>ation <strong>in</strong> caudalblockade for pediatric hernia repair. AnesthAnalg 1998; 86: 54–61.189 Gait<strong>in</strong>i L, Somri M, Vaida S et al. Does theaddition of fentanyl to bupivaca<strong>in</strong>e <strong>in</strong> caudalepidural block have an effect on theplasma level of catecholam<strong>in</strong>es <strong>in</strong> children?Anesth Analg 2000; 90: 1029–1033.190 Ozcengiz D, Gunduz M, Ozbek H et al.Comparison of caudal morph<strong>in</strong>e <strong>and</strong> tramadolfor postoperative pa<strong>in</strong> control <strong>in</strong> childrenundergo<strong>in</strong>g <strong>in</strong>gu<strong>in</strong>al herniorrhaphy.Paediatr Anaesth 2001; 11: 459–464.191 Senel A, Akyol A, Dohman D et al. Caudalbupivaca<strong>in</strong>e-tramadol comb<strong>in</strong>ation for postoperativeanalgesia <strong>in</strong> pediatric herniorrhaphy.Acta Anaesthesiol Sc<strong>and</strong> 2001; 45: 786–789.192 Baris S, Karakaya D, Kelsaka E et al. Comparisonof fentanyl-bupivaca<strong>in</strong>e or midazolam-bupivaca<strong>in</strong>emixtures with pla<strong>in</strong>bupivaca<strong>in</strong>e for caudal anaesthesia <strong>in</strong> children.Paediatr Anaesth 2003; 13: 126–131.193 Memis D, Turan A, Karamanlioglu B et al.Caudal neostigm<strong>in</strong>e for postoperative analgesia<strong>in</strong> paediatric surgery. Paediatr Anaesth2003; 13: 324–328.194 Somri M, Tome R, Teszler CB et al. Doesadd<strong>in</strong>g <strong>in</strong>travenous fentanyl to caudal block<strong>in</strong> children enhance the efficacy of multimodalanalgesia as reflected <strong>in</strong> the plasmalevel of catecholam<strong>in</strong>es? Eur J Anaesthesiol2007; 24: 408–413.195 Yildiz TS, Ozdamar D, Bagus F et al. Levobupivaca<strong>in</strong>e-tramadolcomb<strong>in</strong>ation for caudalblock <strong>in</strong> children: a r<strong>and</strong>omized, doublebl<strong>in</strong>ded,prospective study. Paediatr Anaesth2010; 20: 524–529.196 Panjabi N, Prakash S, Gupta P et al. Efficacyof three doses of ketam<strong>in</strong>e with bupivaca<strong>in</strong>efor caudal analgesia <strong>in</strong> pediatric<strong>in</strong>gu<strong>in</strong>al herniotomy. Reg Anesth Pa<strong>in</strong> Med2004; 29: 28–31.197 Yildiz TS, Korkmaz F, Solak M et al. Clonid<strong>in</strong>eaddition prolongs the duration ofcaudal analgesia. Acta Anaesthesiol Sc<strong>and</strong>2006; 50: 501–504.198 Marhofer P, Krenn C, Plochl W et al.S(+)-ketam<strong>in</strong>e for caudal block <strong>in</strong> paediatricanaesthesia. Br J Anaesth 2000; 84: 341–345.199 Hager H, Marhofer P, Sitzwohl C et al.Caudal clonid<strong>in</strong>e prolongs analgesia fromcaudal S(+)-ketam<strong>in</strong>e <strong>in</strong> children. AnesthAnalg 2002; 94: 1169–1172,table of contents.200 Ko<strong>in</strong>ig H, Marhofer P, Krenn CG et al.Analgesic effects of caudal <strong>and</strong> <strong>in</strong>tramuscularS(+)-ketam<strong>in</strong>e <strong>in</strong> children. Anesthesiology2000; 93: 976–980.201 Kundra P, Deepalakshmi K, RavishankarM. Preemptive caudal bupivaca<strong>in</strong>e <strong>and</strong> morph<strong>in</strong>efor postoperative analgesia <strong>in</strong> children.Anesth Analg 1998; 87: 52–56.202 Naja ZM, Raf M, El Rajab M et al. Nervestimulator-guided paravertebral blockadecomb<strong>in</strong>ed with sevoflurane sedation versusgeneral anesthesia with systemic analgesiafor postherniorrhaphy pa<strong>in</strong> relief <strong>in</strong> children:a prospective r<strong>and</strong>omized trial. Anesthesiology2005; 103: 600–605.203 Lim SL, Ng Sb A, Tan GM. Ilio<strong>in</strong>gu<strong>in</strong>al<strong>and</strong> iliohypogastric nerve block revisited:s<strong>in</strong>gle shot versus double shot technique forhernia repair <strong>in</strong> children. Paediatr Anaesth2002; 12: 255–260.204 Tsuchiya N, Ichizawa M, Yoshikawa Y etal. Comparison of ropivaca<strong>in</strong>e with bupivaca<strong>in</strong>e<strong>and</strong> lidoca<strong>in</strong>e for ilio<strong>in</strong>gu<strong>in</strong>al blockafter ambulatory <strong>in</strong>gu<strong>in</strong>al hernia repair <strong>in</strong>children. Paediatr Anaesth 2004; 14: 468–470.205 Disma N, Tuo P, Pellegr<strong>in</strong>o S et al. Threeconcentrations of levobupivaca<strong>in</strong>e for ilio<strong>in</strong>gu<strong>in</strong>al/iliohypogastricnerve block <strong>in</strong> ambulatorypediatric surgery. J Cl<strong>in</strong> Anesth 2009;21: 389–393.206 We<strong>in</strong>traud M, Lundblad M, Kettner SC etal. Ultrasound versus l<strong>and</strong>mark-based techniquefor ilio<strong>in</strong>gu<strong>in</strong>al-iliohypogastric nerveblockade <strong>in</strong> children: the implications on60 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


plasma levels of ropivaca<strong>in</strong>e. Anesth Analg2009; 108: 1488–1492.207 Willschke H, Bosenberg A, Marhofer P etal. Ultrasonographic-guided ilio<strong>in</strong>gu<strong>in</strong>al/iliohypogastricnerve block <strong>in</strong> pediatric anesthesia:what is the optimal volume? AnesthAnalg 2006; 102: 1680–1684.208 We<strong>in</strong>traud M, Marhofer P, Bosenberg A etal. Ilio<strong>in</strong>gu<strong>in</strong>al/iliohypogastric blocks <strong>in</strong> children:where do we adm<strong>in</strong>ister the local anestheticwithout direct visualization? AnesthAnalg 2008; 106: 89–93,table of contents.209 Dahl V, Raeder JC, Erno PE et al. Pre-emptiveeffect of pre-<strong>in</strong>cisional versus post-<strong>in</strong>cisional<strong>in</strong>filtration of local anaesthesia onchildren undergo<strong>in</strong>g hernioplasty. Acta AnaesthesiolSc<strong>and</strong> 1996; 40: 847–851.210 Cnar SO, Kum U, Cevizci N et al. Effectsof levobupivaca<strong>in</strong>e <strong>in</strong>filtration on postoperativeanalgesia <strong>and</strong> stress response <strong>in</strong> childrenfollow<strong>in</strong>g <strong>in</strong>gu<strong>in</strong>al hernia repair. Eur J Anaesthesiol2009; 26: 430–434.211 Demiraran Y, Ilce Z, Kocaman B et al.Does tramadol wound <strong>in</strong>filtration offer anadvantage over bupivaca<strong>in</strong>e for postoperativeanalgesia <strong>in</strong> children follow<strong>in</strong>g herniotomy?Paediatr Anaesth 2006; 16: 1047–1050.212 Hong JY, Won Han S, Kim WO et al. Fentanylspar<strong>in</strong>g effects of comb<strong>in</strong>ed ketorolac<strong>and</strong> acetam<strong>in</strong>ophen for outpatient <strong>in</strong>gu<strong>in</strong>alhernia repair <strong>in</strong> children. J Urol 2010; 183:1551–1555.213 Riad W, Moussa A. Pre-operative analgesiawith rectal diclofenac <strong>and</strong>/or paracetamol <strong>in</strong>children undergo<strong>in</strong>g <strong>in</strong>gu<strong>in</strong>al hernia repair.Anaesthesia 2007; 62: 1241–1245.214 Gurnaney HG, Maxwell LG, Kraemer FWet al. Prospective r<strong>and</strong>omized observerbl<strong>in</strong>dedstudy compar<strong>in</strong>g the analgesic efficacyof ultrasound-guided rectus sheathblock <strong>and</strong> local anaesthetic <strong>in</strong>filtration forumbilical hernia repair. Br J Anaesth 2011;107: 790–795.215 Clarke FK, Cassey JG. Paraumbilical blockfor umbilical herniorraphy. ANZ J Surg2007; 77: 659–661.216 de Jose Maria B, Gotzens V, Mabrok M.Ultrasound-guided umbilical nerve block <strong>in</strong>children: a brief description of a newapproach. Paediatr Anaesth 2007; 17: 44–50.217 Isaac LA, McEwen J, Hayes JA et al. Apilot study of the rectus sheath block forpa<strong>in</strong> control after umbilical hernia repair.Paediatr Anaesth 2006; 16: 406–409.218 Willschke H, Bosenberg A, Marhofer P etal. Ultrasonography-guided rectus sheathblock <strong>in</strong> paediatric anaesthesia – a newapproach to an old technique. Br J Anaesth2006; 97: 244–249.219 Bray R, Woodhams AM, Vallis CJ et al.. Adouble-bl<strong>in</strong>d comparison of morph<strong>in</strong>e <strong>in</strong>fusion<strong>and</strong> patient controlled analgesia <strong>in</strong> children.Paediatr Anaesth 1996; 6: 121–127.220 Peters J, B<strong>and</strong>ell Hoekstra I, Huijer Abu-Saad H et al. Patient controlled analgesia <strong>in</strong>children <strong>and</strong> adolescents: a r<strong>and</strong>omized controlledtrial. Paediatr Anaesth 1999; 9: 235–241.221 Monitto C, Greenberg R, Kost-Byerly S etal. The safety <strong>and</strong> efficacy of parent-/nursecontrolledanalgesia <strong>in</strong> patients less than sixyears of age. Anesth Analg 2000; 91: 573–579.222 van Dijk M, Bouwmeester N, DuivenvoordenH et al. Efficacy of cont<strong>in</strong>uous versus<strong>in</strong>termittent morph<strong>in</strong>e adm<strong>in</strong>istration aftermajor surgery <strong>in</strong> 0–3-year-old <strong>in</strong>fants; adouble-bl<strong>in</strong>d r<strong>and</strong>omized controlled trial.Pa<strong>in</strong> 2002; 98: 305–313.223 Howard RF, Lloyd-Thomas A, Thomas Met al. Nurse-controlled analgesia (NCA) follow<strong>in</strong>gmajor surgery <strong>in</strong> 10,000 patients <strong>in</strong> achildren’s hospital. Paediatr Anaesth 2010;20: 126–134.224 Kart T, Walther-Larsen S, Svejborg T et al.Comparison of cont<strong>in</strong>uous epidural <strong>in</strong>fusionof fentanyl <strong>and</strong> bupivaca<strong>in</strong>e with <strong>in</strong>termittentepidural adm<strong>in</strong>istration of morph<strong>in</strong>efor postoperative pa<strong>in</strong> management <strong>in</strong> children.Acta Anaesthesiol Sc<strong>and</strong> 1997; 41:461–465.225 Bosenberg A. Epidural analgesia for majorneonatal surgery. Paediatr Anaesth 1998; 8:479–483.226 Moriarty A. <strong>Postoperative</strong> extradural <strong>in</strong>fusions<strong>in</strong> children: prelim<strong>in</strong>ary data from acomparison of bupivaca<strong>in</strong>e/diamorph<strong>in</strong>ewith pla<strong>in</strong> ropivaca<strong>in</strong>e. Paediatr Anaesth1999; 9: 423–427.227 Bosenberg AT, Cronje L, Thomas J et al.Ropivaca<strong>in</strong>e plasma levels <strong>and</strong> postoperativeanalgesia <strong>in</strong> neonates <strong>and</strong> <strong>in</strong>fants dur<strong>in</strong>g 48–72 h cont<strong>in</strong>uous epidural <strong>in</strong>fusion follow<strong>in</strong>gmajor surgery. Paediatr Anaesth 2003; 13:851–852.228 Cucchiaro G, Dagher C, Baujard C et al.Side-effects of postoperative epidural analgesia<strong>in</strong> children: a r<strong>and</strong>omized study compar<strong>in</strong>gmorph<strong>in</strong>e <strong>and</strong> clonid<strong>in</strong>e. PaediatrAnaesth 2003; 13: 318–323.229 Szabova A, Sadhasivam S, Wang Y et al.Comparison of postoperative analgesia withepidural butorphanol/bupivaca<strong>in</strong>e versusfentanyl/bupivaca<strong>in</strong>e follow<strong>in</strong>g pediatricurological procedures. J Opioid Manag2010; 6: 401–407.230 Ivani G, Lampugnani E, De Negri P et al.Ropivaca<strong>in</strong>e vs bupivaca<strong>in</strong>e <strong>in</strong> major surgery<strong>in</strong> <strong>in</strong>fants. Can J Anaesth 1999; 46:467–469.231 Bosenberg AT, Thomas J, Cronje L et al.Pharmacok<strong>in</strong>etics <strong>and</strong> efficacy of ropivaca<strong>in</strong>efor cont<strong>in</strong>uous epidural <strong>in</strong>fusion <strong>in</strong>neonates <strong>and</strong> <strong>in</strong>fants. Paediatr Anaesth2005; 15: 739–749.232 Inanoglu K, Ozcengiz D, Gunes Y et al.Epidural ropivaca<strong>in</strong>e versus ropivaca<strong>in</strong>e plustramadol <strong>in</strong> postoperative analgesia <strong>in</strong> childrenundergo<strong>in</strong>g major abdom<strong>in</strong>al surgery:a comparison. J Anesth 2010; 24: 700–704.233 Klamt J, Garcia L, Stocche R et al. Epidural<strong>in</strong>fusion of clonid<strong>in</strong>e or clonid<strong>in</strong>e plusropivaca<strong>in</strong>e for postoperative analgesia <strong>in</strong>children undergo<strong>in</strong>g major abdom<strong>in</strong>al surgery.J Cl<strong>in</strong> Anesth 2003; 15: 510–514.234 Vetter TR, Carvallo D, Johnson JL et al. Acomparison of s<strong>in</strong>gle-dose caudal clonid<strong>in</strong>e,morph<strong>in</strong>e, or hydromorphone comb<strong>in</strong>edwith ropivaca<strong>in</strong>e <strong>in</strong> pediatric patients undergo<strong>in</strong>gureteral reimplantation. Anesth Analg2007; 104: 1356–1363.235 El-Hennawy AM, Abd-Elwahab AM, Abd-Elmaksoud AM et al. Addition of clonid<strong>in</strong>eor dexmedetomid<strong>in</strong>e to bupivaca<strong>in</strong>e prolongscaudal analgesia <strong>in</strong> children. Br JAnaesth 2009; 103: 268–274.236 Bozkurt P, Kaya G, Yeker Y. S<strong>in</strong>gle-<strong>in</strong>jectionlumbar epidural morph<strong>in</strong>e for postoperativeanalgesia <strong>in</strong> children: a report of 175cases. Reg Anesth 1997; 22: 212–217.237 Kiffer F, Joly A, Wodey E et al. The effectof preoperative epidural morph<strong>in</strong>e on postoperativeanalgesia <strong>in</strong> children. AnesthAnalg 2001; 93: 598–600.238 Chabas E, Gomar C, Villalonga A et al.<strong>Postoperative</strong> respiratory function <strong>in</strong> childrenafter abdom<strong>in</strong>al surgery. A comparisonof epidural <strong>and</strong> <strong>in</strong>tramuscular morph<strong>in</strong>eanalgesia. Anaesthesia 1998; 53: 393–397.239 Berta E, Spanhel J, Smakal O et al. S<strong>in</strong>gle<strong>in</strong>jection paravertebral block for renal surgery<strong>in</strong> children. Paediatr Anaesth 2008; 18:593–597.240 Spl<strong>in</strong>ter WM, Thomson ME. Somatic paravertebralblock decreases opioid requirements<strong>in</strong> children undergo<strong>in</strong>gappendectomy. Can J Anaesth 2010; 57:206–210.241 Fredrickson MJ, Seal P. Ultrasound-guidedtransversus abdom<strong>in</strong>is plane block for neonatalabdom<strong>in</strong>al surgery. Anaesth IntensiveCare 2009; 37: 469–472.242 Niraj G, Searle A, Mathews M et al. Analgesicefficacy of ultrasound-guided transversusabdom<strong>in</strong>is plane block <strong>in</strong> patientsundergo<strong>in</strong>g open appendicectomy. Br J Anaesth2009; 103: 601–605.243 Carney J, F<strong>in</strong>nerty O, Rauf J et al. Ipsilateraltransversus abdom<strong>in</strong>is plane block provideseffective analgesia after appendectomy<strong>in</strong> children: a r<strong>and</strong>omized controlled trial.Anesth Analg 2010; 111: 998–1003.244 Charlton S, Cyna AM, Middleton P et al.Perioperative transversus abdom<strong>in</strong>is plane(TAP) blocks for analgesia after abdom<strong>in</strong>alsurgery. Cochrane Database Syst Rev 2010;Dec 8;(12): CD007705.ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 61


245 Morton NS, O’Brien K. Analgesic efficacyof paracetamol <strong>and</strong> diclofenac <strong>in</strong> childrenreceiv<strong>in</strong>g PCA morph<strong>in</strong>e[see comment].Br JAnaesth 1999; 82: 715–717.246 Till H, Lochbuhler H, Lochbuhler H et al.Patient controlled analgesia (PCA) <strong>in</strong> paediatricsurgery: a prospective study follow<strong>in</strong>glaparoscopic <strong>and</strong> open appendicectomy.Paediatr Anaesth 1996; 6: 29–32.247 Munro F, Fisher S, Dickson U et al. Theaddition of antiemetics to the morph<strong>in</strong>esolution <strong>in</strong> patient controlled analgesiasyr<strong>in</strong>ges used by children after an appendicectomydoes not reduce the <strong>in</strong>cidence ofpostoperative nausea <strong>and</strong> vomit<strong>in</strong>g. PaediatrAnaesth 2002; 12: 600–603.248 Dix P, Mart<strong>in</strong>dale S, Stoddart P. Doublebl<strong>in</strong>dr<strong>and</strong>omized placebo-controlled trial ofthe effect of ketam<strong>in</strong>e on postoperative morph<strong>in</strong>econsumption <strong>in</strong> children follow<strong>in</strong>gappendicectomy. Paediatr Anaesth 2003; 13:422–426.249 Yildiz K, Tercan E, Dogru K et al. Comparisonof patient-controlled analgesia with<strong>and</strong> without a background <strong>in</strong>fusion afterappendicectomy <strong>in</strong> children. Paediatr Anaesth2003; 13: 427–431.250 Jensen SI, Andersen M, Nielsen J et al. Incisionallocal anaesthesia versus placebo forpa<strong>in</strong> relief after appendectomy <strong>in</strong> children –a double-bl<strong>in</strong>ded controlled r<strong>and</strong>omisedtrial. Eur J Pediatr Surg 2004; 14: 410–413.251 Habre W, Wilson D, Johnson CM. Extrapyramidalside-effects from droperidol mixedwith morph<strong>in</strong>e for patient-controlled analgesia<strong>in</strong> two children. Paediatr Anaesth 1999;9: 362–364.252 Wright J. Controlled trial of wound <strong>in</strong>filtrationwith bupivaca<strong>in</strong>e for postoperative pa<strong>in</strong>relief after appendicectomy <strong>in</strong> children. Br JSurg 1993; 80: 110–111.253 Ko CY, Thompson JEJr, Alcantara A et al.Preemptive analgesia <strong>in</strong> patients undergo<strong>in</strong>gappendectomy. Arch Surg 1997; 132: 874–877;discussion 877–878.254 Edwards TJ, Carty SJ, Carr AS et al. Localanaesthetic wound <strong>in</strong>filtration follow<strong>in</strong>g paediatricappendicectomy: a r<strong>and</strong>omised controlledtrial: time to stop us<strong>in</strong>g localanaesthetic wound <strong>in</strong>filtration follow<strong>in</strong>g paediatricappendicectomy? Int J Surg 2011; 9:314–317.255 Lohsiriwat V, Lert-akyamanee N, RushatamukayanuntW. Efficacy of pre-<strong>in</strong>cisionalbupivaca<strong>in</strong>e <strong>in</strong>filtration on postoperativepa<strong>in</strong> relief after appendectomy: prospectivedouble-bl<strong>in</strong>d r<strong>and</strong>omized trial. World J Surg2004; 28: 947–950.256 McNeely J, Farber N, Rusy L et al. Epiduralanalgesia improves outcome follow<strong>in</strong>gpediatric fundoplication. A retrospectiveanalysis. Reg Anesth 1997; 22: 16–23.257 Lejus C, Surbled M, Schwoerer D et al.<strong>Postoperative</strong> epidural analgesia with bupivaca<strong>in</strong>e<strong>and</strong> fentanyl: hourly pa<strong>in</strong> assessment<strong>in</strong> 348 paediatric cases. PaediatrAnaesth 2001; 11: 327–332.258 Wilson GA, Brown JL, Crabbe DG et al. Isepidural analgesia associated with animproved outcome follow<strong>in</strong>g open Nissenfundoplication? Paediatr Anaesth 2001; 11:65–70.259 Brenn B, Brisl<strong>in</strong> R, Rose J. Epidural analgesia<strong>in</strong> children with cerebral palsy. Can JAnaesth 1998; 45: 1156–1161.260 Tsui B, Seal R, Koller J et al. Thoracic epiduralanalgesia via the caudal approach <strong>in</strong>pediatric patients undergo<strong>in</strong>g fundoplicationus<strong>in</strong>g nerve stimulation guidance. AnesthAnalg 2001; 93: 1152–1155.261 Dick AC, Coulter P, Ha<strong>in</strong>sworth AM et al.A comparative study of the analgesiarequirements follow<strong>in</strong>g laparoscopic <strong>and</strong>open fundoplication <strong>in</strong> children. J LaparoendoscAdv Surg Tech A 1998; 8: 425–429.262 McHoney M, Wade AM, Eaton S et al.Cl<strong>in</strong>ical outcome of a r<strong>and</strong>omized controlledbl<strong>in</strong>ded trial of open versus laparoscopicNissen fundoplication <strong>in</strong> <strong>in</strong>fants <strong>and</strong> children.Ann Surg 2011; 254: 209–216.263 Cho JE, Kim JY, Kim JE et al. Epiduralsufentanil provides better analgesia from24 h after surgery compared with epiduralfentanyl <strong>in</strong> children. Acta AnaesthesiolSc<strong>and</strong> 2008; 52: 1360–1363.264 Ben-Meir D, Livne PM, Katz J et al. Cont<strong>in</strong>uousepidural versus nonepidural analgesiafor post-pyeloplasty pa<strong>in</strong> <strong>in</strong> children. JUrol 2009; 182: 1841–1844.265 Chamie K, Tanaka ST, Hu B et al. Shortstay pyeloplasty: variables affect<strong>in</strong>g pa<strong>in</strong><strong>and</strong> length of stay. J Urol 2008; 179: 1549–1552.266 Chamie K, Chi A, Hu B et al. Contemporaryopen ureteral reimplantation withoutmorph<strong>in</strong>e: assessment of pa<strong>in</strong> <strong>and</strong> outcomes.J Urol 2009; 182: 1147–1151.267 Rowney DA, Aldridge LM. Laparoscopicfundoplication <strong>in</strong> children: anaesthetic experienceof 51 cases. Paediatr Anaesth 2000;10: 291–296.268 Sekaran P, MacK<strong>in</strong>lay GA, Lam J. Comparativeevaluation of laparoscopic versusopen nephrectomy <strong>in</strong> children. Scott Med J2006; 51: 15–17.269 Caione P, Lais A, Nappo SG. One-port retroperitoneoscopicassisted pyeloplasty versusopen dismembered pyeloplasty <strong>in</strong> youngchildren: prelim<strong>in</strong>ary experience. J Urol2010; 184: 2109–2115.270 Chert<strong>in</strong> B, Ben-Chaim J, L<strong>and</strong>au EH et al.Pediatric transperitoneal laparoscopic partialnephrectomy: comparison with an agematchedgroup undergo<strong>in</strong>g open surgery.Pediatr Surg Int 2007; 23: 1233–1236.271 Piaggio LA, Noh PH, Gonzalez R. Reoperativelaparoscopic pyeloplasty <strong>in</strong> children:comparison with open surgery. J Urol 2007;177: 1878–1882.272 Ham WS, Im YJ, Jung HJ et al. Initialexperience with laparoendoscopic s<strong>in</strong>gle-sitenephrectomy <strong>and</strong> nephroureterectomy <strong>in</strong>children. Urology 2011; 77: 1204–1208.273 Dick AC, Potts SR. Laparoscopic fundoplication<strong>in</strong> children – an audit of fifty cases.Eur J Pediatr Surg 1999; 9: 286–288.274 Koivusalo AI, Korpela R, Wirtavuori K etal. A s<strong>in</strong>gle-bl<strong>in</strong>ded, r<strong>and</strong>omized comparisonof laparoscopic versus open hernia repair <strong>in</strong>children. Pediatrics 2009; 123: 332–337.275 Woldrich JM, Holmes N, Palazzi-Churas Ket al. Comparison of laparoendoscopic s<strong>in</strong>gle-site,conventional laparoscopic, <strong>and</strong>open nephrectomy <strong>in</strong> a pediatric population.Urology 2011; 78: 74–77.276 Smith RP, Oliver JL, Peters CA. Pediatricrobotic extravesical ureteral reimplantation:comparison with open surgery. J Urol 2011;185: 1876–1881.277 Canon SJ, Jayanthi VR, Lowe GJ. Which isbetter – retroperitoneoscopic or laparoscopicdismembered pyeloplasty <strong>in</strong> children?J Urol 2007; 178: 1791–1795;discussion1795.278 Baez JJ, Luna CM, Mesples GF et al. Laparoscopictransperitoneal <strong>and</strong> retroperitonealnephrectomies <strong>in</strong> children: a change of practice.J Laparoendosc Adv Surg Tech A 2010;20: 81–85.279 D<strong>in</strong>gemann J, Kuebler JF, Wolters M et al.Perioperative analgesia strategies <strong>in</strong> fasttrackpediatric surgery of the kidney <strong>and</strong>renal pelvis: lessons learned. World J Urol2010; 28: 215–219.280 Borkar J, Dave N. Analgesic efficacy ofcaudal block versus diclofenac suppository<strong>and</strong> local anesthetic <strong>in</strong>filtration follow<strong>in</strong>gpediatric laparoscopy. J Laparoendosc AdvSurg Tech A 2005; 15: 415–418.281 S<strong>and</strong>eman DJ, Bennett M, Dilley AV et al.Ultrasound-guided transversus abdom<strong>in</strong>isplane blocks for laparoscopic appendicectomy<strong>in</strong> children: a prospective r<strong>and</strong>omizedtrial. Br J Anaesth 2011; 106: 882–886.282 Freilich DA, Houck CS, Meier PM et al.The effectiveness of aerosolized <strong>in</strong>traperitonealbupivaca<strong>in</strong>e <strong>in</strong> reduc<strong>in</strong>g postoperativepa<strong>in</strong> <strong>in</strong> children undergo<strong>in</strong>g robotic-assistedlaparoscopic pyeloplasty. J Pediatr Urol2008; 4: 337–340.283 Lako SJ, Steegers MA, van Egmond J et al.Incisional cont<strong>in</strong>uous fascia iliaca blockprovides more effective pa<strong>in</strong> relief <strong>and</strong> fewerside effects than opioids after pelvic osteotomy<strong>in</strong> children. Anesth Analg 2009; 109:1799–1803.284 Luhmann SJ, Schootman M, SchoeneckerPL et al. Use of femoral nerve blocks <strong>in</strong>62 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


adolescents undergo<strong>in</strong>g patellar realignmentsurgery. Am J Orthop (Belle Mead NJ)2008; 37: 39–43.285 <strong>Good</strong>arzi M. Comparison of epidural morph<strong>in</strong>e,hydromorphone <strong>and</strong> fentanyl forpostoperative pa<strong>in</strong> control <strong>in</strong> childrenundergo<strong>in</strong>g orthopaedic surgery. PaediatrAnaesth 1999; 9: 419–422.286 Lovstad R, Stoen R. <strong>Postoperative</strong> epiduralanalgesia <strong>in</strong> children after major orthopaedicsurgery. A r<strong>and</strong>omised study of theeffect on PONV of two anaesthetic techniques:low <strong>and</strong> high dose i.v. fentanyl <strong>and</strong>epidural <strong>in</strong>fusions with <strong>and</strong> without fentanyl.Acta Anaesthesiol Sc<strong>and</strong> 2001; 45: 482–488.287 Dadure C, Raux O, Gaudard P et al. Cont<strong>in</strong>uouspsoas compartment blocks aftermajor orthopedic surgery <strong>in</strong> children: a prospectivecomputed tomographic scan <strong>and</strong>cl<strong>in</strong>ical studies. Anesth Analg 2004; 98: 623–628,table of contents.288 Duflo F, Qamouss Y, Remond C et al.Patient-controlled regional analgesia is effective<strong>in</strong> children: a prelim<strong>in</strong>ary report. Can JAnaesth 2004; 51: 928–930.289 Vas L. Cont<strong>in</strong>uous sciatic block for leg <strong>and</strong>foot surgery <strong>in</strong> 160 children. Paediatr Anaesth2005; 15: 971–978.290 Dadure C, Br<strong>in</strong>guier S, Nicolas F et al.Cont<strong>in</strong>uous epidural block versus cont<strong>in</strong>uouspopliteal nerve block for postoperativepa<strong>in</strong> relief after major podiatric surgery <strong>in</strong>children: a prospective, comparative r<strong>and</strong>omizedstudy. Anesth Analg 2006; 102:744–749.291 Ganesh A, Rose JB, Wells L et al. Cont<strong>in</strong>uousperipheral nerve blockade for <strong>in</strong>patient<strong>and</strong> outpatient postoperative analgesia <strong>in</strong>children. Anesth Analg 2007; 105: 1234–1242,table of contents.292 Ludot H, Berger J, Pichenot V et al. Cont<strong>in</strong>uousperipheral nerve block for postoperativepa<strong>in</strong> control at home: a prospectivefeasibility study <strong>in</strong> children. Reg AnesthPa<strong>in</strong> Med 2008; 33: 52–56.293 Dadure C, Br<strong>in</strong>guier S, Raux O et al. Cont<strong>in</strong>uousperipheral nerve blocks for postoperativeanalgesia <strong>in</strong> children: feasibility <strong>and</strong>side effects <strong>in</strong> a cohort study of 339 catheters.Can J Anaesth 2009; 56: 843–850.294 Khoury CE, Dagher C, Ghanem I et al.Comb<strong>in</strong>ed regional <strong>and</strong> general anesthesiafor ambulatory peripheral orthopedic surgery<strong>in</strong> children. J Pediatr Orthop B 2009;18: 37–45.295 Ponde VC, Desai AP, Shah DM et al. Feasibility<strong>and</strong> efficacy of placement of cont<strong>in</strong>uoussciatic per<strong>in</strong>eural catheters solely underultrasound guidance <strong>in</strong> children: adescriptive study. Paediatr Anaesth 2011; 21:406–410.296 Lovstad RZ, Halvorsen P, Raeder JC et al.Post-operative epidural analgesia with lowdose fentanyl, adrenal<strong>in</strong>e <strong>and</strong> bupivaca<strong>in</strong>e <strong>in</strong>children after major orthopaedic surgery. Aprospective evaluation of efficacy <strong>and</strong> sideeffects. Eur J Anaesthesiol 1997; 14: 583–589.297 Bai SJ, Koo BN, Kim JH et al. Comparisonof cont<strong>in</strong>uous epidural <strong>and</strong> <strong>in</strong>travenousanalgesia for postoperative pa<strong>in</strong> control <strong>in</strong>pediatric lower extremity surgery. YonseiMed J 2004; 45: 789–795.298 Eberson CP, Pacicca DM, Ehrlich MG. Therole of ketorolac <strong>in</strong> decreas<strong>in</strong>g length of stay<strong>and</strong> narcotic complications <strong>in</strong> the postoperativepediatric orthopaedic patient. J PediatrOrthop 1999; 19: 688–692.299 Hiller A, Meretoja OA, Korpela R et al.The analgesic efficacy of acetam<strong>in</strong>ophen, ketoprofen,or their comb<strong>in</strong>ation for pediatricsurgical patients hav<strong>in</strong>g soft tissue or orthopedicprocedures. Anesth Analg 2006; 102:1365–1371.300 Castillo-Zamora C, Castillo-Peralta LA,Nava-Ocampo AA. Dose m<strong>in</strong>imizationstudy of s<strong>in</strong>gle-dose epidural morph<strong>in</strong>e <strong>in</strong>patients undergo<strong>in</strong>g hip surgery under regionalanesthesia with bupivaca<strong>in</strong>e. PaediatrAnaesth 2005; 15: 29–36.301 Rodrigues MR, Paes FC, Duarte LT et al.<strong>Postoperative</strong> analgesia for the surgical correctionof congenital clubfoot: comparisonbetween peripheral nerve block <strong>and</strong> caudalepidural block. Rev Bras Anestesiol 2009;59: 684–693.302 Omar AM, Mansour MA, Kamal AS. Psoascompartment block for acute postoperativepa<strong>in</strong> management after hip surgery <strong>in</strong> pediatrics:a comparative study with caudalanalgesia. Reg Anesth Pa<strong>in</strong> Med 2011; 36:121–124.303 Duflo F, Sautou-Mir<strong>and</strong>a V, Pouyau A etal. Efficacy <strong>and</strong> plasma levels of ropivaca<strong>in</strong>efor children: controlled regional analgesiafollow<strong>in</strong>g lower limb surgery. Br J Anaesth2006; 97: 250–254.304 Farid IS, He<strong>in</strong>er EJ, Fleissner PR. Comparisonof femoral nerve block <strong>and</strong> fascia iliacablock for analgesia follow<strong>in</strong>g reconstructiveknee surgery <strong>in</strong> adolescents. J Cl<strong>in</strong> Anesth2010; 22: 256–259.305 van Geffen GJ, Pirotte T, Gielen MJ et al.Ultrasound-guided proximal <strong>and</strong> distal sciaticnerve blocks <strong>in</strong> children. J Cl<strong>in</strong> Anesth2010; 22: 241–245.306 Antok E, Bordet F, Duflo F et al. Patientcontrolledepidural analgesia versus cont<strong>in</strong>uousepidural <strong>in</strong>fusion with ropivaca<strong>in</strong>e forpostoperative analgesia <strong>in</strong> children. AnesthAnalg 2003; 97: 1608–1611.307 Kay RM, Leathers M, Directo MP et al.Perioperative ketorolac use <strong>in</strong> childrenundergo<strong>in</strong>g lower extremity osteotomies. JPediatr Orthop 2011; 31: 783–786.308 Fisher W, B<strong>in</strong>gham R, Hall R. Axillary brachialplexus block for perioperative analgesia<strong>in</strong> 250 children. Paediatr Anaesth 1999;9: 435–438.309 Alt<strong>in</strong>tas F, Bozkurt P, Ipek N et al. Theefficacy of pre- versus postsurgical axillaryblock on postoperative pa<strong>in</strong> <strong>in</strong> paediatricpatients. Paediatr Anaesth 2000; 10: 23–28.310 P<strong>and</strong>e R, P<strong>and</strong>e M, Bhadani U et al. Supraclavicularbrachial plexus block as a soleanaesthetic technique <strong>in</strong> children: an analysisof 200 cases. Anaesthesia 2000; 55: 798–802.311 Fleischmann E, Marhofer P, Greher M etal. Brachial plexus anaesthesia <strong>in</strong> children:lateral <strong>in</strong>fraclavicular vs axillary approach.Paediatr Anaesth 2003; 13: 103–108.312 Thornton KL, Sacks MD, Hall R et al.Comparison of 0.2% ropivaca<strong>in</strong>e <strong>and</strong>0.25% bupivaca<strong>in</strong>e for axillary brachialplexus blocks <strong>in</strong> paediatric h<strong>and</strong> surgery.Paediatr Anaesth 2003; 13: 409–412.313 de Jose Maria B, Tielens LK. Vertical <strong>in</strong>fraclavicularbrachial plexus block <strong>in</strong> children:a prelim<strong>in</strong>ary study. Paediatr Anaesth2004; 14: 931–935.314 Ponde V, Athani B, Thruppal S. Infraclavicularcoracoid approach brachial plexusblock for radial club h<strong>and</strong> repair. PaediatrAnaesth 2007; 17: 863–866.315 Ponde VC. Cont<strong>in</strong>uous <strong>in</strong>fraclavicular brachialplexus block: a modified technique tobetter secure catheter position <strong>in</strong> <strong>in</strong>fants <strong>and</strong>children. Anesth Analg 2008; 106: 94–96.316 Carre P, Joly A, Cluzel Field B et al. Axillaryblock <strong>in</strong> children: s<strong>in</strong>gle or multiple<strong>in</strong>jection? Paediatr Anaesth 2000; 10: 35–39.317 De W<strong>in</strong>dt AC, Asehnoune K, Roquilly A etal. An opioid-free anaesthetic us<strong>in</strong>g nerveblocks enhances rapid recovery after m<strong>in</strong>orh<strong>and</strong> surgery <strong>in</strong> children. Eur J Anaesthesiol2010; 27: 521–525.318 Milbr<strong>and</strong>t TA, S<strong>in</strong>ghal M, M<strong>in</strong>ter C et al.A comparison of three methods of pa<strong>in</strong> controlfor posterior sp<strong>in</strong>al fusions <strong>in</strong> adolescentidiopathic scoliosis. Sp<strong>in</strong>e (Phila Pa1976) 2009; 34: 1499–1503.319 Blumenthal S, Borgeat A, Nadig M et al.<strong>Postoperative</strong> analgesia after anterior correctionof thoracic scoliosis: a prospectiver<strong>and</strong>omized study compar<strong>in</strong>g cont<strong>in</strong>uousdouble epidural catheter technique with<strong>in</strong>travenous morph<strong>in</strong>e. Sp<strong>in</strong>e 2006; 31:1646–1651.320 Gauger VT, Voepel-Lewis TD, Burke CN etal. Epidural analgesia compared with <strong>in</strong>travenousanalgesia after pediatric posteriorsp<strong>in</strong>al fusion. J Pediatr Orthop 2009; 29:588–593.ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 63


321 Taenzer AH, Clark C, Taenzer AH et al.Efficacy of postoperative epidural analgesia<strong>in</strong> adolescent scoliosis surgery: a meta-analysis.Paediatr Anaesth 2010; 20: 135–143.322 Lavelle ED, Lavelle WF, <strong>Good</strong>w<strong>in</strong> R et al.Epidural analgesia for postoperative pa<strong>in</strong>control after adolescent sp<strong>in</strong>al fusion procedureswhich violated the epidural space. JSp<strong>in</strong>al Disord Tech 2010; 23: 347–350.323 <strong>Good</strong>arzi M. The advantages of <strong>in</strong>trathecalopioids for sp<strong>in</strong>al fusion <strong>in</strong> children. PaediatrAnaesth 1998; 8: 131–134.324 Gall O, Aub<strong>in</strong>eau J, Berniere J et al. Analgesiceffect of low-dose <strong>in</strong>trathecal morph<strong>in</strong>eafter sp<strong>in</strong>al fusion <strong>in</strong> children. Anesthesiology2001; 94: 447–452.325 Eschertzhuber S, Hohlrieder M, Keller C etal. Comparison of high- <strong>and</strong> low-dose <strong>in</strong>trathecalmorph<strong>in</strong>e for sp<strong>in</strong>al fusion <strong>in</strong> children.Br J Anaesth 2008; 100: 538–543.326 Tripi PA, Poe-Kochert C, Potzman J et al.Intrathecal morph<strong>in</strong>e for postoperative analgesia<strong>in</strong> patients with idiopathic scoliosisundergo<strong>in</strong>g posterior sp<strong>in</strong>al fusion. Sp<strong>in</strong>e(Phila Pa 1976) 2008; 33: 2248–2251.327 Tobias JD, Ga<strong>in</strong>es RW, Lowry KJ et al. Adual epidural catheter technique to provideanalgesia follow<strong>in</strong>g posterior sp<strong>in</strong>al fusionfor scoliosis <strong>in</strong> children <strong>and</strong> adolescents.Paediatr Anaesth 2001; 11: 199–203.328 Ekatodramis G, M<strong>in</strong> K, Cathre<strong>in</strong> P et al.Use of a double epidural catheter provideseffective postoperative analgesia after sp<strong>in</strong>edeformity surgery. Can J Anaesth 2002; 49:173–177.329 Blumenthal S, M<strong>in</strong> K, Nadig M et al. Doubleepidural catheter with ropivaca<strong>in</strong>e versus<strong>in</strong>travenous morph<strong>in</strong>e: a comparison forpostoperative analgesia after scoliosis correctionsurgery. Anesthesiology 2005; 102:175–180.330 Cassady JJ, Lederhaas G, Cancel D et al. Ar<strong>and</strong>omized comparison of the effects ofcont<strong>in</strong>uous thoracic epidural analgesia <strong>and</strong><strong>in</strong>travenous patient-controlled analgesiaafter posterior sp<strong>in</strong>al fusion <strong>in</strong> adolescents.Reg Anesth Pa<strong>in</strong> Med 2000; 25: 246–253.331 O’Hara JFJr, Cyw<strong>in</strong>ski JB, Tetzlaff JE et al.The effect of epidural vs <strong>in</strong>travenous analgesiafor posterior sp<strong>in</strong>al fusion surgery. PaediatrAnaesth 2004; 14: 1009–1015.332 Arms D, Smith J, Osteyee J et al. <strong>Postoperative</strong>epidural analgesia for pediatric sp<strong>in</strong>esurgery. Orthopedics 1998; 21: 539–544.333 Sucato DJ, Duey-Holtz A, Elerson E et al.<strong>Postoperative</strong> analgesia follow<strong>in</strong>g surgicalcorrection for adolescent idiopathic scoliosis:a comparison of cont<strong>in</strong>uous epiduralanalgesia <strong>and</strong> patient-controlled analgesia.Sp<strong>in</strong>e 2005; 30: 211–217.334 Poe-Kochert C, Tripi PA, Potzman J et al.Cont<strong>in</strong>uous <strong>in</strong>travenous morph<strong>in</strong>e <strong>in</strong>fusionfor postoperative analgesia follow<strong>in</strong>g posteriorsp<strong>in</strong>al fusion for idiopathic scoliosis.Sp<strong>in</strong>e 2010; 35: 754–757.335 <strong>Good</strong>arzi M, Shier NH, Grogan DP. Effectof <strong>in</strong>trathecal opioids on somatosensoryevokedpotentials dur<strong>in</strong>g sp<strong>in</strong>al fusion <strong>in</strong>children. Sp<strong>in</strong>e 1996; 21: 1565–1568.336 Shaw B, Watson T, Merzel D et al. Thesafety of cont<strong>in</strong>uous epidural <strong>in</strong>fusion forpostoperative analgesia <strong>in</strong> pediatric sp<strong>in</strong>esurgery. J Pediatr Orthop 1996; 16: 374–377.337 Turner A, Lee J, Mitchell R et al. The efficacyof surgically placed epidural cathetersfor analgesia after posterior sp<strong>in</strong>al surgery.Anaesthesia 2000; 55: 370–373.338 Lowry KJ, Tobias J, Kittle D et al. <strong>Postoperative</strong>pa<strong>in</strong> control us<strong>in</strong>g epidural cathetersafter anterior sp<strong>in</strong>al fusion for adolescentscoliosis. Sp<strong>in</strong>e 2001; 26: 1290–1293.339 Saudan S, Habre W, Ceroni D et al. Safety<strong>and</strong> efficacy of patient controlled epiduralanalgesia follow<strong>in</strong>g pediatric sp<strong>in</strong>al surgery.Paediatr Anaesth 2008; 18: 132–139.340 Vitale MG, Choe JC, Hwang MW et al.Use of ketorolac trometham<strong>in</strong>e <strong>in</strong> childrenundergo<strong>in</strong>g scoliosis surgery. an analysis ofcomplications. Sp<strong>in</strong>e J 2003; 3: 55–62.341 Rusy LM, Ha<strong>in</strong>sworth KR, Nelson TJ et al.Gabapent<strong>in</strong> use <strong>in</strong> pediatric sp<strong>in</strong>al fusionpatients: a r<strong>and</strong>omized, double-bl<strong>in</strong>d, controlledtrial. Anesth Analg 2010; 110: 1393–1398.342 Engelhardt T, Zaarour C, Naser B et al. Intraoperativelow-dose ketam<strong>in</strong>e does notprevent a remifentanil-<strong>in</strong>duced <strong>in</strong>crease <strong>in</strong>morph<strong>in</strong>e requirement after pediatric scoliosissurgery. Anesth Analg 2008; 107: 1170–1175.343 Rub<strong>in</strong> K, Sullivan D, Sadhasivam S. Areperipheral <strong>and</strong> neuraxial blocks with ultrasoundguidance more effective <strong>and</strong> safe <strong>in</strong>children?Paediatr Anaesth 2009; 19: 92–96.344 Prabhu K, Wig J, Grewal S. Bilateral <strong>in</strong>fraorbitalnerve block is superior to peri-<strong>in</strong>cisional<strong>in</strong>filtration for analgesia after repairof cleft lip. Sc<strong>and</strong> J Plast Reconstr SurgH<strong>and</strong> Surg 1999; 33: 83–87.345 Eipe N, Choudhrie A, Pillai AD et al.Regional anesthesia for cleft lip repair: aprelim<strong>in</strong>ary study. Cleft Palate Craniofac J2006; 43: 138–141.346 Takmaz SA, Uysal HY, Uysal A et al.Bilateral extraoral, <strong>in</strong>fraorbital nerve blockfor postoperative pa<strong>in</strong> relief after cleft liprepair <strong>in</strong> pediatric patients: a r<strong>and</strong>omized,double-bl<strong>in</strong>d controlled study. Ann PlastSurg 2009; 63: 59–62.347 Simion C, Corcoran J, Iyer A et al. <strong>Postoperative</strong>pa<strong>in</strong> control for primary cleft liprepair <strong>in</strong> <strong>in</strong>fants: is there an advantage <strong>in</strong>perform<strong>in</strong>g peripheral nerve blocks?Paediatr Anaesth 2008; 18: 1060–1065.348 Rajamani A, Kamat V, Rajavel VP et al. Acomparison of bilateral <strong>in</strong>fraorbital nerveblock with <strong>in</strong>travenous fentanyl for analgesiafollow<strong>in</strong>g cleft lip repair <strong>in</strong> children. PaediatrAnaesth 2007; 17: 133–139.349 Jonnavithula N, Durga P, Kulkarni DK etal. Bilateral <strong>in</strong>tra-oral, <strong>in</strong>fra-orbital nerveblock for postoperative analgesia follow<strong>in</strong>gcleft lip repair <strong>in</strong> paediatric patients: comparisonof bupivaca<strong>in</strong>e vs bupivaca<strong>in</strong>e-pethid<strong>in</strong>ecomb<strong>in</strong>ation. Anaesthesia 2007; 62:581–585.350 Mane RS, Sanikop CS, Dhulkhed VK et al.Comparison of bupivaca<strong>in</strong>e alone <strong>and</strong> <strong>in</strong>comb<strong>in</strong>ation with fentanyl or pethid<strong>in</strong>e forbilateral <strong>in</strong>fraorbital nerve block for postoperativeanalgesia <strong>in</strong> paediatric patients forcleft lip repair: a prospective r<strong>and</strong>omizeddouble bl<strong>in</strong>d study. J Anaesthesiol Cl<strong>in</strong>Pharmacol 2011; 27: 23–26.351 J<strong>in</strong>dal P, Khurana G, Dvivedi S et al. Intra<strong>and</strong> postoperative outcome of add<strong>in</strong>g clonid<strong>in</strong>eto bupivaca<strong>in</strong>e <strong>in</strong> <strong>in</strong>fraorbital nerveblock for young children undergo<strong>in</strong>g cleftlip surgery. Saudi J Anaesth 2011; 5: 289–294.352 Coban YK, Senoglu N, Oksuz H. Effects ofpreoperative local ropivaca<strong>in</strong>e <strong>in</strong>filtration onpostoperative pa<strong>in</strong> scores <strong>in</strong> <strong>in</strong>fants <strong>and</strong>small children undergo<strong>in</strong>g elective cleft palaterepair. J Craniofac Surg 2008; 19: 1221–1224.353 Obayah GM, Refaie A, Aboushanab O etal. Addition of dexmedetomid<strong>in</strong>e to bupivaca<strong>in</strong>efor greater palat<strong>in</strong>e nerve block prolongspostoperative analgesia after cleftpalate repair. Eur J Anaesthesiol 2010; 27:280–284.354 Mesnil M, Dadure C, Captier G et al. Anew approach for peri-operative analgesiaof cleft palate repair <strong>in</strong> <strong>in</strong>fants: the bilateralsuprazygomatic maxillary nerve block. PaediatrAnaesth 2010; 20: 343–349.355 Sylaidis P, O’Neill T. Diclofenac analgesiafollow<strong>in</strong>g cleft palate surgery. Cleft PalateCraniofac J 1998; 35: 544–545.356 Dawson KH, Egbert MA, Myall RW. Pa<strong>in</strong>follow<strong>in</strong>g iliac crest bone graft<strong>in</strong>g of alveolarclefts. J Craniomaxillofac Surg 1996; 24:151–154.357 Sbitany H, Koltz PF, Waldman J et al.Cont<strong>in</strong>uous bupivaca<strong>in</strong>e <strong>in</strong>fusion <strong>in</strong> iliacbone graft donor sites to m<strong>in</strong>imize pa<strong>in</strong> <strong>and</strong>hospitalization. Cleft Palate Craniofac J2010; 47: 293–296.358 Dashow JE, Lewis CW, Hopper RA et al.Bupivaca<strong>in</strong>e adm<strong>in</strong>istration <strong>and</strong> postoperativepa<strong>in</strong> follow<strong>in</strong>g anterior iliac crest bonegraft for alveolar cleft repair. Cleft PalateCraniofac J 2009; 46: 173–178.359 Cregg N, Conway F, Casey W. Analgesiaafter otoplasty: regional nerve blockade vslocal anaesthetic <strong>in</strong>filtration of the ear. CanJ Anaesth 1996; 43: 141–147.64 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


360 Shayevitz JR, Merkel S, O’Kelly SW et al.Lumbar epidural morph<strong>in</strong>e <strong>in</strong>fusions forchildren undergo<strong>in</strong>g cardiac surgery. J CardiothoracVasc Anesth 1996; 10: 217–224.361 Hammer GB, Ngo K, Macario A. A retrospectiveexam<strong>in</strong>ation of regional plus generalanesthesia <strong>in</strong> children undergo<strong>in</strong>g openheart surgery. Anesth Analg 2000; 90: 1020–1024.362 Peterson K, DeCampli W, Pike N et al.A report of two hundred twenty cases ofregional anesthesia <strong>in</strong> pediatric cardiacsurgery. Anesth Analg 2000; 90: 1014–1019.363 F<strong>in</strong>kel J, Boltz M, Conran A. The effect ofbaricity of <strong>in</strong>trathecal morph<strong>in</strong>e <strong>in</strong> childrenreceiv<strong>in</strong>g tetraca<strong>in</strong>e sp<strong>in</strong>al anaesthesia forcardiac surgery: a prelim<strong>in</strong>ary report. PaediatrAnaesth 2002; 12: 327–331.364 Pirat A, Akpek E, Arslan G. Intrathecalversus IV fentanyl <strong>in</strong> pediatric cardiac anesthesia.Anesth Analg 2002; 95: 1207–1214,table of contents.365 Suom<strong>in</strong>en P, Ragg P, McK<strong>in</strong>ley D et al.Intrathecal morph<strong>in</strong>e provides effective <strong>and</strong>safe analgesia <strong>in</strong> children after cardiac surgery.Acta Anaesthesiol Sc<strong>and</strong> 2004; 48:875–882.366 Hammer GB, Ramamoorthy C, Cao H etal. <strong>Postoperative</strong> analgesia after sp<strong>in</strong>alblockade <strong>in</strong> <strong>in</strong>fants <strong>and</strong> children undergo<strong>in</strong>gcardiac surgery. Anesth Analg 2005; 100:1283–1288,table of contents.367 Leyvi G, Taylor DG, Reith E et al. Caudalanesthesia <strong>in</strong> pediatric cardiac surgery: doesit affect outcome? J Cardiothorac VascAnesth 2005; 19: 734–738.368 Thammasitboon S, Rosen DA, Lutfi R etal. An <strong>in</strong>stitutional experience with epiduralanalgesia <strong>in</strong> children <strong>and</strong> young adultsundergo<strong>in</strong>g cardiac surgery. Paediatr Anaesth2010; 20: 720–726.369 Chu YC, L<strong>in</strong> SM, Hsieh YC et al. Intraoperativeadm<strong>in</strong>istration of tramadol for postoperativenurse-controlled analgesia resulted<strong>in</strong> earlier awaken<strong>in</strong>g <strong>and</strong> less sedation thanmorph<strong>in</strong>e <strong>in</strong> children after cardiac surgery.Anesth Analg 2006; 102: 1668–1673.370 Rosen DA, Hawk<strong>in</strong>berry DW2nd, RosenKR et al. An epidural hematoma <strong>in</strong> an adolescentpatient after cardiac surgery. AnesthAnalg 2004; 98: 966–969,table of contents.371 Gupta A, Daggett C, Drant S et al. Prospectiver<strong>and</strong>omized trial of ketorolac aftercongenital heart surgery. J CardiothoracVasc Anesth 2004; 18: 454–457.372 Birm<strong>in</strong>gham P, Wheeler M, Suresh S et al.Patient-controlled epidural analgesia <strong>in</strong> children:can they do it? Anesth Analg 2003; 96:686–691.373 L<strong>in</strong> Y, Sentivany-Coll<strong>in</strong>s S, Peterson K etal. Outcomes after s<strong>in</strong>gle <strong>in</strong>jection caudalepidural versus cont<strong>in</strong>uous <strong>in</strong>fusion epiduralvia caudal approach for postoperative analgesia<strong>in</strong> <strong>in</strong>fants <strong>and</strong> children undergo<strong>in</strong>gpatent ductus arteriosus ligation. PaediatrAnaesth 1999; 9: 139–143.374 Bozkurt P, Kaya G, Yeker Y et al. Effectivenessof morph<strong>in</strong>e via thoracic epiduralvs <strong>in</strong>travenous <strong>in</strong>fusion on postthoracotomypa<strong>in</strong> <strong>and</strong> stress response <strong>in</strong> children. PaediatrAnaesth 2004; 14: 748–754.375 Ioscovich A, Brisk<strong>in</strong> A, Deeb M et al. Oneshot sp<strong>in</strong>al morph<strong>in</strong>e <strong>in</strong>jection for postthoracotomypa<strong>in</strong> control <strong>in</strong> children [4]. PaediatrAnaesth 2004; 14: 971–972.376 Karmakar M, Booker P, Franks R et al.Cont<strong>in</strong>uous extrapleural paravertebral <strong>in</strong>fusionof bupivaca<strong>in</strong>e for post-thoracotomyanalgesia <strong>in</strong> young <strong>in</strong>fants. Br J Anaesth1996; 76: 811–815.377 Cheung S, Booker P, Franks R et al. Serumconcentrations of bupivaca<strong>in</strong>e dur<strong>in</strong>g prolongedcont<strong>in</strong>uous paravertebral <strong>in</strong>fusion <strong>in</strong>young <strong>in</strong>fants. Br J Anaesth 1997; 79: 9–13.378 Downs C, Cooper M. Cont<strong>in</strong>uous extrapleural<strong>in</strong>tercostal nerve block for post thoracotomyanalgesia <strong>in</strong> children. AnaesthIntensive Care 1997; 25: 390–397.379 Karmakar MK, Booker PD, Franks R.Bilateral cont<strong>in</strong>uous paravertebral blockused for postoperative analgesia <strong>in</strong> an <strong>in</strong>fanthav<strong>in</strong>g bilateral thoracotomy. Paediatr Anaesth1997; 7: 469–471.380 Shah R, Sabanathan S, Richardson J et al.Cont<strong>in</strong>uous paravertebral block for postthoracotomy analgesia <strong>in</strong> children. J CardiovascSurg (Tor<strong>in</strong>o) 1997; 38: 543–546.381 Karmakar M, Critchley L. Cont<strong>in</strong>uous extrapleural<strong>in</strong>tercostal nerve block for postthoracotomy analgesia <strong>in</strong> children. AnaesthIntensive Care 1998; 26: 115–116.382 Gibson MP, Vetter T, Crow JP. Use of cont<strong>in</strong>uousretropleural bupivaca<strong>in</strong>e <strong>in</strong> postoperativepa<strong>in</strong> management for pediatricthoracotomy. J Pediatr Surg 1999; 34: 199–201.383 Matsota P, Livanios S, Mar<strong>in</strong>opoulou E.Intercostal nerve block with Bupivaca<strong>in</strong>e forpost-thoracotomy pa<strong>in</strong> relief <strong>in</strong> children.Eur J Pediatr Surg 2001; 11: 219–222.384 Lynn AM, Nespeca MK, Bratton SL et al.Ventilatory effects of morph<strong>in</strong>e <strong>in</strong>fusions <strong>in</strong>cyanotic versus acyanotic <strong>in</strong>fants after thoracotomy.Paediatr Anaesth 2003; 13: 12–17.385 Morton N, Errera A. APA national audit ofpediatric opioid <strong>in</strong>fusions. Pediatr Anesth2010; 20: 119–125.386 Klimek M, Ubben JF, Ammann J et al.Pa<strong>in</strong> <strong>in</strong> neurosurgically treated patients: aprospective observational study. J Neurosurg2006; 104: 350–359.387 Teo JH, Palmer GM, Davidson AJ. Postcraniotomypa<strong>in</strong> <strong>in</strong> a paediatric population.Anaesth Intensive Care 2011; 39: 89–94.388 Warren DT, Bowen-Roberts T, Ou C et al.Safety <strong>and</strong> efficacy of cont<strong>in</strong>uous morph<strong>in</strong>e<strong>in</strong>fusions follow<strong>in</strong>g pediatric cranial surgery<strong>in</strong> a surgical ward sett<strong>in</strong>g. Childs Nerv Syst2010; 26: 1535–1541.389 Ou CHK, Kent SK, Hammond AM et al.Morph<strong>in</strong>e <strong>in</strong>fusions after pediatric cranialsurgery: a retrospective analysis of safety<strong>and</strong> efficacy. Can J Neurosci Nurs 2008; 30:21–30.390 Chiaretti A, Viola L, Pietr<strong>in</strong>i D et al. Preemptiveanalgesia with tramadol <strong>and</strong> fentanyl<strong>in</strong> pediatric neurosurgery. Childs NervSyst 2000; 16: 93–99;discussion 100.391 Chiaretti A, Genovese O, Antonelli A et al.Patient-controlled analgesia with fentanil<strong>and</strong> midazolam <strong>in</strong> children with postoperativeneurosurgical pa<strong>in</strong>. Childs Nerv Syst2008; 24: 119–124.392 McEwan A, Sigston PE, Andrews KA et al.A comparison of rectal <strong>and</strong> <strong>in</strong>tramuscularcode<strong>in</strong>e phosphate <strong>in</strong> children follow<strong>in</strong>gneurosurgery. Paediatr Anaesth 2000; 10:189–193.ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 65


Section 6.0AnalgesiaContents6.1 Analgesia6.2 Local anesthetics6.2.1 Bupivaca<strong>in</strong>e, levobupivaca<strong>in</strong>e, ropivaca<strong>in</strong>e6.2.2 Lidoca<strong>in</strong>e, Priloca<strong>in</strong>e <strong>and</strong> EMLA6.2.3 Tetraca<strong>in</strong>e (amethoca<strong>in</strong>e) <strong>and</strong> Ametop6.3 Neuraxial analgesics6.3.1 Ketam<strong>in</strong>e <strong>and</strong> clonid<strong>in</strong>e6.4 Opioids6.4.1 Opioid preparations, dosages <strong>and</strong> routes6.4.2 Opioid toxicity <strong>and</strong> side effects6.5 Nonsteroidal anti-<strong>in</strong>flammatory drugs (NSAIDs)6.5.1 NSAID preparations, dose <strong>and</strong> routes6.5.2 NSAID toxicity <strong>and</strong> side effects6.6 Paracetamol6.6.1 Paracetamol preparations, doses <strong>and</strong> routes6.6.2 Paracetamol toxicity <strong>and</strong> side effects6.7 Nitrous oxide (N 2 O)6.7.1 Preparations, dosage <strong>and</strong> adm<strong>in</strong>istration6.7.2 Side effects <strong>and</strong> toxicity6.8 Sucrose6.8.1 Sucrose dosage <strong>and</strong> adm<strong>in</strong>istration6.8.2 Sucrose side effects <strong>and</strong> toxicity6.9 Nonpharmacological strategiesmore comprehensive prescrib<strong>in</strong>g <strong>in</strong>formation, summariesof product characteristics, <strong>and</strong> license status ofspecific agents for children <strong>in</strong> the UK, please consultresources such as the British National Formulary forChildren (2012) available at http://bnfc.org/bnfc <strong>and</strong>the Electronic Medic<strong>in</strong>es Compendium available athttp://emc.medic<strong>in</strong>es.org.uk/.6.2 Local anestheticsMost widely used local anesthetics are amides with theexception of tetraca<strong>in</strong>e (amethoca<strong>in</strong>e), which is an ester(1–4). They all act by reversibly block<strong>in</strong>g sodium channels<strong>in</strong> nerves. They vary <strong>in</strong> onset, potency, potential fortoxicity, <strong>and</strong> duration of effect. Formulations are availablefor topical application to mucosae or <strong>in</strong>tact sk<strong>in</strong>,for local <strong>in</strong>stallation or <strong>in</strong>filtration, for peripheral nerveor plexus blockade, for epidural <strong>in</strong>jection or <strong>in</strong>fusion,<strong>and</strong> for subarachnoid adm<strong>in</strong>istration. Vasoconstrictorsmay be added to reduce the systemic absorption of localanesthetic <strong>and</strong> to prolong the neural blockade. Neuraxialanalgesics such as the a-2-agonist clonid<strong>in</strong>e, the phencyclid<strong>in</strong>ederivative ketam<strong>in</strong>e, or opioids such asfentanyl may be co-adm<strong>in</strong>istered with the local anestheticto prolong the effect of central nerve blocks.6.1 AnalgesiaThis section describes some of the important properties,dos<strong>in</strong>g regimens, <strong>in</strong>teractions, <strong>and</strong> adverse effectsof analgesics for acute pa<strong>in</strong> <strong>in</strong> children.Local anesthetics, opioids, NSAIDs, <strong>and</strong> paracetamolform the pharmacological basis for the majority of analgesicregimens. Ketam<strong>in</strong>e, a dissociative anesthetic withanalgesic properties <strong>and</strong> clonid<strong>in</strong>e, an alpha-2-agonist,are used to provide systemic or neuraxial analgesiaalone or as adjuncts to other agents. For pa<strong>in</strong>ful procedures,<strong>in</strong>haled nitrous oxide has an important role, <strong>and</strong><strong>in</strong> neonatology <strong>in</strong>tra-oral sucrose solution is used. Theavailability of specific opioids, NSAIDs, <strong>and</strong> local anestheticscan vary from country to country.The detailed pharmacology <strong>and</strong> formulations ofthese drugs are available <strong>in</strong> st<strong>and</strong>ard textbooks. For6.2.1 Bupivaca<strong>in</strong>e, levobupivaca<strong>in</strong>e, <strong>and</strong> ropivaca<strong>in</strong>e(i) Preparations <strong>and</strong> routesBupivaca<strong>in</strong>e is an amide LA with a slow onset <strong>and</strong> along duration of action, which may be prolonged bythe addition of a vasoconstrictor. It is used ma<strong>in</strong>ly for<strong>in</strong>filtration anesthesia <strong>and</strong> regional nerve blocks, particularlyepidural block, but is contra<strong>in</strong>dicated for<strong>in</strong>travenous regional anesthesia (Bier’s block). Bupivaca<strong>in</strong>eis a racemic mixture but the S())-isomerlevobupivaca<strong>in</strong>e is also commonly used. A carbonatedsolution of bupivaca<strong>in</strong>e, with faster onset of action, isalso available for <strong>in</strong>jection <strong>in</strong> some countries. Bupivaca<strong>in</strong>eis used <strong>in</strong> solutions conta<strong>in</strong><strong>in</strong>g the equivalent of66 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


0.0625–0.75% (0.625–7.5 mg ml )1 ). In recommendeddoses, bupivaca<strong>in</strong>e produces complete sensory blockade,<strong>and</strong> the extent of motor blockade depends onconcentration. Solutions of 0.0625% or 0.125% areassociated with a very low <strong>in</strong>cidence of motor block, a0.25% solution generally produces <strong>in</strong>complete motorblock, a 0.5% solution will usually produce moreextensive motor block, <strong>and</strong> complete motor block <strong>and</strong>muscle relaxation can be achieved with a 0.75% solution.Hyperbaric solutions of 0.5% bupivaca<strong>in</strong>e maybe used for sp<strong>in</strong>al <strong>in</strong>trathecal block.Levobupivaca<strong>in</strong>e is the S-enantiomer of bupivaca<strong>in</strong>e,<strong>and</strong> it is equipotent but toxicity is slightly less. It isavailable <strong>in</strong> the same concentrations as bupivaca<strong>in</strong>e<strong>and</strong> is used for similar <strong>in</strong>dications; like bupivaca<strong>in</strong>e, itis contra<strong>in</strong>dicated for use <strong>in</strong> <strong>in</strong>travenous regional anesthesia(Bier’s block).Ropivaca<strong>in</strong>e is an amide LA with an onset <strong>and</strong> durationof sensory block that is generally similar to thatobta<strong>in</strong>ed with bupivaca<strong>in</strong>e but motor block may beslower <strong>in</strong> onset, shorter <strong>in</strong> duration, <strong>and</strong> less <strong>in</strong>tense. Itis available <strong>in</strong> solutions of 0.2%, 0.75%, <strong>and</strong> 1%.(ii) Dosage, side effects, <strong>and</strong> toxicityThe dosage of bupivaca<strong>in</strong>e, levobupivaca<strong>in</strong>e, <strong>and</strong> ropivaca<strong>in</strong>edepends on the site of <strong>in</strong>jection, the procedure,<strong>and</strong> the status of the patient: suggested maxima aregiven <strong>in</strong> Table 6.2.1. A test dose may help to detect<strong>in</strong>advertent <strong>in</strong>travascular <strong>in</strong>jection, <strong>and</strong> doses shouldbe given <strong>in</strong> small <strong>in</strong>crements. Slow accumulationoccurs with repeat adm<strong>in</strong>istration <strong>and</strong> cont<strong>in</strong>uous <strong>in</strong>fusions,especially <strong>in</strong> neonates.Table 6.2.1 Suggested maximum dosages of bupivaca<strong>in</strong>e, levobupivaca<strong>in</strong>e,<strong>and</strong> ropivaca<strong>in</strong>eS<strong>in</strong>gle bolus <strong>in</strong>jection Maximum dosage (mgÆkg )1 )Neonates 2Children 2.5Cont<strong>in</strong>uous <strong>in</strong>fusion(postoperative use)Neonates 0.2Children 0.4Maximum <strong>in</strong>fusion rate (mgÆkg )1 Æh )1 )Bupivaca<strong>in</strong>e is 95% bound to plasma prote<strong>in</strong>s witha half-life of 1.5–5.5 h <strong>in</strong> adults <strong>and</strong> 8 h <strong>in</strong> neonates. Itis metabolized <strong>in</strong> the liver <strong>and</strong> is excreted <strong>in</strong> the ur<strong>in</strong>ema<strong>in</strong>ly as metabolites with only 5–6% as unchangeddrug. Bupivaca<strong>in</strong>e is distributed <strong>in</strong>to breast milk <strong>in</strong>small quantities. It crosses the placenta but the ratio offetal concentrations to maternal concentrations is relativelylow. Bupivaca<strong>in</strong>e also diffuses <strong>in</strong>to the CSF.The toxic threshold for bupivaca<strong>in</strong>e is <strong>in</strong> the plasmaconcentration range of 2–4 mgÆml )1 . The two majorb<strong>in</strong>d<strong>in</strong>g prote<strong>in</strong>s for bupivaca<strong>in</strong>e <strong>in</strong> the blood are a1-acid glycoprote<strong>in</strong>, the <strong>in</strong>fluence of which is predom<strong>in</strong>antat low concentrations, <strong>and</strong> album<strong>in</strong>, which playsthe major role at high concentrations. Reduction <strong>in</strong>pH from 7.4 to 7.0 decreases the aff<strong>in</strong>ity of the a1-acidglycoprote<strong>in</strong> for bupivaca<strong>in</strong>e but has no effect on album<strong>in</strong>aff<strong>in</strong>ity. For epidural <strong>in</strong>fusion techniques <strong>in</strong> neonates,the reduced hepatic clearance of amide localanesthetics is the more important factor caus<strong>in</strong>g accumulationof bupivaca<strong>in</strong>e than reduced prote<strong>in</strong> b<strong>in</strong>d<strong>in</strong>gcapacity, particularly as prote<strong>in</strong> levels tend to <strong>in</strong>crease<strong>in</strong> response to surgery.Bupivaca<strong>in</strong>e is more cardio toxic than other amidelocal anesthetics <strong>and</strong> there is an <strong>in</strong>creased risk of myocardialdepression <strong>in</strong> overdose <strong>and</strong> when bupivaca<strong>in</strong>e<strong>and</strong> antiarrhythmics are given together. Propranololreduces the clearance of bupivaca<strong>in</strong>e. Levobupivaca<strong>in</strong>eis slightly less cardio toxic <strong>and</strong> therefore safer butmaximum recommended doses are similar to those ofbuivaca<strong>in</strong>e.Ropivaca<strong>in</strong>e is about 94% bound to plasma prote<strong>in</strong>s.The term<strong>in</strong>al elim<strong>in</strong>ation half-life is around 1.8 h, <strong>and</strong>it is extensively metabolized <strong>in</strong> the liver by the cytochromeP450 isoenzyme CYP1A2. Prolonged use ofropivaca<strong>in</strong>e should be avoided <strong>in</strong> patients treated withpotent CYP1A2 <strong>in</strong>hibitors, such as the selective seroton<strong>in</strong>reuptake <strong>in</strong>hibitor (SSRI) fluvoxam<strong>in</strong>e. Plasmaconcentrations of ropivaca<strong>in</strong>e may be reduced byenzyme-<strong>in</strong>duc<strong>in</strong>g drugs such as rifampic<strong>in</strong>. Metabolitesare excreted ma<strong>in</strong>ly <strong>in</strong> the ur<strong>in</strong>e; about 1% of a doseis excreted as unchanged drug. Some metabolites alsohave a local anesthetic effect but less than that of ropivaca<strong>in</strong>e.Ropivaca<strong>in</strong>e crosses the placenta.6.2.2 Lidoca<strong>in</strong>e, priloca<strong>in</strong>e, <strong>and</strong> EMLA(i) PreparationsLidoca<strong>in</strong>e is an amide LA, which is used for <strong>in</strong>filtrationanesthesia <strong>and</strong> regional nerve blocks. It has a rapidonset of action <strong>and</strong> anesthesia is obta<strong>in</strong>ed with<strong>in</strong> a fewm<strong>in</strong>utes; it has an <strong>in</strong>termediate duration of action. Theaddition of a vasoconstrictor reduces systemic absorption<strong>and</strong> <strong>in</strong>creases both the speed of onset <strong>and</strong> theduration of action. Lidoca<strong>in</strong>e is a useful surface anestheticbut it may be rapidly <strong>and</strong> extensively absorbedfollow<strong>in</strong>g topical application to mucous membranes,<strong>and</strong> systemic effects may occur. Hyaluronidase mayª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 67


enhance systemic absorption. Lidoca<strong>in</strong>e is <strong>in</strong>cluded <strong>in</strong>some <strong>in</strong>jections, such as depot corticosteroids, to preventpa<strong>in</strong> <strong>and</strong> itch<strong>in</strong>g caused by local irritation.Priloca<strong>in</strong>e is an amide local anesthetic with a similarpotency to lidoca<strong>in</strong>e. However, it has a slower onset ofaction, less vasodilator activity, <strong>and</strong> a slightly longerduration of action; it is also less toxic. Priloca<strong>in</strong>e isused for <strong>in</strong>filtration anesthesia <strong>and</strong> nerve blocks <strong>in</strong>solutions of 0.5%, 1%, <strong>and</strong> 2%. A 1% or 2% solutionis used for epidural anesthesia; for <strong>in</strong>travenous regionalanesthesia, 0.5% solutions are used. For dentalprocedures, a 3% solution with the vasoconstrictorfelypress<strong>in</strong> or a 4% solution without is used. A 4%solution with ep<strong>in</strong>ephr<strong>in</strong>e (1 <strong>in</strong> 200 000) is also usedfor dentistry <strong>in</strong> some countries. Carbonated solutionsof priloca<strong>in</strong>e have also been used for epidural <strong>and</strong> brachialplexus nerve blocks. Priloca<strong>in</strong>e is used for surfaceanesthesia <strong>in</strong> a eutectic mixture with lidoca<strong>in</strong>e EMLA.(ii) Doses, side effects, <strong>and</strong> toxicityThe dose of lidoca<strong>in</strong>e depends on the site of <strong>in</strong>jection<strong>and</strong> the procedure but <strong>in</strong> general, the maximum doseshould not exceed 3 mgÆkg )1 (maximum 200 mg)unless vasoconstrictor is also used. Lidoca<strong>in</strong>e hydrochloridesolutions conta<strong>in</strong><strong>in</strong>g ep<strong>in</strong>ephr<strong>in</strong>e (1 <strong>in</strong>200 000) for <strong>in</strong>filtration anesthesia <strong>and</strong> nerve blocksare available; higher concentrations of ep<strong>in</strong>ephr<strong>in</strong>e areseldom necessary, except <strong>in</strong> dentistry, where solutionsof lidoca<strong>in</strong>e hydrochloride with ep<strong>in</strong>ephr<strong>in</strong>e 1 <strong>in</strong>80 000 are traditionally used. The maximum dose ofep<strong>in</strong>ephr<strong>in</strong>e should be 5 microgm/kg )1 <strong>and</strong> of lidoca<strong>in</strong>e5mgÆkg )1 . Ep<strong>in</strong>ephr<strong>in</strong>e-conta<strong>in</strong><strong>in</strong>g solutions shouldnot be used near extremities such as for digital orpenile blocks. Lidoca<strong>in</strong>e may be used <strong>in</strong> a variety offormulations for surface anesthesia. Lidoca<strong>in</strong>e o<strong>in</strong>tmentis used for anesthesia of sk<strong>in</strong> <strong>and</strong> mucous membranes.Gels are used for anesthesia of the ur<strong>in</strong>arytract <strong>and</strong> for analgesia of aphthous ulcers. Topicalsolutions are used for surface anesthesia of mucousmembranes of the mouth, throat, <strong>and</strong> upper gastro<strong>in</strong>test<strong>in</strong>altract. For pa<strong>in</strong>ful conditions of the mouth <strong>and</strong>throat, a 2% solution may be used or a 10% spraycan be applied to mucous membranes. Eye drops conta<strong>in</strong><strong>in</strong>glidoca<strong>in</strong>e hydrochloride 4% with fluoresce<strong>in</strong>are used <strong>in</strong> tonometry. Other methods of dermal delivery<strong>in</strong>clude a transdermal patch of lidoca<strong>in</strong>e 5% forthe treatment of pa<strong>in</strong> associated with postherpetic neuralgia<strong>and</strong> an iontophoretic drug delivery system <strong>in</strong>corporat<strong>in</strong>glidoca<strong>in</strong>e <strong>and</strong> ep<strong>in</strong>ephr<strong>in</strong>e.Lidoca<strong>in</strong>e is bound to plasma prote<strong>in</strong>s, <strong>in</strong>clud<strong>in</strong>g a1-acid glycoprote<strong>in</strong> (AAG). The extent of b<strong>in</strong>d<strong>in</strong>g is variablebut is about 66%. Plasma prote<strong>in</strong> b<strong>in</strong>d<strong>in</strong>g oflidoca<strong>in</strong>e depends <strong>in</strong> part on the concentrations ofboth lidoca<strong>in</strong>e <strong>and</strong> AAG. Any alteration <strong>in</strong> the concentrationof AAG can greatly affect plasma concentrationsof lidoca<strong>in</strong>e. Plasma concentrations decl<strong>in</strong>erapidly after an <strong>in</strong>travenous dose with an <strong>in</strong>itial halflifeof


Priloca<strong>in</strong>e has relatively low toxicity compared withmost amide-type local anesthetics. It is 55% bound toplasma prote<strong>in</strong>s <strong>and</strong> is rapidly metabolized ma<strong>in</strong>ly <strong>in</strong>the liver <strong>and</strong> kidneys <strong>and</strong> is excreted <strong>in</strong> the ur<strong>in</strong>e. Oneof the pr<strong>in</strong>cipal metabolites is o-toluid<strong>in</strong>e, which isbelieved to cause the methemoglob<strong>in</strong>emia observedafter large doses. It crosses the placenta <strong>and</strong> dur<strong>in</strong>gprolonged epidural anesthesia may producemethemoglob<strong>in</strong>emia <strong>in</strong> the fetus. It is distributed <strong>in</strong>tobreast milk. The peak serum concentration of priloca<strong>in</strong>eassociated with CNS toxicity is 20 mgÆml )1 .Symptoms usually occur when doses of priloca<strong>in</strong>ehydrochloride exceed about 8 mgÆkg )1 but the veryyoung may be more susceptible. Methemoglob<strong>in</strong>emiahas been observed <strong>in</strong> neonates whose mothers receivedpriloca<strong>in</strong>e shortly before delivery <strong>and</strong> it has also beenreported after prolonged topical application of a priloca<strong>in</strong>e/lidoca<strong>in</strong>eeutectic mixture <strong>in</strong> children. Methemoglob<strong>in</strong>emiamay be treated by giv<strong>in</strong>g oxygen followed,if necessary, by IV methylthion<strong>in</strong>ium chloride.Priloca<strong>in</strong>e should be used with caution <strong>in</strong> patientswith anemia, congenital or acquired methemoglob<strong>in</strong>emia,cardiac or ventilatory failure, or hypoxia. Priloca<strong>in</strong>ehas been associated with acute attacks ofporphyria <strong>and</strong> is considered unsafe <strong>in</strong> porphyricpatients. Methemoglob<strong>in</strong>emia may occur at lowerdoses of priloca<strong>in</strong>e <strong>in</strong> patients receiv<strong>in</strong>g therapy withother drugs known to cause such conditions (e.g., sulfonamidessuch as sulfamethoxazole <strong>in</strong> co-trimoxazole).(iii) EMLALidoca<strong>in</strong>e forms a mixture with priloca<strong>in</strong>e that has amelt<strong>in</strong>g po<strong>in</strong>t lower than that of either <strong>in</strong>gredient. Thiseutectic mixture conta<strong>in</strong><strong>in</strong>g lidoca<strong>in</strong>e 2.5% <strong>and</strong> priloca<strong>in</strong>e2.5% can produce local anesthesia when appliedto <strong>in</strong>tact sk<strong>in</strong> as a cream. It is used extensively for proceduralpa<strong>in</strong> <strong>in</strong>clud<strong>in</strong>g venepuncture, <strong>in</strong>travenous orarterial cannulation, lumbar puncture, m<strong>in</strong>or dermatologicalprocedures, <strong>and</strong> others (see section 4.0). Theeutectic cream is usually applied to sk<strong>in</strong> under anocclusive dress<strong>in</strong>g for at least 60 m<strong>in</strong> <strong>and</strong> a maximumof 5 h. Transient paleness, redness, <strong>and</strong> edema of thesk<strong>in</strong> may occur follow<strong>in</strong>g application.Eutectic mixtures of lidoca<strong>in</strong>e <strong>and</strong> priloca<strong>in</strong>e areused <strong>in</strong> neonates <strong>and</strong> are safe <strong>in</strong> s<strong>in</strong>gle doses. Therehas been concern that excessive absorption (particularlyof priloca<strong>in</strong>e) might lead to methemoglob<strong>in</strong>emiaparticularly after multiple applications. For this reason,the maximum number of doses per day should belimited <strong>in</strong> the neonate. In some countries, EMLA hasbeen licensed for use <strong>in</strong> neonates provided that theirgestational age is at least 37 weeks, <strong>and</strong> that methemoglob<strong>in</strong>values are monitored <strong>in</strong> those aged 3 months orless. In fact, systemic absorption of both drugs fromthe eutectic cream appears to be m<strong>in</strong>imal across <strong>in</strong>tactsk<strong>in</strong> even after prolonged or extensive use. However,EMLA should not be used <strong>in</strong> <strong>in</strong>fants under 1 yearwho are receiv<strong>in</strong>g methemoglob<strong>in</strong>-<strong>in</strong>duc<strong>in</strong>g drugs; itshould not be used on wounds or mucous membranesor for atopic dermatitis. EMLA should not be appliedto or near the eyes because it causes corneal irritation,<strong>and</strong> it should not be <strong>in</strong>stilled <strong>in</strong>to the middle ear. Itshould be used with caution <strong>in</strong> patients with anemia orcongenital or acquired methemoglob<strong>in</strong>emia.6.2.3 Tetraca<strong>in</strong>e (amethoca<strong>in</strong>e)(i) PreparationsTetraca<strong>in</strong>e is a potent, para-am<strong>in</strong>obenzoic acid esterlocal anesthetic used for surface anesthesia <strong>and</strong> sp<strong>in</strong>alblock. It is highly lipophilic <strong>and</strong> can penetrate <strong>in</strong>tactsk<strong>in</strong>. Its use <strong>in</strong> other local anesthetic techniques isrestricted by its systemic toxicity.For anesthesia of the eye, solutions conta<strong>in</strong><strong>in</strong>g 0.5–1% tetraca<strong>in</strong>e hydrochloride <strong>and</strong> o<strong>in</strong>tments conta<strong>in</strong><strong>in</strong>g0.5% tetraca<strong>in</strong>e have been used. Instillation of a 0.5%solution produces anesthesia with<strong>in</strong> 25 s that lasts for15 m<strong>in</strong> or longer <strong>and</strong> is suitable for use before m<strong>in</strong>orsurgical procedures.A 4% gel (Ametop) is used as a percutaneous localanesthetic. This formulation of 4% tetraca<strong>in</strong>e producesmore rapid <strong>and</strong> prolonged surface anesthesia thanEMLA <strong>and</strong> is significantly better <strong>in</strong> reduc<strong>in</strong>g pa<strong>in</strong>caused by laser treatment of port w<strong>in</strong>e sta<strong>in</strong>s <strong>and</strong> forvenous cannulation. A transdermal patch is effective,<strong>and</strong> patches conta<strong>in</strong><strong>in</strong>g a mixture of lidoca<strong>in</strong>e <strong>and</strong> tetraca<strong>in</strong>ehave also been tried. Tetraca<strong>in</strong>e has been<strong>in</strong>corporated <strong>in</strong>to a mucosa-adhesive polymer film torelieve the pa<strong>in</strong> of oral lesions result<strong>in</strong>g from radiation<strong>and</strong> ant<strong>in</strong>eoplastic therapy. Liposome-encapsulated tetraca<strong>in</strong>ecan provide adequate surface anesthesia.LAT (LET) 4% lidoca<strong>in</strong>e, 0.1% ep<strong>in</strong>ephr<strong>in</strong>e, <strong>and</strong>0.5% tetraca<strong>in</strong>e have been comb<strong>in</strong>ed <strong>in</strong> a gel <strong>and</strong>applied as a surface anesthetic to lacerations of thesk<strong>in</strong> especially the face <strong>and</strong> scalp. It is less a pa<strong>in</strong>fulalternative to LA <strong>in</strong>filtration prior to suture of lacerations.(ii) Dosage side effects <strong>and</strong> toxicityTetraca<strong>in</strong>e: A st<strong>in</strong>g<strong>in</strong>g sensation may occur when tetraca<strong>in</strong>eis used <strong>in</strong> the eye. Absorption of tetraca<strong>in</strong>e frommucous membranes is rapid, <strong>and</strong> adverse reactions canª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 69


undergoes hepatic biotransformation to an activemetabolite norketam<strong>in</strong>e <strong>and</strong> is excreted ma<strong>in</strong>ly <strong>in</strong> theur<strong>in</strong>e as metabolites. Subanesthetic doses of ketam<strong>in</strong>eproduce analgesia. Oral adm<strong>in</strong>istration has been utilizedfor sedation/premedication. Caudal/epiduraladm<strong>in</strong>istration of ketam<strong>in</strong>e produces analgesia butconcern has been expressed regard<strong>in</strong>g potential neurotoxicity.Clonid<strong>in</strong>eClonid<strong>in</strong>e is an alpha2-adrenergic agonist <strong>and</strong> has sedative,anxiolytic, <strong>and</strong> analgesic properties. As a result,potential perioperative benefits <strong>in</strong>clude use for premedication,reduction <strong>in</strong> general anesthetic requirements,analgesia, <strong>and</strong> management of opioid withdrawalsymptoms. Clonid<strong>in</strong>e can be given orally, transdermally,<strong>in</strong>travenously, or epidurally. Clonid<strong>in</strong>e is rapidlyabsorbed. After oral adm<strong>in</strong>istration, about 50% ismetabolized <strong>in</strong> the liver, <strong>and</strong> it is excreted <strong>in</strong> the ur<strong>in</strong>eas unchanged drug <strong>and</strong> metabolites. Clearance <strong>in</strong> neonatesis about one-third of adult levels. The elim<strong>in</strong>ationhalf-life has been variously reported to rangebetween 6 <strong>and</strong> 24 h, <strong>and</strong> extended up to 41 h <strong>in</strong>patients with renal impairment. Clonid<strong>in</strong>e crosses theplacenta <strong>and</strong> is distributed <strong>in</strong>to breast milk. The hypotensiveeffect of clonid<strong>in</strong>e may be enhanced by diuretics,other antihypertensives, <strong>and</strong> drugs that causehypotension. The sedative effect of clonid<strong>in</strong>e may beenhanced by CNS depressants. Clonid<strong>in</strong>e has beenassociated with impaired atrioventricular conduction <strong>in</strong>a few patients, although some of these may have hadunderly<strong>in</strong>g conduction defects <strong>and</strong> had previouslyreceived digitalis, which may have contributed to theircondition.(ii) DosesKetam<strong>in</strong>eFor anesthesia, 2 mgÆkg )1 given <strong>in</strong>travenously over60 s usually produces surgical anesthesia with<strong>in</strong> 30 s ofthe end of the <strong>in</strong>jection <strong>and</strong> last<strong>in</strong>g for 5–10 m<strong>in</strong>.Addition of ketam<strong>in</strong>e 0.25–0.5 mgÆkg )1 to caudallocal anesthetic (compared with a local anestheticalone) prolongs the time to first analgesia <strong>and</strong> reducespostoperative rescue analgesia requirements.Clonid<strong>in</strong>eClonid<strong>in</strong>e is rapidly absorbed after oral adm<strong>in</strong>istration<strong>and</strong> doses of 4 mcgÆkg )1 have been used for premedication.Clonid<strong>in</strong>e has an established role as a sp<strong>in</strong>aladjuvant analgesic <strong>in</strong> pediatric practice, <strong>and</strong> clonid<strong>in</strong>evia the <strong>in</strong>trathecal or caudal/epidural route has agreater effect than the same dose <strong>in</strong>travenously. Additionof 1–2 mcgÆkg )1 clonid<strong>in</strong>e to caudal local anestheticprolongs analgesia <strong>and</strong> reduces postoperativeanalgesic requirements, when compared to local anestheticalone. Sensitivity to side effects (apnea, oxygendesaturation, <strong>and</strong> bradycardia) is greater <strong>in</strong> neonates,<strong>and</strong> cardiovascular <strong>and</strong> sedative side effects have beenreported follow<strong>in</strong>g doses of 5 lgÆkg )1 caudal clonid<strong>in</strong>e<strong>in</strong> children. Epidural clonid<strong>in</strong>e 0.08–0.12 lgÆkg )1 Æh )1produces dose-dependent analgesia when added tolocal anesthetic <strong>in</strong>fusion, <strong>and</strong> higher doses of clonid<strong>in</strong>ealone (0.2 lgÆkg )1 Æh )1 preceded by bolus of 2 lgÆkg )1 )provide analgesia at rest follow<strong>in</strong>g abdom<strong>in</strong>al surgery.(iii) NeuroxicitySevere complications follow<strong>in</strong>g pediatric regional techniquesare rare, but the <strong>in</strong>cidence is higher <strong>in</strong> neonates<strong>and</strong> <strong>in</strong>fants (0.4% vs 0.1% for all regional blocks or1.1% vs 0.49% for epidural blocks alone). Rates ofneurological <strong>in</strong>jury follow<strong>in</strong>g neuraxial analgesia rangefrom 0.13 to 0.4 per 1000 <strong>in</strong> large series, with higherrates follow<strong>in</strong>g epidural catheter techniques than s<strong>in</strong>gleshot caudals. Issues relat<strong>in</strong>g to the potential neurotoxicityof some sp<strong>in</strong>ally adm<strong>in</strong>istered drugs <strong>and</strong> the ethicaluse of unlicensed routes of adm<strong>in</strong>istration havebeen debated for many years.General anesthetics with NMDA antagonist <strong>and</strong>/orGABA agonist activity <strong>in</strong>crease neuronal apoptosis <strong>in</strong>the develop<strong>in</strong>g bra<strong>in</strong> <strong>in</strong> rodents <strong>and</strong> primates <strong>and</strong> haveled to a number of cl<strong>in</strong>ical studies evaluat<strong>in</strong>g neurocognitiveoutcomes follow<strong>in</strong>g exposure to general anesthesia<strong>in</strong> early life. The potential for additional developmentallyregulated sp<strong>in</strong>al toxicity has been the impetus forstudies assess<strong>in</strong>g histopathology <strong>and</strong> apoptosis <strong>in</strong> thesp<strong>in</strong>al cord follow<strong>in</strong>g <strong>in</strong>trathecal drugs <strong>in</strong> neonatalrodent models. Intrathecal bupivaca<strong>in</strong>e produces densesp<strong>in</strong>al analgesia but does not <strong>in</strong>crease apoptosis <strong>in</strong> thebra<strong>in</strong> or sp<strong>in</strong>al cord of neonatal <strong>and</strong> <strong>in</strong>fant rats. Systemicallyadm<strong>in</strong>istered opioids have not been associated with<strong>in</strong>creased apoptosis <strong>in</strong> the bra<strong>in</strong>, <strong>and</strong> similarly <strong>in</strong>trathecalmorph<strong>in</strong>e did not <strong>in</strong>crease apoptosis or produce histopathology<strong>in</strong> the neonatal or <strong>in</strong>fant sp<strong>in</strong>al cord.Ketam<strong>in</strong>e: In adult models, sp<strong>in</strong>al cord toxicity hasbeen demonstrated follow<strong>in</strong>g <strong>in</strong>trathecal adm<strong>in</strong>istrationof ketam<strong>in</strong>e <strong>in</strong> adult sw<strong>in</strong>e, rabbits, <strong>and</strong> dogs. Althoughsome studies have attributed changes to the preservative,adm<strong>in</strong>istration of preservative-free S-ketam<strong>in</strong>e for7 days produced necrotiz<strong>in</strong>g lesions with cellularª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 71


<strong>in</strong>filtrates <strong>in</strong> the cord <strong>and</strong> a 28-day <strong>in</strong>fusion of preservative-freeracemic ketam<strong>in</strong>e produced pathologic changesrang<strong>in</strong>g from mild <strong>in</strong>flammation <strong>and</strong> demyel<strong>in</strong>ation tomarked necrosis. Intrathecal adm<strong>in</strong>istration of preservative-freeketam<strong>in</strong>e <strong>in</strong> neonatal rats has been shown to<strong>in</strong>crease apotosis <strong>and</strong> produce persistent changes <strong>in</strong> sensorythreshold <strong>in</strong> the same dose range as analgesia.Clonid<strong>in</strong>e: The neurotoxicity of epidural clonid<strong>in</strong>ehas been more extensively studied. Repeated bolus orextended cont<strong>in</strong>uous epidural <strong>and</strong> <strong>in</strong>trathecal deliveryof clonid<strong>in</strong>e <strong>in</strong> adult dogs or rats did not result <strong>in</strong> toxicity.Similarly, maximal tolerated doses of <strong>in</strong>trathecalclonid<strong>in</strong>e (300 times analgesic dose) did not <strong>in</strong>creaseapoptosis, produce histopathology <strong>in</strong> the sp<strong>in</strong>al cord,or produce persistent changes <strong>in</strong> sensory thresholds.Table 6.3.1 Typical doses of epidural neuraxial analgesicsDrugS<strong>in</strong>gle dosemicrogm.kg )1 Infusionmicrogm.kg )1 .hr )1 Side effectsClond<strong>in</strong>e 1–2 0.08–0.2 Sedation; doserelated hypotension<strong>and</strong> bradycardia(5 mcgÆkg )1 ); delayedrespiratorydepression<strong>and</strong> bradycardia <strong>in</strong>neonatesKetam<strong>in</strong>e 250–500Halluc<strong>in</strong>ations at higherdosesMorph<strong>in</strong>e 15–50 0.2–0.4 Nausea <strong>and</strong> vomit<strong>in</strong>g;ur<strong>in</strong>ary retention;pruritis; delayedrespiratorydepressionFentanyl 0.5–1 0.3–0.8 Nausea <strong>and</strong> vomit<strong>in</strong>gTramadol 500–2000Nausea <strong>and</strong> vomit<strong>in</strong>gthe adverse effects of its ma<strong>in</strong> metabolite, nor-pethid<strong>in</strong>e.Opioid <strong>in</strong>fusions can provide adequate analgesiawith an acceptable level of side effects. Patient-controlledopioid analgesia is now widely used <strong>in</strong> childrenas young as age 5 years <strong>and</strong> compares favorably withcont<strong>in</strong>uous morph<strong>in</strong>e <strong>in</strong>fusion <strong>in</strong> the older child. NCAwhere a nurse is allowed to press the dem<strong>and</strong> buttonwith<strong>in</strong> strictly set guidel<strong>in</strong>es can provide flexible analgesiafor children who are too young or unable to usePCA. This technology can also be used <strong>in</strong> neonateswhere a bolus dose without a background <strong>in</strong>fusionallows the nurse to titrate the child to analgesia or toanticipate pa<strong>in</strong>ful episodes while produc<strong>in</strong>g a prolongedeffect because of the slower clearance of morph<strong>in</strong>e.Neuraxial adm<strong>in</strong>istration of opioids has a placewhere extensive analgesia is needed, for example, aftermajor abdom<strong>in</strong>al surgery, sp<strong>in</strong>al surgery, or when adequatespread of epidural local anesthetic blockade cannotbe achieved with<strong>in</strong> dosage limits.Table 6.4.1 Opioid potency relative to morph<strong>in</strong>eDrugRelativepotencyS<strong>in</strong>gledose (oral)mg/kgCont<strong>in</strong>uous<strong>in</strong>fusion (IV)micrograms.kg )1 .hr )1Tramadol 0.1 1–2 100–400Code<strong>in</strong>e 0.1–0.12 0.5)1 N/AMorph<strong>in</strong>e 1 0.2–0.4 10–40Hydromorphone 5 0.04–0.08 2–8Fentanyl 50–100 N/A 0.1–0.2 mgÆkg )1 Æm<strong>in</strong> )1or use TCI a systemRemifentanil 50–100 N/A 0.05–4 mcgÆkg )1 Æm<strong>in</strong> )1a Target controlled <strong>in</strong>fusion.or use TCI a system6.4 OpioidsOpioids rema<strong>in</strong> the most powerful <strong>and</strong> widely usedgroup of analgesics. They can be given by many routesof adm<strong>in</strong>istration <strong>and</strong> are considered safe, providedaccepted dos<strong>in</strong>g regimens are used <strong>and</strong> appropriatemonitor<strong>in</strong>g <strong>and</strong> staff education are <strong>in</strong> place. Morph<strong>in</strong>eis the prototype opioid, <strong>and</strong> diamorph<strong>in</strong>e, tramadol,oxycodone, <strong>and</strong> hydromorphone are alternatives tomorph<strong>in</strong>e <strong>in</strong> the postoperative period. Fentanyl, sufentanil,alfentanil, <strong>and</strong> remifentanil have a role dur<strong>in</strong>g<strong>and</strong> after major surgery <strong>and</strong> <strong>in</strong> <strong>in</strong>tensive care practice<strong>and</strong> can be used to ameliorate the stress response tosurgery. Code<strong>in</strong>e <strong>and</strong> dihydrocode<strong>in</strong>e can be used forshort-term treatment of moderate pa<strong>in</strong>. Pethid<strong>in</strong>e(meperid<strong>in</strong>e) is not recommended <strong>in</strong> children ow<strong>in</strong>g to6.4.1 Opioid preparations, dosages, <strong>and</strong> routesMorph<strong>in</strong>eMorph<strong>in</strong>e is the most widely used <strong>and</strong> studied opioid<strong>in</strong> children. Its agonist activity is ma<strong>in</strong>ly at l opioidreceptors (10,11). It can be given by the oral, subcutaneous,<strong>in</strong>tramuscular, <strong>in</strong>travenous, epidural, <strong>in</strong>trasp<strong>in</strong>al,<strong>and</strong> rectal routes. Parenteral adm<strong>in</strong>istration maybe <strong>in</strong>termittent <strong>in</strong>jection; cont<strong>in</strong>uous or <strong>in</strong>termittent<strong>in</strong>fusion of the dose is adjusted accord<strong>in</strong>g to <strong>in</strong>dividualanalgesic requirements. Us<strong>in</strong>g accepted dos<strong>in</strong>g regimens,morph<strong>in</strong>e has been shown to be safe <strong>and</strong> effective<strong>in</strong> children of all ages.The pharmacok<strong>in</strong>etics of morph<strong>in</strong>e <strong>in</strong> children isgenerally considered similar to those <strong>in</strong> adults but <strong>in</strong>neonates <strong>and</strong> <strong>in</strong>to early <strong>in</strong>fancy the clearance <strong>and</strong> pro-72 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


te<strong>in</strong> b<strong>in</strong>d<strong>in</strong>g are reduced <strong>and</strong> the half-life is <strong>in</strong>creased.These differences, which are dependent on gestationalage <strong>and</strong> birth weight, are ma<strong>in</strong>ly due to reducedmetabolism <strong>and</strong> immature renal function <strong>in</strong> the develop<strong>in</strong>gchild. This younger age group demonstrates anenhanced susceptibility to the effects, <strong>and</strong> the sideeffects of morph<strong>in</strong>e <strong>and</strong> dos<strong>in</strong>g schedules must bealtered to take this <strong>in</strong>to account. Morph<strong>in</strong>e has poororal bioavailability as it undergoes extensive first-passmetabolism <strong>in</strong> the liver <strong>and</strong> gut.Morph<strong>in</strong>e dos<strong>in</strong>g schedulesAn appropriate monitor<strong>in</strong>g protocol should be useddependent on the route of adm<strong>in</strong>istration <strong>and</strong> age ofthe child. For neuraxial dos<strong>in</strong>g, see section 6.2.Oral:Neonate: 80 mcgÆkg )1 4–6 hourlyChild: 200–500 mcgÆkg )1 4 hourlyIntravenous or subcutaneous load<strong>in</strong>g dose: (titratedaccord<strong>in</strong>g to response)Neonate: 25 mcgÆkg )1 <strong>in</strong>crementsChild: 50 mcgÆkg )1 <strong>in</strong>crementsIntravenous or subcutaneous <strong>in</strong>fusion:10–40 mcgÆkg )1 Æh )1Patient-controlled analgesia (PCA):Bolus (dem<strong>and</strong>) dose: 10–20 mcgÆkg )1Lockout <strong>in</strong>terval: 5–10 m<strong>in</strong>Background <strong>in</strong>fusion: 0–4 mcgÆkg )1 Æh )1Nurse controlled analgesia (NCA):Bolus (dem<strong>and</strong>) dose: 10–20 mcgÆkg )1Lockout <strong>in</strong>terval: 20–30 m<strong>in</strong>Background <strong>in</strong>fusion: 0–20 mcgÆkg )1 Æh (1 year 100–200 mcgÆkg )1 4 hourlyIntravenous or subcutaneous load<strong>in</strong>g dose: (titratedaccord<strong>in</strong>g to response)Neonate: 10–25 mcgÆkg )1 <strong>in</strong>crementsChild: 25–100 mcgÆkg )1 <strong>in</strong>crementsIntravenous or subcutaneous <strong>in</strong>fusion:2.5–25 mcgÆkg )1 Æh )1Intranasal:100 mcgÆkg )1 <strong>in</strong> 0.2 ml sterile water <strong>in</strong>stilled <strong>in</strong>toone nostril.HydromorphoneHydromorphone is an opioid analgesic related to morph<strong>in</strong>ebut with a greater analgesic potency <strong>and</strong> is usedfor the relief of moderate-to-severe pa<strong>in</strong>. It is a usefulalternative to morph<strong>in</strong>e for subcutaneous use because itsgreater solubility <strong>in</strong> water allows a smaller dose volume.Hydromorphone dos<strong>in</strong>g schedulesOral: 40–80 microg/kg 4 hourlyIntravenous or subcutaneous load<strong>in</strong>g dose: (titratedaccord<strong>in</strong>g to response)Child


Code<strong>in</strong>e dos<strong>in</strong>g schedulesOral, <strong>in</strong>tramuscular or rectal:Neonate or child: 0.5–1 mgÆkg )1 4–6 hourly (carewith repeated doses <strong>in</strong> neonates)Dihydrocode<strong>in</strong>eDihydrocode<strong>in</strong>e is an opioid analgesic related tocode<strong>in</strong>e. It is used for the relief of moderate-to-severepa<strong>in</strong>, often <strong>in</strong> comb<strong>in</strong>ation with paracetamol. Theanalgesic effect of dihydrocode<strong>in</strong>e appears to be primarilydue to the parent compound (unlike code<strong>in</strong>e); itis metabolized <strong>in</strong> the liver via the cytochrome P450 isoenzymeCYP2D6 to dihydromorph<strong>in</strong>e, which haspotent analgesic activity, <strong>and</strong> some is also convertedvia CYP3A4 to nordihydrocode<strong>in</strong>e.Dihydrocode<strong>in</strong>e dos<strong>in</strong>g schedulesOral or <strong>in</strong>tramuscular:>1 year: 0.5–1 mgÆkg )1 4–6 hourlyOxycodoneOxycodone can be given by mouth or by subcutaneousor <strong>in</strong>travenous <strong>in</strong>jection for the relief of moderate-toseverepa<strong>in</strong> (12). It can be given by cont<strong>in</strong>uous <strong>in</strong>fusionor PCA. The oral potency is about twice that ofmorph<strong>in</strong>e, whereas <strong>in</strong>travenously it is about 1.5 timesas potent. Although not widely used at present <strong>in</strong> theUnited K<strong>in</strong>gdom, it may be a useful <strong>and</strong> safe alternativeto morph<strong>in</strong>e <strong>and</strong> code<strong>in</strong>e as an oral opioid.Oxycodone dos<strong>in</strong>g schedulesOral: 100–200 mgÆkg )1 4–6 hourlyTramadolTramadol hydrochloride is an opioid analgesic withnoradrenergic <strong>and</strong> serotonergic properties that maycontribute to its analgesic activity (13,14). Tramadolcan be given by mouth, <strong>in</strong>travenously, or as a rectalsuppository. It has also been given by <strong>in</strong>fusion or aspart of a PCA system.Tramadol is <strong>in</strong>creas<strong>in</strong>gly used <strong>in</strong> children of all ages<strong>and</strong> has been shown to be effective aga<strong>in</strong>st mild-tomoderatepa<strong>in</strong>. It may produce fewer typical opioidadverse effects such as respiratory depression, sedation,<strong>and</strong> constipation; though, it demonstrates a relativelyhigh rate of nausea <strong>and</strong> vomit<strong>in</strong>g.Tramadol dos<strong>in</strong>g schedules:Oral, rectal, or <strong>in</strong>travenous: 1–2 mgÆkg )1 4–6 hourlyFentanylFentanyl is a potent opioid analgesic related to pethid<strong>in</strong>e<strong>and</strong> is primarily a l-opioid agonist. It is morelipid soluble than morph<strong>in</strong>e <strong>and</strong> it has a rapid onset<strong>and</strong> short duration of action. Because of its high lipophilicity,fentanyl can also be delivered via the transdermal(±iontophoresis) or transmucosal routes.Small <strong>in</strong>travenous bolus doses can be <strong>in</strong>jected immediatelyafter surgery for postoperative analgesia <strong>and</strong>PCA systems have been used.After transmucosal delivery, about 25% of the dose israpidly absorbed from the buccal mucosa; the rema<strong>in</strong><strong>in</strong>g75% is swallowed <strong>and</strong> slowly absorbed from the gastro<strong>in</strong>test<strong>in</strong>altract. Some first-pass metabolism occurs viathis route. The absolute bioavailability of transmucosaldelivery is 50% of that for <strong>in</strong>travenous fentanyl.Absorption is slow after transdermal application.The clearance is decreased <strong>and</strong> the half-life of fentanylis prolonged <strong>in</strong> neonates. As with morph<strong>in</strong>e, neonatesare more susceptible to the adverse effects offentanyl, <strong>and</strong> appropriate monitor<strong>in</strong>g <strong>and</strong> safety protocolsshould be implemented when fentanyl is used <strong>in</strong>this age group. There are differences <strong>in</strong> pharmacok<strong>in</strong>eticsbetween bolus doses <strong>and</strong> prolonged <strong>in</strong>fusionwith highly lipophilic drugs such as fentanyl; the context-sensitivehalf-time progressively <strong>in</strong>creases with theduration of <strong>in</strong>fusion.Fentanyl dos<strong>in</strong>g schedulesAn appropriate monitor<strong>in</strong>g protocol should be useddependent on the route of adm<strong>in</strong>istration <strong>and</strong> age ofthe child. For neuraxial dos<strong>in</strong>g, see section 6.3.Intravenous dose: titrated accord<strong>in</strong>g to response0.5–1.0 mcgÆkg )1 (decrease <strong>in</strong> neonates)Intravenous <strong>in</strong>fusion: 0.5–2.5 mcgÆkg )1 Æh )1Transdermal: 12.5–100 mcgÆh )1RemifentanilRemifentanil is a potent short-act<strong>in</strong>g l-receptor opioidagonist used for analgesia dur<strong>in</strong>g <strong>in</strong>duction <strong>and</strong>/orma<strong>in</strong>tenance of general anesthesia. It has also been usedto provide analgesia <strong>in</strong>to the immediate postoperativeperiod. Remifentanil is given <strong>in</strong>travenously, usually by<strong>in</strong>fusion. Its onset of action is with<strong>in</strong> 1 m<strong>in</strong> <strong>and</strong> theduration of action is 5–10 m<strong>in</strong>. Remifentanil is metabolizedby esterases <strong>and</strong> so its half-life is <strong>in</strong>dependent ofthe dose, duration of <strong>in</strong>fusion, <strong>and</strong> age of child.Remifantanil is a strong respiratory depressant. Itcan be used <strong>in</strong> the spontaneously breath<strong>in</strong>g patient as74 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


a low-dose <strong>in</strong>fusion but the child must be nursed <strong>in</strong> anappropriate area with adequate monitor<strong>in</strong>g. Whenappropriate, alternative analgesics should be givenbefore stopp<strong>in</strong>g remifentanil, <strong>in</strong> sufficient time to providecont<strong>in</strong>uous <strong>and</strong> more prolonged pa<strong>in</strong> relief.6.4.2 Opioid toxicity <strong>and</strong> side effectsOpioids have a wide range of effects on a number of differentorgan systems (See Table 6.4.2). These providenot only cl<strong>in</strong>ically desirable analgesic effects but also thewide range of adverse effects associated with opioid use.The profile of side effects is not uniform between theopioids or even between patients tak<strong>in</strong>g the same opioid.The <strong>in</strong>cidence <strong>and</strong> severity of side effects <strong>in</strong> an<strong>in</strong>dividual patient are <strong>in</strong>fluenced by a number ofgenetic <strong>and</strong> developmental factors <strong>and</strong> therefore appropriatemonitor<strong>in</strong>g <strong>and</strong> adverse effect managementshould be performed with the use of opioids.Table 6.4.2 Physiological effects of opioidsCentral nervous systemAnalgesiaSedationDysphoria <strong>and</strong> euphoriaNausea <strong>and</strong> vomit<strong>in</strong>gMiosisSeizuresPruritisPsychomimetic behaviors, excitationRespiratory systemAntitussiveRespiratory depressionfl respiratory ratefl tidal volumefl ventilatory response to carbon dioxideCardiovascular systemM<strong>in</strong>imal effects on cardiac outputHeart rateBradycardia seen on most occasionsVasodilation, venodilationMorph<strong>in</strong>e other opioids ? histam<strong>in</strong>e effectGastro<strong>in</strong>test<strong>in</strong>al systemfl <strong>in</strong>test<strong>in</strong>al motility <strong>and</strong> peristalsis› sph<strong>in</strong>cter toneSph<strong>in</strong>cter of oddiIleocolicUr<strong>in</strong>ary system› ToneUterusBladderDetrusor muscles of the bladderMusculoskeletal system› chest wall rigidity6.5 Nonsteroidal anti-<strong>in</strong>flammatory drugs(NSAIDs)NSAIDs are effective for the treatment of mild ormoderate pa<strong>in</strong> <strong>in</strong> children. In addition to analgesia,they have anti-<strong>in</strong>flammatory <strong>and</strong> antipyretic effects.They are opioid spar<strong>in</strong>g. The comb<strong>in</strong>ation of NSA-IDs <strong>and</strong> paracetamol produces better analgesia thaneither drug alone. Their mechanism of action is the<strong>in</strong>hibition of cyclooxygenase (COX) activity, therebyblock<strong>in</strong>g the synthesis of prostagl<strong>and</strong><strong>in</strong>s <strong>and</strong> thromboxane.Aspir<strong>in</strong>, a related compound, is not used <strong>in</strong>children because of the potential to cause Reye’ssyndrome.6.5.1 NSAID preparations, dose, <strong>and</strong> routesA number of convenient NSAID formulations areavailable:l Ibuprofen tablet <strong>and</strong> syrup formulations for oraladm<strong>in</strong>istration <strong>and</strong> a dispersible tablet for subl<strong>in</strong>gualadm<strong>in</strong>istrationl Diclofenac tablet (dispersible <strong>and</strong> enteric coated),suppository <strong>and</strong> parenteral formulationsllKetorolac for <strong>in</strong>travenous useNaproxen oral tabletsl Piroxicam oral tablets <strong>and</strong> a dispersible subl<strong>in</strong>gualformulationl Ketoprofen oral tablets <strong>and</strong> syrup, parenteral formulationsSelective COX 2 <strong>in</strong>hibitors have been developed withthe expectation that the analgesic <strong>and</strong> anti-<strong>in</strong>flammatoryeffects of NSAIDs would be reta<strong>in</strong>ed while reduc<strong>in</strong>gthe risk of gastric irritation <strong>and</strong> bleed<strong>in</strong>g.However, <strong>in</strong> adult studies potential improvements <strong>in</strong>safety have been offset by an <strong>in</strong>crease <strong>in</strong> the <strong>in</strong>cidenceof adverse cerebral <strong>and</strong> cardiac thrombotic events.Reports of the use of selective COX-2 <strong>in</strong>hibitors <strong>in</strong>children are appear<strong>in</strong>g <strong>in</strong> the literature, which demonstrateequal efficacy with nonselective NSAIDs. However,their role <strong>in</strong> pediatric practice is yet to beestablished. Pharmacok<strong>in</strong>etic data for the neonatal useof ibuprofen have been established from its use <strong>in</strong> patentductus arteriosus closure. Clearance is reduced <strong>and</strong>the volume of distribution is <strong>in</strong>creased. However, itsuse as an analgesic below age 3 months is not recommended,see section 6.5.3.ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 75


Table 6.5.1NSAIDDosemgÆkg )1IntervalhoursMaximum daily dosemgÆkg )1 Æday )1Licensedfrom ageIbuprofen 5–10 6–8 30 3 monthsDiclofenac 1 8 3 6 monthsKetorolac a 0.5 6 2Naproxen 7.5 12 15Piroxicam a 0.5 24 0.5 N/RKetoprofen a 1 6 4a High <strong>in</strong>cidence of GI complications. Not licensed for acutepa<strong>in</strong>.6.5.2 NSAID toxicity <strong>and</strong> side effectsBecause of their mechanism of action, NSAIDs havethe potential to cause adverse effects at therapeuticplasma levels.l Hypersensitivity reactionsl NSAIDs reduce platelet aggregation <strong>and</strong> prolongbleed<strong>in</strong>g time. Therefore, they are usually contra<strong>in</strong>dicated<strong>in</strong> children with coagulation disorders or <strong>in</strong>those who are receiv<strong>in</strong>g anticoagulant therapy.l NSAIDs can <strong>in</strong>hibit prostagl<strong>and</strong><strong>in</strong>-mediated renalfunction, <strong>and</strong> this effect is greater <strong>in</strong> the presence ofrenal disease <strong>and</strong> dehydration. Ibuprofen has beenshown to reduce the glomerular filtration rate <strong>in</strong>neonates by 20%. NSAIDs should not be adm<strong>in</strong>isteredconcurrently with nephrotoxic agents. Renaltoxicity is low <strong>in</strong> healthy children.l NSAIDs can cause gastric irritation <strong>and</strong> bleed<strong>in</strong>g.They are therefore relatively contra<strong>in</strong>dicated <strong>in</strong> childrenwith a history of peptic ulcer disease. Ibuprofenhas the lowest potential for gastric irritation. The riskof adverse GI effects is low when NSAID use is limitedto 1–3 days <strong>in</strong> the postoperative period; it may be furtherreduced by co-prescription of proton pump <strong>in</strong>hibitors,for example, omeprazole <strong>and</strong> H2 antagonists <strong>in</strong>patients at higher risk. Piroxicam, ketorolac, <strong>and</strong> ketoprofenare known to be especially likely to cause GI sideeffects particularly <strong>in</strong> the elderly. In the UK, piroxicamis no longer licensed for acute <strong>in</strong>dications <strong>and</strong> is subjectto special prescrib<strong>in</strong>g <strong>and</strong> monitor<strong>in</strong>g restrictions.l Ow<strong>in</strong>g to excess leukotriene production, NSAIDshave the potential to exacerbate asthma <strong>in</strong> a predisposedsubset of asthmatics. It is estimated that 2% ofasthmatic children are susceptible to aspir<strong>in</strong>-<strong>in</strong>ducedbronchospasm <strong>and</strong> 5% of this subgroup are likely tobe cross-sensitive to other NSAIDs, that is, 1:1000.The <strong>in</strong>cidence of asthma <strong>in</strong> children is <strong>in</strong>creas<strong>in</strong>g, <strong>and</strong>it is important that children who are not sensitive arenot denied the benefits of NSAIDs. History of previousuneventful NSAID exposure should be established<strong>in</strong> asthmatic children whenever possible.Studies have provided some reassur<strong>in</strong>g data regard<strong>in</strong>gthe safety of short-term use of ibuprofen <strong>and</strong> diclofenac<strong>in</strong> asthmatic children. NSAIDs should be avoided<strong>in</strong> children with severe acute asthma.l NSAIDs should be used with caution <strong>in</strong> childrenwith severe eczema, multiple allergies, <strong>and</strong> <strong>in</strong> thosewith nasal polyps. NSAIDs should be avoided <strong>in</strong> liverfailurel Animal studies us<strong>in</strong>g high doses of Ketorolac demonstrateddelayed bone fusion. This has led to concernthat the use of NSAIDs <strong>in</strong> children may delay boneheal<strong>in</strong>g follow<strong>in</strong>g fracture or surgery. This has notbeen supported by human studies, <strong>and</strong> the analgesicbenefits of short-term NSAID use outweigh the hypotheticalrisk of delayed bone heal<strong>in</strong>g: see section 5.8.l NSAIDs are not currently recommended for analgesia<strong>in</strong> neonates due to concerns that they mayadversely affect cerebral <strong>and</strong> pulmonary blood flowregulation.Of the NSAIDs currently available, ibuprofen has thefewest side effects <strong>and</strong> the greatest evidence to supportits safe use <strong>in</strong> children. In a large community-basedstudy <strong>in</strong> children with fever, the risk of hospitalizationfor GI bleed<strong>in</strong>g, renal failure, <strong>and</strong> anaphylaxis was nogreater for children given ibuprofen than those givenparacetamol (15).6.6 ParacetamolParacetamol is a weak analgesic (16,17). On its own, itcan be used to treat mild pa<strong>in</strong>; <strong>in</strong> comb<strong>in</strong>ation withNSAIDs or a weak opioid such as code<strong>in</strong>e, it can beused to treat moderate pa<strong>in</strong>. Studies have demonstratedan opioid spar<strong>in</strong>g effect when it is adm<strong>in</strong>isteredpostoperatively.6.6.1 Paracetamol preparations, doses, <strong>and</strong>routesParacetamol is available for oral adm<strong>in</strong>istration <strong>in</strong>syrup, tablet, <strong>and</strong> dispersible forms. Follow<strong>in</strong>g oraladm<strong>in</strong>istration, maximum serum concentrations arereached <strong>in</strong> 30–60 m<strong>in</strong>. As the mechanism of action iscentral, there is a further delay before maximum analgesiais achieved. Suppositories are available; however,there is wide variation <strong>in</strong> the bioavailability of paracetamolfollow<strong>in</strong>g rectal adm<strong>in</strong>istration. Studies have demonstratedthe need for higher load<strong>in</strong>g doses (of the76 ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79


Table 6.6.1 Paracetamol dos<strong>in</strong>g guide – oral <strong>and</strong> rectal adm<strong>in</strong>istrationAgeRouteLoad<strong>in</strong>gdoseMa<strong>in</strong>tenancedoseMaximum Duration atInterval daily dose maximum(mgÆkg )1 ) (mgÆkg )1 ) (h) (mgÆkg )1 ) dose (h)28–32 Oral 20 10–15 8–12 30 48weeks Rectal 20 15 12PCA32–52 Oral 20 10–15 6–8 60 48weeks Rectal 30 20 8PCA>3 Oral 20 15 4 90 48months Rectal 40 20 6PCA, postconceptual age.Table 6.6.2 IV Paracetamol dos<strong>in</strong>g guideWeight (kg) Dose Interval (h) Maximum daily dose50 1 g 4–6 4 gorder of 40 mgÆkg )1 ) to achieve target plasma concentrationsof 10 mgÆl )1 follow<strong>in</strong>g rectal adm<strong>in</strong>istration.The time to reach maximum serum concentration follow<strong>in</strong>grectal adm<strong>in</strong>istration varies between 1 <strong>and</strong> 2.5 h.Rectal adm<strong>in</strong>istration of drugs is contra<strong>in</strong>dicated <strong>in</strong>neutropenic patients because of the risk of caus<strong>in</strong>g sepsis.Recently, an <strong>in</strong>travenous preparation of paracetamolhas become available. Initial experience with IVparacetamol is that the higher effect site concentrationachieved follow<strong>in</strong>g <strong>in</strong>travenous adm<strong>in</strong>istration is associatedwith higher analgesic potency. When adm<strong>in</strong>isteredIV, it should be given as an <strong>in</strong>fusion over 15 m<strong>in</strong>.There are several published dosage regimens for paracetamol(perhaps <strong>in</strong>dicat<strong>in</strong>g that the optimum regimenis still to be determ<strong>in</strong>ed). The regimen used willdepend on the age of the child, the route of adm<strong>in</strong>istration,<strong>and</strong> the duration of treatment. The clearance<strong>in</strong> neonates is reduced <strong>and</strong> the volume of distributionis <strong>in</strong>creased. The dose of paracetamol therefore needsto be reduced <strong>in</strong> neonates – see Table 1. Bioavailabilityfollow<strong>in</strong>g rectal adm<strong>in</strong>istration is higher <strong>in</strong> the neonate.The current recommendations stated <strong>in</strong> the BNFcare shown <strong>in</strong> Tables 6.6.1 <strong>and</strong> 6.6.2.is limited by the potential for hepatotoxicity that canoccur follow<strong>in</strong>g overdose (exceed<strong>in</strong>g 150 mgÆkg )1 ).Multiple doses may lead to accumulation <strong>in</strong> childrenwho are malnourished or dehydrated. The mechanismof toxicity <strong>in</strong> overdosage is the production of N-acetylp-benzoqu<strong>in</strong>oneim<strong>in</strong>e(NABQI). The amount of NAB-QI produced follow<strong>in</strong>g therapeutic doses of paracetamolis completely detoxified by conjugation withglutathione. In overdosage, glutathione stores becomedepleted allow<strong>in</strong>g NABQI to accumulate <strong>and</strong> damagehepatocytes. Acetylcyste<strong>in</strong>e <strong>and</strong> methion<strong>in</strong>e replenishstores of glutathione <strong>and</strong> are therefore used <strong>in</strong> thetreatment of toxicity.6.7 Nitrous oxide (N 2 O)6.7.1 Preparations, dosage, <strong>and</strong> adm<strong>in</strong>istrationNitrous oxide is supplied compressed <strong>in</strong> metal cyl<strong>in</strong>derslabeled <strong>and</strong> marked accord<strong>in</strong>g to national st<strong>and</strong>ards(18). It is a weak anesthetic with analgesicproperties rapidly absorbed on <strong>in</strong>halation. The blood/gas partition coefficient is low, <strong>and</strong> most of the <strong>in</strong>haledN 2 O is rapidly elim<strong>in</strong>ated unchanged through thelungs. Premixed cyl<strong>in</strong>ders with 50% N 2 O <strong>in</strong> oxygenare available, but it is also occasionally adm<strong>in</strong>isteredat <strong>in</strong>spired concentrations up to 70% with oxygen.Nitrous oxide <strong>in</strong>halation us<strong>in</strong>g a self-adm<strong>in</strong>istrationwith a face mask or mouthpiece <strong>and</strong> ‘dem<strong>and</strong> valve’system is widely used for analgesia dur<strong>in</strong>g proceduressuch as dress<strong>in</strong>g changes, venepuncture, as an aid topostoperative physiotherapy, <strong>and</strong> for acute pa<strong>in</strong> <strong>in</strong>emergency situations, see section 4.0. It is also used <strong>in</strong>dentistry. The system is only suitable for children ableto underst<strong>and</strong> <strong>and</strong> operate the valve, generally thoseover 5 years of age. Heathcare workers must be specificallytra<strong>in</strong>ed <strong>in</strong> the safe <strong>and</strong> correct technique ofadm<strong>in</strong>istration of N 2 O.Nitrous oxide is given us<strong>in</strong>g a self-adm<strong>in</strong>istrationdem<strong>and</strong> flow system operated by the patient unaidedsuch that sedation leads to cessation of <strong>in</strong>halation.Analgesia is usually achieved after 3 or 4 breaths.Recovery is rapid once the gas is discont<strong>in</strong>ued.Cont<strong>in</strong>uous flow techniques of adm<strong>in</strong>istration, wherethe facemask is held by a healthcare worker ratherthan the patient, is capable of produc<strong>in</strong>g deep sedation<strong>and</strong> unconsciousness, <strong>and</strong> therefore the use of thismethod is not <strong>in</strong>cluded <strong>in</strong> this guidel<strong>in</strong>e.6.6.2 Paracetamol toxicity <strong>and</strong> side effectsWhen the maximum daily dose of paracetamol isobserved, it is well tolerated. The maximum daily dose6.7.2 Side effects <strong>and</strong> toxicityNitrous oxide potentiates the CNS depressant effectsof other sedative agents. There is a risk of <strong>in</strong>creasedª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 77


pressure <strong>and</strong> volume from the diffusion of nitrousoxide <strong>in</strong>to closed air-conta<strong>in</strong><strong>in</strong>g cavities <strong>and</strong> is thereforecontra<strong>in</strong>dicated <strong>in</strong> the presence of pneumothorax.Frequent side effects <strong>in</strong>clude euphoria,dis<strong>in</strong>hibition, dizz<strong>in</strong>ess, dry mouth, <strong>and</strong> disorientation.Nausea <strong>and</strong> vomit<strong>in</strong>g can occur. Excessive sedationis managed by discont<strong>in</strong>uation of the gas,oxygen adm<strong>in</strong>istration, <strong>and</strong> basic airway management.Prolonged or frequent use may affect folate metabolismlead<strong>in</strong>g to megaloblastic changes <strong>in</strong> the bonemarrow, megaloblastic anemia, <strong>and</strong> peripheral neuropathy.Depression of white cell formation may alsooccur. Patients who receive N 2 O more frequentlythan twice every 4 days should have regular bloodcell exam<strong>in</strong>ation for megaloblastic changes <strong>and</strong> neutrophilhypersegmentation.Exposure to prolonged high concentrations of N 2 Ohas been associated with reduced fertility <strong>in</strong> men <strong>and</strong>women. It should only be used <strong>in</strong> a well-ventilatedenvironment, which should be monitored <strong>and</strong> ma<strong>in</strong>ta<strong>in</strong>edbelow the UK Occupational Exposure St<strong>and</strong>ardfor atmospheric levels of N 2 O that is 37 2.0 ml maximumEach ‘dip’ of the pacifier is estimated to be 0.2 ml.The effectiveness of sucrose appears to decrease withage, at present it’s use as a primary analgesic shouldbe conf<strong>in</strong>ed to the neonatal period until further <strong>in</strong>formationis available.6.8.2 Sucrose side effects <strong>and</strong> toxicityCough<strong>in</strong>g, chok<strong>in</strong>g, gagg<strong>in</strong>g, <strong>and</strong> transient oxygen desaturationshave been reported; when us<strong>in</strong>g the syr<strong>in</strong>gemethod, the solution should be applied carefully to thetongue one drop at a time. There is some evidence thatadverse effects of sucrose, <strong>in</strong>clud<strong>in</strong>g a temporary<strong>in</strong>crease <strong>in</strong> ‘Neurobiologic Risk’ score, is more frequent<strong>in</strong> very premature <strong>in</strong>fants, particularly those


steps that health care professionals will perform); thesensations the patient can expect to feel (e.g., sharpscratch, numbness); <strong>and</strong> about how to cope with theprocedure.l Relaxation is a state of relative freedom from anxiety<strong>and</strong> skeletal muscle tension, a quiet<strong>in</strong>g or calm<strong>in</strong>gof the m<strong>in</strong>d <strong>and</strong> muscles.Further read<strong>in</strong>gBNFC: The British National Formulary for Children,Vol. 2nd Edition. London: BMJ Publish<strong>in</strong>g GroupLtd, 2012.References1 Morton NS. Ropivaca<strong>in</strong>e <strong>in</strong> children. Br JAnaesth 2000; 85: 344–346.2 Berde C. Local anaesthetics <strong>in</strong> <strong>in</strong>fants <strong>and</strong>children: an update. Pediatr Anesth 2004;14: 387–393.3 Bosenberg A. Pediatric regional anesthesiaupdate. Pediatr Anesth 2004; 14: 398–402.4 Mazoit J, Dalens B. Pharmacok<strong>in</strong>etics oflocal anaesthetics <strong>in</strong> <strong>in</strong>fants <strong>and</strong> children.Cl<strong>in</strong> Pharmacok<strong>in</strong>et 2004; 43: 17–32.5 Persson J. Wherefore ketam<strong>in</strong>e? Curr Op<strong>in</strong>Anaesthesiol 2010; 23: 455–460.6 Dahmani S, Michelet D, Abback PS et al.Ketam<strong>in</strong>e for perioperative pa<strong>in</strong> management<strong>in</strong> children: a meta-analysis of publishedstudies. Pediatr Anesth 2011; 21: 636–652.7 Basker S, S<strong>in</strong>gh G, Jacob R. Clonid<strong>in</strong>e <strong>in</strong>paediatrics – a review. Indian J Anaesth2009; 53: 270–280.8 Schnabel A, Poepp<strong>in</strong>g DM, Kranke P et al.Efficacy <strong>and</strong> adverse effects of ketam<strong>in</strong>e asan additive for paediatric caudal anaesthesia:a quantitative systematic review of r<strong>and</strong>omizedcontrolled trials. Br J Anaesth2011; 107: 601–611.9 Engelman E, Marsala C. Bayesian enhancedmeta-analysis of post-operative analgesicefficacy of additives for caudal analgesia <strong>in</strong>children. Acta Anaesthesiol Sc<strong>and</strong> 2012;Epub ahead of pr<strong>in</strong>t.10 Kart T, Christrup L, Rasmussen M. Recommendeduse of morph<strong>in</strong>e <strong>in</strong> neonates,<strong>in</strong>fants <strong>and</strong> children based on a literaturereview: part 2 – cl<strong>in</strong>ical use. Paediatr Anaesth1997; 7: 93–101.11 Kart T, Christrup L, Rasmussen M. Recommendeduse of morph<strong>in</strong>e <strong>in</strong> neonates,<strong>in</strong>fants <strong>and</strong> children based on a literaturereview: part 1 – pharmacok<strong>in</strong>etics. PaediatrAnaesth 1997; 7: 5–11.12 Kalso E. Oxycodone. J Pa<strong>in</strong> Symptom Manage2005; 29(Suppl): S47–S56.13 Grond S, Sablotzki A. Cl<strong>in</strong>ical pharmacologyof tramadol. Cl<strong>in</strong> Pharmacok<strong>in</strong>et 2004;43: 879–923.14 Allegaert K, de Hoon J, Van Overmeire Bet al. Cl<strong>in</strong>ical pharmacology of non opioidanalgesics <strong>in</strong> neonates. Verh K Acad GeneeskdBelg 2005; 67: 289–315.15 Lesko S, Mitchell A. An assessment of thesafety of pediatric ibuprofen. A practitionerbasedr<strong>and</strong>omized cl<strong>in</strong>ical trial. JAMA1995; 273: 929–933.16 Anderson B, Anderson M, Hastie B. Paracetamolprescrib<strong>in</strong>g habits <strong>in</strong> a children’shospital. N Z Med J 1996; 109: 376–378.17 Anderson B. Acetam<strong>in</strong>ophen analgesia <strong>in</strong><strong>in</strong>fants. Anesth Analg 2001; 93: 1626–1627.18 Bruce E, Franck L. Self-adm<strong>in</strong>isterednitrous oxide (Entonox) for the managementof procedural pa<strong>in</strong>. Pediatr Nurs 2000; 12:15–19.19 Lefrak L, Burch K, Caravantes R et al.Sucrose analgesia: identify<strong>in</strong>g potentiallybetter practices. Pediatrics 2006; 118(Suppl.2): S197–S202.20 Slater R, Cornelissen L, Fabrizi L et al.Oral sucrose as an analgesic drug for proceduralpa<strong>in</strong> <strong>in</strong> newborn <strong>in</strong>fants: a r<strong>and</strong>omisedcontrolled trial. Lancet 2010; 376: 1225–1232.21 Bellieni C, Bagnoli F, Perrone S et al. Effectof multisensory stimulation on analgesia <strong>in</strong>term neonates: a r<strong>and</strong>omized controlledtrial. Pediatr Res 2002; 51: 460–463.22 Cignacco E, Hamers JPH, Stoffel L et al.Rout<strong>in</strong>e procedures <strong>in</strong> NICUs: factors <strong>in</strong>fluenc<strong>in</strong>gpa<strong>in</strong> assessment <strong>and</strong> rank<strong>in</strong>g by pa<strong>in</strong><strong>in</strong>tensity. Swiss Med Wkly 2008; 138: 484–491.23 Uman LS, Chambers CT, McGrath PJ etal. Psychological <strong>in</strong>terventions for needlerelatedprocedural pa<strong>in</strong> <strong>and</strong> distress <strong>in</strong>children <strong>and</strong> adolescents. CochraneDatabase Syst Rev 2006; Oct 18;(4):CD005179.ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 79

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!